Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2017
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article To shine as a deepening, breeding - medical care person of the pharmacist power that clinical pharmacy opens up in the 27th Japan cure association annual convention holding more; ...
大森栄
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2017.
Japanese Article For development of the clinical pharmacy
佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2017.
Japanese Article Medical ethic and study ethic
福嶋義光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2017.
Japanese Article Application to the neurologic regenerative therapy of the iPS cells technology and a disease study
岡野栄之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2017.
Japanese Article About the review of the medical safety management system in the special functioning hospital
山手政伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2017.
Japanese Article Practice of the cancer precision medicine by the exhaustive cancer genetic screening
西原広史1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2017.
Japanese Article University hospital administration of the future intention
山本修一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2017.
Japanese Article Medical practice ... based on patients-centered polypharmacy measures - decision-making joint ownership and sense of values
宮田靖志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2017.
Japanese Article Development - as the social infrastructure technology of clinical application - next generation of the next-generation medical ICT generic technology
矢作尚久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2017.
Japanese Article Pharmaceutical intervention in the foreign chemotherapy and clinical outcome of the interactive information sharing
河添仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2017.
Japanese Article Relations with blood fentanyl levels and 4β-hydroxylation cholesterol level based on the CYP3A5 gene type in patients with cancerous pain and sex differences
石田卓矢1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2017.
Japanese Article The Teicoplanin initial administration plan in the decreased renal function patients: Examination of the usefulness of the high-dose loading dose
植田貴史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2017.
Japanese Article Study on application to identification and the side effect prophylaxis construction of the onset of drug-related side effect predictor
岡田直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2017.
Japanese Article Application to development and clinical practice of the agent diagnostic using the radioactivity label
加納大輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2017.
Japanese Article Study on side effect measures in the use of the Clozapine which aimed at the recovery of patients with treatment-resistant schizophrenia
竹内一平1,2, 半谷眞七子2, 宇野準二1, 藤田潔1, 亀井浩行2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2017.
Japanese Article Study on pharmaceutical products evaluation in the cancer chemotherapy using the mathematics model
地嵜悠吾1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2017.
Japanese Article 3-9-SP1-1. Efforts - of the personnel training - Ogaki Municipal Hospital by "a team system" and "visualization"
吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2017.
Japanese Article 3-9-SP1-2. Duties, education, a study: Way of raising of pharmacist human resources based on a tissue idea and a policy
川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2017.
Japanese Article 3-9-SP1-3. Thought - as activated - chief pharmacist of upbringing and the tissue of the clinical pharmacist
佐藤透1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2017.
Japanese Article 3-9-SP1-4. It is made with personnel training and tissue in Showa University
佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2017.
Japanese Article 4-13-SP2-1. The leadership that is sought by a pharmacist: The current situation and problem
寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2017.
Japanese Article 4-13-SP2-2. Art of the leader of only 1% which people are not doing of 99%
河野英太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2017.
Japanese Article 4-13-SP2-3. From efforts of leadership COML making we raise the motivation of the member and power concentrated
山口育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2017.
Japanese Article 4-13-SP2-4. Leadership - to tie - specialty and tissue when we think about a female leader daringly
石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2017.
Japanese Article 4-13-SP2-5. Mental attitude to show - strong leadership to tear a frame
松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2017.
Japanese Article 5-13-SP3-1. We understand AI definitely and open up the future
澤智博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2017.
Japanese Article 5-13-SP3-2. The current situation and possibility of the AI drug discovery
奥野恭史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2017.
Japanese Article 5-13-SP3-3. Application of the artificial intelligence (AI) in the cancer genomic medicine
東條有伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2017.
Japanese Article 5-13-SP3-4. New pharmacist support tool utilizing the AI
木村隆夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2017.
English Article 3-4-IS1-1. Critical care pharmacists in Japan
Mikihiro Maeda1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-169, 2017.
English Article 3-4-IS1-2. Retrospective study of the effects of rhTPO and rhIL-11 on chemotherapy induced thrombocytopenia in solid tumors
Li Huan1,2, Zhang Zhi-Sheng1,2, Yu Bo2,3, Zhai Qing2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2017.
English Article 3-4-IS1-3. Clinical Pharmacist Interventions in Intensive Care Units in Korea.
Yu-Ri Choi1, Hyo-Jung Park1, Yong-Won In1, Young-Mee Lee1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2017.
English Article 3-4-IS1-4. Delivering value of Clinical Pharmacists in Oncology Care : The Singapore Experience
Lita Chew Sui Tjien1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2017.
English Article 3-4-IS2-1. Pharmacokinetic / pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii infections
Kazuaki Matsumoto1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-174, 2017.
English Article 3-4-IS2-2. Molecular basis for resistance to anti-cancer drugs and development of agents that reverse the resistance
Ryuji Ikeda1, Yasuo Takeda2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2017.
English Article 3-4-IS2-3. Utilization of laboratory data at community pharmacy in Japan
Yoko Ino1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2017.
English Article 3-4-IS2-4. The role of pharmacists for effective inhalation therapy
Junko Tsukamoto1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2017.
English Article 3-4-IS2-5. The current situation surrounding medical services and a role of family pharmacist / pharmacy
Mai Itagaki1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2017.
English Article 3-4-IS2-6. The role of community pharmacists in cancer therapy : current situation and future perspective
Yuko Kanazawa1, Minori Yamaguchi1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2017.
Japanese Article 3-1-S1-1. Clinical reactions of drugs of the immune checkpoint inhibitor
寺田智祐1, 須藤正朝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2017.
Japanese Article 3-1-S1-2. Clinical experience of the immune checkpoint inhibitor
藤阪保仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2017.
Japanese Article 3-1-S1-3. Efforts in clinical department for the cancer immune therapy and type of job crossing-like support Keio University Hospital
浜本康夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2017.
Japanese Article 3-1-S1-4. Role of the pharmacist for proper use promotion of the immune checkpoint inhibitor
渡邊裕之1, 秦晃二郎1, 佐田裕子1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2017.
Japanese Article 3-1-S2-1. Way - Introduction ... to the supportive care individualization that a pharmacist opens up
鈴木賢一1, 辻大樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2017.
Japanese Article 3-1-S2-2. Individualization of infusion reaction measures
葉山達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2017.
Japanese Article 3-1-S2-3. Individualization of retching, vomiting measures
辻大樹1, 清水久範2, 鈴木賢一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2017.
Japanese Article 3-1-S2-4. Individualization for the neutropenia to raise Dose intensity
野村久祥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2017.
Japanese Article 3-1-S2-5. Possibility to individualization judging from the pazopanib pharmacokinetics in malignant soft part tumor and renal cell carcinoma
青山剛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2017.
Japanese Article 3-1-S3-1. To become a pharmacist shining in first aid, an intensive care domain; of - book symposium aim; -
中馬真幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2017.
Japanese Article 3-1-S3-2. We think about route management, phlebitis in first aid, the intensive care domain
中野貴文1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2017.
Japanese Article 3-1-S3-3. Have a pharmacist in bedside; is grasp of the hemodynamics and intervention to medical treatment
川口奈奈子1, 木戸圭晋1, 上田宏1, 五十嵐努1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2017.
Japanese Article 3-1-S3-4. We think about the acute renal failure in first aid, the intensive care domain and pharmaceutical intervention in the TDM!
段林正明1, 高橋一栄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2017.
Japanese Article 3-1-S3-5. Pain, unrest, delirium
橋本麻衣子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2017.
Japanese Article 3-1-S3-6. Medical treatment intervention based on the systemic evaluation in first aid, the intensive care
添田博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2017.
Japanese Article 3-2-S4-1. In antimicrobial proper use - AMR measures, the front of it linking the area -
継田雅美1, 浅田真一1, 齊藤幹央1, 冨塚江利子1, 宮下しずか1, 安藤昌幸1, 高津徳行1, 小林靖奈1, 杉原多公通1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2017.
Japanese Article 3-2-S4-2. Hospital pharmacist for the antimicrobial proper use in the area and cooperation of the health insurance pharmacy
寺沢匡史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2017.
Japanese Article 3-2-S4-4. Background of "non-" appropriate use of the antimicrobial in the treatment at home
齊藤直裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2017.
Japanese Article 3-2-S4-5. Antimicrobial proper use in the area
大曲貴夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2017.
Japanese Article 3-2-S5-1. Perioperative duties of the pharmacist in the operating room
板井進悟1, 磯田和也1, 本田恭子1, 原祐輔1, 嶋田努1, 崔吉道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2017.
Japanese Article 3-2-S5-2. It is venous thromboembolism management ... after the operation to work on after the operation by pharmaceutical management - team in patients
冨澤淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2017.
Japanese Article 3-2-S5-3. With the role that a pharmacist should take for preoperative evaluation - perioperative period for the surgery patients -
阿部猛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2017.
Japanese Article 3-2-S5-4. Role of the health insurance pharmacy pharmacist in the management before operation of the surgery patients
柄澤忍1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2017.
Japanese Article 3-3-S6-1. Deglutition of the condition of a patient and the medicine for eating dysphagia
藤島一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2017.
Japanese Article 3-3-S6-2. At-home pressure sore and nourishment
塚田邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2017.
Japanese Article 3-3-S6-3. Of eating dysphagia in being at home, actually
戸原玄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2017.
Japanese Article 3-3-S6-4. The thing which we see from "how do you take medicine?"
小原道子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2017.
Japanese Article 3-3-S6-5. The thickness adjustment food influences expression of collapse, the elution of the fast disintegration tablet including the orally disintegrating tablet and the efficacy
富田隆1, 幸田幸直2, 工藤賢三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2017.
Japanese Article 3-3-S7-1. Medical treatment aiming at long-term renal graft survival
牛込秀隆1, 大東真理子2, 広中梨沙2, 大坂雅史1, 原田俊平1, 中村緑佐1, 昇修治1, 飯田拓1, 四方敬介2, 吉村了勇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2017.
Japanese Article 3-3-S7-2. The pharmaceutical management in the Nagoya second Red Cross hospital and problem about the seamless cooperation
安田知弘1, 木全司1, 木下元一1, 今井美登子2, 後藤憲彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2017.
Japanese Article 3-3-S7-3. Approach about the carelessness medicine in renal-transplant recipients
林八恵子1, 高道恵理子1, 塚本有子1, 秋岡清一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2017.
Japanese Article 3-3-S7-4. A fact and problem of efforts and the medicine medicine cooperation of the kidney transplantation self-care notebook making in the Tomigusuku center Hospital
大城瑠奈1, 上原あかね1, 上原千晶1, 屋嘉部生子2, 前原礼子3, 大田守人4, 橋本孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2017.
Japanese Article 3-3-S7-5. Efforts at the health insurance pharmacy in the medicine medicine cooperation of renal-transplant recipients
齋藤譲二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2017.
Japanese Article 3-3-S7-6. Efforts of the pharmacist for the purpose of the seamless medical therapy in the kidney transplantation
平田憲史郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2017.
Japanese Article 3-3-S8-1. The faculty of medicine, the current situation and problem of the clinical nutrition education in the NST educational facility
田中芳明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-217, 2017.
Japanese Article 3-3-S8-2. It is ... from the situation of efforts, current situation ... university, the clinic of the clinical nutrition education in the pharmacy education
鈴木彰人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2017.
Japanese Article 3-3-S8-3. Consideration from current situation and problem - Japan and the United States comparison of the life (before graduation and after graduation) education of Japanese dietitian
雨海照祥1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2017.
Japanese Article 3-3-S8-4. Role ... of clinical nutrition - prefectural hospital pharmacist meeting learning on the site
伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2017.
Japanese Article 3-3-S8-5. Efforts to a vein, the enteral feeding management for the purpose of the pharmacist clinic
池永真子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2017.
Japanese Article 3-4-S9-1. Quantitative predictive - repaglinide of the drug interactions based on the physiologic pharmacokinetics model for a case -
工藤敏之1, 伊藤清美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2017.
Japanese Article 3-4-S9-2. The pharmacokinetic interaction of pharmaceutical products and the drink: The mechanism analysis based on the gastrointestinal physiology and quantitative prediction
白坂善之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2017.
Japanese Article 3-4-S9-3. Drug interactions of the new mechanism: The effect reinforcement of the warfarin through the absorption inhibition of vitamin K by the ezetimibe
高田龍平1, 山梨義英1, 山本武人1, 豊田優1, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2017.
Japanese Article 3-4-S9-4. Prediction of choler excretion inhibition and the liver damage with the drug
関根秀一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2017.
Japanese Article 3-9-S10-1. Construction of the pharmacist education system for physical assessment practice
嶺豊春1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2017.
Japanese Article 3-9-S10-2. From the viewpoint of simulation education - physician to a pharmacist aiming at the multi-type of job collaboration -
大澤晋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2017.
Japanese Article 3-9-S10-3. The current situation and problem of the clinical skill education in the pharmacy school
内海美保1, 徳永仁2, 高村徳人2, 白川晶一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2017.
Japanese Article 3-9-S10-4. We make use of the assessment ability that we learned in daily duties and make use in community medical care
橋本貴尚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2017.
Japanese Article 3-9-S10-5. Joint ownership ... of the process of thinking that used cooperation - simulation education of a nurse and the pharmacist in the surgical system mixture ward
瀬浪典子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2017.
Japanese Article 3-9-S11-1. Specialty of the pharmacist whom we constitute cancer team approach in medical care, and the type of job expects
濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2017.
Japanese Article 3-9-S11-2. We evaluate the job of the pharmacist specialized in medical therapy
河原昌美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2017.
Japanese Article 3-9-S11-3. Relation with the research activities of the pharmacist specialized in medical therapy and the staff education
内藤隆文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2017.
Japanese Article 3-9-S11-4. Acquire an authorized pharmacist specialized in American medical therapy
佐藤暖子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2017.
Japanese Article 3-9-S11-5. A specialty and synthesis: The pharmacist image that society seeks
安原眞人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2017.
Japanese Article 3-10-S12-1. Process and assay to lead to guidelines revision
三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2017.
Japanese Article 3-10-S12-2. A calcineurin inhibitor: Kidney transplantation
竹内裕紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2017.
Japanese Article 3-10-S12-3. A calcineurin inhibitor: Pancreas transplantation
上杉美和1, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2017.
Japanese Article 3-10-S12-4. A calcineurin inhibitor: Liver transplantation
福土将秀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2017.
Japanese Article 3-10-S12-5. A calcineurin inhibitor: Lung transplantation
河崎陽一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2017.
Japanese Article 3-10-S12-6. Mycophenolic acid
見野靖晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2017.
Japanese Article 3-10-S12-7. Everolimus and a calcineurin inhibitor: Heart transplant
増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2017.
Japanese Article 3-10-S12-8. Inflection of the genetic information
新岡丈典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2017.
Japanese Article 3-10-S12-9. The actual situation of the use of generic medicine of the immunosuppressive drug
本間真人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2017.
Japanese Article 3-11-S13-1. Significance and role of Academic Detailing for the optimal medical treatment
山本美智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-246, 2017.
Japanese Article 3-11-S13-2. To push forward the proper use of pharmaceutical products
磯部総一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2017.
Japanese Article 3-11-S13-3. Expectation to an academic D tailing
齊藤光江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2017.
Japanese Article 3-11-S13-4. It is ... from the situation of future way - company of the pharmaceutical company MR
土井貞1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2017.
Japanese Article 3-11-S13-5. Practice of the academic D tailing utilizing the pharmaceutical products comparison system
小茂田昌代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2017.
Japanese Article 3-12-S14-1. One form that a pharmacist of the cottage-hospital out of the district thought about in efforts for the proper use of pharmaceutical products in a local inclusion care system
岸本真1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-252, 2017.
Japanese Article 3-12-S14-2. Development of hospital pharmacist duties reflecting the image of treatment at home
荒川隆之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2017.
Japanese Article 3-12-S14-3. Relation ... to at-home palliative care by the hospital pharmacist working in role - district core hospital of the hospital pharmacist in the local inclusion care
辻井聡容1,2, 大垣孝文1, 中永かおり1, 今井清隆1, 木瀬大輔1, 上坂一行1, 森山雅弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2017.
Japanese Article 3-12-S14-4. In a local inclusion care system, how should the hospital pharmacist be associated with pressure sore treatment?
宮川哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2017.
Japanese Article 3-12-S14-5. In a local inclusion care system, how does the pharmacist manage a psychotropic drug?
別所千枝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2017.
Japanese Article 3-12-S14-6. How is the pharmacist associated with nutrition therapy in a local inclusion care system?
樋島学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2017.
Japanese Article 3-12-S14-7. Expectation to the medical care, care integration offer system plan and a pharmacist in Sado
佐藤賢治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2017.
Japanese Article 3-12-S15-1. How to gather drug information in the childhood medical therapy
清水啓道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2017.
Japanese Article 3-12-S15-2. I need this to thing - pharmacist who cannot explain it only in physicians
福家辰樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2017.
Japanese Article 3-12-S15-3. Instruction to patient to seek to a pharmacist from a child life specialist
原田香奈1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2017.
Japanese Article 3-12-S15-4. Education for patients to learn from pediatric allergic educator (PAE)
神林弾1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2017.
Japanese Article 3-12-S16-1. About a vaccination system and recent efforts
佐々木康輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2017.
Japanese Article 3-12-S16-2. Importance of the perinatal vaccination
山口晃史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2017.
Japanese Article 3-12-S16-3. Importance of the childhood vaccination
石川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2017.
Japanese Article 3-12-S16-4. Preparation chemistry of the vaccine
西圭史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2017.
Japanese Article 3-13-S17-1. Expectation to AMR measures and a pharmacist
大曲貴夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2017.
Japanese Article 3-13-S17-2. Response of the drugstore pharmacist in AMR measures
宮崎長一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2017.
Japanese Article 3-13-S17-3. How do you practice Antimicrobial stewardship as hospital pharmacist?
小阪直史1,2, 四方敬介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2017.
Japanese Article 3-13-S17-5. Clinical Pharmacometrics for antimicrobial proper use support (Antimicrobial Stewardship)
辻泰弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2017.
Japanese Article 3-13-S17-6. How are you concerned with surveillance of the use of antimicrobial?
村木優一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2017.
Japanese Article 3-13-S18-1. Anaphylactic pathogenesis with the drug, onset factor and evasion measures
宇野勝次1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-274, 2017.
Japanese Article 3-13-S18-2. Practice of the drug-related liver damage assessment
前田頼伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2017.
Japanese Article 3-13-S18-3. The nephropathic pathogenesis with the drug, the onset factor and the correspondence
平田純生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2017.
Japanese Article 3-13-S18-4. The diagnosis support of the cardiovascular system side effect of pharmaceutical products and the correspondence
長沼美代子1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2017.
Japanese Article 3-13-S19-1. The purpose explanation that "thinks about the adverse event that cannot be settled of the anticancer therapeutic drug from the cut end of the brain science"
野村久祥1, 松尾宏一2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2017.
Japanese Article 3-13-S19-2. Cranial nerve dysfunction with the anticancer medicine
三島健一1, 入江圭一1, 山下郁太1, 松尾宏一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2017.
Japanese Article 3-13-S19-3. Image of mentation change in the chemotherapy to examine from a model animal and condition of a patient
北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2017.
Japanese Article 3-13-S19-4. Cognitive dysfunction (chemobrain) with the cancer medical therapy
小川朝生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2017.
Japanese Article 3-14-S20-1. Can the pharmacist become advance care planning facilitator (ACPF) as the interpersonal support job?
西川満則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-283, 2017.
Japanese Article 3-14-S20-2. Relation to ACP of the hospital pharmacist in the team approach in medical care (EOL care team)
土井直美1, 小林理穂2, 西川満則3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2017.
Japanese Article 3-14-S20-3. It is ... from experience of the ACP as need - Care manager of the advance care planning (ACP) as the interpersonal support job
大城京子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2017.
Japanese Article 3-14-S20-4. Relation of the pharmacist to "the thought of patients, the family" in the at-home palliative care
白石丈也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2017.
Japanese Article 3-14-S20-5. Efforts of "the family drugstore" utilizing the relation ... drug remedy history management blotter to the advance care planning that a drugstore is done
宇都宮励子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2017.
Japanese Article 3-14-S21-1. Trend of the genome information utilization support system development
松下まゆみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2017.
Japanese Article 3-14-S21-2. An evaluation and problem of the usefulness of the genome information utilization support system
山本和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2017.
Japanese Article 3-14-S21-3. Inflection of the genome information utilization support system by the pharmacist
岩本卓也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2017.
Japanese Article 3-14-S21-4. An electronic medical chart and study of the section system to support genomic medicine
安藝理彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2017.
Japanese Article 3-14-S21-5. Joint project with construction - United States Stanford University of the database supporting genomic medicine
橋本康弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2017.
Japanese Article 4-1-S22-1. Examination ... about the effect of the pharmacist intervention from position of the hospital pharmacist to patients with ... outpatient department cancer pain
山田正実1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2017.
Japanese Article 4-1-S22-2. It is ... about the current situation and problems in the medication counseling of the drug for ... medical care from position of the hospital pharmacist
原伸輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2017.
Japanese Article 4-1-S22-3. Analytical technique ... of clinical studies data associated with the mild medical care by ... pharmacist from the position of the analysis person in charge
矢野義孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2017.
Japanese Article 4-1-S22-4. Attempt ... of the outcome evaluation by the pharmaceutical support and pharmacist intervention from the situation of the physician of the palliative care to the patients who expect it of ... pharmacist
端裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2017.
Japanese Article 4-1-S23-1. Diabetes, high blood pressure
嶋村弘史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2017.
Japanese Article 4-1-S23-2. Nephritis, nephrotic syndrome, vasculitis
高坂聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2017.
Japanese Article 4-1-S23-3. Complications - anemia, bone ... which needs management
高山慎太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2017.
Japanese Article 4-1-S23-4. Key to understanding of the medical treatment evidence and applied - adequacy ...
鈴木大介1,2, 畔柳敏弥1, 杉山正2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2017.
Japanese Article 4-1-S23-5. Medical treatment instruction and specialized pharmacist - hospital pharmacist and skill ... which a health insurance pharmacy pharmacist is demanded from
小泉祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2017.
Japanese Article 4-1-S24-1. Authorized examination results and trends such as pharmacists, and the like specialized in a 2016 cancer
濱敏弘1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2017.
Japanese Article 4-1-S24-2. Summary (1) of the summary of the case
市川和哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2017.
Japanese Article 4-1-S24-3. Summary (2) of the case summary
坂田茂代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2017.
Japanese Article 4-1-S24-4. Summary (3) of the case summary
前田章光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2017.
Japanese Article 4-1-S24-5. Summary (4) outpatient department chemotherapy (pancreatic cancer) of the case summary
市田泰彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2017.
Japanese Article 4-1-S24-6. Summary (small cell lung cancer of elderly people) of a fact and the case summary of the pharmaceutical intervention
組橋由記1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2017.
Japanese Article 4-2-S25-1. Definition/concept of sepsis and pathophysiological update
志馬伸朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2017.
Japanese Article 4-2-S25-2. Update 2017 of painkilling, the sedative management in sepsis
吉廣尚大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2017.
Japanese Article 4-2-S25-3. Nourishment management up date in the septicemic treatment
安藝敬生1, 山野修平2, 若杉和美1, 坂元利彰1, 北原隆志1, 佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2017.
Japanese Article 4-2-S25-4. Circulation management in sepsis
原直己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2017.
Japanese Article 4-2-S25-5. Update of infection treatment in sepsis
前田幹広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2017.
Japanese Article 4-2-S26-1. A dicow yl infection and congenital problem
高崎智彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2017.
Japanese Article 4-2-S26-2. Management of a toxoplasma infection and mother children
山崎香織1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2017.
Japanese Article 4-2-S26-3. Management of a cytomegalovirus infection and mother children
長谷川まゆみ1, 山根律子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2017.
Japanese Article 4-2-S26-4. Management of an influenza virus infection and mother children
八鍬奈穂1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2017.
Japanese Article 4-3-S27-1. Control of resilience engineering theory ... complicated adaptation system to fluctuate
中島和江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2017.
Japanese Article 4-3-S27-2. The description of the hospitalization dispensary duties based on the resilience engineering theory and analysis
木下徳康1,2, 上間あおい1, 原伸輔2, 勝浦正人2, 徳永あゆみ1, 北村温美1, 門脇裕子2, 三輪芳弘2, 中島和江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2017.
Japanese Article 4-3-S27-3. Pharmaceutical products safety management from the tissue cross-sectional viewpoint using the incident report
荒井有美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2017.
Japanese Article 4-3-S27-4. A practice case: Polypharmacy outpatient department as the multi-type of job cooperation intervention
矢吹拓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2017.
Japanese Article 4-3-S28-1. Mental attitude in the circulatory organ domain
佐古守人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2017.
Japanese Article 4-3-S28-2. Possibility of the intervention by the pharmacist in the ischemic heart disease domain
上田浩貴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2017.
Japanese Article 4-3-S28-3. Possibility in the arrhythmia disease
梶原洋文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2017.
Japanese Article 4-3-S28-4. Possibility in the heart failure disease
堀内望1, 岸田有希子1, 野崎歩1, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2017.
Japanese Article 4-3-S28-5. Thing to buy to a pharmacist concerned with the circulatory organ domain as a circulatory organ specialist
大八木秀和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2017.
Japanese Article 4-3-S29-1. Approach of the prescription review from a physician
竹屋泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2017.
Japanese Article 4-3-S29-2. It is ... mainly on pharmaceutical viewpoint - pharmacokinetics and drug interactions in the polypharmacy of elderly people
大野能之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2017.
Japanese Article 4-3-S29-3. Efforts to the prescription review by the polypharmacy reduction team
宮澤憲治1, 溝神文博1, 早川裕二1, 加藤雅斗1, 真野澪1, 平野隆司1, 荒井秀典2, 高橋朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2017.
Japanese Article 4-3-S29-4. Communication necessary for a prescription review
平井みどり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2017.
Japanese Article 4-3-S29-5. Including cooperation of way of thinking - medical care, the care of the medication support necessary for a prescription review
川添哲嗣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2017.
Japanese Article 4-4-S30-1. Approach to the medical therapy adequacy in children
齊藤順平1, 石川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2017.
Japanese Article 4-4-S30-2. It is the medical treatment of the antiepileptic drug in the stage AYA from childhood
山本吉章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2017.
Japanese Article 4-4-S30-3. Drug administration support in the stage AYA with the pregnancy
赤嶺由美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2017.
Japanese Article 4-4-S30-4. The safety management of the elderly people medical therapy
溝神文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2017.
Japanese Article 4-4-S30-5. About the drug administration design support accompanied with the organ ability drop by the aging
松元一明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2017.
Japanese Article 4-8-S31-1. The adherence management of the oral therapeutic drug which is able because it is a pharmacist
川上和宜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2017.
Japanese Article 4-8-S31-2. Approach for the improvement in medication adherence which a local drugstore practices
手嶋無限1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2017.
Japanese Article 4-8-S31-3. Importance of the adherence evaluation of the HIV therapeutic drug
増田純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2017.
Japanese Article 4-8-S31-4. Practice of the adherence evaluation of the oral anticancer medicine
小林一男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2017.
Japanese Article 4-8-S31-5. Effect of the medical treatment management based on the protocol in the COPD inhalation therapy
塩飽英二1, 土手賢史1, 金子忍1, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2017.
Japanese Article 4-8-S31-6. Keep adherence; and is ... hepatitis C pharmacist outpatient department ... the maximization of the treatment result
山本晴菜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2017.
Japanese Article 4-9-S32-1. An origin and the times background of the Choosing Wisely campaign
小泉俊三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2017.
Japanese Article 4-9-S32-2. From efforts of global expanse - Australia of Choosing Wisely -
山本美智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2017.
Japanese Article 4-9-S32-3. Efforts in the university hospital
西岡達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2017.
Japanese Article 4-9-S32-4. Communication of Choosing Wisely and medical person, patients
北澤京子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2017.
Japanese Article 4-9-S32-5. Choosing Wisely to regard as medical security from a clinical ethic
寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2017.
Japanese Article 4-9-S33-1. Correspondence to a safe information report system such as pharmaceutical products, medical equipment, and the like bought by a pharmacist
太田美紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2017.
Japanese Article 4-9-S33-2. The current situation and problems of the operation of the safe information report system such as pharmaceutical products, medical equipment, and the like
小原拓1,2,3, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2017.
Japanese Article 4-9-S33-3. The accumulation of the information such as the side effects, and the like of pharmacist specialized in a cancer and evaluation of JADER
土屋雅美1,2, 小原拓3, 眞野成康2,3, 高村千津子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2017.
Japanese Article 4-9-S33-4. Practice of RMP in the local core hospital and reinforcement of the side effect report system
舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2017.
Japanese Article 4-9-S33-5. Expectation to the promotion of the side effect of pharmacist report
益山光一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2017.
Japanese Article 4-11-S34-1. Mitochondrial quality control and adaptation expansion with cilnidipine
西田基宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2017.
Japanese Article 4-11-S34-2. The drug repositioning study which utilized large-scale medical information, and intended improvement in survival rate of patients with cardiopulmonary arrest
座間味義人1,2, 小山敏広3, 石澤有紀4, 新村貴博1,4, 今西正樹2, 武智研志5, 堀ノ内裕也4, 桐野靖2, 中村敏己2, 寺岡和彦2, 池田康将4, 藤野裕道6, 土屋浩一郎7, 玉置俊晃4, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2017.
Japanese Article 4-11-S34-3. Drug repositioning study for anticancer medicine-induced peripheral neuropathy
牛尾聡一郎1, 江角悟1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2017.
Japanese Article 4-11-S34-4. Application of the drug repositioning study in oral mucositis treatment
渡邉真一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2017.
Japanese Article 4-11-S34-5. A systematic review and drug repositioning study using the adverse drug reaction database
今井徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2017.
Japanese Article 4-11-S35-1. It is ... mainly on the efforts in preparation invention - on koro Gee domain of the generic drug
野沢健児1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2017.
Japanese Article 4-11-S35-2. A characteristic of the pharmaceutics of the inhalational powdered drug and new development
岡本浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2017.
Japanese Article 4-11-S35-3. A characteristic and development trend of the percutaneous absorption preparation
勝見英正1, 山本昌1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2017.
Japanese Article 4-11-S35-4. Attempt of the posterior eyes therapy by instillation prescription and the preparation invention that are kind to eyes
長井紀章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2017.
Japanese Article 4-11-S35-5. The intranasal administration of the drug: Characteristic of the distribution after absorption and the administration of drug
坂根稔康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2017.
Japanese Article 4-11-S35-6. With the characteristic of the pharmaceutics of the clinical injection drug bought on the site
神谷貴樹1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2017.
Japanese Article 4-12-S36-1. From <before graduation education> new pharmacy school education to pharmacist lifelong learning
鈴木匡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2017.
Japanese Article 4-12-S36-2. The current situation and problems of the after graduation initial training of the pharmacist
山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2017.
Japanese Article 4-12-S36-3. The life training of the pharmacist: About a Japanese Society of Hospital Pharmacists hospital pharmacy authorization pharmacist system
本間真人1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2017.
Japanese Article 4-12-S36-4. Efforts to pharmacist lifelong learning in the Japan Pharmaceutical Association
宮崎長一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2017.
Japanese Article 4-12-S36-5. Authorization, specialized pharmacist system and third party evaluation
松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2017.
Japanese Article 4-12-S37-1. Schizophrenia medical treatment guidelines: Practice by the EGUIDE project
橋本亮太1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2017.
Japanese Article 4-12-S37-2. Adequacy and antipsychotics reduction
亀井浩行1,2, 岩田仲生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2017.
Japanese Article 4-12-S37-3. About the adequacy of the antiparkinson agent and the pro-anticholinergic drug antiparkinson agent reduction using weight loss - DIEPSS -
佐藤康一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2017.
Japanese Article 4-12-S37-4. Adequacy and weight loss of an antianxiety drug, the sleeping drug prescription
吉尾隆1,2, 松尾和廣1, 宇都宮守2, 鶴岡揚大1, 福島美里1, 中谷真樹1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2017.
Japanese Article 4-12-S38-1. About a new model core curriculum and the education of the psychiatry domain
三輪高市1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-374, 2017.
Japanese Article 4-12-S38-2. Training in the psychiatry neurology ward in the university hospital
佐々木典子1, 池村健治1, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2017.
Japanese Article 4-12-S38-3. Finish business training at psychiatry single department hospital; and from the position of ... student -
亀崎仁矢1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2017.
Japanese Article 4-12-S38-4. Preparations and problem to accept pharmacy business training
中村友喜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2017.
Japanese Article 4-12-S38-5. To become the occupational therapist who is helpful by current situation - clinical practice of the bedside teaching in the psychiatry domain; ...
村尾利之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2017.
Japanese Article 4-12-S38-6. Efforts of the training acceptance burden reduction in the mental hospital
三宅彩香1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2017.
Japanese Article 4-13-S39-1. The pharmacy management utilizing BSC in the local acute phase hospital and future problem
礒野淳一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2017.
Japanese Article 4-13-S39-2. Efforts to the pharmacy management in the middle scale hospital
小串興平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2017.
Japanese Article 4-13-S39-3. Practice of the pharmacy management in the Seki center Hospital
酒向幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2017.
Japanese Article 4-13-S39-4. We aim at the pharmacy that raises management participation in planning awareness by BSC introduction, and acts powerfully
千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2017.
Japanese Article 4-14-S40-1. It is ... for inflection of evaluation of clinical studies and applied - evidence
飯嶋久志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-385, 2017.
Japanese Article 4-14-S40-2. Role of the pharmacist in the multicenter study
橋本浩伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2017.
Japanese Article 4-14-S40-3. Why are the medical statistics necessary? ?
山本紘司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2017.
Japanese Article 4-14-S40-4. Let's practice clinical studies for the problem solving of the medicine!
小茂田昌代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2017.
Japanese Article 4-14-S40-5. Drug economy evaluation to work on by the multi-type of job
池田俊也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2017.
Japanese Article 4-14-S41-3. For the appropriate medication of the nursing facility resident who practiced the cooperation between a pharmacist, the care staff, nurses
白石朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2017.
Japanese Article 4-14-S42-1. Efficacy kinetic analysis of the diabetes therapeutic drug based on clinical record information
前間邦生1,2, 玉城瑶子2, 加唐誠剛東2, 深江真登2, 木下怜子2, 廣田豪2, 家入一郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2017.
Japanese Article 4-14-S42-2. Inflection of the Pharmacometrics for efficacy, pharmacokinetic evaluations in the true clinical practice
平大樹1,2, 寺田智祐2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2017.
Japanese Article 4-14-S42-3. Maintenance of the diabetes therapeutic drug proper use information based on Model-Based Meta-Analysis (MBMA)
家入一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2017.
Japanese Article 4-14-S42-4. Medical optimization by the inflection of MBMA
樋坂章博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2017.
Japanese Article 5-1-S43-1. Diabetes aggravation prophylactic usefulness by the drugstore pharmacist
井上岳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2017.
Japanese Article 5-1-S43-2. Aggravation prevention business of diabetic nephropathy utilizing the community pharmacy in Matsumoto-shi
日野寛明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2017.
Japanese Article 5-1-S43-3. Diabetes aggravation prophylactic significance by the multi-type of job cooperation
宮本高秀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2017.
Japanese Article 5-1-S43-4. The approach of the country for the diabetic nephropathy aggravation prevention and the national situation
米丸聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2017.
Japanese Article 5-1-S43-5. Modeling of the diabetes aggravation prevention utilizing community medical care resources
古川綾1,2, 佐藤朝子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2017.
Japanese Article 5-1-S44-1. How to use steroid
田中廣壽1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-404, 2017.
Japanese Article 5-1-S44-2. - to take a pioneer role of immunosuppressive therapy - immunologic renal disease treatment in the kidney transplantation
竹内裕紀1, 岩本整2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2017.
Japanese Article 5-1-S44-3. Problem of the immunosuppressive therapy in the minimal change type nephrotic syndrome
高坂聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2017.
Japanese Article 5-1-S44-4. Immunosuppressive therapy in the systemic lupus erythematosus
池内秀和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2017.
Japanese Article 5-2-S45-1. About team approach in medical care, treatment at home of the heart failure
高野博之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2017.
Japanese Article 5-2-S45-2. Examine illness of the heart failure; the role of the pharmacist in the medicine medicine cooperation
森川剛1,2, 久保田健1, 岡澤香津子1, 渡辺徳2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2017.
Japanese Article 5-2-S45-3. Attempt of the multi-type of job cooperation by the treatment at home using the ICT system
加藤悠1, 菅原鉄矢2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2017.
Japanese Article 5-2-S45-4. It is ... from the position of role ... nurse of the pharmacist in the team approach in medical care of the heart failure
富山美由紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2017.
Japanese Article 5-2-S45-5. Efforts of pharmacy school life, the pharmacist education in Chiba University
関根祐子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2017.
Japanese Article 5-3-S46-1. How do practice it in clinical studies ... busy settings "", to solve a problem; ...
川田敬1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2017.
Japanese Article 5-3-S46-2. The clinical studies in the emergency domain and application to medical treatment
中野貴文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2017.
Japanese Article 5-3-S46-3. - to think from drug economic examination by the regimen observance of clinical studies - cancer chemotherapy for the outcome improvement that a pharmacist conducts
林誠1, 井上裕貴1, 杉村勇人2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2017.
Japanese Article 5-3-S47-1. tips (art) and training of the pharmaceutical intervention
橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2017.
Japanese Article 5-3-S47-2. We can do it at the small and medium size hospital. Relation ... to infection treatment to put up ... motivation, and to be able to work on
橋口亮1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2017.
Japanese Article 5-3-S47-3. To make use of blood practice - drug levels of Therapeutic Drug Monitoring definitely; ...
山田智之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2017.
Japanese Article 5-3-S47-4. How do you apply it in the patients before utilization - eyes of the drug information in the ward? ...
佐村優1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2017.
Japanese Article 5-3-S47-5. ... to challenge in the relation - pharmacist bullet to the decreased renal function patients
浦田元樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2017.
Japanese Article 5-3-S47-6. Point to conduct ward duties to be the clinical pharmacist who can contribute to medical treatment
寺沢匡史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2017.
Japanese Article 5-4-S48-1. The way of the community medical care cooperation in the super aging society
荒木隆一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2017.
Japanese Article 5-4-S48-2. Drug duties and regional alliances in the convalescent bed
樋島学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2017.
Japanese Article 5-4-S48-3. Drug duties and regional alliances in the chronic phase bed
棗則明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2017.
Japanese Article 5-4-S48-4. Drug duties and regional alliances in the care health center for the elderly
足岡秀樹1,2, 石倉優子1,2, 柳原美夏1, 嘉本玲子2, 足岡規子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2017.
Japanese Article 5-4-S48-5. Cooperation of medical care, the care in the acute phase bed by the information sharing system utilization
小枝伸行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2017.
Japanese Article 5-5-S49-1. A young person pharmacist and clinical pharmacy study to think about from an example of our hospital
鈴木陽介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2017.
Japanese Article 5-5-S49-2. Practice of the study based on the drug duties in clinical settings
末次王卓1, 渡邊裕之1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2017.
Japanese Article 5-5-S49-3. Process of clinical studies by the hospital pharmacist
見野靖晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2017.
Japanese Article 5-5-S49-4. Construction of the information sharing network for development and the "quality of the study" improvement of the "medical quality" improvement-oriented clinical pharmacy study
尾田一貴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2017.
Japanese Article 5-5-S49-5. The clinical pharmacy study that unfolded from "the whisper of the healthcare worker"
田中遼大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2017.
Japanese Article 5-11-S50-1. About the setting of an academic committee and the subcommittee
佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2017.
Japanese Article 5-11-S50-2. About the action program of the academic subcommittee and a member questionnaire result
伊藤清美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2017.
Japanese Article 5-11-S50-3. An evaluation and the management of the drug interactions in the healthcare setting
大野能之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2017.
Japanese Article 5-11-S50-4. About drug interactions guidelines revision
樋坂章博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2017.
Japanese Article 5-11-S50-5. About the correspondence example to the drug interactions in the healthcare setting
木村丈司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2017.
Japanese Article 5-11-S51-1. Problem of an ethic and the PMS of the observational study
松井健志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2017.
Japanese Article 5-11-S51-2. Problem of the healthcare setting about securing of ethicality of the postmarketing surveillance
林昌洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2017.
Japanese Article 5-11-S51-3. It is a questionnaire survey about the patients agreement acquisition, the ethic examination in the investigation after the production and sales for the pharmaceutical company
白ケ澤智生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2017.
Japanese Article 5-11-S51-4. It is the investigation about ethic examination and the subjects agreement in the trust of the investigation and the enforcement after the production and sales
漆原尚巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2017.
Japanese Article 5-12-S52-1. Summary of three medicine cooperation trials between hospital, drugstore, universities in Keio University
山浦克典1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-443, 2017.
Japanese Article 5-12-S52-2. Cooperation trial with Keio hospital pharmacy and the affiliated drugstore
別府紀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2017.
Japanese Article 5-12-S52-3. Examination ... of the tool which is necessary for cooperation - cooperation with hospital, university which we saw from the drugstore
塩津愼二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2017.
Japanese Article 5-12-S52-4. Efforts of medicine, medicine, the medicine cooperation in Showa Pharmaceutical University (specialty college) for the revision model core curriculum business training
渡部一宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2017.
Japanese Article 5-12-S52-5. From the situation of the university hospital accepting the business training student from the several colleges of pharmacy
木村利美1, 川辺桂太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2017.
Japanese Article 5-12-S53-1. Plan intention of the symposium
北條泰輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-452, 2017.
Japanese Article 5-12-S53-2. From the situation of - university hospital regarding personnel training as the role of the pharmacist to make drug discovery, clinical studies accelerate -
寺元剛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2017.
Japanese Article 5-12-S53-3. A role and expectation of the pharmacist to accelerate clinical studies
中井清人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2017.
Japanese Article 5-12-S53-4. From the situation of - company regarding personnel training as the role of the pharmacist to make drug discovery, clinical studies accelerate -
稲垣治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2017.
Japanese Article 5-12-S53-5. It is ... through ... AMED support projects, and the like to regard personnel training as the role of the pharmacist to make drug discovery, clinical studies accelerate
河野典厚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2017.
Japanese Article 5-14-S54-1. Cooperation with other organizations for disaster medical care
若井聡智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-458, 2017.
Japanese Article 5-14-S54-2. Efforts of the pharmacist society
堀越博一1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2017.
Japanese Article 5-14-S54-3. Efforts of the local cooperation hospital
但馬重俊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2017.
Japanese Article 5-14-S54-4. From the situation of cooperation - public hospital with the administration -
田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2017.
Japanese Article 5-14-S54-5. Efforts of the local basic hospital for disasters
雪本江里子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2017.
Japanese Article 5-14-S54-6. Cooperation and personnel training of the pharmacist engaged in a disaster
小林映子1, 佐川剛毅1, 安藤和佳子2, 井上陽平3, 追木正人4, 大塚万記子5, 近藤智幸6, 下石和樹7, 滝澤康志8, 原田真理9, 雪本江里子10, 石田耕太1, 森一博11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2017.
Japanese Article To prevent effect - fatigue and a pain of the stretching for the making of health, and to dissolve; ...
山本利春1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2017.
Japanese Article Academic F1-1. It is examination about the investigation support after the production and sales of the hospital pharmacist for the pharmaceutical products risk management plan
有馬秀樹1,2, 近藤直樹3, 田崎正信4, 寺元剛5, 水井貴詞6, 渡邉達也7, 近藤智子8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2017.
Japanese Article Academic F1-2. "The research about the pharmaceutical management of the perioperative patients and the pharmacist duties in the operating room"
舟越亮寛1,2, 柴田ゆうか3, 柴田みづほ4, 小西寿子5, 堀内賢一6, 佐藤裕紀7, 古谷一平8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2017.
Japanese Article Academic F2-1. The participation of the pharmacist starting polypharmacy measures and research of the usefulness
武藤浩司1,2, 小田慎3, 佐藤康一4, 澁田憲一5, 樋島学6, 別所千枝7, 吉岡睦展8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2017.
Japanese Article Academic F2-2. Participation of the hospital pharmacist in medical therapy in the convalescence in the local inclusion care system and research of the usefulness
岸本真1,2, 荒川隆之3, 宮川哲也4, 溝神文博5, 藤原久登6,7, 酒向幸8, 川崎美紀9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2017.
Japanese Article Academic F2-3. Research about the handling of the medical information of the pharmacist accompanied with the revision of the Personal Information Protection Law
池田和之1,2, 岡橋孝侍3, 小枝伸行4, 高田敦史5, 関谷泰明6, 青柳吉博7, 黒田知宏8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2017.
Japanese Article Academic F2-4. We conduct research for becoming it the marketing of the drug necessary for the healthcare setting
渡辺享平1,2, 大津史子3, 後藤伸之2, 佐々木忠徳4, 原田幸子5, 山川雅之6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2017.
Japanese Article LS1-1. Role of the hospital pharmacist sought by community medical care
荒木隆一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2017.
Japanese Article LS1-2. The communicative competence that is demanded from hospital pharmacist in the local inclusion care system
杉本なおみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2017.
Japanese Article LS2. The management of the immune checkpoint inhibitor in Kyushu University Hospital team iCI
渡邊裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2017.
Japanese Article LS3. How to use Chinese medicine deepening theory - Chinese medicine to begin with the evidence, use -
飯塚徳男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2017.
Japanese Article LS4. It is ... mainly on generic safety of medicine - country combination research result of the anticancer agent
永井純正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2017.
Japanese Article LS5. Than the example of polypharmacy - Tochigi medical center settled by the multi-type of job -
菅原健一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2017.
Japanese Article LS6. Change, thing ... in there It is ... from ... drug control instruction to ward drug duties
後藤一美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2017.
Japanese Article LS7. We think about adherence of the elderly people atrial fibrillation from the viewpoint of the pharmacist
山村恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2017.
Japanese Article LS8. Mainly on strategy and personnel training - cancer medical care to show a pharmacist power -
吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2017.
Japanese Article LS10. Operation, management of the treatment with immune checkpoint inhibitor facing it by a team
小泉知展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2017.
Japanese Article LS11. Tracing report ... as pharmacist duties - information infrastructure which one step stepped into for 2025
萱野勇一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2017.
Japanese Article LS12. Mainly on medical therapy - polypharmacy measures of elderly people -
秋下雅弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2017.
Japanese Article LS13-1. Around team approach in medical care - Rash Management in the lung cancer molecules target treatment from the situation of the physician -
西野和美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2017.
Japanese Article LS13-2. Around team approach in medical care - Rash Management in the lung cancer molecules target treatment than the position of the pharmacist -
中多陽子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2017.
Japanese Article LS14. A stakeholder and risk communication in the cancer medical therapy
濱敏弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2017.
Japanese Article LS15. ... pharmacist searching optimal antiemesis therapy is ... with being able to do it
林稔展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2017.
Japanese Article LS16. Relation ... that ... production and the quality are close to the production of biomedicine
大政健史1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2017.
Japanese Article LS17. Having learned through sepsis
遠藤重厚1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2017.
Japanese Article LS18. Including the relation of form - pharmacist of medical care and care in the future -
佐々木淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2017.
Japanese Article LS19. Medical therapy and supportive care of cancer
加藤俊介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2017.
Japanese Article LS20. Is the team approach in medical care self-satisfaction of the medical person?
川口英俊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2017.
Japanese Article LS21-1. Paradigm shift of the condition of a patient and the treatment of the gonarthrosis
渡辺淳也1,2, 青木保親1,3, 中嶋隆行1,3, 高澤誠1,3, 久保田剛1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2017.
Japanese Article LS21-2. Medicamentosus nephropathic expression mechanism
増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2017.
Japanese Article LS22. ... which thinks about heart failure pandemic - ideal-like elderly people heart failure treatment in this country
元木博彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2017.
Japanese Article LS23. How do you explain a generic drug to the nation? ... which deepens the understanding to ... individual differences
澤田康文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2017.
Japanese Article LS24. - to think about the treatment that fixed its eyes on an importance - great vessels disorder of blood sugar, blood pressure, the lipid change in patients with diabetes
坂本昌也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2017.
Japanese Article LS26. The step of the pharmacist authorization system specialized in a cancer and the future prospects
谷川原祐介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-522, 2017.
Japanese Article LS27. Discussion over "G-CSF proper use guidelines"
高野利実1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2017.
Japanese Article LS29. Medical expenses reduction effect by Drug Vial Optimization of the anticancer medicine and anticancer medicine closed system anesthesia drug transportation system (CSTD)
濱宏仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2017.
Japanese Article LS30. Glaucoma and instillation adherence
本庄恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2017.
Japanese Article LS31-1. Paradigm shift in multiple myeloma treatment
内山倫宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2017.
Japanese Article LS31-2. Medication management to push forward multiple myeloma treatment smoothly
網野一真1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2017.
Japanese Article 3-5-O1-01. Relative examination with midazolam blood level and the consciousness evaluation scale in the sedative patients with the liver, the impaired renal function
種田靖久1, 森光輝1, 篠田康孝1, 松村知洋1, 中尾俊也1, 宇佐美英績1, 山口均2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2017.
Japanese Article 3-5-O1-02. Population pharmacokinetics/pharmacodynamic analysis of the apixaban in patients with atrial fibrillation
上島智1, 平大樹2, 冨塚知歩1, 野村実希1, 木村悠馬1, 山根拓也1, 田淵陽平2, 伊藤英樹3, 大野聖子3, 小澤友哉3, 堀江稔3, 寺田智祐2, 桂敏也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2017.
Japanese Article 3-5-O1-03. Blood change of pregabalin in patients with cancer and analysis of the individual differences factor of the onset of central nerve symptom
吉川望美1, 内藤隆文1, 八木達也1, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2017.
Japanese Article 3-5-O1-04. Examination of the incompatibility with sodium benzoate and other agents and examination of the efficacy change of the agent
林八恵子1, 吉田忍2, 伊藤由佳子3, 門居久嗣1, 遠藤正憲1, 塚本有子1, 西澤嘉四郎2, 河渕真治3, 栄田敏之3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2017.
Japanese Article 3-5-O1-05. Effect of CYP3A5 genetic polymorphism giving it to the change between the individual of the quantity of tacrolimus body exposure in renal-transplant recipients and the Everolimus
加賀谷英彰1, 新岡丈典1, 齋藤満2, 井上高光2, 沼倉一幸2, 羽渕友則2, 佐藤滋3, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2017.
Japanese Article 3-5-O2-06. Effect of the gastric-acid secretion inhibitor to give to pharmacokinetics of the gefitinib
横田隼人1, 小林裕幸1, 佐藤一洋2, 奥田佑道2, 伊藤宏2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2017.
Japanese Article 3-5-O2-07. Evaluation of the side effect expression of bosentan by the clarithromycin combination
岩男元志1, 鈴木陽介1, 佐藤雄己1, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2017.
Japanese Article 3-5-O2-08. Inspection of the effect that CYP2C19 genetic polymorphism gives to drug interaction of etizolam and itraconazole
山本武人1,2, 降旗謙一3,4, 樋坂章博5, 森豊隆志6, 大越和章3, 草山静子3, 本橋慧樹7, 森敬子1, 岩坪威7,8, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2017.
Japanese Article 3-5-O2-09. The change of blood tacrolimus levels early after the renal transplantation: Effect of the CYP3A gene expression with interleukin-6
榎屋友幸1, 池村健治2, 濱田裕悟2, 西川晃平3, 岩本卓也1,2, 杉村芳樹3, 奥田真弘1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2017.
Japanese Article 3-5-O2-10. Analysis ... of the CYP3A expression of fundamental researches - liver drop mechanism about the pharmacokinetic safety of the highly-concentrated green tea polyphenol
五十嵐信智1, 小川壮介1, 廣部隆太1, 今理紗子1, 楠欣己1, 山下真鈴1, 水上七帆1, 金子未歩1, 杉山清1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2017.
Japanese Article 3-5-O3-11. Comparison of the usefulness of the non-fixed form antipsychotics for the Parkinson's disease patients by the Bayes style meta analysis
池谷怜1, 川崎洋平1,2, 山田浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2017.
Japanese Article 3-5-O3-12. Usefulness of the examination of blood clotting for the hemorrhagic side effect of apixaban
梅山遥1,2, 片田佳希1, 中川俊作1, 丸山志穂子1, 松田裕也1, 尾崎淳子1, 齋藤成達2, 米澤淳1, 中川貴之1, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2017.
Japanese Article 3-5-O3-14. The blood toxicity with the SP therapy is a useful predictor of a survival period and the pathological tissue response rate
奈良克彦1, 山下裕玄2, 山本武人3, 大久保聡1, 高田龍平1, 瀬戸泰之2, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2017.
Japanese Article 3-5-O3-15. The manufacture of the new hospital preparation seleno orally disintegrating tablet and the evaluation
中尾元紀1, 土江亜季1, 松尾世為子1, 畝佳子1, 覺野律1, 吉岡千晶2, 植松勇伍2, 緒方文彦2, 川崎直人2, 長井紀章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2017.
Japanese Article 3-5-O4-16. Estimate of the cutoff value of the rescue use that can distinguish presence or absence of continuous pain in the use of fentanyl quick-release preparation patients
城山亮輔1,2, 山本武人1, 穂積淳2, 岡村知美1,2, 金井良晃2, 高田龍平1, 長瀬幸恵1, 住谷昌彦2, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2017.
Japanese Article 3-5-O4-17. Examination of the new diabetes onset risk in the statin remedy patients
加藤正太郎1, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2017.
Japanese Article 3-5-O4-18. Association between perioperative volume of infusion and ileus in the large intestine resection
西健太郎1,2, 守田和憲1, 田上治美1, 高森啓史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2017.
Japanese Article 3-5-O4-19. Suggestion of the new instillation prescription using mineral nanoparticles: Improvement in bioavailability of water-soluble drug carteolol
大竹裕子1, 本田茜1, 岡森那々海1, 上野祥奈1, 岡本紀夫2, 下村嘉一2, 長井紀章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2017.
Japanese Article 3-5-O4-20. Examination - using effect on erectile dysfunction - salt sensitive hypertension model rat of the eplerenone associated with the high blood pressure
浅野岳人1, 片岡智哉2, 岸本大輝3,4, 堀田祐志1, 前田康博1, 川出義浩1, 金山博臣3, 木村和哲1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2017.
Japanese Article 3-5-O5-21. Attempt of the governance of the pharmaceutical products-related master in MID-NET
高田敦史1, 朴珍相1, 山下貴範1, 野尻千夏1, 伊豆倉理江子1, 平山ふみ1, 堀田多恵子2, 康東天2, 中島直樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2017.
Japanese Article 3-5-O5-22. Of the in-hospital drug information in the drug information room collect it and effectively utilize it
山田千代子1, 小野陽介1, 台蔵剛士1, 藤崎幸代1, 南憲一1, 安田明子1, 山田留美子1, 岡田ちひろ1, 稲垣沙織1, 才田絢加1, 南川知央1, 渡辺真梨奈1, 吉田正暢1, 久保杏奈1, 北侑未1, 米澤美和1, 虎瀬和子1, 下川千賀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2017.
Japanese Article 3-5-O5-23. It is compared the haemorrhage symptom with oral anticoagulant drug (DOAC) with the warfarin by the data mining using adverse drug reaction database (JADER) directly
島戸茜1, 波多野正和1, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2017.
Japanese Article 3-5-O5-24. Development and clinical evaluations of the side effect monitoring management tool for antipsychotics
石田俊介1, 坂東寛1, 武智研志2, 今西正樹1, 座間味義人1,3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2017.
Japanese Article 3-5-O5-25. About efforts to conduct attention instruction such as the driving, and the like surely
岩瀬由枝1, 鶴田昌吾1, 山本恭平1, 伊藤友恵1, 大野愛1, 久保田敏行1, 杉浦洋二1, 勝見章男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2017.
Japanese Article 3-5-O6-26. Is there the gender gap in the efforts of the pharmacist for a pregnant woman, the nursing mother? - Thing - that we were able to see it from questionary survey
加藤祥世1, 井出和希2,3, 小林豊1, 北村修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2017.
Japanese Article 3-5-O6-27. The reporting with the drug information offer duties (1) - inside the hospital E-mail in the hospital is transmitted to the staff for local acute phase; or ...
和久津稔1, 黒田和1, 村上絢美1, 佐々木海1, 根本詩織1, 田中敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2017.
Japanese Article 3-5-O6-28. Collection and evaluation of the daily life term of the patients about the side effect using the crowdsourcing
臼井美紗1, 荒牧英治2, 若宮翔子2, 川口美咲3, 丸山順也3, 早川智久3, 青森達3, 望月眞弓3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2017.
Japanese Article 3-5-O6-29. It is examined extraction and the solution to problems in the intelligence after the pharmaceutical products marketing by the MS using the workshop
壁矢健司1, 佐藤宏樹2,3, 堀里子3, 三木晶子3, 三浦康正4, 澤田康文3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2017.
Japanese Article 3-5-O6-30. Construction of intelligence, the offer system for OTC pharmaceutical products proper use for registration distributors
望月美里1, 堀里子2, 三木晶子2, 佐藤宏樹2,3, 吉田豊4, 石川香織4, 大石美也4, 澤田康文2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2017.
Japanese Article 3-6-O7-01. The anticholinergic load has an influence on the ADL of the rehabilitation to patients with old stroke in the convalescent rehabilitation ward
小瀬英司1, 草間基之1, 平井利幸2, 関利一2, 林宏行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2017.
Japanese Article 3-6-O7-02. Examination about the factor affecting the akathisia expression by the Aripiprazole
白濱雅史1, 有村洋平1, 永田健一郎1, 石田茂1, 齊藤麻美1, 渡邊裕之1, 江頭伸昭1, 宮崎恭輔2, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2017.
Japanese Article 3-6-O7-03. Fundamental researches about fundamental researches about the dry skin mechanism at anticancer agent Erlotinib remedy
金子未歩1, 横山貴俊1, 吉野真花奈1, 今理紗子2, 楠欣己1, 水上七帆1, 五十嵐信智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2017.
Japanese Article 3-6-O7-04. Investigation about the blood glucose level change of neonates in the indometacin administration
大久保翔1, 赤嶺由美子1, 安達裕行2, 高橋勉2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2017.
Japanese Article 3-6-O7-05. Elucidation of neonatal hypoglycaemia frequencies and the risk factor after the impending premature birth treatment with the ritodrine hydrochloride
下川頌子1, 坂田明子1, 嶋田努1, 崔吉道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2017.
Japanese Article 3-6-O8-06. About the effect that the medication counseling by the pharmacist in the child psychiatry outpatient department gives in adherence of the children patient
山下朋江1, 杉本篤言2,3, 吉永清宏2, 折目直樹4, 松崎陽子2, 今井朗子1, 佐藤裕英1, 川原史子1, 高橋栄一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2017.
Japanese Article 3-6-O8-07. Association of the medication adherence in patients during oral anticoagulant drug internal use for atrial fibrillation directly and the sick recognition
宮崎元康1, 中島章雄1, 仲村佳彦2, 坂元佑哉1, 後藤美和1, 内山将伸1, 岡村圭祐3, 光武良晃3, 浦田秀則3, 神村英利4, 松尾宏一1, 今給黎修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2017.
Japanese Article 3-6-O8-08. Usefulness evaluation of the medicine medicine cooperation using the interactive tracing report in the treatment with oral anticancer agent
長谷川晃司1, 春名康裕1, 武田智子1, 和田淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2017.
Japanese Article 3-6-O8-09. Result of the cooperation protocol with the local health insurance drugstore which assumed IT a base
平井利幸1, 寺門祐介1, 堀晴香1, 藤貫晴奈1, 渡邉文之2, 篠原久仁子3, 亀井美和子2, 関利一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2017.
Japanese Article 3-6-O8-10. The exploring of the new cloudiness factor for patients with Japanese cataract: Amyloid β accumulation aggravates cortex muddiness
長井紀章1, 真野裕1, 大竹裕子1, 柴田哲平2, 久保江理2, 佐々木洋2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2017.
Japanese Article 3-6-O9-11. Examination about the hemorrhagic adverse event of anti-platelet agent prasugrel
土井崇1, 芦川直也1, 渡邉操1, 川根誉代1, 佐合裕子1, 永田恵2, 窪田浩之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2017.
Japanese Article 3-6-O9-12. Safe examination of the loading dose of the rivaroxaban apixaban in the deep vein thrombosis
吉田紗理1, 藤江直輝1, 立川奈保美1, 伊藤千恵1, 三島芳枝1, 的場美香1, 高木麻里1, 吉田智江1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2017.
Japanese Article 3-6-O9-13. Analysis of the risk factor of the hypomagnesemia
西村文宏1, 宮村重幸1, 大嶋秀一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2017.
Japanese Article 3-6-O9-14. Examination of the factor associated with the side effect expression of nintedanib in our hospital
名取世津子1, 土屋裕伴1, 腮尾成美1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2017.
Japanese Article 3-6-O9-15. Study on proper use of the transdermal absorbing form preparation in the Parkinson's disease
安高勇気1,2, 藤岡伸助3, 芝口浩智4, 清見文明5, 原暦2, 緒方憲太郎1,2, 坪井義夫3, 神村英利1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2017.
Japanese Article 3-6-O10-18. Comparison of the onset of anemia situation by treatment with interferon bass and the treatment in the genotype type 2 hepatitis C with Sofosbuvir bass
大滝康一1,2, 久保靖憲2, 新田悠一朗2, 鈴木智之2, 小竹斗志之2, 三嶋一登2, 小野尚志2, 小川聡2, 福土将秀2, 田崎嘉一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2017.
Japanese Article 3-6-O10-19. Comprehensive examination of the physical frailty and drug adverse effect in the elderly inpatient
川上瑛子1,2,3, 大山茜2, 竹屋泰2, 小泉美希1, 中嶋恒男2, 竹屋美幸2, 武田朱公3, 鷹見洋一2, 山本智也1, 伊東範尚2, 山本浩一2, 杉本研2, 三輪芳弘1, 楽木宏実2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2017.
Japanese Article 3-6-O10-20. About the polypharmacy measures of the elderly patients in the neurology ward
西田承平1, 林祐一2, 鈴木昭夫1, 小林亮1, 吉見千明1, 犬塚貴2, 伊藤善規1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2017.
Japanese Article 3-6-O11-21. Efficiency of promotion and compounding of medicines duties of the pharmaceutical products proper use that the prescription input support task by the pharmacist results in
森木邦明1, 高橋真巳1, 長谷川一将1, 金田達也1, 高根浩1, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2017.
Japanese Article 3-6-O11-22. The current situation investigation (multicenter study) end results report of the polypharmacy in Tokyo
林太祐1,2, 安武夫2, 城田幹生3, 関礼輔4, 齋藤雅俊5, 新倉卓6, 古屋順一7, 堀井剛史8, 屋城由樹9, 伊藤芳弘10, 奥野靖隆11, 南雲成12, 阿部和史13, 濃沼政美14
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2017.
Japanese Article 3-6-O11-23. Risk of developing polypharmacy and associated - multicenter study - in Tokyo of drug control instruction duties
堀井剛史1,2, 安武夫3, 南雲成4, 屋城由樹7, 奥野靖隆5, 古屋順一6, 新倉卓8, 林太祐10, 齋藤雅俊9, 関礼輔11, 城田幹生12, 伊藤芳弘13, 阿部和史15, 濃沼政美14
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2017.
Japanese Article 3-6-O11-25. The intervention of the pharmacist is useful in time in therapeutic range control of the warfarin: Retrospective cohort study
安泰成1, 小瀬英司2, 島津明日香2, 吉川明彦1, 林宏行2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-567, 2017.
Japanese Article 3-6-O12-26. The actual situation of the polypharmacy at blood medical patients hospitalization
諸角一成1, 稲垣淳2, 菊池隆希2, 木下滉子1, 丹村貴之1, 長谷川和徳1, 大矢美緒1, 川合結乃1, 中村康夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2017.
Japanese Article 3-6-O12-27. Efforts to the polypharmacy cancellation by the ward permanent residence pharmacist
豊田倫之1, 富施哲也1, 松谷直樹1, 根岸美由紀1, 麻生一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2017.
Japanese Article 3-6-O12-28. Screening of the polypharmacy using the bringing medicine evaluation template and analysis of the usefulness
荻上尚樹1, 小久江伸介1, 大野能之1, 白根達彦1, 長瀬幸恵1, 小島太郎2, 秋下雅弘2, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2017.
Japanese Article 3-6-O12-29. Burden on nurse reduction effect accompanied with the bringing medicine initial intervention by the pharmacist
伊賀正典1, 齋藤彩子1, 亀井陽子1, 井上朋子1, 高野温志1, 向井夏紀1, 松沼篤1, 興野克典1, 藤掛佳男2, 町田充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2017.
Japanese Article 3-6-O12-30. The current situation of the "disease severity for the regular hospital, medical care, nursing necessary degree" of the bringing medicine evaluation
南目梨江1, 柴田智恵1, 南目祐希1, 渡辺美恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2017.
Japanese Article 3-7-O13-01. Medical safety measures in the mention method standardization enforcement of the oral medicine prescription and the evaluation
小川勝弘1, 安達真紀子1, 涌嶋伴之助1, 金田達也1, 森木邦明1, 秦英司1, 椎木芳和1,2, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2017.
Japanese Article 3-7-O13-02. Analysis and preventive measures of the incident in the ethical pharmacy against dispensing errors
福士真由美1, 種村菜奈枝1, 漆原尚巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2017.
Japanese Article 3-7-O13-03. About the communalization of doubt inquiry contents
中川義浩1, 大橋邦央1, 桑原貴美子1, 浮池聡子1, 眞弓健介1, 鶴崎泰史1, 山形真一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2017.
Japanese Article 3-7-O13-04. Efforts to the preoperation heart ischemia evaluation in the non-operation on the heart patients
平田備子1, 森本さとみ2, 永井京子1, 黒田優5, 坂本元3, 中村洋一郎4, 林太郎6, 大西尚7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2017.
Japanese Article 3-7-O13-05. Pharmacist duties in the Aichi Medical University Hospital hospitalization and release support center
井戸田麻由1, 野々垣知行1, 宇野英理子1, 山之内博明1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2017.
Japanese Article 3-7-O14-06. The making of the injection drug dilution set for the purpose of the drug accident decrease and the effect
田中怜1, 大坂巌2, 佐藤哲観2, 對馬隆浩3, 岩本由美子4, 藤井真理子4, 柴本薫4, 三木直子4, 森川歩4, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2017.
Japanese Article 3-7-O14-07. Establishment of the doubt inquiry system in the foreign chemotherapy
松岡秀和1, 高橋佳代1, 桑原清人1, 石原唯1, 木内直美1, 松岡美樹2, 関根佳代1, 吉田善紀1, 辻村秀樹1, 大谷美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2017.
Japanese Article 3-7-O14-08. As for the specialist in nonrecognition newcomer medicines, and the like in the Aichi Medical University Hospital, it is setting, the operation of the evaluation section and example
黒瀬優輔1, 深谷さおり1, 野々垣知行1, 宇野英理子1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2017.
Japanese Article 3-7-O14-09. Efforts in the Aichi Medical University Hospital for the safe use reinforcement of pharmaceutical products out of the adaptation
宇野英理子1, 野々垣知行1, 深谷さおり1, 黒瀬優輔1, 山之内博明1, 大西正文1, 斎藤寛子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2017.
Japanese Article 3-7-O14-10. Specialist in nonrecognition newcomer medicine, construction of the in-hospital surveillance system about contraindications, the off-label use
池谷修1, 青森達2, 中田英夫1, 戸枝美奈子1, 山口雅也1, 望月眞弓1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2017.
Japanese Article 3-7-O15-12. Investigation about weight loss, the discontinuation situation in the Lenvatinib therapy
恒川龍二1, 前勇太郎2, 横川貴志2, 鈴木亘2, 鈴木賢一2, 高橋俊二3, 須貝威1, 濱敏弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2017.
Japanese Article 3-7-O15-13. Usefulness of the comprehensive management from an early stage in the foreign pazopanib treatment of the progressive renal carcinoma
藤堂真紀1, 高橋美賀1, 池田勧1, 眞壁秀樹1, 小山政史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2017.
Japanese Article 3-7-O15-14. Examination of ten EGFR mutation-positive non-small cell lung cancer where we introduced Osimertinib into
金永進1, 南貴之1, 筒井俊晴1, 宮下義啓1, 花輪和己1, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2017.
Japanese Article 3-7-O15-15. Investigation ... about the anxiety about challenge (the eighth report) - outpatient department oral chemotherapy to a drugstore, the pharmacist future
大石学1, 末次祐子1, 中尾妃佐1, 光吉杏美香1, 中野一樹1, 祖川由樹1, 栗原朝子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2017.
Japanese Article 3-7-O16-16. The effect that intensity of treatment of the GC therapy in the progressive urothelial carcinoma and myelosuppression give to prognosis
笹野知海1, 山本圭祐1, 都甲海1, 中道秀徳1, 矢部勝茂1, 米田達明2, 塩川満1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2017.
Japanese Article 3-7-O16-17. Fact-finding of the polypharmacy in patients who received colon cancer chemotherapy
地主隆文1, 鈴木直哉1, 前川英輝1, 木下愛1, 山本翔太1, 藤田果那1, 庄崎沙耶1, 田中耕太1, 山田将悟1, 菊地義明1, 藤林遼1, 高橋誠1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2017.
Japanese Article 3-7-O16-19. The effectiveness and safety in the GEM + nab-PTX therapy
濱武清範1, 小西史子1, 足立那々緒1, 奥村優介1, 美和孝之1, 仲忠士1, 松本弘誠1, 中西輝1, 岩井真里絵1, 福井美礼1, 小島一晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2017.
Japanese Article 3-7-O16-20. Examination about cost effectiveness and the safety of the ramucirumab + paclitaxel therapy for progress, recurrent stomach cancer
西川智子1, 木村美智男1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2017.
Japanese Article 3-7-O17-21. Taste bitter masking of pharmaceutical products by the small molecule peptide
森本栞1, 原口珠実1, 小島穂菜美1, 吉田都1, 内田享弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2017.
Japanese Article 3-7-O17-22. The taste bitter masking effect with the drink of zopiclone tablets using the taste sensor and examination of the mechanism
吉田都1, 宇田篤史2, 原口珠実1, 小島穂菜美1, 山本和宏2, 平井みどり3, 内田享弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2017.
Japanese Article 3-7-O17-23. Examination about the formulations with the division appliance of the secantless tablet
久志田郁1, 滝町友惠1, 清水善仁1, 高瀬文超1, 多賀允俊1, 山本康彦1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2017.
Japanese Article 3-7-O17-24. Enhancement and evaluation of the prescription inspection system of the new oral anticoagulant drug utilizing the check sheet
石川直人1, 押切華映1, 坪井真友子1, 高崎新也1, 菊地正史1, 小原拓1, 赤坂和俊1, 木皿重樹1, 松浦正樹1, 山口浩明1, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2017.
Japanese Article 3-7-O17-25. Efforts to the physician burden reduction for doubt inquiry
上吹越夕輝1, 伊藤光輝1, 佐野元基1, 堂園陽子1, 村瀬真理子1, 坂野昌志1, 中島博文1, 杉浦茂樹1, 山田洋治1, 寺井文廣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2017.
Japanese Article 3-7-O18-26. An association between experience, knowledge and consciousness about the package insert of the instruction to patient about the driving: Questionary survey 1 quantitative data for staff of general hospital
春日章宏1, 大森一郎1, 山口裕之1, 古川源1, 斉藤晴彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2017.
Japanese Article 3-7-O18-27. An association between experience, knowledge and consciousness about the package insert of the instruction to patient about the driving: Questionary survey 2 qualitative data for staff of general hospital
山口裕之1, 大森一郎1, 春日章宏1, 古川源1, 斉藤晴彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2017.
Japanese Article 3-7-O18-28. The approach that promoted proper use of the zolpidem tartrate, and reduced a fall fall risk
城田幹生1, 林恵子2, 若杉有希3, 遠藤真理子4, 梅澤正美5, 佐藤英吾6, 佐藤浩子3, 林星舟5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2017.
Japanese Article 3-7-O18-29. Investigation of the psychotropic drug involved in the fall in the inpatient
阪岡倫行1, 桑原秀徳1, 静村知恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2017.
Japanese Article 3-7-O18-30. Proper use promotion ... of construction - midazolam injection of the emphasis management high-risk medicine setting and regime
篠田健一1,2, 桧物拓也1, 松本俊明1, 森田智恵子1, 五十嵐諭二1, 高堂昌子2, 野々村誠2, 風間泰蔵2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2017.
Japanese Article 3-8-O19-01. Examination about the effectiveness of the loxoprofen Na for the EGFR tyrosine kinase inhibitor-induced eruption
飯村洋平1, 下村斉1, 今中景子1, 山口学2, 川崎徳仁2, 小中千守2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2017.
Japanese Article 3-8-O19-02. The alkalinization agent prevents an irinotecan-induced neutropenia
濱野裕章1, 三井茉綸2, 座間味義人1,2, 新村貴博2, 武智研志3, 岡田直人1, 今西正樹1, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2017.
Japanese Article 3-8-O19-03. Examination - using the order of peg filgrastim administration elligibility cases logistic-regression analysis that paid its attention to predictive - RDI
神林祐子1,2,3, 石川剛2,4, 金沢元洪2, 中嶋佑樹1,2, 河野留美2, 井原憲彦1,2, 田渕祐輔1, 吉田直久4, 細川豊史3, 高山浩一5, 四方敬介1, 田口哲也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2017.
Japanese Article 3-8-O19-04. Comparison with plasma oxaliplatin levels and total platinum concentration about the onset of oxaliplatin-induced accumulation-related peripheral neuropathy prediction
武田茉子1, 武貞和希1, 河渕真治1, 伊藤由佳子1, 栄田敏之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2017.
Japanese Article 3-8-O19-05. Effect of IL-6 giving it to thrombocytopenia of the chemoradiotherapy induction using the platinum and the MCP-1 genetic polymorphism
藤田一馬1, 新岡丈典1, 本山悟2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2017.
Japanese Article 3-8-O20-06. Experimental examination about the scattering characteristics in the restroom of urinary excreted anticancer medicine
佐藤淳也1, 工藤賢三2, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2017.
Japanese Article 3-8-O20-07. Examination of the filter method introduction for anticancer medicine exposure monitoring in the work environment of the healthcare worker
中山由理恵1, 入佐俊弘1, 秦晃二郎1, 中嶋一惠1, 橋本昂介1, 石田茂1, 渡邊裕之1, 江頭伸昭1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2017.
Japanese Article 3-8-O20-08. Efforts to a safe examination no bacteria guarantee in the anticancer agent stock of pharmaceutical preparation making for coinfusion duties facilitation
森本麻友1,2, 加納大輔1, 望月伸夫1, 吉野名穂子1, 田中将貴1, 山口卓哉2, 久野真理2, 山口正和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2017.
Japanese Article 3-8-O20-09. Costs investigation of pharmaceutical economic assessment - TRIPLE study of the standard three-drug antiemesis therapy for the highly emetic chemotherapy in our country
清水久範1, 鈴木賢一2, 内倉健3, 大橋養賢4, 山中竹春5, 橋本浩伸6, 後藤功一7, 松井礼子8, 関順彦9, 島田俊一10, 池田俊也11, 池上直己12, 濱敏弘2, 山本信之13, 佐々木忠徳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2017.
Japanese Article 3-8-O20-10. Prescription suggestion and medical expenses reduction effect in the pharmacist outpatient department on oral anticancer medicine remedy patients
郷真貴子1, 木村美智男1, 川地志緒里1, 川地雄基1, 浅野裕紀1, 岩井美奈1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2017.
Japanese Article 3-8-O21-11. The establishment of the absolute level of human serum cetuximab assay which applied electron impact mass spectrometry and comparison with the immunologic assay about the fixed-quantity characteristic
柴田海斗1, 内藤隆文1, 岡村純2, 細川誠二2, 峯田周幸2, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-595, 2017.
Japanese Article 3-8-O21-13. The effect that use of aprepitant at the hematopoietic stem cell transplantation pre-treatment gives in pharmacokinetics of tacrolimus
湯澤薫1, 折山豊仁1, 山本武人1,2, 大野能之1, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 596-596, 2017.
Japanese Article 3-8-O21-14. Effect of the CYP3A5 genetic polymorphism on blood tacrolimus levels measurements by the ACMIA, CLIA, ECLIA, LTIA method
赤嶺由美子1, 加賀谷英彰1, 佐藤滋2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2017.
Japanese Article 3-8-O21-15. Acute rejection after the brain death lung transplantation and examination about the association of blood tacrolimus levels
福井彩香1, 佐藤裕紀1, 杉本充弘1, 中川俊作1, 中川貴之1, 濱路政嗣2, 本山秀樹2, 青山晃博2, 陳豊史2, 伊達洋至2, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2017.
Japanese Article 3-8-O22-16. Initial dose setting of vancomycin in consideration of the membrane oxygenator for children, the priming volume at sustained hemofiltration dialysis enforcement
諏訪淳一1, 村田美帆1, 熊谷祐梨1, 藤田幹生1, 石原溶子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2017.
Japanese Article 3-8-O22-17. The effectiveness and safety of the vancomycin loading dose in the decreased renal function patients
杉田裕貴1,2, 田中絵美1, 久井裕美子1, 細見健悟1, 小牧佐知子1, 稲田智子1, 高子優子1, 増本憲生1, 大槻裕朗1, 岡村昇3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2017.
Japanese Article 3-8-O22-18. Factorial experiments of the Ganciclovir-induced neutropenia using the data mining technique
今井俊吾1, 山田武宏1, 小林正紀1, 笠師久美子1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2017.
Japanese Article 3-8-O22-19. The identification of the factor involved in onset of hypokalemia with the amphotericin B preparation liposome: Usefulness of the prophylactic potassium preparation administration
岡田直人1, 今西正樹1, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2017.
Japanese Article 3-8-O22-20. Evaluation of the medicinal solution preparation environment in the ward which assumed atmospheric fine particles and a floating live germ an index
矢野貴久1, 森日登美1, 安永幸枝1, 服部佳奈子2, 諸熊由子1,2, 清祐麻紀子1,2, 神野俊介1, 豊田一弘1, 下野信行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2017.
Japanese Article 3-8-O23-21. The system to snuggle up to hope of the medical drug self-care of the palliative care unit inpatient
椎崎正秀1,2, 前間邦生1,2, 原口勝3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2017.
Japanese Article 3-8-O23-22. The search of the factor affecting hypercalcemia indicating the resistance for zoledronic acid and the correspondence
有田仁紀1, 坂本真紀1, 大津秀一2, 小杉隆祥3, 西澤健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2017.
Japanese Article 3-8-O23-23. Examination of the cancellation time of oral hypoglycemics in consideration of the hypoglycemia risk of the use of strong opioid patients in the cancer terminal phase
岩津慎次郎1,2, 鎌田理沙子2, 高瀬冴子2, 土井綾子2, 西村美馨子2, 本間崇正2, 松丸沙織2, 後藤健志2, 遠山幸男2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 鷹見繁宏1, 板倉由縁3, 木村和哲4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2017.
Japanese Article 3-8-O23-24. Comparison with other opioid of out of the blood after the hydromorphone intravenous administration using the effect part compartment model and the effect part concentrations change
壁谷めぐみ1,2, 湯浅周1,2, 長尾清治2, 久保直子1,2, 日比聡1, 長谷川慎一2,3, 伊奈研次2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2017.
Japanese Article 3-8-O23-25. Factor analysis of the polypharmacy in elderly people with the cancerous pain
森尾佳代子1, 前田一石2, 横田勲3, 仁木一順1, 上島悦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2017.
Japanese Article 3-8-O24-26. Examination about the expression situation and the antiemesis therapy of retching, vomiting at the Carboplatin combination therapy in patients with gynecologic cancer
三好孝法1, 松尾尚美1, 鶴田南奈子1, 川俣洋生1, 弓削乃利人2, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2017.
Japanese Article 3-8-O24-27. Example that suffered from side effect measures including chemotherapy-induced retching vomiting (CINV) in the BEP therapy for AYA generation patients
藤本伸一郎1, 吉田宏二1, 中村友紀1, 淺野肇1, 柳江正嗣1, 藤原季美子1, 黒井扶美恵1, 月岡康行1, 森嶋祥之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2017.
Japanese Article 3-8-O24-28. Examination about the effectiveness of our hospital antiemetic drug set at the cisplatin administration
上ノ段友里1, 折田博之2, 倉光絵里奈3, 福山康朗3, 富田珠美1, 永田茂之2, 甲斐成一郎2, 縄田好一1, 是永大輔2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2017.
Japanese Article 3-8-O24-29. Examination about the dosage of the cisplatin giving poor control of retching
藤井宏典1, 飯原大稔1, 石原正志1, 小林亮1, 鈴木昭夫1, 田中善宏2, 山口和也2, 吉田和弘2, 伊藤善規1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2017.
Japanese Article 3-8-O24-30. Digestive organ symptom protective efficacy with the antiemetic at hepatic artery chemoembolisation enforcement using the epirubicin
坂本達彦1, 齋藤佳敬1, 小林正紀1, 山田武弘1, 笠師久美子1, 中井正人2, 小川浩司2, 井関健1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2017.
Japanese Article 3-10-O25-01. For business training to connect with fact-finding - lifelong learning of the EBM education in the hospital business training -
榎本貴一1,5, 野澤 (石井) 玲子2, 小坂鎮太郎3,5, 木村泰4,5, 福永貴志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2017.
Japanese Article 3-10-O25-02. The efforts of the resident teacher in the business training: Introduction and improvement of the case base type learning in resuscitation/living body information monitor, the examination by a stethoscope training
梅村朋1, 吉見陽1, 白松貴子2, 日比陽子3, 伊藤教道3, 山田清文3, 野田幸裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2017.
Japanese Article 3-10-O25-03. Attitude survey about the genetic screening for the drugstore in Hiroshima-shi
池田佳代1, 細井徹1, 吉井美智子1, 杉山政則2, 小澤光一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2017.
Japanese Article 3-10-O25-04. Change of the consciousness by the attitude survey for the psychiatry prescription to a drugstore pharmacist and the patients in psychiatry communication workshop enforcement
成井繁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2017.
Japanese Article 3-10-O25-05. Analysis of the questionnaire results of the pharmacist upbringing class that can play an active part in the treatment at home of patients with heart failure
大沢沙弓1, 橋本直子1, 石井貴浩1, 三浦剛2, 関根祐子3, 高野博之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2017.
Japanese Article 3-10-O26-06. Significance of the follow-up training of the non-expert skill for the accession second year
新井亘1, 増田裕一1, 矢嶋美樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2017.
Japanese Article 3-10-O26-07. The education training for the pharmacist staff and the construction of the personnel training support system and the evaluation
山本知広1, 八木達也1, 加藤文美1, 青野浩直1, 高井伸彦1, 見野靖晃1, 堀雄史1, 内藤隆文1, 川上純一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2017.
Japanese Article 3-10-O26-08. Construction of a pharmacist education ladder, the educational program and examination of problems
井口恵美子1, 阿部多一1, 猪股克彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2017.
Japanese Article 3-10-O26-09. Activity contents of the Shiga cancer medical therapy conference aiming at the formation and the personnel training of the network between institutions and the effect
大辻貴司1, 野田哲史2, 須藤正朝2, 光家勉3, 原口久義4, 近藤博紀5, 大岡千寿子6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2017.
Japanese Article 3-10-O26-09. Reinforcement of training enforcement and anti-disaster measures in the pharmacy for the disaster
安田親由1, 蜜田哲也1, 種田靖久1, 浅野裕紀1, 松村知洋1, 松岡知子1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2017.
Japanese Article 4-4-O27-01. The shifts from the carbapenem-based licensing system under the intervention reinforcement system by the pharmacist to a use registration system and evaluation of the usefulness
小野祐志1, 新家恵子1, 村田充弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2017.
Japanese Article 4-4-O27-02. Clinical outcome evaluation of the antimicrobial surveillance system in patients receiving carbapenem-based antimicrobial
藤林彩里1, 丹羽隆1,2, 竹市朱里1,2, 鈴木景子1,2, 太田浩敏2, 中山麻美2, 土屋真由美2, 畠山大二郎2, 鈴木昭夫1, 村上啓雄2, 伊藤善規1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2017.
Japanese Article 4-4-O27-03. Relations of use metrics of the carbapenem-based antimicrobial in our hospital and the Pseudomonas aeruginosa-resistant rate
三好由希子1, 高根浩1,2, 岡田健作2,3, 森下奨太2,4, 室田博美4, 中本成紀3, 美甘由雅子2, 上灘紳子2, 島田美樹1, 千酌浩樹2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2017.
Japanese Article 4-4-O27-04. Examination about ESBL-producing Escherichia coli bloodstream infection treatment
藤居賢1,3, 品川雅明2, 國本雄介1, 清治翔伍1, 木明智子1, 中田浩雅1, 野田師正1, 高橋聡3,4, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2017.
Japanese Article 4-4-O27-05. Chemosensitive change of Escherichia coli under antimicrobial restrictions in our hospital
武田龍馬1, 木村順平1, 半澤里佳1, 原田瑞記2, 山田和範2, 本間和加子1, 中村博彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2017.
Japanese Article 4-4-O28-06. An effect and safety of examination - linezolid and quinupristin - dalfopristin of the therapeutic drug for the vancomycin resistant enterococcus bacteremia: Meta analysis ...
渡部智貴1,2, 半田智子2, 新藤学1, 加藤一郎1, 加藤裕久2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2017.
Japanese Article 4-4-O28-07. Risk factor of the onset of renal failure with vancomycin
植木哲也1,2,5, 實松絵美子1, 篠原義剛1, 村上由花2, 宮崎晶2, 坂本佳子2, 眞柴晃一3, 中嶋弥穂子4, 中嶋幹郎5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2017.
Japanese Article 4-4-O28-08. Clinical outcome evaluation by the proper use intervention to all patients received the antifungal agent parenteral injection
竹市朱里1,2, 丹羽隆1,2, 鈴木景子1,2, 藤林彩里1, 太田浩敏2, 中山麻美2, 土屋真由美2, 山本昌代2, 畠山大二郎2, 鈴木昭夫1, 村上啓雄2, 伊藤善規1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2017.
Japanese Article 4-4-O28-09. Examination about the onset situation and the course of the fungal diseases in blood medical patients
岸孝行1, 中川雅史1, 西出貴義1, 中村純子1, 喜多由紀1, 泉本裕美1, 樫葉利人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2017.
Japanese Article 4-4-O28-10. Evaluation of the prescription surveillance by the pharmacist for all injectable antimicrobial
大橋健吾1, 松岡知子1, 篠田康孝1, 吉田真也1, 新井かおり1, 竹中梨恵1, 加藤未紗1, 森卓之1, 林秀樹2, 杉山正2, 吉村知哲1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2017.
Japanese Article 4-4-O29-11. The use situation in our hospital of the drug that seriously ill hypoglycemia is felt uneasy about
中村栄子1, 竹之下博正2, 茨木一夫3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2017.
Japanese Article 4-4-O29-12. Investigation about the use situation and the understanding degree of the medicine for external application for a foot, the nail tinea of patients with diabetes
後藤綾1, 魚住由貴1, 伊藤純子2, 吉川昌江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2017.
Japanese Article 4-4-O29-13. The body water rate decrease in the body composition does not occur in four weeks in the early period of SGLT2 inhibitor administration with the water to drink instruction in patients with Japanese type 2 diabetes
西村博之1, 吉田陽1, 塩山由紀1, 守田彩文1, 杉山正悟2, 栗並昇2, 稗島州雄2, 梶原敬三2, 陣内克紀2, 陣内冨男2, 陣内秀昭2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2017.
Japanese Article 4-4-O29-14. Look at the rear about the concomitant drug of patients taking SGLT2 inhibitor; a mark observational study
森悠太1, 橋本直子1, 峯昌吾1, 廣瀬雅教2, 長谷川洋2, 高野博之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2017.
Japanese Article 4-4-O29-15. The effect that polypharmacy gives for blood sugar control
石郷友之1, 中田圭2, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2017.
Japanese Article 4-4-O29-16. Analysis of the onset mechanism of the diabetic xeroderma that paid its attention to water transport protein
水上七帆1, 金子未歩1, 吉野真花奈1, 横山貴俊1, 今理紗子2, 楠欣己1, 五十嵐信智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2017.
Japanese Article 4-4-O30-17. Effect on valacyclovir-induced renal failure comparison of the combination pain-killer using adverse event spontaneous report database FAERS
近藤悠希1, 鶴橋智子1, 赤石彩乃1, 岩崎慎也1, 稲葉一郎1,2, 石塚洋一1, 入江徹美1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2017.
Japanese Article 4-4-O30-18. Safe examination of the tolvaptan in patients who had the renal failure
小武和正1, 川上恭弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2017.
Japanese Article 4-4-O30-19. The analysis of the antioxidant action of acetaminophen and the metabolite and application to chronic kidney disease treatment
兵藤沙耶1, 門脇大介2, 成田勇樹1, 平田純生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2017.
Japanese Article 4-4-O30-20. Examination about the remedy situation and the decreased renal function inhibitory effect of AST-120
三宅健文1, 塩見紗和子1, 松吉延之2, 山村健太2, 田近友美3, 黒田一成3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2017.
Japanese Article 4-5-O31-01. Evaluation of the medication counseling to Kawasaki's disease immunoglobulin therapy
綾部ゆか1, 前原美桜1, 佐古有紀1, 田中和行1, 渡辺美和1, 松本俊治1, 佐藤友紀2, 兵藤純夫3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2017.
Japanese Article 4-5-O31-02. Look back, and have experience for - Langerhans' cell histiocytosis with pharmaceutical intervention to the orphan disease in the municipal hospital pediatric ward; and -
近藤素代1, 堀内保孝1, 梅沢洸太郎3, 西澤和倫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2017.
Japanese Article 4-5-O31-03. Efforts to medication counseling contents standardization using pediatric medication counseling Tours
富松裕美1, 若杉陽子1, 村上裕子1, 石田茂1, 齊藤麻美1, 渡邊裕之1, 江頭伸昭1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2017.
Japanese Article 4-5-O31-04. It is ... through role - drug instruction and the prescription suggestion of the pharmacist for the case that was able to leave suddenly in just before the end-of-life later stage, death period with there not being it of the relation for mild medical care
奥野昌宏1, 高柳信子1, 中田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2017.
Japanese Article 4-5-O31-05. Efforts and evaluation of medical treatment management (PBPM) based on the protocol of the chemotherapy in the surgery ward
福田未音1, 石田茂1, 益口賢1, 齊藤麻美1, 渡邊裕之1, 中西良太2, 沖英次2, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2017.
Japanese Article 4-5-O32-06. The current situation and problem of the pharmacist duties in the convalescent rehabilitation ward
中嶋淑枝1, 箱崎歩美1, 豊澤敦1, 牛尾幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2017.
Japanese Article 4-5-O32-07. Process before leading to the ward drug duties start in the small and medium size hospital
平野泰健1, 横山佳寿子1, 石垣智加1, 杉本ひろみ2, 竹中ゆかり3, 森信早穂子4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2017.
Japanese Article 4-5-O32-08. Efforts (interhospital cooperation in the public corporation Hospital) second report to the education about ward drug duties
畠山卓1, 吉田みず季1, 陳内博之2, 松本麻美2, 滝島さやか3, 新倉卓4, 市川卓哉4, 根岸真利子5, 橋本理恵子6, 星谷佐江子6, 松本智子1, 中村英子7, 松本啓一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2017.
Japanese Article 4-5-O32-09. It is ... about the cooperation with a role and multi-type of job cooperation - osteoporosis medical treatment and the doctor of the pharmacist in the orthopedics ward of our hospital at old clinical department
萩行正博1, 重本顕史2, 澤口毅2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2017.
Japanese Article 4-5-O32-10. For the cooperation with current situation - ward pharmacist in the pharmaceutical intervention of the operating room pharmacist -
中村将之1, 恩地紀美江1, 松村早希子1, 阪口勝彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2017.
Japanese Article 4-5-O33-11. Efforts - of the drug department in appearance care - cancer special hospital which the professional of the anticancer agent provides
田中侑希1, 疋田絵梨1, 清美奈1, 堀口和美2, 白石範子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2017.
Japanese Article 4-5-O33-12. Efforts of CDTM in the cancer chemotherapy
高瀬美咲枝1, 清水雅子2, 藤井友紀1,3, 高橋美由喜3, 小川浩平1,4, 経田克則5, 原拓央6, 柴田和彦1,7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2017.
Japanese Article 4-5-O33-13. Examination of the intervention effect of the pharmacist on bevacizumab-induced high blood pressure
後藤慎平1, 二瓶哲1,2, 千葉健史1,2, 高橋宏彰1, 木村聡元3, 岩渕修1, 佐藤文彦1, 工藤賢三1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2017.
Japanese Article 4-5-O33-14. Examination of the benefit for the encounter improvement in medication adherence by the sitting pharmacist
池川貴和子1,2, 鎌田隼1, 鈴木秀隆1, 出町健1, 五十嵐隆志1, 須釜由香1,3, 鈴木真也1, 高橋邦雄2, 山口正和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2017.
Japanese Article 4-5-O33-15. Construction and evaluation of the patients with cancer support system by the pharmacist cooperation
奥田泰考1, 本田泰斗2, 大島香菜3, 加藤誠一4, 大塚祥貴5, 前原央奈6, 稲見玲子7, 高田節子8, 米澤亜耶9, 森美鈴10, 山中都起子10, 山口博紀10, 藤井博文10, 中澤寛仁1, 須藤俊明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2017.
Japanese Article 4-5-O34-16. Efforts and evaluation for the Azacitidine appropriate administration
水野貴仁1,3, 深津昌弘1, 小崎耕自1, 梶口智弘2, 大津史子3, 鷹見繁宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2017.
Japanese Article 4-5-O34-17. It is an investigation about neutrophil count and the febrile neutropenia before the administration in the paclitaxel therapy of the administration for every three weeks in the ovarian cancer
渡邊裕之1, 吉井由美2, 木村錦子1, 和田良浩1, 久保直子1, 寺田知恵子1, 神野正敏2, 梶井節子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2017.
Japanese Article 4-5-O34-18. Approach of the pharmacy using the PDCA cycle in the cancer medical therapy
木全司1, 鈴木雅人1, 高原悠子1, 牧原明秀1, 松丸沙織1, 吉田弘樹1, 木下元一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2017.
Japanese Article 4-5-O34-19. Examination (multicenter fact-finding) for the commonization of the confirmation item of the pharmacist in the cancer medical therapy regimen
大橋養賢1, 太田貴洋2, 鈴木真也2, 篠原旭2, 元茂拓法3, 植木大介4, 小沼大祐5, 龍島靖明6, 宇田川涼子7, 田路章博8, 家岡昌弘9, 小暮友毅10, 平池美香子11, 魚井みゆき12, 吉野名穂子2, 川崎敏克2, 山口正和2, 谷地豊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2017.
Japanese Article 4-5-O34-20. Is the CDDP short hydration method safe?
小島一晃1, 濱武清範1, 小西史子1, 美和孝之1, 仲忠士1, 松本弘誠1, 中西輝1, 奥村優介1, 飯田有香1, 北英夫2, 菅理晴3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2017.
Japanese Article 4-5-O35-21. Intervention of the ward pharmacist to use of ω 3 system lipid microsphere in the NICU
松野薫1, 花井美月1, 横山稔厚1, 向山直樹1, 平井孝典1, 成瀬徳彦1, 水谷年男1, 森一博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2017.
Japanese Article 4-5-O35-22. One case - that we contributed to lifesaving from pancytopenia by participation in planning - pharmaceutical intervention to team approach in medical care by the pharmacist permanent residence to the ICU
内田淳1, 福嶋知樹1, 橘田文彦1, 原田大希2, 菅原久徳2, 高三野淳一2, 針井則一2, 森口武史2, 手塚春樹1, 河田圭司1, 松田兼一2, 鈴木正彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2017.
Japanese Article 4-5-O35-23. The effect that intervention gives to Days of therapy and chemosensitivity on antimicrobial choice in the intensive care unit
澤田真嗣1, 藤田将輝1,2, 中西裕明1, 大山翔1, 堀内あす香1, 近藤大志2, 小野保2, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 下間正隆2, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2017.
Japanese Article 4-5-O35-24. Effect by the pharmacist assignment to the intensive care unit
岡田和博1, 國重志都1, 島崎博士1, 勝俣はるみ1, 鹿瀬陽一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2017.
Japanese Article 4-5-O35-25. About intervention to vancomycin initial administration plan in the intensive care unit
曽我弘道1, 福島将友1, 前田朱香1, 福地祐亮1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2017.
Japanese Article 4-5-O36-26. Pharmacist intervention effect after the discontinuation protocol introduction for epidural anaesthesia
平井瑞希1, 坂本江里1, 吉田綾奈1, 久保村優1, 長原真梨子1, 岡田慧1, 三浦義彦1, 伊勢雄也1, 片山志郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2017.
Japanese Article 4-5-O36-27. Efforts to operating room drug duties in our hospital
日江井和英1, 渡邉裕斗1, 松下隆行1, 安田翔1, 佐藤和也1, 塚原民夫1, 宇佐見文隆1, 堀内正1, 高木久美子2, 梶川真樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2017.
Japanese Article 4-5-O36-28. Relations of remedy medicine and the delirium onset for acute phase before hospitalization in the ward
細谷龍一郎1,2, 佐藤洋平3, 石田恵充佳4, 鎌田智幸5, 戸根修3, 日野斉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2017.
Japanese Article 4-5-O36-29. Held ... of efforts - Kinki first aid fur Matthew tical rally for the training of the pharmacist who can contribute to emergency care
松井俊典1, 藤江直輝2, 大谷美奈子3, 川口博資4, 服部雄司5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2017.
Japanese Article 4-5-O36-30. The current situation and measures of the caffeinism in the lifesaving center
廣瀬正幸1,2, 平川昭彦3, 平岩歳久1,2, 竹本雄一1,2, 今井一輝1,2, 白石洋輔1,2, 加藤貴大1,2, 山田成樹1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2017.
Japanese Article 4-6-O37-01. The multi-type of job perception F and efforts to the prescription adequacy in the psychiatry medical treatment ward using the attendance to a physician medical examination
門田善法1, 小原尚利2, 渡辺周3, 堀輝4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2017.
Japanese Article 4-6-O37-02. Examination of the effectiveness of the suvorexant for the medical treatment of the delirium
小川博史1, 福田喬士1, 中島悠介1, 前田貴子1, 澤田真嗣1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2017.
Japanese Article 4-6-O37-03. Relations of a benzodiazepine system/non-benzodiazepine system sleep inducing drug and the delirium
加藤豊範1, 加藤亜起1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2017.
Japanese Article 4-6-O37-04. 1 case ... which was able to contribute to relation ... neurologic manifestation control with patients with at-home advanced age cancer admitted to the mental hospital
加藤剛1,4, 宗像彩香1, 澤口真紀1, 北川綾子1, 鈴木隆晴2, 小野田忠3, 鈴木順子4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2017.
Japanese Article 4-6-O37-05. Effect of the CYP2D6 genetic polymorphism giving it to onset of extrapyramidal symptoms in patients with schizophrenia
伊藤雄大1, 山本和宏1, 西岡達也1, 久米学1, 槇本博雄1, 大塚郁夫2, 菱本明豊2, 曽良一郎2, 平井みどり1, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2017.
Japanese Article 4-6-O38-06. Effect of the cerebral fluid transitivity in the treatment with vancomycin on patients with childhood bacterial meningitis
甚目陽子1, 中島優子1, 加藤美樹1, 見崎知子1, 竹内正幸1, 山之内博明1, 大西正文1, 斎藤寛子1, 上甲眞宏2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2017.
Japanese Article 4-6-O38-07. One case of the infants who conducted vancomycin medical treatment monitoring under the sustained dialysis enforcement
潮平英郎1,2, 伊差川サヤカ1, 山田智史1, 砂川智子1, 仲松正司2,3, 与那覇房子1, 外間惟夫1, 藤田次郎2,3, 中村克徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2017.
Japanese Article 4-6-O38-08. Examination of the initial administration plan in the Teicoplanin administration
堀内あす香1, 澤田真嗣1, 藤田将輝1, 中西裕明1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2017.
Japanese Article 4-6-O38-09. Development of the renal function monitoring tool in the psychiatry special hospital
北村郁1, 早船真弘2, 川瀬公一1, 石井正巳1, 岩爪昭子1, 與田美穂子1, 山村康比古3, 越田晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2017.
Japanese Article 4-6-O38-10. Rearward investigation of a dose and the administration continuance of the pazopanib
田中寛之1,2, 平賀博明3, 武隈洋4, 三浪圭太5, 橋下浩紀1, 原林透5, 永森聡5, 遠藤雅之1, 菅原満4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2017.
Japanese Article 4-6-O39-11. The Takayasu's arteritis one case that blood infliximab densitometry contributed to the condition of a patient control
増井翔1,2, 米澤淳1,2, 大谷祐基1, 佐野慎介1,2, 朝倉佳代子1, 谷口理沙1, 山田早紀3, 西谷真彦3, 井澤和司3, 河合朋樹3, 西小森隆太3, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2017.
Japanese Article 4-6-O39-12. 2 case of patients with severe impaired renal function that we analyzed pharmacokinetic in the intensive care unit after the voriconazole transluminal administration
衛藤大輝1, 金子哲也1, 田中遼大1, 甲斐真也2, 鈴木陽介1, 佐藤雄己1, 大地嘉史2, 安田則久2, 後藤孝治2, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2017.
Japanese Article 4-6-O39-13. Theoretical consideration about the lactational safety in the rizatriptan administration nursing mother
大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2017.
Japanese Article 4-6-O39-14. The pharmacokinetic examination that intended individualization medical therapy of the Donepezil (donepezil tablets)
阿部武由1, 森崎訓明2, 溝川ゆみ子3, 山口佳津騎4, 渡邊政博5, 土屋浩一郎6, 二宮昌樹7, 中妻章7, 石川一朗8, 村尾孝児9, 中村祐8, 芳地一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2017.
Japanese Article 4-6-O39-15. The intake of the green tea reduces plasma nadolol levels in the healthy volunteer in the single time
尾形浩1, 阿部理1,2, 大野雄康1, 小野委成1, 三坂眞元1, 三浦至2, 色摩弥生3, 矢部博興2, 下村健寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2017.
Japanese Article 4-6-O40-16. The CYP2J2 activity inhibition with antihypertensive medications and analysis of the action mecha-nism
池村憲明1,2, 山折大1,2, 小林千夏3, 上条しのぶ2, 大森栄1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2017.
Japanese Article 4-6-O40-17. Effect on CYP4F2 activity of the concomitant drug raising a side effect onset risk of the Fingolimod, CYP4F2 inhibitory action of the HMG-CoA reductase inhibitor
渡辺宏晃1,2, 山折大1,2, 上条しのぶ2, 大森栄1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2017.
Japanese Article 4-6-O40-18. We look at the rear about the effect of the proton pump inhibitor giving it to a methotrexate excretion delay and study a mark
清宮啓介1, 津田壮一郎1, 森毅彦2, 清水隆之2, 加藤淳2, 菊池拓2, 櫻井政寿2, 甲田祐也2, 外山高朗2, 岡本真一郎2, 望月眞弓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2017.
Japanese Article 4-6-O40-19. Effect of a concomitant drug giving it to an internal change of the new antiepileptic drug Perampanel and the liver damage
淺野理子1, 米澤淳1, 山本将太1, 廣住育美1, 杉本充弘1, 中川俊作1, 池田昭夫2, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2017.
Japanese Article 4-6-O40-20. Effect of the CYP3A5 genetic polymorphism giving it to interaction of calcineurin inhibitor tacrolimus and fluconazole in the heart transplant remoteness period
高吉真弥1, 和田恭一1,2, 松田紗知1, 寺田侑加1, 老田章1, 高田充隆2, 瀬口理3, 簗瀬正伸3, 福嶌教偉3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2017.
Japanese Article 4-6-O41-21. About the case that reached the change of prescription by doubt inquiry based on the examination data with the Hitachinaka health IT - network
砂押直樹1, 玉井典子2, 関利一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2017.
Japanese Article 4-6-O41-22. Examination of doubt inquiry after the prescription issuance with the test value in the JCHO Kyushu Hospital
小倉秀美1, 川久保充章1, 釘原瑤子1, 上津沙織1, 吉国健司1, 桑村恒夫1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2017.
Japanese Article 4-6-O41-23. Usefulness evaluation of the group work holding to utilize the clinical test value that we displayed in a prescription
岸田義博1, 貴島幸子2, 兼重晋1, 山村伸也1, 竹野将行1, 高木淳一1, 丸野重信1, 増田智先2, 瀬尾隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2017.
Japanese Article 4-6-O41-24. Simplification of doubt inquiry based on the prior agreement at a hospital and the health insurance pharmacy
讓原千広1, 小川紗知1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2017.
Japanese Article 4-6-O41-25. A doubt inquiry of the substitute prescription for the bringing medicine principle nonuse and reporting to the health insurance pharmacy
台蔵剛士1, 山田留美子1, 北侑未1, 島岡純平1, 渡辺真梨奈1, 南川知央1, 才田絢加1, 竹森麻美1, 岡田ちひろ1, 諸田真由美1, 寺佳帆理1, 安田明子1, 下川千賀子1, 山田千代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2017.
Japanese Article 4-6-O42-26. Polypharmacy measures that a pharmacist collaborates with a physician and works on in an area
末松文博1, 折口秀樹2, 小倉秀美1, 吉国健司1, 藤本裕司3, 成重賢司4, 星野正俊4, 有吉俊二4, 脇園隆二4, 土橋卓也5, 後藤渉6, 太崎博美7, 村本眞由美8, 植木哲也9, 日高博司10, 入江利行11, 園田美樹12, 江本伸哉13
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2017.
Japanese Article 4-6-O42-27. Correspondence to polypharmacy by the multicenter collaboration and examination of the solution
阿登大次郎1, 小牟田豊1, 八代哲也1, 田中雅隆2, 枡井純子3, 岩佐ミユキ3, 金ソッセ4, 三木芳晃5, 萱野勇一郎5, 辻本喜則6, 小林政彦6, 東海秀吉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2017.
Japanese Article 4-6-O42-28. Examine illness in the chemotherapy of patients with malignant brain tumor; construction of the cooperation and the usefulness
渡邉美菜子1, 熊倉康郎1, 矢野亨治1, 石井沙也加1, 大岡史治2, 本村和也2, 夏目敦至2, 若林俊彦2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2017.
Japanese Article 4-6-O42-29. The cooperation reinforcement between pharmacists by the operation of the pharmacist medical care reporting book and analysis of the usefulness
渡邉雄貴1, 西垣和香2, 市川和哉1, 鈴木裕介3, 千崎康司1, 伊藤瑞規4, 勝野雅央5, 葛谷雅文3, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2017.
Japanese Article 4-6-O42-30. [Residual medicine adjustment PBPM which if local, we shared for Residual medicine zero] Analysis of ... one year and future problem ...
寺門祐介1, 平井利幸1, 高村浩亮2, 渡邉文之3, 亀井美和子3, 樗木昭4, 篠原久仁子5, 関利一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2017.
Japanese Article 4-7-O43-01. Examination and practice ... by reinforcement - workshop of the cooperation between a pharmacist, the care staff, nurses aiming at the appropriate medication of the nursing facility resident
鳥居雄治1, 白石朗1, 馬来秀行2, 三木晶子3, 堀里子3, 佐藤宏樹3,4, 笹川賢一1, 加藤洋一1, 舟橋健一1, 山本大輔2, 小西ゆかり2, 浅井康平2, 臼井順信1, 澤田康文3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2017.
Japanese Article 4-7-O43-02. Usefulness of the at-home visit drug instruction by the pharmacist of the pharmacist outpatient department
上野良夫1, 後藤美恵子2, 玉木真紀子3, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1,3, 前田剛4, 森由弘4, 厚井文一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2017.
Japanese Article 4-7-O43-03. It is ... for proper use from a relation to efforts - bringing medicine of the pharmacist in the local inclusion care ward
加瀬浩二1, 松田公子1, 坂間淳孝2, 秀野武彦2, 浅井禎之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2017.
Japanese Article 4-7-O43-04. Outcome evaluation of the CKD seal developed in whole Shiga for five years
磯野哲一郎1,2, 國津侑貴1, 増田恭子1, 平大樹1, 荒木久澄2, 荒木信一2, 宇津貴2, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2017.
Japanese Article 4-7-O43-05. Approach - for the member drugstore of the attempt - Nagasaki-shi pharmacist society of the medical treatment support system maintenance by an attitude survey and the grouping organization to the transfer between narcotics retail dealers
手嶋無限1, 丸木寿郎1, 河内梨恵1, 西村泰徳1, 南野潔1, 神近竜二1, 松尾英俊1, 井石政之1, 七嶋和孝1, 井手陽一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2017.
Japanese Article 4-7-O44-06. Role of the pharmacy service under health insurance drugstore pharmacist in the at-home palliative care
田邉一尊1, 藤田隆司2, 木村寛子1, 横田修1, 船橋信吾1, 桑原智江1, 小次紀子1, 山本新一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2017.
Japanese Article 4-7-O44-07. Consideration about the electrocardiogram utilization in the pharmaceutical management
尾上洋1, 中田和枝1, 坂田直哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2017.
Japanese Article 4-7-O44-08. Efforts (the second report) of the pharmacist in the treatment at home (fluid therapy)
藤田由1, 西美佐1, 橋本昌子2, 杉田尚寛3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2017.
Japanese Article 4-7-O44-09. Study on effect on utilization behavior in health care by usefulness of the lipid measurement in the drugstore and the consultation encouragement
丸山順也1, 長谷川菖子1, 多田紀夫2, 橋口正行1, 望月眞弓3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2017.
Japanese Article 4-7-O44-10. At fact-finding - disaster of the disaster prevention measures for the pharmacy service under health insurance drugstore in Iwate, to make duties continue; ...
大森英美1, 島田真衣1, 富田隆1, 畑澤博巳2, 工藤賢三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2017.
Japanese Article 4-7-O45-11. Evaluation after the efforts and the introduction to duties visualization of pharmaceutical products SPD for 3 years
関屋裕史1, 緒方豊2, 梶原隆広3, 長友隆雄1, 奥村学1, 岩切智美1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2017.
Japanese Article 4-7-O45-12. The adoption pharmaceutical products choice from a point of view of running it in the hospital targeted for DPC
脇田真之1, 岡村吏華1, 吉井千菊1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2017.
Japanese Article 4-7-O45-13. Management contribution by the simple poking each other of pharmaceutical products leaving a shed amount and the medical affairs calculation amount
佐藤昌博1, 設樂誉1, 千葉光1, 阿部優1, 鈴木康弘1, 佐藤真凡1, 庄司晃2, 鈴木康弘2, 熊谷智惠子1, 齋藤利彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2017.
Japanese Article 4-7-O45-15. We study the search of the syndrome therapeutic drug after the cardiopulmonary resuscitation that assumed drug repositioning a cut end
新村貴博1, 座間味義人1,2, 小山敏広3, 武智研志4, 今西正樹1,2, 堀ノ内裕也5, 石澤有紀5, 池田康将5, 藤野裕道6, 土屋浩一郎7, 玉置俊晃5, 石澤啓介1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2017.
Japanese Article 4-7-O46-17. The search of the optimum doses of the hospital preparation levothyroxine sodium bougie and stable examination
南いく子1, 志田あゆみ1, 山際岳朗1, 大村友博1, 中川貴之1, 中川俊作1, 矢野育子1, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2017.
Japanese Article 4-7-O46-18. Clinical pharmacokinetic study of the mianserin bougie in Japanese healthy elderly men
市倉大輔1,5, 縄田修一1,5, 神山紀子2, 清水愛美1,5, 肥田典子3,4, 山崎太義4, 竹ノ下祥子4, 内田直樹3,4, 峯村純子1,5, 佐々木忠徳5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2017.
Japanese Article 4-7-O46-19. Examination about the placebo setting of the soft plaster in the researcher-led clinical study
米村雅人1,2, 岡野朋果2, 竹野美沙樹2, 石川寛4, 橋本浩伸8, 川崎敏克2, 金澤秀子7, 清原祥夫5, 横田知哉6, 全田貞幹3, 齊藤真一郎2, 山口正和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2017.
Japanese Article 4-7-O46-20. The problem of a plan, the analytical technique of the conventional clinical study and suggestion of the substitute technique
堀口みき1, 竹内正弘1, 宇野一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2017.
Japanese Article 4-7-O47-21. Importance - of efforts - cholesterol compartmentation utilizing the electrophoretic compartmentation wave pattern aiming at the proper use of the dyslipidemia therapeutic drug and the lipoprotein fraction
吉年正宏1, 西村恵美2, 森口美華子2, 家田正子1, 前田和成2, 月岡康行1, 中江健市2, 森嶋祥之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2017.
Japanese Article 4-7-O47-22. Use effect of the PCSK9 inhibitor
大宮寛子1, 吉田夕貴1, 三輪耕次1, 田中伸享2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2017.
Japanese Article 4-7-O47-23. 2 cases that was effective in the distance walked and the hemodynamics for six minutes in the low number of times administration of inhalational type pulmonary hypertension therapeutic drug iloprost
村津直子1, 和田恭一1, 向井優太朗1, 寺川伸江1, 川端一功1, 老田章1, 大郷剛2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2017.
Japanese Article 4-7-O47-24. Examination of the itching onset factor in patients with varicose veins of lower extremities
高井靖1, 西村善幸2, 平本恵一3, 大井一弥3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2017.
Japanese Article 4-7-O47-25. Relative examination with Health Assessment Questionnaire and the drug-taking behavior disorder in patients with rheumatoid arthritis
佐々木恵一1, 近森綾子1, 柳原有希1, 木本泰孝2, 堀内孝彦2, 橋本昌文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2017.
Japanese Article 4-7-O48-26. 2-Hydroxypropyl-β-cyclodextrin intraventricular administration therapy for the inborn character dysbolism Niemann-Pick disease C type
石塚洋一1, 深浦まど香1, 近藤悠希1, 竹尾透2, 中潟直己2, 江良択実3, 東大志1, 本山敬一1, 有馬英俊1, 倉内祐樹1, 香月博志1, 亀井竣輔1, 首藤剛1, 甲斐広文1, 松尾宗明4, 檜垣克美5, 大野耕策6, 入江徹美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2017.
Japanese Article 4-7-O48-27. Investigation analysis of the glucose insulin (GI) therapy for the hyperkalemia
本多美佳子1, 吉岡大樹1, 佐道紳一1, 吉野走1, 岡正拓1, 永延佳子2, 鎌田昭江2, 樋口則英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2017.
Japanese Article 4-7-O48-28. Look at the rear about the heart failure condition of a patient of patients with tolvaptan remedy heart failure; a mark observational study
峯昌吾1, 橋本直子1, 森悠太1, 廣瀬雅教2, 長谷川洋2, 高野博之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2017.
Japanese Article 4-7-O48-29. Treatment response in the congestive heart failure of copeptin and usefulness by the tolvaptan administration decision making
岩下菜摘子1,2, 奈良典子1, 佐藤亮佑1, 中戸川知頼1, 小林俊一1, 座間さゆり1, 前川喜代司1, 三田充男2, 菱沼滋2, 庄司優2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2017.
Japanese Article 4-7-O48-30. Effect of the new epilepsy medicine giving it to the oxidative stress, serum albumin level of a seriously disabled child, the person
森本真仁2, 北岡泰介2, 橋本俊顕1, 浜田茂明1, 京谷庄二郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2017.
Japanese Article 4-8-O49-01. Case-control study about the risk factor of CINV with the CHOP therapy
奥野雅樹1, 土手賢史1, 上島未友紀1, 野崎歩1, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2017.
Japanese Article 4-8-O49-02. It is ... about cost-effectiveness of evaluation - Fosaprepitant of the antiemesis therapy for the moderate emetic risk regimen that assumed oral intake calorie an index
野崎孝徒1, 立道貴清1, 三崎彩香1, 高橋咲衣1, 岩澤春奈1, 山口佳津騎1, 田中裕章1, 篠原尚樹1, 元木貴大1, 北岡陸男2, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2017.
Japanese Article 4-8-O49-03. Evaluation of the late start period retching vomiting expression risk factor in the slight emetic risk cancer chemotherapy
平池美香子1, 鳥山陽子2, 横田千明3, 谷口潤4, 花田聖典5, 津曲恭一6, 大窪典子7, 高武嘉道8, 坂田光平9, 川俣洋生10, 後藤隆11, 鶴崎泰史12, 小薮真紀子1, 下川元継13, 林稔展1,14
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2017.
Japanese Article 4-8-O49-05. Case-control study about the tolerability of duloxetine for chemotherapy-induced peripheral neuropathy
金子忍1, 塩飽英二1, 土手賢史1, 野崎歩1, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2017.
Japanese Article 4-8-O50-06. Use of G-CSF preparation fact-finding in patients who received chemotherapy in the Kasugai Municipal Hospital
冨田庸介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2017.
Japanese Article 4-8-O50-07. Usefulness of the Pegfilgrastim second prophylactic administration of the febrile neutropenia in the breast cancer adjuvant chemotherapy
柿原圭佑1, 葉田昌生1, 三上忠司1, 中嶋陽一1, 松崎雄1, 寺松早紀1, 蔵王なつか1, 大塚弘子2, 山口美樹2, 三輪啓介3, 藤井裕史1, 田中眞紀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2017.
Japanese Article 4-8-O50-08. Effect of dexamethasone doses giving it to the skin toxicity with the docetaxel/cyclophosphamide (TC) therapy for the breast cancer
北澤文章1, 藤田佳史2, 角陽子1, 上田久美1, 中山優子3, 高良恒史3, 佐原敏之1, 国府孝敏4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2017.
Japanese Article 4-8-O50-09. Construction of the situation of eye disorders with the cancer chemotherapy and the ophthalmology practice cooperation system
関根佳代1, 吉田善紀1, 大谷美子1, 辻村秀樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2017.
Japanese Article 4-8-O50-10. We look at the rear about the risk factor of eye disorders by the paclitaxel and examine a mark
野口裕介1, 川島悠吾1, 丸山恵未1, 瓦比呂子1, 徳山洋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2017.
Japanese Article 4-10-O51-01. Examination of the risk factor of the side effect of nivolumab
太田明秀1, 元茂拓法2, 高田慎也3, 岡野翔1, 遠藤雅之3, 大江利治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2017.
Japanese Article 4-10-O51-02. Association with eruption and the effect of treatment by the nivolumab in the non-small cell lung cancer
下村一景1, 清水淳市2, 橋本直弥1, 大矢由子2, 古田裕美2, 香川友祐2, 渡辺尚宏2, 山口哲平2, 上村剛大2, 堀尾芳嗣2, 稲熊一英1, 樋田豊明2, 水野靖也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2017.
Japanese Article 4-10-O51-03. An example of the non-small cell lung cancer with suspected polymyalgia rheumatica symptom by the nivolumab
今井雄介1, 内海裕美1, 田中雅幸1, 藤井良平1, 西山徳人1,2, 打谷和記1, 岡崎和一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2017.
Japanese Article 4-10-O51-04. 1 case that developed acute myocardial infarction during nivolumab administration
長谷川浩司1, 岩城晃一1, 石坂忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2017.
Japanese Article 4-10-O51-05. Look at the rear about the immune-mediated adverse event of the nivolumab; mark investigation
中川佳子1, 竹本将士1, 鬼頭典子1, 伊豆田美晴1, 手崎世織1, 田代雄祐1, 森川琢也1, 青木有希1, 奥苑朱加1, 井口祐美子1, 黒田純子1, 木村和哲1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2017.
Japanese Article 4-10-O52-06. One case of head and neck cancer which caused IRRs of Gr3 in pre-medication DEX 13.2 mg, the FP + Cmab therapy received APR, Chlorpheniramine 5 mg
堀之内藍1, 鈴木真也1, 池川貴和子1, 鎌田隼1, 魚住真哉1, 田原信2, 山口正和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2017.
Japanese Article 4-10-O52-07. One patient whom myocardial infarction by the red thrombus developed in during XELOX + bevacizumab therapy
土岐真路1, 前田幹広1, 坂上逸孝1, 田中恒明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2017.
Japanese Article 4-10-O52-08. TS-1 and an example of mass taking oxycodone
野澤彰1, 巽香菜1, 篠田公夫2, 知久毅2, 野澤 (石井) 玲子3, 加賀谷肇3, 高橋治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2017.
Japanese Article 4-10-O52-09. About the analysis of a trace element and carbon in one report patients hair of the selenium lack by the long-term intravenous alimentation management and the nitrogen stable isotope
藤野陵二1, 村松博士2, 木村治3, 佐藤英二1, 遠藤哲也3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2017.
Japanese Article 4-10-O52-10. The side effect management at methotrexate excessive quantity internal use
山本飛翔1, 前田幹広1, 坂上逸孝1, 増原慶壮2, 田中恒明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2017.
Japanese Article 4-10-O53-11. Improvement - of the medication counseling in hepatitis C treatment of the evaluation - IFN-free of the medication counseling
高橋佐和1, 見元尚1, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2017.
Japanese Article 4-10-O53-13. Outcome evaluations such as serum calcium concentrations monitoring and the prescription suggestion, and the like in the denosumab enforcement outpatient
木村周古1, 新田悠一朗1, 相馬亮太1, 飯田慎也1, 小野尚志1, 三嶋一登1, 福土将秀1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2017.
Japanese Article 4-10-O53-14. Relation of the pharmacist at the radioactive anticancer agent radium 223 outpatient department administration to patients with castration-resistant prostate cancer with metastases to bone
望月伸夫1, 加納大輔1, 中村直樹2, 中神佳宏3, 松原伸晃4, 根本幸一5, 柳澤かおり5, 野村恵一5, 山口正和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2017.
Japanese Article 4-10-O53-15. Patients satisfaction investigation for the pharmacist duties in the foreign chemotherapy room
畠山織江1, 岩川悟1, 齊藤有希1, 志賀隆1, 佐藤邦義1, 荒川隆太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2017.
Japanese Article 4-10-O54-16. It is duties about the stopping medicine and the evaluation during the preoperation of the resident pharmacist in the admitting department
加藤梓沙1,2, 伊藤佳織1, 波多野正和1, 石戸谷その1, 上野美幸1, 阿部幸恵1, 角里恵子1, 荒川悠樹1, 友松恵子1,2, 森舞子1, 覚前有希子1, 平岩歳久1, 加藤さや香1, 牧原俊康1, 津川透1, 鈴木孝幸1, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2017.
Japanese Article 4-10-O54-17. Fact-finding of the pharmacist outpatient department for the small molecule type molecular target drug
早坂州生1, 芦崎雅之1, 出町拓也1, 北山秀則1, 竹内公美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2017.
Japanese Article 4-10-O54-18. Usefulness of the pharmacist outpatient department in the medical treatment to the IBD patients
中村健志1, 土江晴江1, 土井教雄1, 石原慎之1, 玉木宏樹1, 西村信弘1, 直良浩司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2017.
Japanese Article 4-10-O54-19. Examination of the usefulness of the pharmacist outpatient department for the stroke prevention of recurrence
藤田将輝1, 西村暢子1, 中西裕明1, 堀内あす香1, 神田英一郎1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2017.
Japanese Article 4-10-O54-20. Construction of the pharmacist duties in the pregnant woman nursing mother medical therapy domain
小川智孝1, 大西莉加1, 山本里香1, 小椋千絵1, 長谷川聡子2, 小南伸子2, 上田智弘3, 横山直樹4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2017.
Japanese Article 4-10-O55-21. Questionary survey about the duties that the encounter by the pharmacist sits
須釜由香1,2, 五十嵐隆志1, 池川貴和子1, 鎌田隼1, 鈴木秀隆1, 出町健1, 鈴木真也1, 山口正和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2017.
Japanese Article 4-10-O55-22. Prescription suggestion - at efforts - biological drug introduction of the pharmacist outpatient department by the rheumatic registration pharmacist
雪矢良輔1, 奥田佳子1, 畠中英理子1, 梶田貴司1, 奥野智之1, 上田睦明1, 石丸裕康2, 八田和大2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2017.
Japanese Article 4-10-O55-23. Our hospital large intestine ERAS revision by the pharmacist-led multi-type of job conference and effect on failure of the sutures
中澤孝文1, 山本晃平1, 川口真由子1, 山崎香織1, 鶴岡裕太2, 中村貴子1, 鈴木貴明1, 宮内英聡3, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2017.
Japanese Article 4-10-O55-24. Examination about the drug global assessment adjustment addition results of the haemodialysis introduction patients
浦嶋和也1,2, 森南沙那恵1, 鍵谷真希2,3, 平野一2,3, 能見勇人2,3, 鈴木典子1, 鈴木薫1, 西原雅美1, 東治人2,3, 勝間田敬弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2017.
Japanese Article 4-10-O55-25. Construction ... of the system about efforts - injection high risk medicine of the proper use of the syringe pump essential drug by the other types of job collaboration
喜久山有沙1, 大城匡史1, 三田井菜菜子1, 高見洋二4, 池川智子5, 上原直美3,5, 國分千代1, 新崎修2,5, 橋本孝夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2017.
Japanese Article 4-10-O56-26. It is an investigation about the compliance of guidelines on infection prophylaxis antimicrobial after the operation in the Mie University faculty of medicine hospital
中川裕司1, 森川祥彦1, 水谷栄梨1, 岡本明大1, 本多立1, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2017.
Japanese Article 4-10-O56-27. Example ... of the denosumab used for efforts - solid cancer metastases to bone to proper use by the in-hospital use situation investigation and reporting of pharmaceutical products
於本崇志1, 朝賀純一1, 青木朋彦1, 長澤佳昭1, 佐藤文彦1, 工藤賢三1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2017.
Japanese Article 4-10-O56-28. The combination of statin and heart disease therapeutic drug situation investigation
岡崎彰仁1, 山根真也1, 岩城晃一1, 石坂忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2017.
Japanese Article 4-10-O56-29. Attempt of the antipsychotics weight loss in the outpatient based on a 2016 medical service fees revision
坂本靖之1, 助川鶴平2, 佐藤康一1, 三島直也3, 門野恵莉4, 堀浩政1, 光山忠史4, 西川正直5, 永見幸人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2017.
Japanese Article 4-10-O56-30. Study on use fact-finding of the sleep inducing drug for elderly people and medication support based on PK/PD
原田桂作1,2, 多田遼太郎3,4, 村木理英4, 村本眞由美1, 名倉弘哲2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2017.
Japanese Article 5-4-O57-01. Evaluation about the thromboembolism in bevacizumab treated patients using adverse drug reaction database (JADER) of PMDA
松村千佳子1, 地嵜悠吾1, 矢野義孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2017.
Japanese Article 5-4-O57-02. Associated factor of proteinuria in the Bevacizumab administration
藤林遼1, 鈴木直哉1, 地主隆文1, 藤田果那1, 木下愛1, 庄崎沙耶1, 田中耕太1, 山本翔太1, 前川英輝1, 山田将悟1, 菊地義明1, 高橋誠1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2017.
Japanese Article 5-4-O57-03. Retrospective cohort study about stomatitis with the antiEGFR antibody combination colon cancer chemotherapy
板倉祥嗣1, 土手賢史3, 亀位耕平2, 津田正博1, 小林由佳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2017.
Japanese Article 5-4-O57-04. The effect that renal function and the evaluation method give for colon cancer postoperative CapeOX therapy
伊藤文香1, 市川和哉1, 宮崎雅之1, 岡島亜衣1, 近藤舞子1, 茂木俊樹1, 安藤雄一2, 千崎康司1, 永井拓1, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2017.
Japanese Article 5-4-O57-05. Investigation about the onset of hypersensitivity of oxaliplatin
松由幸司1, 山口雄士1, 佐藤和也1, 保母泰斗1, 近藤章吾1, 桜井由美子2, 塚原民夫1, 堀内正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2017.
Japanese Article 5-4-O58-06. Effective evaluation of the Short Hydration method for the nephrotoxicity with the etoposide cisplatin therapy
稲田顕慶1, 山際岳朗1, 池見泰明1, 今井哲司1, 祝千佳子1, 家永嘉子1, 石橋直哉1, 深津祥央1, 金永学2, 永井宏樹3, 平井豊博2, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2017.
Japanese Article 5-4-O58-07. Examination about the body-surface area revision of the renal function index in the cisplatin administration
槙原克也1, 寺沢匡史1, 内山ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2017.
Japanese Article 5-4-O58-08. Effect of lassitude and the carnitine excretion with the cisplatin administration
池崎友明1,2, 鈴木健介4, 神原健太3, 梶浦新也2, 三輪敏郎2, 田辺公一5, 菓子井達彦2, 北澤英徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2017.
Japanese Article 5-4-O58-09. Examination of the adverse event expression situation and the effect predictor of the nivolumab in the Minami-3-jo, Sapporo Hospital
梅原健吾1, 島田歩2, 岡山有希1, 野表しおり1, 東田貴之1, 後藤桂輔1, 岡崎泰香1, 高田寛奈1, 若本あずさ1, 初山多恵1, 佐藤秀紀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2017.
Japanese Article 5-4-O58-10. Examination of the risk factor of the dermatopathy with lenalidomide in patients with multiple myeloma
杉富行1, 中村香織2, 西上泰生1, 才郷博久1, 花井誉1, 華見3, 井上盛浩3, 萩原政夫3, 高畠啓輔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2017.
Japanese Article 5-5-O59-01. Questionary survey about the use of the restroom for men during anticancer medicine administration
景秀典1, 井野川徹1, 高山慎司1, 河野友昭1, 細川恵子2, 山内照夫3, 後藤一美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2017.
Japanese Article 5-5-O59-02. Maintenance ... of the practice system using the PDCA cycle in the multicenter questionary survey - Aichi cancer practice cooperation base Hospital about anticancer agent exposure measures
宇都宮純平1, 黒田純子2, 鈴木大吾3, 山関智恵4, 間瀬悟5, 米山英二6, 河田健司7, 室圭8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2017.
Japanese Article 5-5-O59-03. Attitude survey of the pharmacist in 67 hospitals about the negative pressure vial
高子優子1, 細見健悟1, 関佳世1, 吉間美保子1, 山尾多鶴子1, 田中絵美1, 久井裕美子1, 杉田裕貴1, 小牧佐知子1, 稲田智子1, 増本憲生1, 大槻裕朗1, 岡本禎晃2, 金啓二3, 名徳倫明4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2017.
Japanese Article 5-5-O59-04. Investigation of the pollution status of the person of preparation gloves in the cyclophosphamide preparation using Vildagliptin shield (EQUASHIELD) and the surrounding environment
前田章光1, 下村一景1, 栗原幸司1, 高橋新次1, 橋本直弥1, 長谷川彩子1, 小原真紀子2, 高畑知帆子2, 稲熊一英1, 水野靖也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2017.
Japanese Article 5-5-O59-05. Examination ... in the multicenter anticancer agent exposure investigation - cancer practice cooperation base Hospital in foreign chemotherapy room 7 institution
田代雄祐1, 黒田純子1, 松田日出三2, 太田秀基2, 河田健司3, 室圭4, 木村和哲5,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2017.
Japanese Article 5-5-O60-07. Inspection of the quantity of exposure decrease effect by the use of closed system system for the anticancer medicine preparation
濱宏仁1, 成橋和正2, 杉浦伸一2, 中西弘和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2017.
Japanese Article 5-5-O60-08. It is ... from full-scale introduction and evaluation ... anticancer agent preparation of closed system anesthesia drug transportation system (CSTD) to administration management
松田圭一郎1, 延川正雄1, 齋藤順1, 菅原拓也1, 荒井浩一1, 山口しのぶ2, 二瓶祥子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2017.
Japanese Article 5-5-O60-09. Usefulness of the plastic needle for the foreign insoluble matter occurring at a paclitaxel preparation
八木健太1, 武田達明1, 牛尾聡一郎1, 江角悟1, 鍛治園誠1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2017.
Japanese Article 5-5-O60-10. Examination of "the quality" of the foreign chemotherapy person in charge of treatment with safe anticancer medicine pharmacist in response to needs
伊藤武志1,3, 上田綾佳1,3, 山下知香1, 横井恵1, 黒岩勇人1, 野々内裕紀1, 勝島詩恵2,3, 柳原一宏2,3, 濱口良彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2017.
Japanese Article 5-6-O61-01. An evaluation of the doubt inquiry protocol about the antimicrobial consumption and analysis
川村和宏1, 南和志1, 石倉一樹1, 田村健悦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2017.
Japanese Article 5-6-O61-02. Examination of the background factor in Clostridium difficile antigen-positive patients
大柿滋1, 田上恵梨2, 牛島智子1,2, 宮村重幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2017.
Japanese Article 5-6-O61-03. Examination about the time to antimicrobial administration start in sepsis and the consciousness of the healthcare worker
遠山泰崇1, 堀光愛子1, 福島祐子1, 新宮裕美1, 幸沙和1, 末延裕海1, 小野友香理1, 井上真1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2017.
Japanese Article 5-6-O61-04. Intermediate evaluation and problem of the AMR action plan result target in the chronic phase medical treatment Hospital
水谷一寿1, 佐藤貴範2, 本間友香3, 齋藤美緒3, 森岡まゆみ3, 上田修4, 中谷玲二4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2017.
Japanese Article 5-6-O61-05. Effect on antimicrobial doses and culture submission according to the renal function of non-intervention case by the introduction of the antimicrobial round
杢保貴幸1, 徳竹裕貴1, 大西優里1, 石井康友2, 植田宏治3, 松岡裕士4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2017.
Japanese Article 5-6-O62-06. We look at the rear of the effect on liver, renal function views with the meropenem hydrate generic drug administration and examine a mark
中蔵伊知郎1,2,3, 坂倉広大1,2, 今西嘉生里1,2, 岩川精吾3, 福田利明1, 佐光留美1, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2017.
Japanese Article 5-6-O62-07. Effect of expression time and the other agents combination of the drug-related QT prolonged with the new quinolone antibacterial
松尾純1,2, 山折大1,2, 村井健太郎1,2, 三村享1,2, 大森栄1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2017.
Japanese Article 5-6-O62-08. Investigation about the relationship of renal function and the thrombocytopenia in the short-term administration of the linezolid
平塚公己1, 川村充史2, 小松敏彰1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2017.
Japanese Article 5-6-O62-09. One patient who presented with metronidazole (MNZ) encephalopathy in the young people whom we discovered by team approach in medical care early
内木義泰1,4, 征矢佳輔2,4, 池田淳司3, 伊藤陽一1, 清水雄策3, 竹内信道4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2017.
Japanese Article 5-6-O62-10. An example of patients with ulcerative colitis who had the cytomegalovirus enterocolitis that showed dermatopathy with the foscarnet Na hydrate
橋本陽1, 小出哲朗1, 着本望音2, 石川久高1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2017.
Japanese Article 5-7-O63-01. Attitude survey about the behavioral disorder in the use of nonprescription drug of the consumers using the focus group interview
立矢由佳1, 堀里子2, 三木晶子2, 佐藤宏樹2,3, 高橋亜貴子4, 澤田康文2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2017.
Japanese Article 5-7-O63-02. The phototoxicity of the preventive measures against ultraviolet rays product and the measures
富岡節子1, 山崎直毅2, 山崎勝弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2017.
Japanese Article 5-7-O63-04. About the current situation of the use of generic medicine promotion and a future problem
尾形梨名1, 佐谷怜子1, 福山宗宏1, 佐谷圭一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2017.
Japanese Article 5-7-O63-05. About the efforts toward 80% of generic medicine rate of use and a future problem
佐谷怜子1, 尾形梨名1, 福山宗宏1, 佐谷圭一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2017.
Japanese Article P0001-3-PM. Correspondence and consideration of the Epinephrine autoinjector injection 0.3 mg voluntary recall (class 1)
萱野勇一郎1, 高柳和代1, 岡千恵1, 山本聖子1, 後藤卓也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2017.
Japanese Article P0003-3-PM. About the efforts of the alert indication function at "pharmaceutical products needing a laboratory study" prescription
小口正義1, 宮崎雄紀1, 水谷妙子1, 唐澤綾1, 田中文1, 神戸千紘1, 山崎夕貴1, 登内盛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2017.
Japanese Article P0005-3-PM. About the administration of the evaluation department such as specialist in nonrecognition newcomer medicines, and the like in the Ehime University faculty of medicine hospital
高田裕介1,2, 徳田力3, 田坂祐一1,4, 飛鷹範明1,2, 山田文哉1,4,5, 鈴木純1,4, 田中亮裕1,2, 泉谷裕則1,5, 田中守1,2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2017.
Japanese Article P0007-3-PM. Analysis of the medicine damage situation and efforts of the pharmacy
青柳和代1, 岩田真子1, 貝瀬眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2017.
Japanese Article P0009-3-PM. Effect and problem to the ward by the ward fixed number medicine review
鈴木博晃1, 小沼大祐1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2017.
Japanese Article P0011-3-PM. Efforts ... to operating room pharmacist duties - efficiency
竹ノ内早紀子1, 柳沢京子1, 朝日仁美1, 古林園子1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2017.
Japanese Article P0013-3-PM. Of the dead stock antitumor agents about effectively utilizing it
中村武夫1, 蒲谷亘2, 増田信也2, 佐藤優子2, 木村えり2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2017.
Japanese Article P0002-4-AM. The construction of the ordering management support system using injection order data and the effect
渡辺健太1, 齊藤美聡1, 山本健一1, 樺澤恵美1, 山本晃平1, 須藤知子1, 松島徹1, 石井晃1, 横山威一郎1, 中村貴子1, 鈴木貴明1, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2017.
Japanese Article P0004-4-AM. Efforts to reduction of the bad stock in the middle scale hospital and the significance
唐橋久恵1, 藤島ひとみ1, 平尾尚之1, 壽崎佳輔1, 眞鍋雄一郎1, 佐藤直樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2017.
Japanese Article P0006-4-AM. Cost cut by the construction of the parenteral injection supply system in PIH Health Hospital - Whittier
松浦誠1,2, Shunsuke Toyoda1,3, 小野寺健1,4, Chang Carmen3, Mccowan Diane3, 高橋寛1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2017.
Japanese Article P0008-4-AM. About correspondence at the pharmacist absence in the institution belonging to association of Kumamoto medical corporation chief pharmacist society
川崎裕美1, 谷口隆幸2, 森伸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2017.
Japanese Article P0010-4-AM. Current situation ... of the pharmaceutical products bar code indication to proposal - pillow packing for use of pharmaceutical products bar code
増井里紗1, 池田和之1, 吉川一吾1, 辻力夫1, 杉山幸正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2017.
Japanese Article P0012-4-AM. An evaluation and attitude survey about the pharmaceutical products administrative work in the operating room by the intervention of the pharmacist
柳澤京子1, 竹ノ内早紀子1, 朝日仁美1, 古林園子1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2017.
Japanese Article P0014-4-AM. Maintenance of the medicine regime for the clinical study for appropriate enforcement of the clinical study
有馬秀樹1,2, 豊田貴美子1,2, 篠崎寛一1,2, 構木泰信1,2, 近藤智子2, 丸本芳雄2, 内田豊1, 古川裕之1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2017.
Japanese Article P0016-4-AM. Improvement of CRC duties in the Okinawa Hospital
岩尾卓朗1, 鈴田浩孝1, 上原智博1, 鈴木寛人1, 永野真久1, 則松郁香1, 中嶋浩太郎1, 河野大希1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2017.
Japanese Article P0015-3-PM. Attempt of the precision regime maintenance about trial
鈴田浩孝1, 河野大希1, 中嶋浩太郎1, 岩尾卓朗1, 則松郁香1, 永野真久1, 鈴木寛人1, 上原智博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2017.
Japanese Article P0017-3-PM. The attitude survey for the duties of the open-label pharmacist concerned with a trial and investigation in the real duties load
白澤宏美1, 山下克也3, 鶴崎泰史2, 高武嘉道1, 村田健司1, 山形真一2, 中川義浩2, 芳賀克夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2017.
Japanese Article P0018-4-AM. Operation of the anticoagulant, antithrombocytic agent check sheet in our hospital
堂薗吉彬1, 棚田訓彰1, 安河内亮太1, 中島一1, 今村陽子1, 池田浩和1, 高橋浩二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2017.
Japanese Article P0020-4-AM. Management of the drugs for clinical test in the charge clinical department domain by the ward pharmacist
河濟泰生1, 下野梨麻1, 若林和貴1, 硲貴和子1, 有馬秀樹1, 内田豊1, 古川裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2017.
Japanese Article P0022-4-AM. One case that had a diagnosis of Wilson disease during SLE treatment
立川奈保美1, 池下智之1, 吉田紗理1, 古川夏1, 石樋康浩1, 三島芳枝1, 的場美香1, 高木麻里1, 吉田智江1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2017.
Japanese Article P0024-4-AM. It is the intervention of the surgery ward pharmacist for patients with infection after the operation that showed a rise in serum potassium value
河上卓弥1, 馬場俊彰1, 堀友美1, 松谷洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2017.
Japanese Article P0026-4-AM. For the reduction of the incident accident in the emergency ward
加藤まゆ1, 安井一正1, 西澤圭祐1, 高橋弘泰1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2017.
Japanese Article P0028-4-AM. Point to keep in mind of the intervention of the ICU charge pharmacist after having done a change ridge in a regular hospital from the ICU
安井一正1, 高橋弘泰1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2017.
Japanese Article P0030-4-AM. The diffusion phenomenon that resulted from a very small amount of continuous intravenous infusion root that combined a syringe pump with an infusion pump
長井美樹1, 望月真維1, 伊藤裕司2, 菅島加奈子3, 三田浩子3, 加藤木玉江3, 石川洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2017.
Japanese Article P0032-4-AM. Effect and the evaluation that the duties contents change that took advantage of the prescription input support by the pharmacist gives for ward drug duties
飯田慎也1, 井上正朝1, 寒藤雅俊1, 都築仁美1, 山下恭範1, 大滝康一1,2, 小川聡1, 福土将秀1, 粟屋敏雄3, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2017.
Japanese Article P0034-4-AM. About efforts to improvement in ward drug control instruction duties in our hospital
永松秀紹1, 吉川直利1, 江本侑子1, 片岡万里奈1, 横田学1, 村上照幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2017.
Japanese Article P0036-4-AM. The representation prescription situation that a pharmacist receives in the cardiovascular surgery ward
前川綾子1, 西村健二1, 益本周治1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2017.
Japanese Article P0038-4-AM. Examination (followup) of standardization, the efficiency of ward drug duties, the medication counseling in surgery, the oral surgery ward
加藤さやか1, 本木龍二1, 田村賢士1, 金子智一1, 松井孝之1, 寺田伊知郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2017.
Japanese Article P0042-4-AM. Fact-finding about the pharmaceutical management of the high-risk medicine
中村俊貴1, 宮下博幸1, 小林義和1, 小林由布子1, 八木澤啓司1, 斎藤太寿1, 小林彦登1, 齋藤雅俊1, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2017.
Japanese Article P0044-4-AM. Than the staff questionnaire after the evaluation - ward drug duties start of the ward pharmacist in the small and medium size hospital ...
石垣智加1, 横山佳寿子1, 平野泰健1, 服巻陽子2, 杉本ひろみ3, 白井孝則4, 中村守4, 竹中ゆかり5, 森信早穂子6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2017.
Japanese Article P0046-4-AM. Look back on drug global assessment adjustment addition - start one year in our hospital; and -
野村理恵1,2, 森美穂2, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2017.
Japanese Article P0048-4-AM. For improvement in number of the calculation of the drug global assessment adjustment addition
石野陽一1, 村山佳子1, 和田淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2017.
Japanese Article P0050-4-AM. Cooperation of a physician, the pharmacist for the promotion of the appropriate medical treatment
菅井千尋1, 原島久美1, 箱崎かおり1, 飯山久美子1, 田上明子1, 串田一樹2, 安藤浩巳1, 水村恒雄1, 山本健2, 廣原正宜2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2017.
Japanese Article P0052-4-AM. Efforts to the antimicrobial proper use during the operation in our hospital
黒田幸佑1, 角本久美子1, 山原慶子1, 宇埜可南子1, 西井有希1, 小泉祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2017.
Japanese Article P0054-4-AM. A pharmacist is an evaluation of the promotion of the ward antimicrobial medicine proper use by being stationed
大石博史1, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2017.
Japanese Article P0056-4-AM. Effect ... of efforts - prescription checking standardization of the ward drug duties in the maternity ward and the foreign cooperation
木永舞1, 山本珠実1, 西郷智香1, 西口由梨亜1, 相澤実里1, 坂井恵理子1, 政賢悟1, 本田義輝1, 齋藤秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2017.
Japanese Article P0058-4-AM. Efficiency of duties obtained from the making of the standard judgment chart for drug self-care of the inpatient and the utilization
尾崎正和1, 谷澤香名子1, 岡野智史1, 植松俊成1, 古川裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2017.
Japanese Article P0060-4-AM. About ward drug duties and the current situation evaluation in Osaka University School of Dentistry Hospital
大石美奈子1, 戸田史恵1, 森功美子1, 高安敏子1, 上田紘子1, 上田幹子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2017.
Japanese Article P0062-4-AM. Investigation of the drug-related incident contents in NICU/GCU ward
砂川由佳1, 瑞慶山にいな1, 伊差川サヤカ1, 与那覇房子1, 外間惟夫1, 中村克徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2017.
Japanese Article P0064-4-AM. Evaluation method of the simple and easy, accurate internal use self-discipline by the pharmacist
辻屋朝美1, 西山啓介1, 三宅麻文1, 宮本直治1, 椎橋美月2, 楠本雅美2, 白田全弘3, 水野裕美子4, 河原宏之1, 石川弘子1, 尾上雅英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2017.
Japanese Article P0066-4-AM. Improvement report of the electronic edition internal use prescription system utilizing the bar code
桑田康宏1, 上田源治1, 徳永恵土2, 土肥大典1,3, 真壁秀樹1, 川井信孝3, 寺岡俊哉4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2017.
Japanese Article P0019-3-PM. Efforts of the pharmacist for the "disease severity for the regular hospital, medical care, nursing necessary degree" evaluation
生越由美1, 田中奈桜1, 藤井克至1, 窪田彩花1, 北野祐香1, 宮部泰輔1, 黒川拓也1, 東達也1, 上田善美1, 田村憲昭1, 十田達也1, 安達克明1, 井上敦介1, 廣畑和弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2017.
Japanese Article P0021-3-PM. Quality improvement (QI) activity in ward duties
鬼窪利英1, 三浦篤史1, 伊藤隆哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2017.
Japanese Article P0023-3-PM. Introduction of the antithrombotic drug resumption protocol after the surgery in our hospital
秋山裕史1,2,3, 石崎直妙2, 袴塚康史2, 大和田万裕美2, 稲田寛之1, 海老根香里1, 川又亜由美1, 関利一1, 檜山和寛3, 中野順隆3, 神賀正博3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2017.
Japanese Article P0025-3-PM. The effect that the combination of tramadol acetaminophen combination tablets gives to PT-INR on warfarin remedy patients
矢野賢明1, 飛鷹範明1, 橋本麻央1, 山下登1, 安永大輝1, 田中守1, 田中亮裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2017.
Japanese Article P0027-3-PM. Relation of the pharmacist in the vitamin K preparation medication method change for neonates, the infants vitamin K deficiency hemorrhagic disease
岩崎瑛子1, 川下絵莉香1, 津田武典1, 竹田健志1, 菅田優子1, 伊藤千恵1, 的場美香1, 高木麻里1, 吉田智江1, 藤田敬子2, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2017.
Japanese Article P0029-3-PM. Ogura Memorial Hospital ICU, investigation about the pharmaceutical support in the backward ward of CCU
前田朱香1, 福島将友1, 曽我弘道1, 福地祐亮1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2017.
Japanese Article P0031-3-PM. Research about the association of cerebrospinal fluid reducing symptom and chemical sensitivity and electromagnetic wave hypersensitivity
鈴木高弘1, 中里直美2, 篠永正道3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2017.
Japanese Article P0033-3-PM. Efforts for the qualitative improvement of drug control instruction duties
水津智樹1, 畑裕基2, 桶本幸2, 河合実3, 小林勝昭2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2017.
Japanese Article P0035-3-PM. The effect that the ward duties of the pharmacist give for the mean hospitalization of the inpatient
吉戒渉1, 地嵜悠吾1, 松村千佳子1, 矢野義孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2017.
Japanese Article P0037-3-PM. Role of the pharmacist in the urination care team
林剛史1, 古川大樹1, 梅山昌乃2, 森田睦美3, 長谷川雅哉1, 山本茂樹4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2017.
Japanese Article P0039-3-PM. Investigation of the reporting duties of the working full time pharmacist in the extensive critical care center
東洋慶武1, 稲村広敏1, 國本雄介1, 藤居賢1, 益子寛之1, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2017.
Japanese Article P0041-3-PM. Examination of the inhalant instruction using the check list in the respiratory medical service
肥田野綾1, 上村賢介1, 高橋成博1, 佐藤明美2, 寺田正樹3, 内坪誉歳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2017.
Japanese Article P0043-3-PM. Efforts - second report ... for the pharmacist duties construction in the local inclusion care ward
佐藤伸輔1, 櫻井淳二1, 渡辺昌子1, 岡田優1, 野上佳奈子1, 宮内康夫1, 阿部順1, 武者栄美子1, 石澤文章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2017.
Japanese Article P0045-3-PM. Look back on the case that experienced about efforts of the drug global assessment adjustment addition in our hospital in ... ward; and ...
稲垣沙緒理1, 野村理恵1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2017.
Japanese Article P0047-3-PM. What is made by ward drug duties with electronic medical chart introduction?
中村和彦1, 中村嘉孝1, 山田圭子1, 大萱藍子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2017.
Japanese Article P0049-3-PM. ... which was able to reduce 10% of the hospitalization bringing medicine in intervention result - orthopedics ward of the ward charge pharmacist to polypharmacy
山元孝俊1, 安井洋一2, 河野博隆2, 森川馨3, 中島圭佑1, 細野浩之4, 安野伸浩1,3, 渡邊真知子1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2017.
Japanese Article P0053-3-PM. Efforts about the proper use of the pharmacist-led perioperative prophylactic antimicrobial in our hospital
栗崎貴啓1,2, 續政哉1, 相方靖史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2017.
Japanese Article P0055-3-PM. Questionary survey to 3 types of job about psychopathic ward drug duties in the Kusatsu Hospital
公文理紗子1, 大石千代1, 中村美貴1, 福田のぞみ1, 山田雅彦1, 宇治宏美1, 甲斐由起1, 桝井章典1, 栗原鑑三2, 別所千枝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2017.
Japanese Article P0057-3-PM. The analysis of the doubt inquiry example in the merger mind center ward in the Kyushu medical center and the pharmacist image that is sought
藤田強記1, 福山雄卯介2, 林稔展3, 西野隆3, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2017.
Japanese Article P0059-3-PM. Effect of the pharmacist intervention by the ward drug duties start in neurology, the respiratory internal medicine, internal secretion, metabolism, diabetes medical service
田崎智也1, 大野梨絵1, 河野洋平1, 関屋裕史1, 岩切智美1, 奥村学1, 有森和彦1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2017.
Japanese Article P0061-3-PM. Fact-finding of the warfarin induction and future view
小西麻美子1, 澤田真嗣1, 山崎映美1, 堀内あす香1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2017.
Japanese Article P0065-3-PM. Making and evaluation of the medical calculation tool
河村聡志1, 末延道太1, 梅野智美1, 岩崎和広2, 紀雅之3, 菅田哲治2, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2017.
Japanese Article P0067-3-PM. The prospects of the Primary care duties for the patients addicted to the poison in medicine thing of the pharmacist
冨永麻里子1, 今浦将治1, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2017.
Japanese Article P0069-3-PM. Intervention and evaluation by the pharmacist at biological drug introduction in the psoriasis medical therapy
平出耕石1,2, 宮本義浩1, 古田愛果1, 安田憲隆1, 佐竹史章3, 大原満梨奈3, 森知花3, 岡田純子3, 加藤武司1, 神谷秀喜3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2017.
Japanese Article P0071-3-PM. Examination - using data of effect - VISTA Project that the simple and easy intervention through the notebook gives in recognition for the medication counseling using the notebook of the pharmacist
清水麻里奈1, 庄司雅紀1, 荒川行生1, 恩田光子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2017.
Japanese Article P0073-3-PM. Examination - using data of effect - VISTA Project which simple and easy intervention using the prescription notebook by the pharmacist gives in the appropriate use degree of the prescription notebook of patients
森田圭祐1, 庄司雅紀1, 荒川行生1, 恩田光子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2017.
Japanese Article P0075-3-PM. Effect of the antimicrobial doses suggestion according to cancellation medicine's confirmation and the renal function by the pharmacist interview before our hospital prostate biopsy
清川明慶1, 齊藤亮1, 矢田康司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2017.
Japanese Article P0077-3-PM. Efforts of the pharmacist concerned with common use medicine management before hospitalization in the admitting department
中根優1, 南貴之1, 遠藤愛樹1, 向山明彦1, 花輪和己1, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2017.
Japanese Article P0079-3-PM. Evaluation and problem ... of the pharmacist duties in the examination ... patients synthesis support center about the factor of the observance situation and the discontinuation mistake of the discontinuation before surgery, examination
中下愛実1,2, 野澤まゆ1, 小林奈央1, 堀寧1,2, 山田徹1, 五十嵐洋子2, 内藤厚子2, 倉林工2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2017.
Japanese Article P0081-3-PM. About outside Parliament information sharing through a start and the medicine medicine cooperation of confirmation of foreign bringing medicine before hospitalization duties
馬上雅光1, 上平美穂子1, 永山美佐枝2, 小野広枝2, 梶原徹1, 渡邉義久3, 高橋浩子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2017.
Japanese Article P0083-3-PM. It is ... led by an importance - stomach ESD, EMR case of the cooperation in the on admission bringing medicine's confirmation from the outpatient department in front of the art
渡辺篤1, 宮森伸一1, 升田夏希1, 岩崎歩1, 柳田祐子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2017.
Japanese Article P0085-3-PM. It is ... mainly on current situation - urology department of the suggestion to a physician in the pharmacist outpatient department
久保嘉靖1, 三浦恵理1, 高柳信子1, 奥野昌宏1, 中田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2017.
Japanese Article P0087-3-PM. The system construction (pharmacist outpatient department) for the cancer instruction to patient management charges 3 calculation
鶴崎泰史1, 大橋邦央1, 丸田基史1, 後藤由起子1, 藤田強記1, 横田千明1, 山形真一1, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2017.
Japanese Article P0089-3-PM. About the relation of the pharmacist to cancer instruction to patient management charges 3 calculation and foreign chemotherapy
小笠原健1, 虻川詩希子1, 金沢久男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2017.
Japanese Article P0091-3-PM. Relation (the second report) to the drug introduction patients in the pharmacist outpatient department
川久保充章1, 釘原瑶子1, 上津沙織1, 居塚しのぶ1, 小倉秀美1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2017.
Japanese Article P0093-3-PM. The construction of the outside Parliament internal use anticancer agent instruction system and change of cancer instruction to patient management charges 3
鈴木雅人1, 木全司1, 松丸沙織1, 笠井翼1, 高原悠子1, 牧原明秀1, 吉田弘樹1, 山室理2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2017.
Japanese Article P0095-3-PM. Operation of the pharmacist outpatient department for patients with lung cancer and the enforcement situation
前田剛司1, 鈴木敦詞1, 鈴木大吾1, 坂田洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2017.
Japanese Article P0097-3-PM. Examination about the cancer support pharmacist foreign current situation in our hospital and the usefulness
神原康佑1, 荻原好章1, 大塚識稔1, 原景子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2017.
Japanese Article P0099-3-PM. The consultation of the pregnancy, the nursing domain is foreign
一木幸奈1, 勝野晋哉1, 山田哲也1, 鷹見繁宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2017.
Japanese Article P0101-3-PM. Medication support of the pharmacist for Daclatasvir Asunaprevir combination therapy patients
山本恭平1, 鶴田昌吾1, 岩瀬由枝1, 新海大智1, 野澤孝子1, 渡辺裕之1, 中村和行1, 伊藤友恵1, 大野愛1, 久保田敏行1, 杉浦洋二1, 勝見章男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2017.
Japanese Article P0103-3-PM. Usefulness of the foreign medication counseling in the direct action type antiviral therapy for the hepatitis C
岡田莉奈1, 平野公美1, 冨田奈々1, 松本ゆいこ1, 杉山幸子1, 山川花朱美1, 宮本康敬1, 影山富士人2, 渡邉進士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2017.
Japanese Article P0105-3-PM. The effect that inspiratory flow rate reduction in the inhalation therapy of patients with bronchial asthma, COPD gives to hoarseness
森田淳一1, 金沢昂1, 大和田有1, 大内崇代1, 岩崎英次1, 長南達也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2017.
Japanese Article P0107-3-PM. Research about a question and the solution to medicine which patients have
山田航輔1, 富岡裕菜1, 大久保駿一1, 笹木拓郎1, 高橋雅也1, 沖垣圭亮1, 横川祐美1, 寺原史貴1, 齊藤俊一郎1, 船木映二1, 橋本義宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2017.
Japanese Article P0109-3-PM. Operation and evaluation of the tracing report which outpatient department exclusive duty pharmacist intervened in positively
満田正樹1, 尾崎加織1, 石本昌裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2017.
Japanese Article P0111-3-PM. Establishment of discontinuation instruction duties before operation based on a protocol in the orthopedics outpatient department
安東大智1, 山村亮太1, 五十川達哉1, 宮本弥生2, 永野俊玲1, 泊一秀3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2017.
Japanese Article P0113-3-PM. Search of the factor associated with the onset of the delirium after the operation concerned
宮部泰輔1, 生越由美1, 黒川拓也1, 東達也1, 田村憲明1, 安達克明1, 井上敦介1, 廣畑和弘1, 結城奈津子2, 山野純弘3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2017.
Japanese Article P0115-3-PM. Evaluation - of the check sheet for evaluation - adrenalin injection (Epinephrine autoinjector injection) instruction of explanation, instruction duties in the pharmacist outpatient department
見目英継1, 菊岡慶1, 寺田有希1, 小暮宗介1, 折井孝男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2017.
Japanese Article P0068-4-AM. Examination about the drug confirmation duties for the preoperation patients in the outpatient department
萩歩美1, 組橋由記1, 福島ゆかり1, 鈴江朋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2017.
Japanese Article P0070-4-AM. Elba building in patients on dialysis, efforts in the foreign instruction of the Grazoprevir
如田真貴1, 後藤渉1, 大穂有恒2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2017.
Japanese Article P0072-4-AM. Analysis ... of an intervention case and the continuous intervention case from evaluation - outpatient department of an evaluation of the usefulness in the pharmacist outpatient department and the medical economic effect after the discharge
土屋裕伴1, 日野亜莉沙1, 光田恵里香1, 齋藤由貴1, 諸橋賢人1, 腮尾成美1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2017.
Japanese Article P0074-4-AM. It is analyzed the factor with the time in the prehospital common use medicine's confirmation
祖川倫太郎1, 西村文1, 江越寿美代1, 木村早希子1, 田崎正信1, 成澤寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2017.
Japanese Article P0076-4-AM. Efforts of the pharmacist for the discontinuation management before surgery of the outpatient
樽野麻依1, 梶田貴司1, 庄司賀子1, 木口真佐恵1, 佐藤香苗1, 野澤直美1, 久乗しのぶ1, 奥野智之1, 上田睦明1, 福田奈津子2, 原里美2, 林野泰明3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2017.
Japanese Article P0078-4-AM. The effect that an outpatient in front of the anesthesiology art gave appropriate management and ward drug duties of the stop medicine in front of the art
土屋翔子1, 長水正也1, 鵜飼めぐみ1, 野田雅人1, 岡本有紀子1, 佐藤由美子1, 六鹿浩1, 森下修行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2017.
Japanese Article P0080-4-AM. Efforts of the pharmacist in the hospitalization support
小林奈央1, 中下愛実1,2, 野澤まゆ1, 堀寧1,2, 山田徹1, 五十嵐洋子2, 内藤厚子2, 倉林工2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2017.
Japanese Article P0082-4-AM. Intervention effect of the pharmacist for outpatients in front of the anesthesiology art
岡崎裕太朗1, 木村丈司1, 戸田飛鳥1, 阪上倫行1, 江口舞1, 西岡達也1, 久米学1, 槇本博雄1, 平井みどり1, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2017.
Japanese Article P0084-4-AM. Evaluation of the practice system that a pharmacist attends the encounter of the physician in the foreign chemotherapy
北出紘規1, 北国憲剛1, 安藤友貴1, 森光恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2017.
Japanese Article P0086-4-AM. About the effectiveness of the medicine medicine cooperation for protocol joint ownership in oral anticancer agent side effect measures
中川雅史1, 泉本裕美1, 岸孝行1, 宮内実奈絵1, 吉岡厚子1, 狩谷佳寛1, 樫葉利人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2017.
Japanese Article P0088-4-AM. Activity evaluation of the foreign chemotherapy room exclusive duty pharmacist alone system for 3 years
合澤啓二1, 岩田一史1, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2017.
Japanese Article P0090-4-AM. Inspection of the usefulness of by medical examination front for the use of foreign drug patients by the pharmacist
今岡寛美1, 榎本美幸1, 伊藤友一1, 森住誠1, 石原美加1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2017.
Japanese Article P0092-4-AM. Efforts of by drug medical examination front for the medical care for the outpatient
木村桃子1, 魚住菜月1, 亀井健人1, 石田直2, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2017.
Japanese Article P0094-4-AM. It is ... through examination - pharmacist outpatient department of the future problem for the efforts to foreign cancer medical therapy, doubt inquiry in the chemotherapy center
神田英一郎1, 大坪達弥1, 加藤良隆1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2017.
Japanese Article P0096-4-AM. Effect of the Residual medicine adjustment in the pharmacist outpatient department
大原正之1, 斉藤匡昭1, 高山冴子1, 藤原斉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2017.
Japanese Article P0098-4-AM. Efforts to the group support program by the multi-type of job team in the outpatient specialized in dementia
古川公美子1, 堀田牧2, 小山明日香2, 丸山貴志2, 園田恵2, 遊亀誠二2, 石川智久2, 橋本衛2, 齋藤秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2017.
Japanese Article P0100-4-AM. Real-time team approach in medical care in the dialysis rounds that a pharmacist and dietitian are accompanied by
中川聡1, 八城学1, 相澤政明1, 清水健史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2017.
Japanese Article P0102-4-AM. Examination of the method not to be choked, and to inhale dry powder preparation
中村敏史1, 伊藤稔宏1, 山本雅史2, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2017.
Japanese Article P0104-4-AM. Relation of the instruction situation and the pharmacist of the chronic hepatitis C therapeutic drug
永井智子1, 内田将吾1, 上田恒治1, 奥村明彦2, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2017.
Japanese Article P0106-4-AM. Inhalation therapy support in the pharmacist outpatient department: It is unified inhalational instruction and evaluation methods
野田幸裕1, 浮貝真子1, 後藤綾1, 肥田裕丈2, 宮崎雅之2, 山田清文2, 吉見陽1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2017.
Japanese Article P0108-4-AM. Efforts (the second report) for grasp and the improvement of the use of inhalant situation in our hospital in inhalational adherence
荒木寛也1, 坂柳悦章1, 西川隆一1, 澤柳直樹1, 藤井友和1, 辻博幸1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2017.
Japanese Article P0110-4-AM. About operation to confirm discontinuation instructions without posting a pharmacist in the hospitalization support center by exclusive duty
大谷寧次郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2017.
Japanese Article P0114-4-AM. Intervention of the use situation of the oral hepatitis C therapeutic drug in our hospital and the pharmacist
小倉功1, 竹下和輝1, 松山哲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2017.
Japanese Article P0116-4-AM. Evaluation of the prescription modified supporting duties in the surgery ward
山中真理1, 宮城明実1, 辻村行啓1, 荒川大輔1, 塩川満1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2017.
Japanese Article P0118-4-AM. Development second report of the foreign present situation and pharmacist duties specialized in Oriental medicine to be in the faculty of medicine hospital
日置智津子1, 伊藤エミ1, 中井賀世子1, 宇高一郎1, 村重史子1, 椎名昌美1, 武田卓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2017.
Japanese Article P0120-4-AM. Improvement of doubt introduction duties by the efforts (the fifth report) CDTM introduction for joint medical treatment (CDTM) in the community medical care
小川壮寛1, 松下明2, 守安洋子1, 田中綾1, 河南真衣1, 中島利裕1, 中尾直1, 江川孝4, 島田憲一3, 高見陽一郎3, 高橋正志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2017.
Japanese Article P0122-4-AM. The current situation of education and the teeth medicine cooperation using the high-performance patients simulator for the dentist
大月理恵子1, 小川敦1, 大川恭昌1, 勝部理早1, 蔵田靖子1, 日野隼人1, 白石奈緒子1, 錦織淳美1, 名和秀起1, 山口貴子2, 万代康弘2, 大澤晋3, 北村佳久1, 清水裕雄4, 那須保友2, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2017.
Japanese Article P0124-4-AM. Improvement ... of the dramatic increase and generic drug availability ratio of strategy and evaluation - drug control instruction number using the balance scorecard
遠藤正憲1, 山口瑞彦1, 藤井重治1, 塚本有子1, 赤瀬朋秀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2017.
Japanese Article P0126-4-AM. It is tried the raising at the confirmation time by the pharmacist in the clinical path making
宗田一記1, 山口進1, 石井啓貴1, 佐久間淳一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2017.
Japanese Article P0117-3-PM. The efforts to the germfree preparation duties of use of heart surgery pharmaceutical products by the operating room charge pharmacist and the evaluation
白石洋輔1, 竹本雄一1, 廣瀬正幸1, 平岩歳久1, 加藤貴大1, 今井一輝1, 太田秀基1, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2017.
Japanese Article P0119-3-PM. Efforts about the examination for protein urine protocol introduction at the bevacizumab ramucirumab administration and future problem
熊谷修一1, 目黒聡子1, 酒井由希子1, 野口真利1, 佐藤晃一1, 永倉史子1, 川口裕花1, 渡辺京彦1, 大川真里奈1, 高山裕子1, 山内泰一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2017.
Japanese Article P0121-3-PM. Investigation about the Residual medicine adjustment of the outside Parliament prescription
塚元美江1, 富士谷昌典1, 西井有希1, 黒田幸佑1, 杤尾香奈1, 北山明子1, 小泉祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2017.
Japanese Article P0125-3-PM. Consideration about the external environment analysis at balun strike scorecard making for hospital pharmacist
金田昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2017.
Japanese Article P0127-3-PM. The review of the pharmacist duties in the operating room in our hospital and future examination
北川奈津子1, 桶谷純子1, 山口翔平1, 荒井涼子1, 小池田玲子1, 平木祥子1, 土田英昭2, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2017.
Japanese Article P0130-4-AM. Examination - of electronic prescription notebook use and application - two ways communication model for patients and a pharmacist
田代朋子1, 本田卓也1, 折井孝男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2017.
Japanese Article P0132-4-AM. Examination of the use master who should enroll in a drug-related system in the hospital managing by a handwritten prescription
谷口美悠1, 竹林太志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2017.
Japanese Article P0134-4-AM. Efforts for the record making duties improvement by the template introduction
魚住秀親1, 水之江峻介1, 岡本美由紀1, 下山真智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2017.
Japanese Article P0129-3-PM. Examination of the prescription misdecrease effect by the customization of the pharmaceutical products master
浦崎圭太1, 植村太志1, 一木万奈美1, 長谷川徹1, 菱田栄子1, 久田純生1, 河井和子1, 伊藤和幸1, 磯谷聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2017.
Japanese Article P0131-3-PM. Promotion and drug control instruction support of the antimicrobial proper use based on the expansion of the antimicrobial proper use check system at impaired renal function
松本薫1, 佐藤篤郎1, 永田実1, 加藤直紀1, 天野哲史1, 鈴木裕之1, 八並ゆかり1, 榊原奈美1, 伊藤昌美1, 鈴木厚志1, 板倉由縁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2017.
Japanese Article P0133-3-PM. The computerization of the drug application record in the Mie University faculty of medicine hospital and the evaluation
岡本明大1, 濱口直美1,2, 水谷栄梨1, 岩本卓也1, 安積良紀3, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2017.
Japanese Article P0135-3-PM. The effect that the introduction of the database for the prescription check gives to the number of doubt inquiries
岩田一史1, 宮崎美香1, 合澤啓二1, 秋吉明子1, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2017.
Japanese Article P0137-3-PM. Inquired analysis about the off-label use put to the drug information room
村上ひろみ1, 金子美智子1, 天田斉子1, 橋爪孝弘1, 田中怜1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2017.
Japanese Article P0139-3-PM. Effect on transluminal dose of clopidogrel sulfate tablets by the simultaneous suspension with magnesium oxide tablets
青木学一1,2, 加藤雅大2, 有馬志保1, 長井賢一郎1, 長光亨1, 尾鳥勝也1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2017.
Japanese Article P0141-3-PM. Making of the antithrombotic drug off-period check tool in the digestive organ endoscope practice
若林千草1, 益子里美1, 秋本円香1, 植田生織1, 松本麻美1, 松本啓一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2017.
Japanese Article P0143-3-PM. The construction of the database about the injection drug incompatibility information and evaluation of the usefulness
中川貴弘1, 伊藤健二1, 上田祥子1, 上見藍子1, 北庄司敦久1, 西井拓人1, 原義浩1, 宮本紅喜1, 宮本訓子1, 山地亜希1, 山道麻葉1, 薮内新平1, 森朝紀文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2017.
Japanese Article P0145-3-PM. A medicine bag and efforts to English version making of the drug reporting paper
井上理咲子1, 赤沢翼1, 上山麻衣1, 瀬戸恵介1, 吉川至1, 増田純一1, 近藤直樹1, 坂本治彦1, 桑原健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2017.
Japanese Article P0149-3-PM. Efficiency of the bringing medicine report by the cooperation with the drug information management room
二上佳世子1, 松森智士1, 高野由美子1, 大越美根子1, 政氏藤玄1, 小堀勝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2017.
Japanese Article P0151-3-PM. Analysis about the rhabdomyolysis, and the like of the new quinolone antibacterial using Japanese adverse event spontaneous report database (JADER)
太田涼介1, 平田敦士1, 畑武生2, 能登啓介1, 福井愛子1, 西原雅美2, 勝間田敬弘2, 松岡寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2017.
Japanese Article P0153-3-PM. A relative evaluation of prostaglandin system eye drops and the asthma using JADER: Comparison with beta-blocker eye drops
大山勝宏1, 杉浦宗敏1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2017.
Japanese Article P0155-3-PM. Research about the alcohol-containing drug
相良有里1, 齋藤雅俊1, 左右田和枝1, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2017.
Japanese Article P0157-3-PM. Examination for HBV history confirmation using eXChart and regimen integration effect of the examination order tool
山中理1,2, 阿部史誉1, 益澤明3, 中山英夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2017.
Japanese Article P0159-3-PM. The future way to regard as the mention contents of the pharmaceutical products risk management plan from update frequency
平山優花1, 相良克海1, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2017.
Japanese Article P0161-3-PM. About problems at reuse of the questions and answers record of the drug information room
関谷泰明1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2017.
Japanese Article P0163-3-PM. About the activities of the Fukui pharmacist society pharmaceutical affair information center
平賀貴志1, 矢野七恵2, 古俵美穂2, 山瀬美香2, 高畠栄一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2017.
Japanese Article P0136-4-AM. "The secant design" of the tablet judging from a package insert, interview form
若林進1, 田中秀和2, 藤澤哲也3, 三上明子4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2017.
Japanese Article P0138-4-AM. Use and application of the correspondence manual and PMDA adverse drug reaction database according to the serious side effect disease in pharmacist duties
冨田淳子1, 梁木美幸1, 立道貴清1, 越野優希1, 綾野武司1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2017.
Japanese Article P0140-4-AM. Fact-finding of the risk minimization activity for patients for the enumeration risk of pharmaceutical products risk management plan
市江敏和1,2, 浅川博翔2, 鈴木大介1,2, 寺崎嘉正1, 林秀樹2, 畔柳敏弥1, 杉山正2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2017.
Japanese Article P0142-4-AM. Making of the drug intoxication reporting application using package insert information data
田中正臣1, 田中彰一1, 武田瑛司1, 宮腰恵生1, 森野太一1, 山岡幸1, 竹内正真1, 宮越貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2017.
Japanese Article P0144-4-AM. The construction of the existing intellect non-intellect automatic judgment system of the adverse event spontaneous report by the exhaustive mapping of the side effect term and inspection by SGLT2
多門啓子1, 吉川達也1, 五島誠1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2017.
Japanese Article P0146-4-AM. Management and evaluation of off-label use pharmaceutical products
上田彩1, 杉村春奈1, 北山知里1, 望月智子1, 小野寺夕貴1, 坂上逸孝1, 田中恒明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2017.
Japanese Article P0148-4-AM. Comparison between conventional signal detecting method and association analysis for the purpose of the search of the adverse event by the pharmaceutical products interaction
野口義紘1, 上野杏莉1, 大坪愛美1, 勝野隼人1, 杉田郁人1, 兼松勇汰1, 吉田阿希1, 江崎宏樹1,2, 舘知也1, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2017.
Japanese Article P0150-4-AM. Investigation of the information about taste, the smell, and the like of the drug for children
花沢祐紀1, 佐田宏子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2017.
Japanese Article P0152-4-AM. The construction of the information on adverse drug reactions uniform management method in our hospital and the analysis
北村憲雅1, 大竹野久雄1, 横尾賢乗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2017.
Japanese Article P0156-4-AM. It is ... using RMP of investigation and problem - tolvaptan of the RMP utilization situation in our hospital
中村友哉1, 枦秀樹1, 宮原由香里1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2017.
Japanese Article P0158-4-AM. We develop the current situation investigation and the application of the inquiry record from the type of job other than at psychiatry single department hospital in Okayama
黒住由依1, 三木恵美1, 笹岡健二1, 三宅彩香1, 馬場大樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2017.
Japanese Article P0160-4-AM. Construction and example analysis of the system managing a doubt inquiry and the consultation meeting a demand contents
田中義輝1, 岡田由加1, 橋爪博隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2017.
Japanese Article P0162-4-AM. Remedy-related evaluation at antimicrobial mixture for children by the sensory evaluation
田杭直哉1, 下道友莉恵1, 黒田香織1, 竹下絵梨香1, 長谷川茉莉子1, 吉田直樹1, 近藤匡慶1, 菅谷量俊1, 高瀬久光1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2017.
Japanese Article P0164-4-AM. Efforts for the computerization of the collection of in-hospital pharmaceutical products
内藤哲哉1, 坂本亜沙美1, 執行素美1, 小森美佳1, 小宮孝俊1, 堤一貴1, 田中和江1, 三輪涼子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2017.
Japanese Article P0165-3-PM. Attitude survey about the occupational exposure of the pharmacist at powders formulations
前田志津子1, 杉原数美1, 田山剛崇1, 三宅勝志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2017.
Japanese Article P0169-3-PM. Association of a use and the adherence of the 5-aminosalicylic acid preparation in patients with inflammatory bowel disease
池田澪樺1, 高瀬友美1, 宮崎元康1, 中島章雄1, 坂元佑哉1, 藤木将勝1, 松尾宏一1, 今給黎修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2017.
Japanese Article P0171-3-PM. Examination about the remedy situation and the prescription trend of the antihypertensive medications in patients with cerebral hemorrhage and the antithrombotic drug
近藤真由1, 栗原江未1, 大石丸美1, 岩武幹乃1, 山村真貴子1, 臼井和明1, 植中英恵1, 森田佳博1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2017.
Japanese Article P0173-3-PM. Evaluation to pharmacist intervention by the convalescent rehabilitation ward staff
小西愛1, 奥野靖隆1, 妻鹿宏美1, 永田文恵1, 梶原博視1, 外間健吾1, 近藤幸男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2017.
Japanese Article P0175-3-PM. Attitude survey for the anti-doping in the environmental change of the business group team
村上達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2017.
Japanese Article P0177-3-PM. Examination of the choice reason at the DOAC change of patients with non-valvular atrial fibrillation in our hospital outpatient department prescription
早坂美希1, 千葉貴志1, 上村新吾1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2017.
Japanese Article P0179-3-PM. Questionary survey about acquisition, the transmission of the pharmaceutical products safety information in Hiroshima
桑原秀徳1, 川上恵子1, 光廣貴紀1, 岡本直樹1, 安原昌子1, 武郷徹1, 福原伸治1, 佐和章弘1, 池本雅章1, 中村亜由美1, 秋本伸1, 常友盛勝1, 鵜池敏令1, 内海敦志1, 中本匡美1, 柴田ゆうか1, 泉谷悟1, 豊見敦1, 松本俊治1, 谷口雅敏1, 日浦和徳1, 中村徹志1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2017.
Japanese Article P0181-3-PM. Examination about the Helicobacter pylori sanitization success rate using the vonoprazan
篠原裕1, 武田良平2, 本多正彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2017.
Japanese Article P0183-3-PM. Risk factor analysis of the non-alcoholic fatty liver disease in the clinical survey
数馬南美1, 伊藤千裕1,2, 清水清香3, 井上岳1,2, 氏原淳2, 山田悟4, 常松令3, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2017.
Japanese Article P0185-3-PM. It is ... about use of a relation and the bringing medicine to report - polypharmacy as a result of Kanagawa hospital pharmacist party duties investigation questionnaire
小林求1,2, 濃沼政美1,3, 前田拓哉1, 藤原久登1,4, 瀧本淳1, 芦塚拓也1, 湯本哲郎1,5, 飯田純一1, 長井真梨子1, 河原英子1, 小森智也1, 佐々木寿子1, 白鳥千穂1, 宮田広樹1, 佐藤透1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2017.
Japanese Article P0187-3-PM. Use of generic medicine ratio investigation in the common use medicine of the staff of a school
守内匡1, 守内典子1, 松井ひろみ1, 田中治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2017.
Japanese Article P0189-3-PM. The adverse event expression of pregabalin situation in initial recommended dose or less
前田知穂1, 末松直幸1, 後藤正道2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2017.
Japanese Article P0191-3-PM. We work on risk minimization of the nintedanib on the basis of the use situation under the true clinical practice
柳本正憲1, 長尾由佳1, 益本周治1, 赤木晋介1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2017.
Japanese Article P0193-3-PM. Fact-finding about the Shakuyakukanzoto long-term continuous use patients
井口智恵1,2, 市田千穂1, 伊藤千裕1,2, 井上岳1,2, 清原寛章3, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2017.
Japanese Article P0195-3-PM. Renal function during L-amphotericin B administration and fact-finding of blood K-value
末延道太1, 佐脇久美1, 穴井美玖1, 佐藤史織1, 原尻学志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2017.
Japanese Article P0197-3-PM. Examination - second report - of the use of sleeping drug manual introduction aiming at proper use
嶋崎千絵1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2017.
Japanese Article P0199-3-PM. Investigation about the use situation and the side effect expression of Ledipasvir/Sofosbuvir combination tablets in the Toho University medical center Sakura Hospital
井澤香1, 土井啓員1, 佐野君芳1, 真坂亙1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2017.
Japanese Article P0201-3-PM. Examination about the use dose of the ST medical mixture prophylaxis for the pneumocystis pneumonia
古賀清弘1, 石丸隆之1, 谷川昇1, 藤田玲奈1, 野中敏治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2017.
Japanese Article P0168-4-AM. Do the antihypertensive medications influence a fracture site? - Inspection - of antihypertensive medications and the blood pressure in the fracture site
小野悠香里1, 渡邉啓太1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2017.
Japanese Article P0170-4-AM. The treatment satisfaction investigation for the anticoagulant of patients with non-valvular atrial fibrillation in the Kosei society Takeda Hospital: Using Anti-Clot Treatment Scale (ACTS)
礒田果林1, 中埜梓1, 鏑木めぐみ1, 松田貴臣1, 林千麗1, 妹尾恵太郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2017.
Japanese Article P0172-4-AM. The actual situation and measures of the polypharmacy in the medical treatment ward
土元研史1, 安田礼子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2017.
Japanese Article P0174-4-AM. Attempt of the use fact-finding of the S zopiclone remedy patients and the intervention
福田翔一1, 馬原大志1, 渕上俊介1, 車塚千穂1, 今井隆人1, 小林龍1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2017.
Japanese Article P0176-4-AM. Comparison about Japan and the drugstore business of the United States
蓮元憲祐1, 吉田綾乃2, 玉田美香2, 柴田実香2, 横井正之1,3, Roger K Thomas4, 荒井國三2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2017.
Japanese Article P0178-4-AM. A side effect during use of rheumatoid arthritis therapeutic drug methotrexate and the situation investigation that used investigation - adverse drug reaction automatic monitoring system about the examination interval
五十嵐敏明1, 今野彩1, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2017.
Japanese Article P0180-4-AM. Apixaban in treatment of the venous thromboembolism and recurrent inhibition purpose, use fact-finding of the rivaroxaban
奥村浩樹1, 牧田亮1, 田中佳子1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2017.
Japanese Article P0182-4-AM. Questionary survey about the needs of the combination drug to look at from patients
亀井進太郎1, 佐藤雄己1, 小野優子1, 内匠幸恵1, 後藤伴美1, 田名網悠1, 岡部耕平1, 津下遥香1, 森永裕子1, 天田耕平1, 小野寛之1, 野々下航1, 炭元隆宏1, 衛藤大輝1, 鈴木芳1, 白岩健1, 藤原涼1, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2017.
Japanese Article P0184-4-AM. Change of the prescription trend by 70 pieces of fomentation restrictions in our center
淀川進也1, 黒崎由希子1, 小坂若那1, 冨岡謙二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2017.
Japanese Article P0186-4-AM. Effect on studies of the migraine headache in the pharmacy student
平野貴法1, 石井正和1, 石橋正祥1, 加藤大貴2, 笹井英世3, 野田朋宏4, 井上剛4, 巖本三壽1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2017.
Japanese Article P0188-4-AM. The use situation investigation of the rivaroxaban in our hospital
坂柳悦章1, 荒木寛也1, 西川隆一1, 澤柳直樹1, 藤井友和1, 辻博幸1, 塚本久之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2017.
Japanese Article P0190-4-AM. Relation of the use situation and the pharmacist of vigabatrin in the Gifu comprehensive medical care center
井上壽江1, 篠田あすみ1, 村田庄司1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2017.
Japanese Article P0192-4-AM. About the effectiveness and the safety of the chronic hepatitis C therapeutic drug
徳井志野1, 山口泰弘1, 赤崎大恭1, 浦本邦弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2017.
Japanese Article P0194-4-AM. Investigation about the factor having an influence on hypotensive frequency by the carperitide and the expression
田實裕介1, 冨山成章1, 橋元良枝1, 前山瑞穂1, 松ヶ野聡美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2017.
Japanese Article P0196-4-AM. The situation investigation of patients using pharmaceutical products having an influence on the driving
石井大輔1, 前澤佳代子1,2, 橋本竜1, 玉井一也1, 小林俊喜2, 渡邊鷹志2, 石井裕太2, 杉山奈津子1,2, 加藤芳徳2, 伊東岳2, 百瀬泰行1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2017.
Japanese Article P0198-4-AM. In our hospital is the examination about the change of prescription reason of oral anticoagulant drug (DOAC) directly
中野敬太1, 石郷友之1, 藤居賢1, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2017.
Japanese Article P0200-4-AM. Recognition investigation of the physician for pharmaceutical products having an influence on the driving
橋本竜1, 前澤佳代子1,2, 玉井一也1, 石井大輔1, 本多珠里都2, 石井裕太2, 小林俊喜2, 渡邊鷹志2, 杉山奈津子1,2, 加藤芳徳2, 伊東岳2, 百瀬泰行1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2017.
Japanese Article P0202-4-AM. Rearward investigation about the side effect expression of pregabalin risk in the decreased renal function patients
宮澤秋子1, 高濱和弘1, 二川俊隆1, 松元真哉1, 稲葉るり1, 前川彩乃1, 谷真琴1, 松田絹代1, 武田泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2017.
Japanese Article P0203-3-PM. Examination about an interruption reason and the quantity of disposal of the on admission bringing drug
森澤さおり1, 加藤正太郎1, 佐々木克也1, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2017.
Japanese Article P0207-3-PM. Calculation of depression speed stabilization time of the Ca blocker based on large-scale postmarketing surveillance data
野田紗也香1, 佐藤倫広2,3, 鈴木裕之1, 八木朋美1, 村上任尚2, 目時弘仁2, 村井ユリ子1, 中村仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2017.
Japanese Article P0209-3-PM. Use fact-finding about the lithium carbonate using receipt data
大場延浩1, 飯島桃子1, 川鍋未来1, 梅田貴史1, 北村菜穂1, 吉野成泰1, 小林直子1, 堤大輔1, 林宏行1, 久保田潔2, 福岡憲泰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2017.
Japanese Article P0211-3-PM. Estimate of the effect that a very small amount of adjustment of the dosage of the large amount anticancer medicine gives in medical expenses reduction
植木亮磨1, 横山雄一1, 篠原義剛1, 植木哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2017.
Japanese Article P0215-3-PM. Study on standardization of prophylaxis, the therapy for the delirium in the inpatient
藤田ちひろ1, 宮竹香歩1, 内藤雅人1, 下雅意彩1, 竹村敏也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2017.
Japanese Article P0217-3-PM. For investigation medical expenses reduction about the prescription situation of the injection anticancer agent in Aomori
兵藤塁1, 照井一史1, 中川潤一1, 横山明子1, 細井一広1, 明石真弓2, 佐藤和洋3, 神雅昭4, 田中南美英5, 田村健悦6, 中村一成7, 本間聖明8, 宮崎晃臣9, 矢田康司10, 山本章二11, 下山律子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2017.
Japanese Article P0219-3-PM. The calculation situation investigation of the Yamaguchi prefecture institution after the 2016 medical service fees revision
植松俊成1, 守田和彦1, 久保田厚子1, 中川麻子1, 永見康男1, 藤田亜弓1, 宮川貴行1, 松久哲章1, 古川裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2017.
Japanese Article P0204-4-AM. Investigation of the medicine charge reduction effect by the difference in standard optimization method of the anticancer agent and adoption standard
関川洋史1, 坂井由紀1, 三澤昭彦1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2017.
Japanese Article P0206-4-AM. The dispensary duties efficiency using the PDCA cycle and cost reduction
三上友寛1, 林八恵子1, 小川暁生1, 高道恵理子1, 山口瑞彦1, 遠藤正憲1, 塚本有子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2017.
Japanese Article P0208-4-AM. Examination of the adverse event of the SGLT2 inhibitor using an adverse event spontaneous report database
向井淳治1, 面谷幸子1, 長井克仁1, 初田泰敏1, 名徳倫明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2017.
Japanese Article P0210-4-AM. The medical expenses reduction effect that quantity of prescription restrictions of the ad usum externum anti-inflammatory analgesics result in
山田ゆきの1, 長谷川佳孝2,3, 前田守2,3, 栗山健志2,3, 萩原毅2,3, 月岡良太2,3, 森澤あずさ2,3, 大石美也2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2017.
Japanese Article P0212-4-AM. Costs minimization analysis of the antiMRSA medicine in MRSA pneumonia
中川直人1, Leanne Lai2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2017.
Japanese Article P0214-4-AM. Examination of the validity evaluation technique of the injection vial standard in the pemetrexed preparation
中村暢彦1, 中嶋江美2, 森田直2, 岡田知子2, 籠本基成2, 小林政彦2, 矢野義孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2017.
Japanese Article P0216-4-AM. Relative analysis with the childhood otitis media onset in Tochigi and a heat and cold difference and the virus outbreak
高橋彩花1, 加藤芳徳2, 鈴木和磨2, 守田侑真2, 山根晃大2, 杉山奈津子2, 伊東岳2, 前澤佳代子2, 鈴木雅史1,2, 生野登3, 百瀬泰行1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2017.
Japanese Article P0218-4-AM. The pharmacy management by the BSC introduction
白川亮1, 今城江理1, 塩浦真菜1, 結城惠美1, 中莖大輔1, 柳田義一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2017.
Japanese Article P0220-4-AM. Conquest of the pharmacist staff decrease in drugstore job evaluation analysis crisis by the efforts in our hospital
守屋久美代1, 鴛渕るか1, 永里京子1, 内田香織1, 野村秀哉1, 米丸寿幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2017.
Japanese Article P0221-3-PM. Approach to interaction evasion at oral medicine combination
佐藤真奈1, 四方公亮1, 伊東充1, 出雲正治1, 井上由紀1, 佐藤香織1, 長谷川英雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2017.
Japanese Article P0223-3-PM. Efforts ... of the education for patients by examination - hepatic disease classroom about the interaction of the direct action type antiviral drug in hepatitis C treatment
大塚恵子1, 渡部智貴1, 新藤学1, 加藤一郎1, 金田暁2, 杉浦信之3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2017.
Japanese Article P0225-3-PM. One case of the pulmonary embolism history patients who conducted Helicobacter pylori sanitization under the warfarin remedy, and monitored PT-INR
門村将太1, 福田由布子1, 井藤達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2017.
Japanese Article P0227-3-PM. Effect (the third report) that combination of tramadol in the warfarin remedy patients gives to INR
安部望美1, 細野智美1, 青沼和隆2, 住田孝之2, 平松祐司2, 山崎正志2, 関堂充2, 神林泰行1, 本間真人1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2017.
Japanese Article P0229-3-PM. Examination - using the nutrient for intestinal administration varying in study on effect - property of the diet to give to absorption of rifampicin
大津亜都1, 河野洋平1, 下村斉2, 青山隆夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2017.
Japanese Article P0231-3-PM. The clinical case which the effect reinforcement of the concomitant drug was seen in by macrolide derivative antimicrobial
天海祐紀1, 吉成徹1, 増渕龍一郎1, 石崎憲1, 渡邊紘子1, 赤羽正之1, 岩瀬利康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2017.
Japanese Article P0233-3-PM. Possibility ... of the new interaction through 2 case - protein binding which caused PT-INR extension by pazopanib - warfarin combination
辻本高志1, 上田晃1, 川本由加里1, 後藤仁和1, 村西雄貴2, 山本祥太2, 川口愛2, 千葉博基2, 秋野文臣2, 田中博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2017.
Japanese Article P0235-3-PM. The effect of antacids to give LDLC drop effect of the rosuvastatin: Rearward medical record investigation
土屋美香1, 立沢正臣1, 小川竜一2, 金素案1, 金城直樹1, 大久保淳史1, 小山内美樹1, 下嶋和代1, 宮崎招久1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2017.
Japanese Article P0237-3-PM. Examination about the pharmacokinetic interaction with tacrolimus and the concomitant drug in renal-transplant recipients
熊谷優1, 加賀谷英彰1, 新岡丈典1, 齋藤満2, 井上高光2, 沼倉一幸2, 羽渕友則2, 佐藤滋3, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2017.
Japanese Article P0239-3-PM. One case that predicted voriconazole and drug interaction of the warfarin using PISCS, and was given administration plan
渡辺裕貴1,2, 鷲尾彩菜1,2, 稲垣彩美1,2, 臼田昌弘1,2, 市倉大輔1,2, 縄田修一1,2, 峯村純子1,2, 佐々木忠徳1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2017.
Japanese Article P0241-3-PM. Case of patients with gynecologic cancer which showed effect attenuation of the warfarin after the aprepitant start, and showed the effect reinforcement after the fosfluconazole addition
名和田幸介1, 川中明宏1, 渡邊太朗1, 白野陽正1, 三好生典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2017.
Japanese Article P0243-3-PM. Examination - in examination - nitroglycerine sublingual tablet of the interaction with the commercial denture adhesive and ethical drug
脇屋義文1, 高木祐輔1, 横井元気1, 武田悠1, 梅村雅之1, 吉田彩乃2, 柳原保2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2017.
Japanese Article P0245-3-PM. Effect on LDL-C by the combination of rosuvastatin and acid-secreting antagonist
臼窪一平1, 横田睦美1, 大橋史嵩1, 丸山卓哉1, 岩堀真弓1, 槙田芳1, 下山あさ子1, 嘉屋則子1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2017.
Japanese Article P0222-4-AM. One case that we changed to edoxaban from poor control of the warfarin in the patients whom deep vein thrombosis developed in during pulmonary tuberculosis treatment
原田卓弥1, 奥野昌弘1, 中田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2017.
Japanese Article P0224-4-AM. Efficiency of an approach and the reporting of the drug interaction evasion using the automatic prescription checking system
大柿佳織1, 枦秀樹1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2017.
Japanese Article P0228-4-AM. The current situation investigation in the Mie University faculty of medicine hospital about the use of concomitant drug which should consider direct action type oral anticoagulant drug (DOAC) and weight loss
高崎美和1, 杉本浩子1, 池村健治1, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2017.
Japanese Article P0230-4-AM. Examination about the solubility of the piperazine frame-containing drug which assumed the remedy with the tea leaves drink
阪上彩子1, 福井希1, 中村任1, 岩永一範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2017.
Japanese Article P0232-4-AM. Evaluation of the drug interaction of Glecaprevir/Pibrentasvir (GLE/PIB)
松永英治1, Rajneet K. Oberoi2, Matthew P. Kosloski2, Andrew Campbell2, Wei Liu2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2017.
Japanese Article P0234-4-AM. 1 case that blood level of tacrolimus increased during the immunosuppressive therapy after the heart transplant by August first of the lunar calendar
中北和樹1,2, 和田恭一1,2, 松田紗知1, 老田章1, 三好英理3, 堀由美子3, 高田充隆2, 瀬口理3, 簗瀬正伸3, 福嶌教偉3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2017.
Japanese Article P0236-4-AM. The effect that esomeprazole gives to an effect of the warfarin
井坂由佳1, 澤近萌1, 土岐浩介1,2, 本間真人1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2017.
Japanese Article P0238-4-AM. Usefulness of the Perampanel blood level monitoring for patients with refractory epilepsy
森美穂1, 山本吉章1,3, 中井正彦1, 臼井直敬2, 賀川義之3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2017.
Japanese Article P0240-4-AM. The effect that the combination of a proton pump inhibitor and the H2 blocker gives to an effect and a side effect of the dasatinib in the chronic myelogenous leukemia
高武嘉道1, 木村修徳2, 鶴崎泰史1, 山形真一1, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2017.
Japanese Article P0242-4-AM. Report about the PT-INR measurement in the combination of warfarin potassium and antimicrobial
高橋義弥1, 谷田拓也1, 七尾亮子1, 飯坂美香1, 丸山俊夫1, 高橋豊1, 野々山由香理1, 櫻井正之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2017.
Japanese Article P0244-4-AM. The effect that aprepitant administration in the hematopoietic stem cell transplantation gives to blood level of tacrolimus
中込早苗1, 中澤佑介1, 安藤尚美1, 五十嵐貴之2, 原田大1, 北村正樹1, 川久保孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2017.
Japanese Article P0246-4-AM. 2 cases that PT-INR extended to by a hyperuricaemia therapeutic agent change in the warfarin remedy patients
鈴木一志1, 松本晃一1, 高橋利幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2017.
Japanese Article P0247-3-PM. Efforts about the examination for protein urine protocol introduction at the bevacizumab ramucirumab administration and future problem
熊谷修一1,2, 目黒聡子1, 酒井由希子1, 野口真利1, 佐藤晃一1, 永倉史子1, 川口裕花1, 渡辺京彦1, 大川真里奈1, 高山裕子2, 山内泰一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2017.
Japanese Article P0249-3-PM. Examination about the effect on OS/PFS of RDI in the stomach cancer ramucirumab + paclitaxel therapy and adverse event
森下拓哉1, 井上裕貴1, 松本修一1, 片岡政人2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2017.
Japanese Article P0251-3-PM. Introduction of short hydration in our hospital and example
神谷力嗣1, 日野澤孝明1, 岡平将志1, 後藤伸之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2017.
Japanese Article P0253-3-PM. The current situation investigation about weight loss, the discontinuation of the nabPTX + GEM therapy in patients with pancreatic cancer
指宿貴博1, 古川卓也2, 久保田豊2, 深沢健一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2017.
Japanese Article P0255-3-PM. Examination of the usefulness to anticancer agent proper use by the participation of the pharmacist in cancer chemotherapy patients measurement of body weight
元木孝1, 館内謙太郎1, 後藤勝博1, 高柳昌宏1, 千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2017.
Japanese Article P0248-4-AM. A treatment result of the KRd therapy for the multiple myeloma in our hospital and examination of the side effect
西村直朗1, 桑村恒夫1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2017.
Japanese Article P0250-4-AM. Construction of the cancer chemotherapy regimen authentication system that a pharmacist consolidated taking the opportunity of hospital integration
伴晶子1,5, 岡戸洋1,5, 筧由紀子1, 山田卓摩1,5, 佐藤知香1,5, 小林和子2,5, 竹内亜由美2,5, 岩本公一3, 小川明男4,5, 小島義博1, 生田宏次4,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2017.
Japanese Article P0252-4-AM. Optimization of anticancer agent preparation duties by the regimen management system (CROSS) introduction
鳥越史宙1, 大西亜以子1, 松本浩明1, 石部由利子1, 奥田敏勝1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2017.
Japanese Article P0254-4-AM. Analysis of doubt inquiry in the chemotherapy inspection
荒川裕貴1, 桂川健司1, 遠山幸男1, 久田達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2017.
Japanese Article P0256-4-AM. About the introduction of the electronic medical chart system of the childhood cancer chemotherapy regimen management
坂本有里恵1, 森口沙里1, 宇戸祐介1, 渡邉綾子1, 齋藤あゆみ1, 研真梨子1, 中西有璃1, 野田有貴子1, 乗松耕平1, 籾井佳奈1, 愛甲佳未1, 由良沙央理1, 岸本早百合1, 三輪祐太朗1, 廣瀬晃子1, 藤永仁美1, 大前隆広1, 石田達彦1, 上田里恵1, 加古学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2017.
Japanese Article P0257-3-PM. About efforts and usefulness for the cancer medical therapy of the pharmacist who collaborated with the physician in the outpatient clinic
青孝明1, 柘植麻里奈1, 杉本恵理1, 粟野恵介1, 山川恵子1, 近藤智彦1, 木村匡男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2017.
Japanese Article P0259-3-PM. Intervention from the treatment preferences of the breast origin phyllodes tumor to side effect management
田代美佳1, 田井浩子1, 大河万顕1, 小畑紋菓1, 瀬名波宏昌1, 川口進一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2017.
Japanese Article P0261-3-PM. Use fact-finding of the ramucirumab for progress, the recurrent gastric cancer which is impossible of curative resection in our hospital
林美和子1, 唐澤綾1, 濱至寛1, 登内盛治1, 五味邦之2, 島田宏2, 三原基弘2, 梶川昌二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2017.
Japanese Article P0263-3-PM. Can the efforts of the prophylaxis by the multi-type of job relieve dermatopathy by the panitumumab? Investigation ... of the expression situation and the patients background factor of ... dermatopathy
里村藍子1, 永村陽一郎1, 遠藤春野1, 坂榮里絵2, 山口雄3, 中根実3, 日野斉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2017.
Japanese Article P0265-3-PM. It is ... in the making - nivolumab Pembrolizumab clinical introduction of the immune-mediated side effect measures algorithm
遠藤真理1, 佐藤亜希1, 本田弘1, 中島繁美1, 服部千恵子2, 菅原俊一3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2017.
Japanese Article P0267-3-PM. Expectation from one case of the use of high-dose drug terminally ill patients to a pharmacist associated with team approach in medical care to see
福地祐司1,4, 竹下光弘1,4, 江坂尚枝1, 吉川真一4, 吉田進4, 神崎憲雄2, 江尻友三2, 松田徹3, 早乙女浩之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2017.
Japanese Article P0269-3-PM. Efforts to HBV reactivation measures in our hospital
松本実1, 尾形歩美1, 松井香保里1, 上池和子1, 栗下一義2, 片岡直樹2, 渡辺嵩史3, 吉本拓人1, 岩村伸一4, 溝渕樹1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2017.
Japanese Article P0271-3-PM. For practice of medical treatment management (PBPM) based on intervention fact-finding - protocol of the pharmacist in the foreign chemotherapy room -
和田依子1, 樋口美奈子1, 佐々木好美1, 岩坪沙奈恵1, 山口竜司1, 中野行孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2017.
Japanese Article P0273-3-PM. HBV reactivation prophylactic efforts (the second report) in the cancer chemotherapy
貝瀬眞由美1, 須田剛士2, 粉川直明1, 柴田真由美3, 小川るり子4, 堀内亮佑5, 寺島健史5,6, 内山聖7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2017.
Japanese Article P0258-4-AM. The regimen choice for enforcement planned patients supports adjuvant chemotherapy after the breast cancer technique
内田美伽1, 原竜太郎1, 濱浦睦雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2017.
Japanese Article P0260-4-AM. The effect that pharmacist outpatient department introduction gives for physician office hours and treatment (patients satisfaction, side effect measures)
秦英司1, 小川勝弘1, 岩本秀人3, 岩井ちさと1, 足立美菜子1, 栢木啓介1, 長谷川一将1, 大谷豊司2, 金田達也1, 椎木芳和1, 高根浩1, 武中篤3, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2017.
Japanese Article P0262-4-AM. The activities after the dermatopathy measures team start in the Kyushu cancer center and the future prospects
坂本由希子1, 魚井みゆき1, 宮本聖子1, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2017.
Japanese Article P0264-4-AM. Efforts by the multi-type of job in the cardiac activity evaluation at the anticancer medicine administration with the cardiotoxicity
内田将吾1, 宇都宮節夫2, 見田真紀3, 山関智恵1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2017.
Japanese Article P0266-4-AM. The current situation and problem of the palliative care of our hospital judging from the cancer pain management
久保田綾乃1, 海野亜実1, 牧野和也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2017.
Japanese Article P0268-4-AM. 1 case that a complete response was obtained by R + Devic relief therapy after the R + CHOP therapy in the elderly people with diffuse large B-cell lymphoma
杉原弘記1, 岡本伸也1, 竹井英介1, 川真田修2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2017.
Japanese Article P0272-4-AM. Change of the HBV screening test rate of use after the PBPM introduction
丸田基史1, 山形真一1, 鶴崎泰史1, 宮成信友2, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2017.
Japanese Article P0276-4-AM. Construction and evaluation of the simple mark remote inspection system for the anticancer agent preparation
田中裕章1, 高橋功一1, 安宅希美子1, 青木加奈1, 山口佳津騎1, 元木貴大1, 井上達也1, 樋口和子1, 篠原尚樹1, 野崎孝徒1, 辻繁子1, 朝倉正登1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2017.
Japanese Article P0278-4-AM. The making of the preparation manual of the anticancer agent administered intraspinally in the Hirosaki University faculty of medicine hospital and introduction of the modi operandi
横山明子1, 照井一史1, 兵藤塁1, 中川潤一1, 細井一広1, 下山律子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2017.
Japanese Article P0280-4-AM. A problem after the use expansion of closed system anesthesia drug transportation system (CSTD) and examination of the countermeasure
柴山匠1, 上村美月1, 中屋優香1, 藤村裕司1, 町田宏美2, 菊池健樹1, 松井孝之1, 寺田伊知郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2017.
Japanese Article P0282-4-AM. Evaluation of anticancer agent exposure measures by the closed system anesthesia drug transportation system "neo-shield" introduction
山下千草1, 川原裕1, 小山紀久美2, 佐野雅昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2017.
Japanese Article P0284-4-AM. One case that gastric cancer SOX therapy was treated with being at home for patients with amyotrophy-related lateral sclerosis, and continued
阿部一仁1, 坪井一人2, 良元和久2, 梶本徹也2, 柏木秀幸2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2017.
Japanese Article P0286-4-AM. For improvement in consciousness for exposure to anticancer medicine measures - safe handling -
坂田茂代1, 山口文子1, 田辺真里1, 佐藤透1, 永田菜美子2, 榊原辰弥2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2017.
Japanese Article P0288-4-AM. An effect and exposure measures in the Abiraterone ester acetate tablets crush remedy
白石童子1, 坂本歩1, 早乙女彩子1, 福地祐司2, 竹下光弘1,2, 早乙女浩之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2017.
Japanese Article P0290-4-AM. Environmental pollution investigation after anticancer agent exposure measures
石嶋麗1, 間瀬広樹1, 杉村勇人1, 小林恵里奈1, 坂倉喜代美2, 嶽加奈子2, 山森ゆみ2, 北俊之3, 秋山哲平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2017.
Japanese Article P0294-4-AM. Usefulness ... of the anticancer medicine preparation support equipment with new attempt - stock tray of anticancer medicine preparation duties using the anticancer medicine preparation support equipment
榊原隆志1,2, 滝本典夫1,2, 菅原志穂1,2, 神谷幸江1,2, 足立守1, 吉田憲生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2017.
Japanese Article P0296-4-AM. Investigation about the anticancer medicine pollution around the urinal by the urination in the standing position
江刺晶央1, 土屋雅美1, 村尾知彦1, 下山順士1, 猪岡京子1, 高村千津子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2017.
Japanese Article P0298-4-AM. The resolution removal test with the ozone water of 5-FU pollution gloves and the infusion solution bag surface
古田祐美子1, 土手賢史1, 岩根裕紀1,2, 小林由佳1,2, 成橋和正2, 杉浦伸一2, 中西弘和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2017.
Japanese Article P0300-4-AM. Examination of the effective formula of the ethanol non-component docetaxel preparation by the warming
杉浦央1, 斎藤由起子1, 浅見祥崇2, 下山哲哉2, 佐々木慎司1, 加藤ゆか1, 横山雄一1, 福田耕太郎1, 伊藤邦彦2, 小林道也2, 近藤覚也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2017.
Japanese Article P0302-4-AM. Reduction effect to the anticancer agent environmental pollution that education to the staff and the introduction of the closed system anesthesia infusion system give
清水潤一1, 田邉直人1, 鈴木裕美2,3, 遠藤玲子2,3, 井上泉子2, 小澤桂子2,3, 古嶋薫3, 加藤敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2017.
Japanese Article P0304-4-AM. Drug department office worker, education about the risk by the anticancer agent exposure to medical attendant
山田卓摩1, 伴晶子1, 佐藤知香1, 岡戸洋1, 小林和子1, 竹内亜由美1, 工藤優子1, 小島義博1, 小川明男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2017.
Japanese Article P0306-4-AM. Examination of the need of the knowledge of the pharmacist for the anticancer agent exposure and consciousness and the education
井上龍亮1, 杉山奈津子1,2, 鎌田愛梨2, 森下真旺2, 宮沢唯2, 久保倫美1, 坂口貴大1, 宮内輝人1, 吉成宏顕1, 植松久美子1, 伊東岳2, 加藤芳徳2, 前澤佳代子1,2, 箭内雅実3, 橋本秀雄1, 百瀬泰行1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2017.
Japanese Article P0308-4-AM. Attitude survey about the excretion instruction to patients in the chemotherapy
小山拓弥1, 下川福子1, 賀川義規2, 南原誠1, 船越幸代1, 川嵜英二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2017.
Japanese Article P0310-4-AM. Attitude survey for effect on ward duties by the rotation of anticancer medicine preparation duties in our hospital and preparation duties
古林園子1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2017.
Japanese Article P0312-4-AM. Efforts of exposure to our hospital measures in anticancer agent (HD)
和賀信継1, 細川友子2, 渋谷丈太郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2017.
Japanese Article P0314-4-AM. Examination of the quantity of fluorouracil attaching to a PTP sheet of the Tegafur combination oral medicine
小松原早織1, 武田有紀1, 高見陽一郎1, 浦上知香1, 笹原莉子1, 島田倫栄1, 福島由貴1, 小川壮寛2, 安倉央2, 江川孝3, 島田憲一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2017.
Japanese Article P0316-4-AM. Introduction of anticancer agent automatic preparation device APTOECAchemo and the future prospects
松本浩明1, 奥田敏勝1, 鳥越宙史1, 石部由利子1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2017.
Japanese Article P0318-4-AM. The value-added examination that is useful in development of the end-point necessary to choose a closed system anesthesia connection appliance and medical security
税所篤行1, 西川直也1, 小山勝真1, 幸田恭治1, 古川裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2017.
Japanese Article P0275-3-PM. Inspection of the medical expenses reduction effect by the use of vial multiple times of the injectable anticancer agent
泉智基1, 河添仁1, 沖野真季1, 飛鷹範明1, 田中守1, 田中亮裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2017.
Japanese Article P0277-3-PM. The value-added examination that is useful in development of the end-point which is necessary for the injectable equivalence ingredient anticancer medicine choice and medical security
西川直也1, 税所篤行1, 小山勝真1, 幸田恭治1, 古川裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2017.
Japanese Article P0279-3-PM. Examination about the CSTD introduction at digestive organ cancer chemotherapy preparation
鈴木直哉1, 地主隆文1, 山田将悟1, 藤田果那1, 山本翔太1, 庄崎沙耶1, 田中耕太1, 木下愛1, 前川英輝1, 藤林遼1, 菊地義明1, 高橋誠1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2017.
Japanese Article P0281-3-PM. Preparation precision comparison ... with new attempt ... anticancer medicine preparation support equipment of anticancer medicine preparation duties using the anticancer medicine preparation support equipment and the person using the inspection system
菅原志穂1,2, 滝本典夫1,2, 榊原隆志1,2, 神谷幸江1,2, 足立守1, 吉田憲生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2017.
Japanese Article P0283-3-PM. About stocktaking and measures by the anticancer agent exposure investigation
愛知佑香1, 井上裕貴1, 高木理央1, 上床遥1, 吉田美紀2, 松本修一1, 北川智余栄3, 佐藤康幸4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2017.
Japanese Article P0285-3-PM. Examination of the dissolution dilution method for the Pinorubin injection which does not give a flotage
中村江理1, 伊藤綾希子1, 舩木健光1, 佐々木静香1, 鈴木英則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2017.
Japanese Article P0287-3-PM. Nurse satisfaction investigation in the BD F seal (TM) closed system anesthesia infusion system
田村悟1, 宇都直哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2017.
Japanese Article P0289-3-PM. The exposure measures situation investigation in the Nagoya Ekisaikai Hospital
牛膓沙織1, 高取裕司1, 野村翔1, 藤井仁2, 纐纈理香2, 米山文彦3, 池上信昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2017.
Japanese Article P0291-3-PM. Effect of the closed system anesthesia drug transportation system introduction in the cancer chemotherapy
上原友美1, 堀内智裕1, 中松穂菜美1, 鶴永大貴1, 中島理恵1, 中村有莉恵1, 赤星真広1, 石神誠子1, 池増鮎美1, 神門孝典1, 佐多照正1, 奥村浩2, 前之原茂穂2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2017.
Japanese Article P0293-3-PM. Introduction effect of the anticancer agent preparation technology acquisition degree evaluation ladder
片山宏章1, 榊原辰弥1, 増島広幸1, 秋山加菜1, 望月敬浩1, 粂哲雄1, 橋爪孝弘1, 村上ひろみ1, 永田菜美子1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2017.
Japanese Article P0295-3-PM. Examination for the use expansion of the closed system anesthesia drug transportation system in the Shizuoka Prefectural Shizuoka cancer center
永田菜美子1, 榊原辰弥1, 片山宏章1, 宮口貴守1, 伊藤雅子1, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2017.
Japanese Article P0297-3-PM. Fact-finding about core ring at anticancer agent preparation
目黒裕史1, 本多伸二1, 内藤舞1, 浜田久美子1, 佐分利美帆子1, 三松史野1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2017.
Japanese Article P0299-3-PM. Efforts for the use of closed system anesthesia appliance entire surface introduction at anticancer agent preparation
辻亜紀1, 足立充司1, 宮麻紀子1, 六車裕一1, 森岡浩子1, 辻俊美1, 中野静香1, 野村浩英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2017.
Japanese Article P0301-3-PM. Evaluation of the each closure performance of the closed system anesthesia connection appliance using cyclophosphamide
小林由佳1,2, 岩根裕紀1,2, 古田祐美子1, 成橋和正2, 杉浦伸一2, 中西弘和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2017.
Japanese Article P0303-3-PM. Abacterial inspection of chemosafe syringe (R) after the anticancer agent preparation
鶴永大貴1, 上原友美1, 堀内智裕1, 中松穂菜美1, 中島理恵1, 中村有莉恵1, 赤星真広1, 石神誠子1, 池増鮎美1, 佐多照正1, 日高好博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2017.
Japanese Article P0305-3-PM. Is the sampling sheet useful as a rating system of the anticancer medicine cleaning work?
本吉ゆかり1, 高橋喜統1, 多賀允俊1, 荒井涼子1, 鷹見沙八佳1, 西川美香子1, 安田紗奈子1, 山本康人1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2017.
Japanese Article P0307-3-PM. Efforts for the anticancer medicine exposure measures expansion using the closed system anesthesia drug transportation system and future problem
宮本聖子1, 衛藤智章1, 森田明子1, 魚井みゆき1, 坂本由希子1, 佐々木由香1, 笹川玲奈1, 薮内由里香1, 北原愛子1, 永田祐子1, 松木奈緒子1, 永山智子1, 菊池茜1, 大石博史1, 築田晃直1, 松元俊博1, 古海和博1, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2017.
Japanese Article P0309-3-PM. Comparison between ceremony of investigation - machine and 2-layer-related filter type - about the usability of the closed system anesthesia drug transportation system
井口菜摘1, 鈴木毅1, 石井岳夫1, 難波有智1, 水野いず美2, 門田靜明3, 与那覇房子1, 外間惟夫1, 中村克徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2017.
Japanese Article P0311-3-PM. Economical examination in the introduction expansion of closed system anesthesia drug transportation system (CSTD)
細見誠1, 後藤愛実1, 西原雅美1, 有田由美2, 勝間田敬弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2017.
Japanese Article P0313-3-PM. About the efforts of anticancer agent exposure measures in our hospital
沢仁美1, 山本真史1, 鈴木日奈子2, 末吉博美2, 渡邉昌代2, 廣内真由美2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2017.
Japanese Article P0315-3-PM. About the introduction of the anticancer agent formulations inspection system in our hospital
中尾真美1, 木下圭一2, 森伸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2017.
Japanese Article P0317-3-PM. Examination of a system, a line of flow, the item aiming at reduction of the occupational exposure with the anticancer medicine in the cottage-hospital out of the district
岸本真1, 長ヶ原琢磨1, 長命章佳1, 大園ゆかり1, 屋敷大輔1, 荻尾夕起子1, 吉村真1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2017.
Japanese Article P0319-3-PM. Side effect management (one patient who detected phlebothrombus of lower extremities) of the regorafenib
高山俊輔1, 小谷野大地1, 増田裕子1, 鍵山智樹1, 土肥大典1, 舘林恵美1, 真壁秀樹1, 佐伯俊昭1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2017.
Japanese Article P0321-3-PM. Examination about the enforcement continuance of preventive treatment and the chemotherapy of the dermatopathy with the antiEGFR antibody medicine
坂本竜平1, 向井淳治2, 小竹優希1, 穴田真奈美1, 濱崎淳哉1, 竹原涼子1, 奥田広志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2017.
Japanese Article P0323-3-PM. An example with suspected nephrotic syndrome by Bevacizumab
米北浩人1, 須藤学拓2, 和泉隆平3, 中村英治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2017.
Japanese Article P0325-3-PM. Possibility of the side effect reduction effect of the Juzentaihoto on colon cancer chemotherapy
小林大祐1, 田中翔子1, 大坪達弥1, 澤田真嗣1, 中村吉隆2, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2017.
Japanese Article P0329-3-PM. Effect on endocytosis of the cisplatin by the Mg combination
安田恵1, 岸本修一2, 天野学1, 福島昭二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2017.
Japanese Article P0331-3-PM. Investigation about infusion reaction by the Trastuzumab emtansine therapy and the thrombocytopenia
中嶋陽一1, 葉田昌生1, 三上忠司1, 柿原圭佑1, 白石亘1, 松崎雄1, 菊池衣里佳1, 寺松早紀1, 蔵王なつか1, 大塚弘子2, 山口美樹2, 藤井裕史1, 田中眞紀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2017.
Japanese Article P0333-3-PM. The use situation of the peg filgrastim in the dose-denseEC therapy
加藤秀明1, 辻愛美1, 白崎由貴1, 西出洋志1, 坂井伸成1, 宇野美津江1, 森富男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2017.
Japanese Article P0335-3-PM. Study on tardive hypothyroidism development situation after the Nivolumab administration cancellation
堀井徳光1, 高木雄一1, 松本富夫1, 舘脇正充2, 吉田匠生2, 福島康次2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2017.
Japanese Article P0337-3-PM. Examination of the intervention effect of the pharmacist on low Ca blood symptom reduction in the orthopedics ward
佐々木祐太1, 宮田篤1, 小暮友毅1, 槇恒雄1, 山本宏1, 魚谷弘二2, 中田英二2, 杉原進介2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2017.
Japanese Article P0339-3-PM. Examination about the risk factor of the onset of serious neutropenia in the S-1+ cisplatin therapy for patients with progress, recurrent stomach cancer
川地志緒里1, 木村美智男1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2017.
Japanese Article P0341-3-PM. Study on frequency of the enforcement situation and the QT interval prolonged of the electrocardiogram in the Osimertinib administration case
石田善昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2017.
Japanese Article P0343-3-PM. 2 cases that developed systemic dermatopathy by nivolumab
大澤友裕1, 二村洋平2, 石黒崇2, 梅田道1, 安田昌宏1, 水井貴詞1, 堀場あかね2, 吉田勉2, 米田和史3, 澤祥幸4, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2017.
Japanese Article P0345-3-PM. One patient whom bevacizumab was continuously administered to after the protein urine expression
関口展貴1, 宮田智陽1, 岩水雅俊1, 篠原佳祐1, 杉山昌秀1, 渡邊将隆1, 油井信明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2017.
Japanese Article P0347-3-PM. Examination of the use actual situation and usefulness of the G-CSF preparation peg filgrastim in the gynecology of our hospital and problems
小山佐知子1, 山本侑佳1, 成瀬徳彦1, 廣村勝彦2, 水野公雄2, 森一博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2017.
Japanese Article P0349-3-PM. Investigation about an adverse event and the fat-free body mass in the oxaliplatin combination regimen
上田宏1, 大澤万智子1, 五十嵐努1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2017.
Japanese Article P0351-3-PM. Clinical study about the adverse event reduction effect of the elental combination private business agent in DTX + CDDP + 5-FU (DCF therapy) for the cancer of the esophagus
菅原充広1, 堅田親利2, 高橋かおる3, 高橋亜紀子3, 深沢佐恵子4, 坂本泰理5, 小泉和三郎2, 厚田幸一郎1,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2017.
Japanese Article P0353-3-PM. The onset situation of redness, the eruption in the breast cancer TC therapy and relations with the season
田畑真一1, 大島千佳1, 戸塚孝治1, 新井成俊1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2017.
Japanese Article P0355-3-PM. One case that suffered from correspondence of the vascular pain with the XELOX therapy
澤柳直樹1, 西川隆一1, 藤井友和1, 辻博幸1, 塚本久之1, 楠泰臣2, 大橋紀文3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2017.
Japanese Article P0357-3-PM. Association between genetic polymorphism and neutropenic expression situation of UGT1A1 in patients who received irinotecan-containing regimen
片桐将志1, 石井照樹1, 佐野嘉容子1, 中西順子1, 原田典和1, 加地努1, 向井栄治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2017.
Japanese Article P0359-3-PM. Search of the risk factor of the early onset oxaliplatin-induced erasion neuropathy
清水加奈子1,2, 山田治美1,3, 中村裕義1,2,3, 加藤芳徳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2017.
Japanese Article P0361-3-PM. Symptom improvement effect of the sodium azulene sulfonate tranexamic acid mouth wash on stomatitis with the anticancer medicine
薮田直希1, 須藤正朝1, 森井博朗1, 野田哲史1, 若杉吉宣1, 山本優1, 井堀仁美1, 河原幸恵1, 中村春香1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2017.
Japanese Article P0363-3-PM. Evaluation of the effectiveness of the existing therapeutic drug for anticancer agent-induced stomatitis
原隆裕1, 渡邉真一3, 飛鷹範明3, 田中守3, 高取真吾2, 山内行玄1, 畑晶之1, 田中亮裕3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2017.
Japanese Article P0365-3-PM. An investigation about the hiccups due to cancer chemotherapy and examination of the development factor
津久井千之1, 入岡凌1, 渡部晃裕1, 桑村雅子1, 大塚尚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2017.
Japanese Article P0367-3-PM. The efforts of the hydration change in the cisplatin-containing regimen and evaluation
谷澤範彦1, 草冨翔太1, 細谷拓史1, 前田太一1, 金森紀幸1, 谷山幸信1, 吉村はる美1, 小川純也1, 斉藤孝次1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2017.
Japanese Article P0369-3-PM. Investigation of the effectiveness of the end of the Goshajinkigan for peripheral neuropathy by the paclitaxel and the Processed Aconite Root
小田薫1, 川尻尚子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2017.
Japanese Article P0320-4-AM. About the use situation of the peg filgrastim in patients who received FEC therapy of our hospital
木内直美1,3, 関根佳代1,3, 辻村秀樹2,3, 熊谷匡也3,4, 大谷美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2017.
Japanese Article P0322-4-AM. Prescription fact-finding of the opioid preparation in patients with oral mucositis onset after chemistry, the radiotherapy
百賢二1, 中原香菜子1, 高木彰子1, 濃沼政美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2017.
Japanese Article P0324-4-AM. Examination of frequencies and the risk factor of the Colin symptom in the FOLFIRINOX therapy
伊藤智代1, 中出順也1, 嶋田努1, 崔吉道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2017.
Japanese Article P0326-4-AM. Examination of the expression situation and the predictor of the hypomagnesemia with the antiEGFR antibody component regimen in our hospital
森下友紀1, 谷岡洋亮2, 徳山ことみ1, 岡本裕子1, 岡本知久1, 福澤祐幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2017.
Japanese Article P0328-4-AM. Investigation of the neutropenia by the ramucirumab in our hospital
仁田美保子1, 中林真紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2017.
Japanese Article P0332-4-AM. Questionary survey for peripheral neuropathy with the oxaliplatin administration and making of the Goshajinkigan remedy protocol and the evaluation
奥澤文敏1, 福井圭亮1, 北野恵莉子1, 衣田奈央1, 田中こずえ1, 鈴鹿隆晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2017.
Japanese Article P0334-4-AM. An example with suspected immune thrombocytopenia by the nivolumab in our hospital
大田和歩1, 古谷智裕1, 野村実由1, 白木政博1, 柳田祐子1, 北口聡一2, 田中英夫3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2017.
Japanese Article P0336-4-AM. Attempt of the side effect expression situation of nivolumab treated patients and the immune-mediated adverse event check
茂木佳子1, 成田康之1, 遠藤麗2, 佐藤賢1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2017.
Japanese Article P0338-4-AM. Examination of the intervention method of the pharmacist in the adverse event of the nivolumab
稻垣沙織1, 米澤美和1, 久保杏奈1, 小野陽介1, 南憲一1, 安田明子1, 台蔵剛士1, 吉田正暢1, 岡田ちひろ1, 才田絢加1, 南川知央1, 渡辺真梨奈1, 山田千代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2017.
Japanese Article P0340-4-AM. Safe investigation and patients attitude survey of the nivolumab for the non-small cell lung cancer
中西大介1, 畑地治2, 柳川泰裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2017.
Japanese Article P0342-4-AM. The effect that the self-mouth care instruction in the drugstore gives for the onset of oral mucositis with the capecitabine administration
溝口優1, 島田理美1, 関悠人1, 高浦万里江1, 重山昌人1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2017.
Japanese Article P0344-4-AM. Examination of the side effect frequency of the Osimertinib introduction patients in our hospital and the expression factor
東田貴之1, 梅原健吾1, 岡山有希1, 野表しおり1, 岡崎泰香1, 後藤桂輔1, 高田寛奈1, 若本あずさ1, 初山多恵1, 佐藤秀紀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2017.
Japanese Article P0346-4-AM. Effect on treatment continuation that the efforts of the pharmacist for the supportive care adequacy of the pemetrexed and a delay of the vitamin B12 administration give
光家勉1, 北村登喜生1, 青木桃子1, 中村祐樹1, 米川恭史1, 渡部なおみ1, 富田国男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2017.
Japanese Article P0348-4-AM. The effect that ramucirumab administration under the antihypertensive medications internal use gives to blood pressure
林克剛1, 遠藤尚美1, 小野裕紀1, 鈴木薫1, 菅井博文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2017.
Japanese Article P0350-4-AM. Identification of the risk factor about the neutropenia onset by Cabazitaxel under the prophylaxis of Pegfilgrastim
影山明1, 中澤佑介1, 安藤尚美1, 原田大1, 北村正樹1, 浅野晃司2, 川久保孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2017.
Japanese Article P0352-4-AM. Investigation of the enforcement situation and the onset of hypothyroidism situation of the thyroid function tests in the sunitinib remedy patients
加藤良隆1, 井上渉1, 渡邉愛梨1, 邵仁哲2, 大坪達弥1, 神田英一郎1, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2017.
Japanese Article P0354-4-AM. Factor analysis of the impaired renal function protraction at the Docetaxel/Cisplatin/5-fluorouracil combination therapy for the progress cancer of the esophagus case
毛利順一1,2, 堅田親利3, 熊沢加奈1, 植田茉梨絵2, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2017.
Japanese Article P0356-4-AM. Examination about the safety of the prognostic factor of patients who received progress, recurrent pancreatic cancer chemotherapy and the second treatment (S-1 therapy)
五十川万喜幸1, 木村美智男1, 岩井美奈1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2017.
Japanese Article P0358-4-AM. The proper use of the early period of lenalidomide doses for the multiple myeloma and examination of the treatment continuity
谷川大夢1, 宇佐美英績2, 木村美智男2, 矢野忠1, 吉村智哲2, 市川訓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2017.
Japanese Article P0360-4-AM. Effect on intensity of treatment with the administration of the primary prophylaxis of the peg filgrastim in the breast cancer chemotherapy
近藤博紀1, 横幕香織1, 上田潤哉1, 黒川愛美1, 河崎一久1, 三露久生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2017.
Japanese Article P0362-4-AM. Effect on oligochromemia with the rasburicase administration in patients with malignant lymphoma
木村雄太1, 三浦清文1, 高田慎也1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2017.
Japanese Article P0364-4-AM. A risk of developing myelosuppression factor search at postoperative chemotherapy enforcement before breast cancer technique and investigation about the G-CSF proper use condition
古谷智裕1, 柳田祐子1, 野村実由1, 大田和歩1, 白木政博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2017.
Japanese Article P0366-4-AM. Examination of the protective efficacy of the Hangeshashinto mouth wash for stomatitis with the kidney cancer molecules target medicine
水野加奈子1, 吉川英里1, 飯澤泉2, 藤堂由紀2, 浜手ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2017.
Japanese Article P0368-4-AM. Examination of the onset of hypersensitivity situation and the risk factor of the intravenous anticancer agent in our hospital
槇枝大貴1,4, 田中奈緒美2, 岡脇誠3, 山口佳之3, 小野浩重4, 二宮洋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2017.
Japanese Article P0370-4-AM. Examination about the safety of DOAC for the venous thromboembolism that occurred during bevacizumab administration
田川誠二1, 新谷拓也1, 村地泰1, 勝浦正人1, 門脇裕子1, 水野裕八2, 山口修2, 坂田泰史2, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2017.
Japanese Article P0371-3-PM. Use experience of nivolumab in the decreased renal function patients
山下悟史1, 岸川春樹1, 長谷悠紀1, 平野真健1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2017.
Japanese Article P0373-3-PM. Polypharmacy fact-finding of patients with cancer
辻俊輔1, 松崎幸司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2017.
Japanese Article P0375-3-PM. Association of the adverse event in melphalan large doses patients and the pharmacokinetic parameter
内山将伸1, 宮崎元康1, 高松泰2, 神村英利3, 松尾宏一1, 今給黎修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2017.
Japanese Article P0377-3-PM. The hepatitis B screening enforcement situation investigation in the Hekinan Municipal Hospital
伊藤昌美1, 片山広美1, 榊原奈美1, 八並ゆかり1, 鈴木裕之1, 黒田信行1, 永田実1, 加藤直紀1, 鈴木めぐみ1, 天野哲史1, 松本薫1, 石井彩子1, 佐藤篤郎1, 鈴木厚志1, 板倉由縁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2017.
Japanese Article P0379-3-PM. Effect on neutropenia by the presence or absence of ramucirumab combination in the gastric cancer
鹿沼綾1, 高橋幸三1, 角川幸男1, 金銅葉子1, 中多陽子1, 坂上嘉浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2017.
Japanese Article P0381-3-PM. The adverse event expression of Pembrolizumab situation for the non-small cell lung cancer
田中麻理子1, 井上咲姫1, 櫛田宏幸1, 岸本歩1, 宮地修平1, 砂金秀美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2017.
Japanese Article P0383-3-PM. An example with suspected Trousseau syndrome with the Pembrolizumab administration
柏木佑貴1, 真砂聖1, 藏本裕信1, 依藤健之介1, 足立恵子1, 前田翠1, 井上明香2, 岡田信彦2, 鈴木雄二郎2, 松本章士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2017.
Japanese Article P0385-3-PM. Pharmacist Proactive Telephone Monitoring (PPTM) system construction for the adverse event early detection of the immune checkpoint inhibitor and the usefulness
吉田光一1, 福土将秀1, 寺川央一1, 木村周古1, 山下恭範1, 小野尚志1, 三嶋一登1, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2017.
Japanese Article P0387-3-PM. About an association between EGFR mutation in the gene and dermatopathy in our hospital EGFR-TKI introduction patients
安宅希美子1, 立道貴清1, 越野優希1, 山下紗矢佳1, 大野麻由1, 山口佳津騎1, 田中裕章1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2017.
Japanese Article P0389-3-PM. We look at the rear of the effect on patients with malignant melanoma and lung cancer predictor of the nivolumab treatment and examine a mark
細井一広1, 中川潤一1, 兵藤塁1, 阿保成慶1, 照井一史1, 下山律子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2017.
Japanese Article P0391-3-PM. The enforcement situation of the HBV screening test of patients who received cancer chemotherapy in our hospital
掛札聡美1, 石井紀子1, 宍倉啓介1, 山口智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2017.
Japanese Article P0393-3-PM. One case of the lung adenocarcinoma which developed type I diabetes mellitus during antiPD-1 antibody administration
長谷川英利1, 松井駿亮1, 豊田悠二1, 本田富得1, 古川哲也1, 中泉伸彦2, 前野恭宏2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2017.
Japanese Article P0395-3-PM. It is analysis ... of the questionnaire results in the ... 26th Japan cure association annual convention about the needs that a pharmacist engaging in cancer medical care seeks in a company and academia
岩本卓也1, 荻原琢男2, 河原昌美3, 宮本祐司4, 中田雄一郎5, 小島義幸6, 高橋克昌7, 大槻純男8, 宇都口直樹9, 宮崎公一10, 石田竜弘11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2017.
Japanese Article P0397-3-PM. S-1 proper use investigation in the outside Parliament prescription judging from test value
三村一平1, 秋元知也1, 添田真司1, 唐木田一成2, 高清水眞二3, 坂巻文雄4, 野村栄治5, 齋藤雄紀6, 渡邊昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2017.
Japanese Article P0399-3-PM. 1 case that was given mFOLFOX 6 therapy to patients on dialysis
谷村紀代子1, 波多野友希1, 秋吉由利子2, 菊井利伸1, 木村文彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2017.
Japanese Article P0401-3-PM. Comparison - of the duties that questionary survey - health insurance pharmacy pharmacist, hospital pharmacist about the medicine medicine cooperation in the foreign cancer chemotherapy demand mutually
石橋正祥1, 長野未来1, 石井正和1, 木内祐二2, 巖本三壽1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2017.
Japanese Article P0403-3-PM. Use results investigation of Ramucirumab in our hospital
前川英輝1, 地主隆文1, 木下愛1, 山本翔太1, 田中耕太1, 庄崎沙耶1, 藤田果那1, 山田将悟1, 菊地義明1, 藤林遼1, 鈴木直哉1, 高橋誠1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2017.
Japanese Article P0405-3-PM. Examination about the setting of Carboplatin doses depending on renal function in the DeVIC therapy for the non-Hodgkin's lymphoma
山口雄士1, 高木佐矢香1, 近藤章吾1, 佐藤和也1, 松由幸司1, 塚原民夫1, 堀内正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2017.
Japanese Article P0407-3-PM. Rearward investigation about successful execution rate and the pCR (histologic complete fruition) rate in the preoperative chemotherapy
杉山奈津子1, 小川智江1, 柳澤深月1, 久保陽加1, 伊東岳1, 加藤芳徳1, 前澤佳代子1, 齊藤光江2, 百瀬泰行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2017.
Japanese Article P0409-3-PM. Examination of the predictor of the effectiveness of the nivolumab for patients with non-small cell lung cancer in our hospital
川端歩実1, 桂英之1, 高田直子1, 湊明志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2017.
Japanese Article P0372-4-AM. Examination of the risk factor about the serious blood poison-related expression in patients who received Carboplatin pemetrexed combination therapy
荒木良介1,2, 計良貴之1, 加藤加奈恵1, 菱沼隆一1, 高木彰紀2, 増田豊2, 浜本知之2, 田中恒明3, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2017.
Japanese Article P0374-4-AM. Safe comparison of the injectable docetaxel forerunner pharmaceutical products and ethanol non-component docetaxel injection generic medicine
佐藤家恒1, 遠藤征裕2, 佐藤博樹1, 平泉達哉2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2017.
Japanese Article P0376-4-AM. The effect that α-Defensin gives to a pro-discharge transporter
保田元気1, 窪田篤人1, 更科壮太2, 小林正紀3, 井関健3,4, 高橋夏子5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2017.
Japanese Article P0378-4-AM. One patient who made electrolyte revision in the hypocalcemia with the zoledronic acid administration
合原嘉寿1, 福石和久1, 林稔展1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2017.
Japanese Article P0380-4-AM. Investigation about the use situation and the adverse event expression of nivolumab in the Oita Red Cross hospital
安部智英1, 久枝真一郎1, 山添太一朗1, 宗広樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2017.
Japanese Article P0382-4-AM. Examination of the factor influencing onset of cardiovascular disease with the anthracycline anticancer medicine
中里健志1, 土屋裕伴1, 国吉央城1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2017.
Japanese Article P0384-4-AM. Examination about Carboplatin for the non-small cell lung cancer in our hospital and the factor of the intensity of treatment drop of the albumin suspension type paclitaxel combination therapy
細川朋弘1, 藤原佑貴1, 塩谷美由紀2, 吉田千尋3, 三崎伯幸3, 河野洋二4, 岸本伸人4, 清水圭子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2017.
Japanese Article P0386-4-AM. One patient who showed PT-INR rise by combination of Osimertinib and warfarin
吉本有里1,2, 小園亜希2, 田川幸1, 諫見圭佑1, 福澤美夕1, 中村康彦1, 山道研1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2017.
Japanese Article P0388-4-AM. Effect of the foreign chemotherapy room permanent residence of the pharmacist specialized in a cancer
藤井友和1, 澤柳直樹1, 西川隆一1, 荒木寛也1, 坂柳悦章1, 辻博幸1, 塚本久之1, 楠泰臣2, 朝倉亮子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2017.
Japanese Article P0390-4-AM. About an association between dose revision and high blood pressure by the weight fluctuation of the bevacizumab in the lung cancer
金澤絵莉1, 谷口潤1, 東島彰人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2017.
Japanese Article P0392-4-AM. About the current situation of the relation of the pharmacist in the fecundity preservation and future possibility
網野一真1, 六波羅孝2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2017.
Japanese Article P0394-4-AM. Efforts to the use situation and the safety management system of nivolumab in our hospital
名坂輝子1, 大和由美子1, 石原真一2, 竹澤豊3, 吉田武史4, 真下陽子5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2017.
Japanese Article P0396-4-AM. One case that bleeding of the cancer of parotid gland with the skin permeation decreased by hydrozincite starch dispersion
伊佐治麻里子1, 鶴谷勝実1, 木村王芳2, 白井博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2017.
Japanese Article P0398-4-AM. Example that was effective by the osimertinib administration using the simple suspension method
荒木邦宏1, 斉藤匡昭1, 大原正之1, 木村正行1, 藤原斉1, 杉山直幸2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2017.
Japanese Article P0400-4-AM. Case of DLBCL given R-GCVP therapy, R-CHOP therapy after the haemodialysis introduction
安森奈緒子1, 林稔展1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2017.
Japanese Article P0402-4-AM. Did the trend of doubt inquiry about the chemotherapy change with improvement of pharmaceutical management in a foreign chemotherapy room and the ward?
及川淳1, 小笠原信敬1, 三浦宏真1, 村上正一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2017.
Japanese Article P0404-4-AM. Usefulness of the each source of information about the renal function of the anticancer agent and the liver function adjustment
溝口由梨香1, 森裕也1, 枦秀樹1, 太田哲徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2017.
Japanese Article P0406-4-AM. Examination of the effect predictor of the immune checkpoint inhibitor nivolumab in the non-small cell lung cancer
藤原聡子1, 東恩納司1, 蔵田靖子1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2017.
Japanese Article P0408-4-AM. One case of the acute myeloid leukemia who had the heart failure that Gemtuzumab ozogamicin was effective
木下滉子1, 稲垣淳2, 菊池隆希2, 諸角一成1, 丹村貴之1, 長谷川和徳1, 大矢美緒1, 川合結乃1, 中村康夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2017.
Japanese Article P0410-4-AM. Consideration about the effect of a blood culture round, the antimicrobial round in our hospital critical care center
前原大輔1, 坂井良美1, 土井本和久1, 横田聖子1, 福井由美子1, 兵頭純子1, 池田覚2, 当麻美樹2, 岩田健太郎3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2017.
Japanese Article P0412-4-AM. A dose and clinical response of micafungin in our hospital, examination about the safety
吉田悦朗1, 臼井和明1, 宇都宮奈々1, 近藤真由1, 長谷川将1, 宗本佐知子1, 上地純子1, 森田佳博1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2017.
Japanese Article P0414-4-AM. The use situation investigation of the therapeutic drug according to the disease severity of Clostridium difficile-related loose bowels in our hospital
大西優里1, 杢保貴幸1, 徳竹裕貴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2017.
Japanese Article P0416-4-AM. Examination of the risk factor of thrombocytopenia in linezolid treated patients
酒井幹康1, 成瀬国男1, 渡口賢隆2, 坪井伸治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2017.
Japanese Article P0418-4-AM. Examination of the dose of the daptomycin for the MRSA
鶴山萌子1, 永野真久2, 山科卓也1, 宮田拓周1, 小田原真希1, 松本紗織1, 松尾尚美1, 入江健司1, 三好孝法1, 川俣洋生1, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2017.
Japanese Article P0420-4-AM. Efforts to proper use of the carbapenem-based medicine by the ICT pharmacist
小林薫1, 白坂友基1, 中村満江2, 山本岳雄3, 工藤温子4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2017.
Japanese Article P0422-4-AM. An example of the intractable scabies
高野尊行1, 柿沼博子1, 小林由香1, 石橋楽至1, 中丸朗1, 薄井啓一郎2, 仲澤恵3, 池野義彦4, 阿久津郁夫5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2017.
Japanese Article P0424-4-AM. The effect that an antimicrobial registration system gives to achievement of drug-resistant measures action plan result index
岡冨大輔1,2,3,4,5, 山西紀子1, 宅江良隼1, 芝美代子2, 山水有紀子3, 明見能成4, 谷口雅敏1, 松田裕之5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2017.
Japanese Article P0426-4-AM. The effectiveness and safety of the MEPM6g administration in the bacterial meningitis
栗村淳子1, 新沼佑美1, 阿部誠也1, 関さやか1, 佐藤直也1, 猪狩崇子1, 児山麻佑1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2017.
Japanese Article P0428-4-AM. Consideration about the candidemia in our hospital
飯尾志帆1,2, 小橋文亜紀1, 斎藤良子2, 本木直樹2, 亀山礼子2, 船屋諭史2, 竹原朗2, 川根隆志2, 蛭谷一彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2017.
Japanese Article P0430-4-AM. About an infective endocarditis case in our hospital for the past 7 years
上原奈緒1, 桑村恒夫1, 阿部名月1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2017.
Japanese Article P0432-4-AM. Proper use investigation at beginning to use of the patients whom specific antimicrobial in the Nissei Hospital was used for several times
池田久雄1,2, 平田貴宏1,2, 足立充司1, 古久保有希子1, 森岡浩子1, 大野典子2, 小瀬戸昌博2, 野村浩英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2017.
Japanese Article P0434-4-AM. Construction of the designated antimicrobial management system which a pharmacist intervenes in positively
吉田美樹1, 細野美幸1, 村岡美彩1, 酒井由貴江1, 山崎千恵1, 中明幹雄1, 高畑英信1, 竹村さおり2, 山本知代美2, 永田肇2, 村本由子3, 又野禎也3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2017.
Japanese Article P0436-4-AM. New efforts in the Akita pharmacist infection control workshop for the antimicrobial proper use support
齊藤伸1, 藤原洋之2, 今村亘3, 高橋満里4, 佐々木修5, 石田良樹6, 後藤敏晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2017.
Japanese Article P0438-4-AM. Examination about the staphylococcus aureus bacteremia in the municipal Kushiro General Hospital
鎌田裕介1, 菅野雄太1, 瓜智都1, 菅原大輔1, 竹谷美穂1, 森本淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2017.
Japanese Article P0440-4-AM. Efforts of the oral third generation cephem-based antimicrobial proper use in the outpatient department and the effect
小曳恵里子1, 平畠正樹1, 三宅里美1, 中浴伸二4, 安藤基純5, 池末裕明1, 平井雄三2, 土井朝子3, 橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2017.
Japanese Article P0442-4-AM. Inhibition measures of the tazobactam piperacillin consumption by case intervention and the registration system introduction and the effect
塩田智子1,2, 谷長美菜子1, 高橋一栄1,2, 足立幸人2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2017.
Japanese Article P0444-4-AM. One patient who received a triple-drug therapy for nontuberculous Mycobacterium (NTM) of the subcutaneous abscess
小野寺潤1, 杉山奈々美1, 五味裕介1, 二瓶大輔1, 山際一也1, 杉木正2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2017.
Japanese Article P0446-4-AM. Efforts for the proper use of the carbapenem-based antimicrobial in our hospital
田村直斗1, 佐藤悠太1, 斉藤匡昭1, 木村正行1, 藤原斉1, 進藤誠子2, 袴田陽子3, 金田浩人4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2017.
Japanese Article P0448-4-AM. Proper use investigation of injectable metronidazole in the intraperitoneal infections disease in our hospital and the concomitant drug
平田貴宏1, 池田久雄1, 足立充司1, 野村浩英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2017.
Japanese Article P0450-4-AM. Examination about the antimicrobial consumption index associated with chemosensitive results
小林義和1,6, 吉岡祐貴1,6, 川崎祥平1,6, 田中伸幸2,6, 山田昌矢3,6, 岩本公一3,4,6, 浅野昌彦5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2017.
Japanese Article P0452-4-AM. The administration situation of the daptomycin in the Kure medical center, Chinese cancer center first aid domain
前田龍人1,2, 竹山知志2, 佐藤岳春1, 渡辺光1, 國原将洋1, 二五田基文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2017.
Japanese Article P0454-4-AM. The effect that the antimicrobial administration support by the pharmacist gave to antimicrobial consumption and Pseudomonas aeruginosa sensitivity
松木祥彦1, 石毛宏治1, 石田雅也1, 金井絵美1, 富田千尋1, 西沢大樹1, 大島香1, 寺田裕1, 小川真美江1, 杉田恵1, 米井万紀子1, 相馬雄介1, 大貫利乃1, 菊地聡美1, 兼村友輔1, 林美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2017.
Japanese Article P0456-4-AM. Efforts of the dose adequacy of the carbapenem-based medicine by doubt inquiry
田中悠子1, 南和志1, 田村健悦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2017.
Japanese Article P0458-4-AM. Comparison between vonoprazan and effect of the existing proton pump inhibitor in the Helicobacter pylori sanitization treatment
児玉暁人1, 今井兼貴1, 岩田智津子1, 森信介1, 長生幸司2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2017.
Japanese Article P0460-4-AM. Of result and MRSA bacteremia treatment of the use of antiMRSA medicine patients round in the Nagaoka Red Cross hospital, actually
丸山智幸1, 小林謙一1, 西堀武明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2017.
Japanese Article P0411-3-PM. About an effect of the pharmacist intervention at new hepatitis C therapeutic drug introduction in our hospital
八道智絵1, 井藤あいな1, 桑原冴佳1, 中島早苗1, 吉村一樹1, 木村真衣1, 真鍋詩織1, 中林真紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2017.
Japanese Article P0413-3-PM. Investigation about the use situation of the carbapenem-based antimicrobial in our hospital
松田凌地1, 榎本俊介1, 山口美奈1, 日戸章人1, 松坂昌宏1, 鈴木寧1, 冨家俊弥1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2017.
Japanese Article P0415-3-PM. Analysis of the antimicrobial choice in the ESBL-producing bacteria detection patients
森田淳介1, 田子尚史1, 國分真理1, 新木美枝1, 山賀章一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2017.
Japanese Article P0417-3-PM. Examination of the dose of Linezolid to the consecutive hemodiafiltration (CHDF) patients
小田原真希1, 山科卓也1, 宮田拓周1, 鶴山萌子1, 松本紗織1, 松尾尚美1, 入江健司1, 三好孝法1, 川俣洋生1, 辻泰弘2, 神村英利3, 加留部善晴3, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2017.
Japanese Article P0419-3-PM. Evaluation of MIC and the effect of treatment of vancomycin
徳山ことみ1,2,3,4,5, 馬生良則2, 小坂紀子2, 二階堂弘美3, 安藤由香4, 矢野朋文5, 福澤祐幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2017.
Japanese Article P0421-3-PM. It is effect on infection after the operation by the antimicrobial internal use cancellation after the operation in the nose endoscopic operation
虎瀬和子1, 南憲一1, 下川千賀子1, 山田千代子1, 渡邉珠代2, 作本真3, 長谷川博紀4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2017.
Japanese Article P0423-3-PM. 1 case that responded to meropenem for Enterobacter agglomerans bacteremia early
綺田尚久1, 藤原信二1, 速水亮一2, 中村忠之3, 原田吉将4, 道智賢市5, 西嶋長1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2017.
Japanese Article P0425-3-PM. Examination of 8 cases that a high dose gave ABPC/MCIPC combination drug to for MSSA infection
菅原隆文1, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2017.
Japanese Article P0427-3-PM. Evaluation about the antimicrobial consumption according to the clinical department between Rousaibyoin of Kyushu, Yamaguchi District
亀田敬子1, 管田彩乃2, 臼井和明3, 松永智子4, 岩切啓太5, 木本秀樹6, 谷口一成5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2017.
Japanese Article P0429-3-PM. Examination of the use background of the levofloxacin IV infusion of our hospital in the pneumonia practice
菅野小雪1, 續橋明1, 吉田信太郎1, 畑伸一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2017.
Japanese Article P0431-3-PM. Safety assessment of Liposomal-Amphotericin B for the decreased renal function patients
加藤未紗1, 松岡知子1, 大橋健吾1, 篠田康孝1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2017.
Japanese Article P0433-3-PM. We look at the rear in the use of daptomycin case of our hospital and examine a mark
宮川貴誌1, 森本裕美1, 渡部久美1, 宮川志穂1, 南仁惠1, 甲斐絢子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2017.
Japanese Article P0435-3-PM. The thrombocytopenia of Linezolid treated patients and investigation of the factor
伊藤貴亮1, 佐藤圭吾1, 菅野和1, 河上昭一1, 西和哉1, 佐賀利英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2017.
Japanese Article P0437-3-PM. 1 case that gave VCM gradual decrease therapy for intractable Clostridium difficile association enterocolitis repeatedly
小池彩子1,3, 花房伸幸1,3, 河村茉衣1,3, 廣田あゆ子1,3, 橋本健二2, 奥格3, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2017.
Japanese Article P0439-3-PM. Examination about the use situation and the proper use of the metronidazole note in our hospital
浦崎清美1, 玉城哲子1, 城間盛彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2017.
Japanese Article P0441-3-PM. Consideration about the use situation of the daptomycin in our hospital
茂木美香1, 松永真1, 須藤雄太1, 関陽介1, 藤田俊也1, 小林恭子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2017.
Japanese Article P0443-3-PM. Effect of the clinical path introduction for the antimicrobial proper use prophylactic after the operation in a lap product, the female clinical department
渡辺典子1, 相曽啓史1, 鳥羽三佳代2, 佐瀬裕子1, 大島乃里子3, 杉井麻耶1, 石渡泰芳1, 永田将司1, 高橋弘充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2017.
Japanese Article P0445-3-PM. After the operation about efforts of our hospital in the infection prophylaxis antimicrobial proper use
藤重瑶子1,2, 松本浩1,2, 濱野公俊1,2, 宮地悠輔2, 山崎行敬3, 長島梧郎2, 國島広之3, 坂下裕子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2017.
Japanese Article P0447-3-PM. Efforts of Antimicrobial Stewardship (AS) which adopted inspection and feedback after the prescription by the ward pharmacist and the evaluation
竹川七生1,2, 大畠雅子1, 関戸茜衣1, 小田井剛2, 牧野以佐子1, 前田拓哉1, 三上二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2017.
Japanese Article P0449-3-PM. Community-acquired pneumonia, examination of the use of antimicrobial with the antiPseudomonas aeruginosa activity in the initial treatment for medical care, care-related pneumonia
加戸義大1, 奥村佳史1, 森田孝子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2017.
Japanese Article P0451-3-PM. Antimicrobial stewardship team intervention and effect
齋藤佑輔1, 海崎佳史2, 塗茂裕一3, 細田清美4, 岩井和之5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2017.
Japanese Article P0453-3-PM. About the prescription actual situation of the detection situation and the faropenem of substrate specific expansion type β - lactamase-producing Escherichia coli in our hospital
大田栄一1, 久保勝1, 由本綾乃2, 中野晃子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2017.
Japanese Article P0455-3-PM. Relation of Antimicrobial Stewardship Team activity and the pharmacist in our hospital
赤沢翼1, 大橋裕丈1, 足立遼子1, 片浪雄一2, 山元佳2, 忽那賢志2, 増田純一1, 目崎和久3, 近藤直樹1, 坂本治彦1, 桑原健1, 大曲貴夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2017.
Japanese Article P0457-3-PM. Efforts and problem of the ICT in the blood culture-positive subjects round
高橋真一1, 奥津利晃1, 渡邉あゆみ1, 内藤淳嗣1, 蔭山博之1, 平島徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2017.
Japanese Article P0459-3-PM. Effect on main antimicrobial AUD by support, the intervention round to the use of carbapenem-based antimicrobial patients
小林謙一1,3, 丸山智幸1,3, 西堀武明2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2017.
Japanese Article P0461-3-PM. Efforts about the cooperation with the activity of the ward pharmacist in the delirium measures of the inpatient and the dementia delirium support team (DST)
市川大介1, 藤野優菜1, 安江佳南1, 小田真澄1, 古谷佳美1, 中田早苗1, 齋藤文佳1, 猪木初枝2, 涌谷陽介3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2017.
Japanese Article P0465-3-PM. Evaluation by the questionary survey of the pharmacist interview before medical examination in the psychiatry outpatient department
進健司1,2, 牛島悠一1, 梅田勇一1, 小林大介2, 川尻雄大2, 金澤康範1, 神村英利3, 島添隆雄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2017.
Japanese Article P0467-3-PM. About the effect on prescription contents by the Vegetamin cancellation and patients
福山雄卯介1, 林佳奈子1, 後藤史子1, 千代延桜子1, 中村敦士1, 宮崎敦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2017.
Japanese Article P0469-3-PM. One case of patients with intractable schizophrenia that resulted in a sudden liver damage during cataplexy and Clozapine treatment with lithium
石川哲也1, 小林純子1, 金田昌子2, 伊藤誠紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2017.
Japanese Article P0471-3-PM. Preventive measures against BPSD aggravation by a dementia care team and the ward pharmacist cooperation
佐々木貴寛1, 伊藤香織1, 相馬真志1,2, 中村悦子1, 飯田優太郎1,2, 熊谷英樹3, 小川義敬1, 中嶋俊之4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2017.
Japanese Article P0473-3-PM. About the effect that delirium high risk medicine gives to the delirium onset of patients with dementia
大久保優1,5, 清水一紀2,5, 奥村佳史1, 横谷弘子3,5, 内藤喜隆4,5, 池田知聖5, 森田孝子1,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2017.
Japanese Article P0475-3-PM. The single agent of the antipsychotics for patients with schizophrenia about becoming it
幸邦憲1, 田代早紀1, 吉見幸那1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2017.
Japanese Article P0479-3-PM. The effectiveness of the serotonin reuptake inhibitor in the treatment of patients with depression 18 years or younger and safe evaluation
太田祐里奈1, 嶋田修治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2017.
Japanese Article P0481-3-PM. Fact-finding in benzodiazepine, addition of the suvorexant for patients during the non-benzodiazepine drugs remedy and the change
高取士剛1, 藤井達也1, 菅大地2, 三上大貴1, 久保淳一1, 高木明彦1, 鈴木千波1, 佐藤公人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2017.
Japanese Article P0483-3-PM. Survey about the clinical path in the psychiatry supermarket emergency ward
中武久美子1, 江藤英倫1, 本園奈緒美1, 中川伴子1, 重松淳哉1, 小嶋享二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2017.
Japanese Article P0462-4-AM. Efforts of prescription suggestion and the antipsychotics weight loss using the SCAP method
松田紗祐里1, 熊谷範之1, 伊藤明人1, 宇部太郎1, 千葉芙美1, 村上遥1, 松谷英里1, 佐藤裕大1, 宮本亜希1, 新沼さおり1, 新沼央子1, 熊谷壽美子1, 菊地秋子1, 鵜浦利江1, 三浦清彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2017.
Japanese Article P0464-4-AM. The case that contributed to the medical therapy for the psychiatry outpatient by the pharmacist outpatient department introduction
牛島悠一1, 進健司1,2, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2017.
Japanese Article P0466-4-AM. About the relation of the pharmacist for patients with eating disorders of the laxative abuse type
山本ゆりえ1,2, 圓岡大典1, 田村奈穂2, 戸田健太2, 長坂久乃3, 北田忍3, 河合啓介2, 廣井明夫1, 水野宏一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2017.
Japanese Article P0468-4-AM. Comparison about a sleep effect of suvorexant and non-benzodiazepine system sleeping drug zolpidem and the effect on delirium
鈴木恵子1, 田中怜1, 松本晃明2, 新里馨3, 篠道弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2017.
Japanese Article P0470-4-AM. Examination for the adequacy of the medical therapy in schizophrenia
麻那古信之1, 山本智也1,2, 立入頌子1, 杉浦知佳1, 勝浦正人1, 門脇裕子1, 田中萌子3, 工藤紀子4, 山森英長3, 安田由華3, 渡邉衡一郎5, 稲田健6, 三輪芳弘1, 橋本亮太3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2017.
Japanese Article P0472-4-AM. About the relation of the pharmacist in the dementia care team
中田吉則1,2, 亀山隆2, 滝沢なぎさ2, 片野貴大1, 佐藤江莉1, 重共孝一1, 河井良智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2017.
Japanese Article P0474-4-AM. Examination of the rehospitalization factor in schizophrenia
杉沢諭1, 渡邊直優2, 片岡由衣2, 永井努1, 栗原竜也1, 常岡俊昭3, 田中佐知子2, 木内祐二2, 稲本淳子3, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2017.
Japanese Article P0476-4-AM. Efforts for the proper use of the benzodiazepine receptor agonist for hospitalization elderly people
梅元晃美1, 中出奈津子1, 東昌代1, 道下孝恒1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2017.
Japanese Article P0478-4-AM. Introduction of the flowchart in the delirium treatment toward PBPM
吹谷真紀子1, 鈴木ひとみ1, 八代佳子1, 齊藤伸1, 工藤和彦1, 一関美江子1, 篠田和人1, 仙葉悠紀1, 木元健寛1, 金美紀1, 佐藤恵葉1, 水沢重則1, 後藤敏晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2017.
Japanese Article P0480-4-AM. The effect that SST - medication self-care program that other types of job cooperate with a pharmacist and perform gives medication awareness
西川幸輝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2017.
Japanese Article P0482-4-AM. The current situation investigation of the serum lithium densitometry in our hospital
小林純子1, 石川哲也1, 伊藤誠紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2017.
Japanese Article P0484-4-AM. Examination of the usefulness of the ulinastatin vagina suppository in the early or threatened labour
伊藤緑1, 穂苅郷美1, 増田雅行1, 真坂亙1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2017.
Japanese Article P0486-4-AM. Attitude survey of the medical staff about the pharmacist duties in the maternity ward
南雲まい1, 川口寿子1, 仁平陽子1, 影山名織1, 齋藤謙治1, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2017.
Japanese Article P0488-4-AM. Relation of the pharmacist in the methotrexate administration therapy of the ectopic pregnancy patients in hope of fecundity preservation
村田文1, 新木美枝1, 伊藤理廣2, 山賀章一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2017.
Japanese Article P0490-4-AM. Drug control instruction to lying in woman and future problem
浅野志津1, 砂場亜希1, 日浦亜実1, 平井淳子1, 林裕治2, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2017.
Japanese Article P0492-4-AM. The actual situation of the antihypertensive medications prescription for the pregnant woman: Examination based on receipt data
小原拓1,2,3, 大久保孝義4, 佐藤倫広5, 石黒真美2,3, 目時弘仁5, 菊谷昌浩2,3, 西郡秀和6, 赤沢学7, 八重樫伸生2,6, 栗山進一2,3,8, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2017.
Japanese Article P0494-4-AM. Examination for the change of Breastfeeding Recommendation at nursing accompanied with revision from the Drugs in Pregnancy and Lactation ninth edition to the tenth edition
増田寛樹1, 野坂真梨子1, 岡田裕子2, 前田恵里2, 溝口優1, 渡邊美智留1, 桑原弘行1, 山口友明3, 鷲見正宏4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2017.
Japanese Article P0496-4-AM. Fact-finding of the use drug in the delactation case
清水彩子1, 渡邉将隆1, 油井信明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2017.
Japanese Article P0498-4-AM. Examination of the side effect frequency of the generic drug ritodrine hydrochloride infusion liquid varying in an additive
藤谷みなみ1, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2017.
Japanese Article P0500-4-AM. Attitude survey for "a use drug table" for the patients explanation in our hospital maternity ward
石橋摩耶1, 佐藤綾子1, 佐藤貞子2, 谷川原真吾3, 堤栄二1, 鈴木伸男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2017.
Japanese Article P0502-4-AM. Examination of the onset of itch with the ritodrine administration in patients with pressure style, premature birth
日野光記枝1, 宇佐美英績1, 大橋健吾1, 高田裕子1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2017.
Japanese Article P0504-4-AM. 1 case of the pregnant woman whom we produced rhabdomyolysis by ritodrine hydrochloride administration, and congenital myotonica dystrophia was diagnosed in children by
佐藤裕美1, 小山絹子1, 森本雅子1, 福野和治1, 松川雅子1, 西部幸一1, 今井桂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2017.
Japanese Article P0506-4-AM. Examination of the instruction contents adequacy for folic acid, the carnitine drop by the use of antiepileptic drug
吉井圭佑1,2, 原 (野上) 愛2, 梶俊策3, 見尾光庸2, 杉山哲大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2017.
Japanese Article P0508-4-AM. Examination about the bronchial asthma merger pregnancy
木藤一美1, 橋本隆信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2017.
Japanese Article P0510-4-AM. Investigation of the effect to give to a mother's body, the neonates judging from a relation with pharmacist in the gestational diabetes
三上有希1, 澤井麻記1, 野崎歩1, 長嶋一昭2, 藤井剛3, 小林由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2017.
Japanese Article P0512-4-AM. Making of the pharmaceutical products database (Kitasato version) about a drug and the nursing
花島玲子1, 持田裕子2, 春日井公美2, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2017.
Japanese Article P0514-4-AM. Examination about the usefulness of the use of pain-killer algorithm based on the aspirin asthma risk assessment
満木由布菜1, 塩見めぐみ1,2, 久嶋則行3, 栗林みどり4, 矢島慶子1, 荒井梨江1, 春山幸子1, 三木明徳3, 尾鳥勝也1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2017.
Japanese Article P0516-4-AM. A relation and the current situation to a nursing mother taking a psychotropic drug
手島慶子1, 三宅永華1, 奥村理紗1, 三宅沙央莉1, 中谷香織1, 岩城晶文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2017.
Japanese Article P0518-4-AM. Attitude survey of the health insurance pharmacy for the information communalization in a pregnant woman, the nursing mother medical therapy domain in the Hamamatsu, Shizuoka district
峯田保恵1, 加藤和佳奈1, 宮城明実1, 塩川満1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2017.
Japanese Article P0520-4-AM. The construction of the neonates withdrawal syndrome check system and intervention as a pregnant woman, the nursing mother medical therapy authorization pharmacist
三好文子1, 松重奈央1, 出雲貴文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2017.
Japanese Article P0485-3-PM. Efforts about the drug mother's milk transitivity reporting
門倉史枝1, 國東佑美1, 本上ほなみ1, 二星知紗1, 永井浩章1, 井上智恵1, 見上千昭1, 西窪奈津子1, 西尾孝1, 辻本勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2017.
Japanese Article P0487-3-PM. Efforts to bowel control based on the constipation treatment protocol that collaborated with the ward staff in the maternity ward and the evaluation
木村純子1, 高木祥子1, 立松あき2, 江口美智2, 加藤紀子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2017.
Japanese Article P0489-3-PM. Collaboration work ... with making and side effect evaluation ... Dr., the nurse midwife of the tool in the use of nifedipine to impending premature birth treatment
杉浦あゆみ1, 小島昌代1, 桑山隼1, 石田直美2, 佐々治紀3, 桜田宏明1, 山村益己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2017.
Japanese Article P0491-3-PM. Evaluation of the reporting book to the pregnant woman by the pharmacist
辻村早由稀1, 加賀正基1, 松井乃利子1, 柴山芳之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2017.
Japanese Article P0493-3-PM. Analysis of questionnaire results and the inquiry example targeted for a physician about a pregnant woman, the nursing mother medical therapy
大野愛1, 伊藤友恵1, 野澤孝子1, 山本恭平1, 岩瀬由枝1, 鶴田昌吾1, 石上仁美1, 猪岡真己1, 久保田敏行1, 杉浦洋二1, 勝見章男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2017.
Japanese Article P0495-3-PM. Mother's milk shift prediction - second generation antihistamine of the drug by in silico using ADMET Predictor and metabolite, foreign element -
板垣文雄1, 末松歩1, 秋好悠1, 渡邊真知子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2017.
Japanese Article P0497-3-PM. Pregnant woman, attitude survey for the medicine in the nursing mother
平澤裕美子1, 羽藤加奈恵1, 上野杏菜1, 田頭尚士1, 常久幸恵2, 多田克彦3, 中村和恵4, 木内司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2017.
Japanese Article P0499-3-PM. Medical treatment for the high blood pressure that occurred in puerperium
野木山史恭1, 相馬まゆ子1, 佐々木洋一1, 今田愛也2, 猪爪信夫2, 吉田博3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2017.
Japanese Article P0501-3-PM. It is analgesic effect investigation of the periodical administration of intravenous acetaminophen in the painkilling after the cesarean section
酒井彩乃1, 野洌孝二1, 大岡千寿子1, 久保田理恵1, 池田遼太1, 神田雄史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2017.
Japanese Article P0503-3-PM. The case that consisted of the treatment enforcement for a feeling of itching with the ritodrine hydrochloride readministration if the pregnancy was possible continuously
巖西真1, 金本賢枝1, 平大樹1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2017.
Japanese Article P0505-3-PM. 1 case that became with positive STS for syphilis, and took amoxicillin for a long term during pregnancy
横山雅子1, 加瀬和也1, 夏目義明1, 中山昌樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2017.
Japanese Article P0507-3-PM. The current situation of the mental disorder merger pregnant medical treatment in our hospital
桐林美緒1, 矢吹恵美1, 後藤明人1, 金田美咲緒1, 三浦裕美子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2017.
Japanese Article P0509-3-PM. Effect by a pregnant woman, a nursing mother medical therapy authorization pharmacist conducting the pregnancy, the nursing and the introduction education in the medicine domain on business trainee, new face pharmacist
松重奈央1, 三好文子1, 出雲貴文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2017.
Japanese Article P0511-3-PM. Examination of the factor associated with the perinatal period bleeding of the parturient third oxytocin treated patients
柿沼博子1, 高野尊行1, 小祝梓1, 小林由香1, 柿沼貴広1, 石橋楽至1, 中丸朗1, 太田邦明2, 白石悟2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2017.
Japanese Article P0513-3-PM. The case that the antiphospholipid syndrome merger pregnancy patients reached the childbirth with aspirin internal use, a heparin calcium self injection safely
後藤紗希1, 和田淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2017.
Japanese Article P0515-3-PM. Questionnaire research about the actual situation of recognition and the use for the medicine of a pregnant woman of the third pregnancy trimester or the nursing mother
糸川知江1,2, 角英2, 形部文寛2, 妹尾友美3, 高田薫3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2017.
Japanese Article P0517-3-PM. Examination about a gestational period and the side effect of tocolytic agent for the early or threatened labour in our hospital
油布朋子1, 服部純尚2, 高橋邦雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2017.
Japanese Article P0519-3-PM. Efforts for the improvement in drug knowledge of a nurse, the nurse midwife in the maternity ward
加藤和佳奈1, 峯田保恵1, 塩川満1, 中村光世2, 村越毅3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2017.
Japanese Article P0521-3-PM. Examination of the clinical usefulness of blood emptiness, the blood score for the early or threatened labour
石川未奈子1, 中村卓巨1, 山本高範1, 鬼頭大輔1, 溝口和代1, 紀平力2, 日下秀人2, 前川有香2, 吉村公一2, 前田眞2, 阿部康治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2017.
Japanese Article P0522-4-AM. Examination about the precision of the disposable-type pen type insulin injection appliance
秋山滋男1,3, 青木智之2,3, 荻原貴之2, 村上正己3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2017.
Japanese Article P0524-4-AM. Examination about the predictor of the insulin therapy necessity or not at discharge in the type 2 diabetes education inpatient
石田翔1, 吉川明良1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2017.
Japanese Article P0526-4-AM. Medication adherence by the change to once a week DPP-4 inhibitor, effect on change and treatment result of the diabetes treatment satisfaction questionnaire
西村亮1, 佐藤雄一2, 中田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2017.
Japanese Article P0528-4-AM. Fact-finding about the chic day of patients with diabetes
染谷光洋1, 長沼敬子1, 山崎友里絵1, 石尾有司1, 谷口亮央1, 前田柾幸1, 中島史雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2017.
Japanese Article P0530-4-AM. Fact-finding about the maneuver after the insulin self injection introduction
高松真依1, 田邉史子1, 松本亜佐美1, 三橋真由美1, 光川由佳子1, 秋本法人1, 小林早苗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2017.
Japanese Article P0532-4-AM. Search of the patients needs in the SMBG apparatus
飯干茜1, 大石将義1, 古浜健一1, 湯本哲郎2, 稲葉健二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2017.
Japanese Article P0534-4-AM. Questionary survey of the usability of the pre-filled type insulin instillator for the insulin initial introduction patients
谷聡美1, 薄元里衣1, 田頭尚士1, 木内司1, 肥田和之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2017.
Japanese Article P0536-4-AM. Examination about the patients background of the hypoglycemia case in the emergency visit
猪子美保1, 藤森和則1, 間瀬悟1, 近藤有1, 坪井伸治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2017.
Japanese Article P0538-4-AM. The effect that a change gives to blood sugar control on gliclazide from glimepiride
中島啓二1, 宇佐美英績1, 臼井一将1, 多賀小枝子1, 新井かおり1, 安部絵里1, 伊藤加代1, 蜜田哲也1, 柴田大河2, 傍島裕司2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2017.
Japanese Article P0540-4-AM. Inspection of the usefulness of the diabetes therapeutic drug Dulaglutide through the self-injection introduction instruction by the pharmacist
石田詞子1,2, 小野達也1,2, 岩田芳枝1, 西田英之1, 徳山尚吾2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2017.
Japanese Article P0542-4-AM. About the case that contributed to the number of the prescription increase of the Dulaglutide in our hospital
山下大貴1, 重松沙希1, 内山有理香1, 平川雅章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2017.
Japanese Article P0544-4-AM. Examination of the usefulness of the low-dose ipragliflozin (25 mg of daily doses)
谷内幸恵1, 織田展成2, 大森亜衣2, 高橋知子2, 奥田理香2, 笹山潔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2017.
Japanese Article P0546-4-AM. Examination of the usefulness in the blood sugar control of the sustained Exenatide preparation
尾形朱史鈴1, 若松遼介1, 石塚仁保1, 能登数馬2, 須藤大雄1, 棚谷貢1, 飛澤国広1, 小林龍3, 小原秀治1, 小原郁司1, 渡辺浩明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2017.
Japanese Article P0550-4-AM. Examination of the usefulness of the SGLT2 inhibitor in patients with type 2 diabetes
松本尚子1, 早川伸樹1,2, 津川透1,3, 林高弘3,4, 福井愛子1, 亀井浩行1, 松尾悠志2, 吉野寧維2, 鈴木敦詞2, 山田成樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2017.
Japanese Article P0552-4-AM. The use situation investigation of the SGLT-2 inhibitor in our hospital
駒井勇太1, 田仲祐子1, 坂口結斗1, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 仲村亮太1, 森智子1, 人見百合子1, 石井英之1, 氏川郁穂1, 村雲智久1, 石井奈津季1, 久田潤平1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 竹治優紀1, 松元あみ1, 水野康平1, 山中愛美1, 吉村美菜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2017.
Japanese Article P0554-4-AM. Association of hypoglycemic action and the CPI of patients with type 2 diabetes taking DPP-4 inhibitor (sitagliptin)
土井佳子1, 真井雄規1, 小笠原綾香1, 石田陽美1, 津田雅大1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2017.
Japanese Article P0556-4-AM. Illness medicine cooperation using systems construction and the diabetes cooperation notebook of the diabetes instruction to patient
中嶋直也1, 青山栄司1, 土屋辰司1, 吉田昌樹1, 中澤千寿1, 竹内松美1, 谷知彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2017.
Japanese Article P0523-3-PM. The effect that all inpatient diabetes practice management (hospital wide diabetes management, HDM) by CDE-J gives to the surgery patients
伊藤隆哉1, 小山貴夫1, 中野和佳1, 矢野目英樹2, 石津美紀3, 太田隆4, 田内克典5, 山下浩6, 山内恵史7, 相澤徹6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2017.
Japanese Article P0525-3-PM. An understanding degree and education problem of the diabetes education patients
染谷真理子1, 飯嶋友美1, 山下春香1, 引地華子1, 味岡絢子1, 川崎昌子1, 田澤匡1, 辻桃子1, 福田光司1, 原信田努1, 圓崎信也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2017.
Japanese Article P0527-3-PM. The hypoglycemia effect with the SGLT2 inhibitor and effect on serum uric acid level
櫻井淳二1, 菅原愛美2, 佐藤伸輔1, 渡辺昌子1, 阿部順1, 岡田優1, 野上佳奈子1, 宮内康夫1, 武者栄美子1, 高橋知子2, 大河原雄一2, 石澤文章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2017.
Japanese Article P0529-3-PM. Patients understanding degree investigation for the medication counseling to the SGLT2 inhibitor remedy patients
平野陽子1, 渡瀬友貴1, 古俵孝明1, 渡辺享平1,2, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2017.
Japanese Article P0531-3-PM. Investigation of the seriously ill hypoglycemia risk patients based on "blood sugar control target of elderly people diabetes"
長尾彰太1, 吉岡睦展1, 若松雄太1, 杉生雅和1, 石津智司1, 辻隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2017.
Japanese Article P0533-3-PM. Comparison of blood glucose level and HbA1c in once a week preparation and the once a day preparation of the GLP-1 receptor agonist
臼井美佳1, 足立恵子1, 依藤健之介1, 前田翠1, 松本章士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2017.
Japanese Article P0535-3-PM. Evaluation - effect of the usefulness of the Dulaglutide on elderly people and examination ... of the side effect factor
山田早1, 土屋裕伴1, 大島聡子1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2017.
Japanese Article P0537-3-PM. Survey of the medical treatment for patients with diabetes during use of anticancer agent of our hospital
永渕学1, 久保壮史1, 植山寛1, 親泊広大1, 春口温子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2017.
Japanese Article P0539-3-PM. Examination about the association between effectiveness and renal function of the dapagliflozin
石橋楽至1, 小林由香1, 柿沼博子1, 高野尊行1, 中丸朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2017.
Japanese Article P0541-3-PM. Fact-finding about the recognition of the blood sugar control target in patients with elderly people diabetes
小鷹篤1, 米川綾1, 安齋沙織1, 佐藤知奈美1, 杉井龍1, 飯塚敏美1, 亀山俊1, 堀口雅巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2017.
Japanese Article P0543-3-PM. Examination about the effectiveness and the spin-off of the SGLT2 inhibitor
水谷彰史1, 久保淳一1, 鈴木千波1, 蝦名勇樹1, 佐藤裕資1, 森田眞樹子1, 高木明彦1, 佐藤公人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2017.
Japanese Article P0545-3-PM. Investigation about the kidney protection effect of the ipragliflozin
坂田美咲1, 秋吉明子1, 平田憲史郎1, 下石和樹1, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2017.
Japanese Article P0547-3-PM. Examination of the usefulness of the once a week GLP-1 receptor agonist Dulaglutide introduction patients
久嶋真紀子1, 野口景子1, 葛葉守1, 中野玲子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2017.
Japanese Article P0549-3-PM. 1 case of the IgG 4 associated diseases that developed steroid diabetes
伊東崇仁1, 水澤清1, 川井龍美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2017.
Japanese Article P0551-3-PM. Examination of the combined effect of metformin and the DPP-4 inhibitor in patients with type 2 diabetes
福井沙季1, 早川伸樹1,2, 津川透1,3, 林高弘3,4, 福井愛子1, 亀井浩行1, 牧和歌子2, 中山将吾2, 鈴木敦詞2, 山田成樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2017.
Japanese Article P0553-3-PM. Effect - that the band of the need - HbA1c level of the response in consideration for psychology of the patients with diabetes gives to quality of life
千野佑莉1, 中井義人1, 竹平理恵子1, 田畑光久2, 山田悟2, 有田悦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2017.
Japanese Article P0555-3-PM. The use situation investigation of the diabetes combination medicine
石橋真実1, 大森麻江1, 金井美緒1, 日浦亜実1, 森英樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2017.
Japanese Article P0557-3-PM. It is examined construction and the usefulness of the pass on the diabetes education hospitalization weekend
中尾ユミ1, 勅使河原眞也1, 森美樹1, 田口あさみ1, 南中二三代2, 和田真明3, 佐久間陽子4, 稲角利彦1, 櫻井美由紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2017.
Japanese Article P0558-4-AM. Effect of levocarnitine on anemia of artificial dialysis patients
林智樹1, 磯崎久美子1, 齊田峻1, 佐藤数馬1, 稲本正行1, 井上美津子2, 徳田崇利3, 斎藤明3, 島田慰彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2017.
Japanese Article P0560-4-AM. Examination about the effect of the proton pump inhibitor on ferritin level of patients on dialysis
小林由香1, 高野尊行1, 柿沼博子1, 石橋楽至1, 中丸朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2017.
Japanese Article P0562-4-AM. Blood level management of tacrolimus (TAC) one-month after the kidney transplantation in our hospital
平井さやか1, 菊地明子1, 松本崇史1, 神田茜1, 後藤知美1, 宮坂能乃1, 本橋彩1, 鈴木宏和1, 小熊梢1, 篠原克典1, 近藤正巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2017.
Japanese Article P0564-4-AM. Examination of the usefulness with the carnitine preparation chronic administration in patients on dialysis
宮腰恵生1, 星貴薫1, 柳谷束1, 山岡幸1, 寺館圭祐1, 森野太一1, 宮越貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2017.
Japanese Article P0566-4-AM. Water management in the tolvaptan medication situation and the everyday life of patients with polycystic kidney
遠藤彩香1, 佐久間大樹1, 向山明彦1, 花輪和己1, 温井郁夫2, 若杉正清2, 神宮寺禎巳2, 小林義文1, 山本誠一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2017.
Japanese Article P0568-4-AM. The renal function evaluation in the health insurance pharmacy and proper use of pharmaceutical products
堀川真由美1, 島崎友美1, 志村優衣1, 三枝隼樹1, 弓削史司2, 大野豊3, 大久保淑子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2017.
Japanese Article P0570-4-AM. Effect on iron-related test value of the ferric citrate hydrate tablets in haemodialysis patients
植田徹1, 森脇崇1, 田中早紀1, 辻川正彦1, 国府孝敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2017.
Japanese Article P0559-3-PM. Examination of the usefulness of the ferric citrate hydrate administration in haemodialysis patients
星貴薫1, 高橋友樹1, 柳谷束1, 福井清奏1, 福村悠太1, 藤澤春香1, 宮腰恵生1, 森野太一1, 宮越貴之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2017.
Japanese Article P0561-3-PM. The effect that a change of the EPO preparation to use for haemodialysis patients gives to anemia in renal disease control
高嶋祥匡1, 鈴木大介1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2017.
Japanese Article P0563-3-PM. Effect of treatment examination of the Sucroferric oxyhydroxide 250 mg administration in our hospital outpatient department patients on dialysis a day
花木真美子1, 成山真一2, 高橋仁美1, 澁谷浩二3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2017.
Japanese Article P0565-3-PM. It is ... through one case of examination - system construction of the intervention point of the pharmacist in the kidney transplantation team setup of our hospital and the initial kidney transplantation
渡辺則夫1, 伊藤正輝1, 横山泰昭1, 鈴木正論1, 安室修1, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2017.
Japanese Article P0567-3-PM. DSA positive is suspected just before living renal transplantation and is examined the case receiving rituximab in a hurry
是松良隆1, 平井聡史1, 金本人美2, 山本恵美3, 錦建宏4, 橋口裕樹2, 本山健太郎4, 藤永理恵子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2017.
Japanese Article P0569-3-PM. Attitude survey about the response to renal-transplant recipients of the health insurance pharmacy pharmacist for the medicine medicine cooperation construction
今屋由似1,2, 牛之濱風見1, 中嶋洋生1, 山田保俊2, 菅原英輝1, 武田泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2017.
Japanese Article P0571-3-PM. The use situation of the direct action type oral anticoagulant drug and patients background
荒川桃子1, 櫻田啓介1, 菅大地2, 三上大貴3, 谷口知明1, 藤井達也3, 中山美穂1, 久保淳一3, 樋浦一哉1, 飛澤国広1, 鈴木千波3, 小原秀治1, 佐藤公人3, 小原郁司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2017.
Japanese Article P0573-3-PM. Inspection and measures of the on-site problems simple suspension method introduction ten years later
山本理香子1, 水野絵莉1, 壁谷めぐみ1, 岡本千晴1, 湯浅周1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2017.
Japanese Article P0575-3-PM. Example that the changes from a buprenorphine patch to tramadol tablets were able to be given well
長谷康史1, 小島正照1, 荒木良介1, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2017.
Japanese Article P0577-3-PM. The intervention situation investigation for the polypharmacy
谷口潤1, 渡邊ありさ1, 高田正温1, 東島彰人1, 白川敦規2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2017.
Japanese Article P0579-3-PM. Effect of the prothrombin complex (factor IX complex) on cerebral hemorrhage complicated during warfarin internal use
辰巳典子1, 槙原克也1, 森川雅史2, 内山ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2017.
Japanese Article P0581-3-PM. The effectiveness of duloxetine in the chronic lumbago
立石健史1,2, 南里泰弘2, 林博志2, 田中一範2, 西川裕行2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2017.
Japanese Article P0583-3-PM. Examination about the usefulness of the vonoprazan in the H.pylori sanitization
横山尚美1, 近藤有1, 坪井伸治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2017.
Japanese Article P0585-3-PM. Basic investigation to aim at quality of life maintenance, the improvement of the hemophilic patients by the pharmacist
阿部憲介1,2, 神尾咲留未1, 近藤旭1, 後藤達也1, 佐々木晃子3, 伊藤ひとみ3, 佐藤功4, 佐藤博2, 伊藤俊広4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2017.
Japanese Article P0587-3-PM. Factor analysis about the dosage in the ascorbic acid-containing polyethylene glycol electrolyte preparation
佐藤将嗣1, 藤澤千里2, 根岸健一2, 指山浩志3, 大部智栄子4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2017.
Japanese Article P0589-3-PM. Examination about safety after the DOAC administration in the low weight patients in our hospital and the effectiveness
飯田拓真1, 寺口徹1, 高崎亮宏2, 福永浩也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2017.
Japanese Article P0591-3-PM. The effect that transfusion history gives in serum iron and ferritin at erythropoietin administration for anemia of prematurity
杉理江1, 松浦優里1, 佐野良輔1, 中山幹子1, 仙波靖士1, 久保井徹2, 林武文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2017.
Japanese Article P0593-3-PM. Examination of the appropriate medication method of the chronic constipation therapeutic drug agate Pross ton
渡邊瞭1, 濱宏仁1, 田中詳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2017.
Japanese Article P0595-3-PM. An example of the pharmacist intervention in patients receiving biopreparation
長岡麻沙美1, 大津貴寛1, 津曲恭一1, 尾之江剛樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2017.
Japanese Article P0597-3-PM. It is a report about the proper use of the infection prophylaxis antimicrobial after the operation by the intervention of the pharmacist
古谷一平1, 小栗良介1, 土川拓也1, 田中佳子1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2017.
Japanese Article P0599-3-PM. Associated with the outcome that the increase of the number of the drugs which are not recommended in guidelines is poor: J-MELODIC study subanalysis
志方敏幸1, 福井美保2, 真鍋恵理2, 高本光次郎1, 坂本淳一3, 伊藤都裕4, 増山理2, 辻野健2,3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2017.
Japanese Article P0601-3-PM. Efforts to the prescription to set with instructions book instructions in the delirium treatment, preventive preparation
中島彰子1, 出口有佳理1, 野崎純子1, 仁熊敬枝2, 井上真一郎3, 橋本幸子1, 宮川真澄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2017.
Japanese Article P0603-3-PM. The effectiveness in the early use of the tolvaptan
吉田夕貴1, 大宮寛子1, 三輪耕次1, 田中伸享2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2017.
Japanese Article P0605-3-PM. DAA (Direct Acting Antivirals) treatment result for the C type chronic liver disease and examination of the initial unsuccessful case
松川雅子1, 佐藤裕美1, 福野和治1, 西部幸一1, 今井桂子1, 古家乾2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2017.
Japanese Article P0607-3-PM. The postnatal characteristics hemophilia 2 case that we experienced in our hospital
森田雅之1, 荒木佐知子1, 山野惣平1, 松本哲哉1, 月光淳1, 玉置秀成1, 中村智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2017.
Japanese Article P0609-3-PM. Inspection of the change of proBNP in the administration of SGLT2 inhibitor
谷口仁孝1, 徳村博子1, 山本彩佳1, 千葉恵美子1, 渡邉美樹1, 坂井愛実1, 前田典子1, 水野稜子1, 松田恵理1, 小原祐子1, 加納みゆき1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2017.
Japanese Article P0611-3-PM. About the inflection to examination and treatment preferences of the immunoglobulin refractory predictive score for patients with Kawasaki's disease
小笠原蓉子1, 齋藤はるか1, 千葉里菜1, 竹中真衣1, 比毛有理子1, 佐藤圭吾1, 目崎香苗1, 河上昭一1, 西和哉1, 佐賀利英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2017.
Japanese Article P0613-3-PM. Inhalational instruction reexamination in the Fujinomiya Municipal Hospital
北村修1, 小林豊1, 勝又一雄1, 川口洋実1, 小林義典1, 加藤祥世1, 旭典之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2017.
Japanese Article P0615-3-PM. Safety of caffeine for children within 28 weeks
渡辺真梨奈1, 山田留美子1, 下川千賀子1, 山田千代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2017.
Japanese Article P0617-3-PM. Change of the number of Functional Independence Measure before and after the rehabilitation enforcement and the use drugs
大坪愛実1, 舘知也1,2, 勝野隼人1, 上野杏莉1, 吉田阿希1, 兼松勇太1, 杉田郁人1, 野口義紘1, 樋島学3, 青山智2, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2017.
Japanese Article P0572-4-AM. Construction of Formulary System about the uric acid generation antagonist based on a systematic review
金井紀仁1, 鈴木義人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2017.
Japanese Article P0574-4-AM. Example that suffered from glycemic control, a surgical site infection by Polypharmacy
若松雄太1, 吉岡睦展1, 長尾彰太1, 杉生雅和1, 石津智司1, 小林敦子2, 辻隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2017.
Japanese Article P0576-4-AM. Fact-finding of the prescription cascade in patients with dementia
山崎美保1, 谷本愛花1, 楢原史子1, 馬屋原慈理1, 渡辺貴志1, 前田頼伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2017.
Japanese Article P0578-4-AM. 1 case that we made golimumab introduction for intractable ulcerative colitis
深海広平1, 高田宏文1, 前田直就1, 橋野文花1, 西村実佳1, 稲村勝志1, 南橋薫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2017.
Japanese Article P0580-4-AM. The effectiveness of the treatment with indacaterol for patients with chronic obstructive pulmonary disease or long time effect type anticholinergic drug and safe evaluation
大島美奈都1, 嶋田修治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2017.
Japanese Article P0582-4-AM. Analysis about the prescription situation of the anticoagulant in patients with non-valvular atrial fibrillation and the proper use
伊藤あゆみ1, 中川隼一1, 原俊博1, 大貫麻友美1, 蔭山博之1, 平島徹1, 芝田貴裕2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2017.
Japanese Article P0584-4-AM. Fact-finding of the drug doses confirmation to the decreased renal function patients in our hospital
岡健太郎1, 久松大介1, 石原祥史1, 木村繁和1, 林貴子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2017.
Japanese Article P0586-4-AM. Comparison of the effect of treatment by the difference of the immunoglobulin preparations in the Kawasaki's disease
堀勇太1, 山口賢一郎2, 浦本邦弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2017.
Japanese Article P0588-4-AM. Examination about the Edaravone administration for the ALS
櫻塲秀一1, 原弘士1, 五十嵐俊1, 城倉健2, 天野悠3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2017.
Japanese Article P0590-4-AM. It is ... for the introduction that is smoother by security than relation ... of the pharmacist in the treatment with oral antiHCV medicine
中嶋めぐみ1, 大橋健吾1, 西川智子1, 篠田康孝1, 郷真貴子1, 岩井美奈1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2017.
Japanese Article P0592-4-AM. Examination about the effectiveness and the adverse event of the basiliximab induction therapy in the lung transplantation
川西秀明1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2017.
Japanese Article P0594-4-AM. Safe examination about the antithrombocytic agent internal use continuation at abdominal aortic aneurysm stent graft interpolation technique enforcement
今尾瑞季1, 阪井祐介1, 千崎康司1, 古森公浩2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2017.
Japanese Article P0596-4-AM. The effect that the medication method of the Xa inhibitor in our hospital gives to solidification test value
太田洋貴1, 西村寿貴2, 福島剛志2, 上田賢太郎1, 生島五郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2017.
Japanese Article P0598-4-AM. The reporting of optimum doses of allopurinol in the decreased renal function patients and change of the uric acid level
大岩拓馬1, 加藤麻理乃1, 福井悠美1, 浅野嘉之1, 伊東和真1, 前田剛司1, 坂田洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2017.
Japanese Article P0600-4-AM. RAS family gene, RAP1A are inhibited by miR-101-5p
柴山良彦1, 阪東芳則1, 原友貴1, 久保儀忠1, 井関健2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2017.
Japanese Article P0602-4-AM. Satisfaction investigation after the sleeping drug remedy in the inpatient
稲川覚子1, 阿藤友美1, 川端志津1, 伊藤真美1, 松元美香1, 大谷道輝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2017.
Japanese Article P0604-4-AM. 1 case that was improved by combination therapy of the Evolocumab for the FH patients
小澤章裕1, 中山菜実1, 鈴木美帆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2017.
Japanese Article P0606-4-AM. Introduction of the pharmaceutical management check seat for transluminal treated patients in Nagasaki
松永典子1,2, 樋口則英2,3, 渡辺一章2,4, 井上高彦2,5, 増田淳士2,6, 吉村彰剛2,7, 廣瀬知子2,8, 北原隆志1, 佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2017.
Japanese Article P0608-4-AM. Treatment result of Interferon-free DAAs for chronic hepatitis C in our hospital
植松卓也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2017.
Japanese Article P0610-4-AM. Example that was given etretinate by the simple suspension method for harlequin ichthyosis
勝弘毅1, 小西友美1, 市野貴信2, 阿部康治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2017.
Japanese Article P0612-4-AM. Development of the symptom monitoring tool for patients having difficulty in mutual understanding by the language
東恩納司1, 牛尾聡一郎1, 建部泰尚1, 吉田奈々子1, 江角悟1, 小川敦1, 村川公央1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2017.
Japanese Article P0614-4-AM. Comparison between 24 hours urine collection and renal function evaluation using the Cockcroft-Gault type in patients with cancer
稲秀士1, 宮本拓也1, 鈴木智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2017.
Japanese Article P0616-4-AM. Examination of liver function in Sofosbuvir/ribavirin combination therapy and the liver fibrosis improvement effect on C type chronic liver disease
小林真菜1, 瀬尾佳世3, 西條由夏1, 森本愛梨1, 加藤愛梨1, 笹谷佳菜子1, 大谷綾1, 中尾啓子1, 笹瀬典子1, 金啓二1, 金秀基2, 金守良2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2017.
Japanese Article P0618-4-AM. The "working" behavior modification of the pharmacist makes the main constituent person of illness treatment transform patients
杉原真理1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2017.
Japanese Article P0619-3-PM. Cooperation with the community pharmacy by the outside Parliament prescription clinical test value notation
佐藤弘1, 岡部真希1, 青柳京子1, 前田江里奈1, 金内幸子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2017.
Japanese Article P0621-3-PM. Efforts to PBPM enforcement for doubt inquiry decrease for the high quality medical offer
冨岡太一1, 三浦怜1, 山野惣平1, 松本哲哉1, 月光淳1, 玉置秀成1, 中村智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2017.
Japanese Article P0623-3-PM. Evaluation by the doubt inquiry simplification of the outside Parliament prescription
町田充1, 伊賀正典1, 興野克典1, 内田隆道1, 亀井陽子1, 後藤孝之1, 河合奈々江1, 田村結美1, 鈴久名成美1, 野田政充2, 岡邦雄2, 堀野忠夫2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2017.
Japanese Article P0625-3-PM. Inspection of the use actual situation and the benefit of the tracing report in our hospital
奥村宣彦1, 出雲貴文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2017.
Japanese Article P0627-3-PM. On the basis of the current situation of doubt inquiry utilizing the test value in the outside Parliament prescription and the questionary survey to problem - drugstore pharmacist; and ...
安藤友貴1, 北出紘規1, 森光恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2017.
Japanese Article P0629-3-PM. Attitude survey about the antimicrobial in the health insurance pharmacy
東野愛理1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2017.
Japanese Article P0631-3-PM. Medical expenses reduction effect in the Residual medicine adjustment in the Saitama Prefectural cancer center
武井大輔1, 丸林万希子1, 大塚公庸1, 中村益美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2017.
Japanese Article P0633-3-PM. It is efforts of the foreign cancer chemotherapeutic drug medicine cooperation using the prescription notebook to "the pharmacist with a view of the face"
平田司1, 佐藤貴教1, 村井佐和1, 吉田幸史1, 柴田亜由美1, 土谷隆紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2017.
Japanese Article P0635-3-PM. Examine CKD disease for the medical treatment management that continued; to construction - prescription notebook of the medicine cooperation renal function information sharing - by the "CKD seal" pasting
矢羽羽雅行1, 松崎幸司1, 吉原真由美2, 小原史生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2017.
Japanese Article P0637-3-PM. The current situation of the inhalational instruction in our hospital respiratory organs medical service
今井孝1, 藤原直也1, 佐伯由美子1, 酒井牧子1, 小西龍也2, 河野通盛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2017.
Japanese Article P0639-3-PM. Evaluation of the usefulness about the test value, cancer chemotherapy regimen name indication to outside Parliament prescription
大熊実季1, 平手大輔1, 小島雅和1, 平田萌1, 新沼芳文1, 本郷文教1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2017.
Japanese Article P0641-3-PM. Fact-finding of efforts and a pharmacy student to inhalation therapy support utilized the medicine medicine cooperation in our hospital and the inhalational instruction in the neighborhood health insurance pharmacy that we shared
柳澤友希1, 黒須智博1, 稲田佑亮1, 齋藤洋映1, 伊藤優2, 八重樫雅3, 夏目義明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2017.
Japanese Article P0643-3-PM. Inflection of the outside Parliament prescription addition information and evaluation by patients with cancer
久保田康生1, 齋藤佳敬1, 原田幸子1, 深井敏隆1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2017.
Japanese Article P0645-3-PM. It is ... from the opinion comparison between ... insurance pharmacist and our hospital pharmacist about the information at discharge demanded by the cooperation with the health insurance pharmacy
高儀佳代子1, 清水けいこ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2017.
Japanese Article P0647-3-PM. Efforts to the information contact book between institutions in the Hainan Hospital [2] It is ... about the current situation and the task which we saw from ... questionary survey
深澤淑子1, 大谷寧次郎1, 眞野加奈子1, 森健太郎1, 水谷彩伽1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2017.
Japanese Article P0649-3-PM. Inhalational instruction practical skill class to develop by the multi-type of job
高橋愛由子1, 三木芳晃1, 塚本啓介1, 伊藤絵理1, 大原ひとみ1, 片岡麻美1, 竹田優希1, 松枝奈津子1, 田中昭洋1, 谷岡真帆1, 中村薫子1, 西垣玲奈1, 上田哲也2, 長谷川吉則2, 萱野勇一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2017.
Japanese Article P0651-3-PM. The use situation investigation about the at-home intravenous feeding in the Kushiro Red Cross hospital
渡邊清人1, 高柳昌宏1, 千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2017.
Japanese Article P0655-3-PM. An evaluation and medicine medicine cooperation for the doubt inquiry correspondence from the health insurance pharmacy that assumed an in-hospital drugstore a window
室井政子1, 柴田昌彦1, 菅田優子1, 竹田健志1, 櫨山葉子1, 山東真寿美1, 高木麻里1, 吉田智江1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2017.
Japanese Article P0657-3-PM. A questionnaire and the current situation investigation to a health insurance pharmacy pharmacist about the outside Parliament prescription doubt inquiry correspondence
八木橋美里1, 工藤香澄2, 中野有瑛1, 馬場親紀1, 鈴木常義2, 中村一成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2017.
Japanese Article P0659-3-PM. Examine illness using the contact paper between pharmaceutical products institutions; efforts to medicine cooperation
田村和彦1, 財津孝希1, 瀧内瑛輔1, 嶋崎千絵1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 新関みどり1, 近藤和宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2017.
Japanese Article P0620-4-AM. Efforts of the doubt inquiry simplification protocol in the outside Parliament prescription of the Saitama Prefectural cancer center
丸林万希子1, 武井大輔1, 大塚公庸1, 中村益美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2017.
Japanese Article P0622-4-AM. Construction of the new medicine medicine cooperation in our district
一ノ瀬由衣1, 山脇一浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2017.
Japanese Article P0624-4-AM. Effect on Residual medicine adjustment after the doubt inquiry simplification protocol introduction
島崎友美1, 堀川真由美1, 志村優衣1, 三枝隼樹1, 弓削吏司2, 大野豊3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2017.
Japanese Article P0626-4-AM. Ring - of the medicine medicine cooperation to spread through 12 wards of - Osaka about the efforts in two years in Osaka railroad hospital "meeting of the medicine medicine cooperation promotion"
小牟田豊1, 阿登大次郎1, 齋藤玲奈1, 古谷真依子1, 八代哲也1, 田中博来2, 日高眞理2, 水野直子2, 山田公一3, 栗生正也4, 藤井博昭5, 安永政利6, 林泰広7, 守島繁昭8, 田中雅隆9, 常松明生10, 藤井義博11, 森本定則12, 安部力13, 上田祥子14, 菅野文15, 東海秀吉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2017.
Japanese Article P0628-4-AM. The questionnaire results to the health insurance pharmacy about outside Parliament prescription mentions such as the renal function test value, and the like and the need, examination about problems
杉本吉春1, 浅原慶徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2017.
Japanese Article P0630-4-AM. Questionary survey about the test value utilization situation in efforts and the pharmacy service under health insurance drugstore before leading to the test value printing start to outside Parliament prescription
中野有瑛1, 青柳伸一2, 馬場親紀1, 山田文義2, 中村一成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2017.
Japanese Article P0632-4-AM. Difference in consciousness with an insurance pharmacist and the hospital pharmacist as the medicine medicine cooperation disincentive
伊東佳美1, 山口俊司2, 坂東勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2017.
Japanese Article P0634-4-AM. Efforts of the medical treatment management support that a drugstore pharmacist cooperated with the medical care team for peritoneal dialysis patients
福澤翔太1, 矢野亨治1, 山田恵里1, 伊藤文香1, 加藤博史1, 平松哲明2, 高井奈美3, 日比恵美子3, 坂田史子4, 鈴木康弘4, 水野正司4, 伊藤恭彦4, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2017.
Japanese Article P0636-4-AM. Utilization - of the inhalational instruction training and inhalational evaluation list for regional alliances - health insurance pharmacy pharmacist who aimed at the improvement of asthma and COPD treatment
藤井尚子1, 池末裕明1, 楠田かおり1, 薩摩由香里1, 森本茂文1, 富井啓介2, 橋田亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2017.
Japanese Article P0638-4-AM. For pharmacist-based inhalational instruction and information sharing in connection with a local dispensing pharmacy
畠山義史1, 麻生美佐子1, 田仲奈津美1, 吉川英里1, 浜手ひとみ1, 渡辺彰2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2017.
Japanese Article P0642-4-AM. Efforts of the medicine medicine cooperation in the Komaki Municipal Hospital
水谷貴樹1,2, 山本泰大1,2, 山本将司1,2, 平野茂樹1,2, 戸田康裕1,2, 浅井宏昭2,3, 川合紀行2,4, 松山苑未2,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2017.
Japanese Article P0644-4-AM. It is ... about the information at discharge demanded by the cooperation with the health insurance pharmacy from the meeting of the cooperation with ... health insurance pharmacy
清水けいこ1, 高儀佳代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2017.
Japanese Article P0646-4-AM. Efforts to the information contact book between institutions in the Hainan Hospital [1] It is ... about the operation of the ... contact book
眞野加奈子1, 大谷寧次郎1, 深澤淑子1, 水谷彩伽1, 森健太郎1, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2017.
Japanese Article P0648-4-AM. One case that we shared the patients information at discharge by a community medical care cooperation system, and it became possible to conduct the medication counseling that continued
小川充恵1,2,3, 山崎肇1, 篠原裕子2, 中野道雄2, 小枝伸行3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2017.
Japanese Article P0650-4-AM. Efforts aiming at the medicine medicine cooperation promotion using the PDCA cycle
末永亘1, 大窪典子1, 山下典子1, 津曲恭一1, 尾之江剛樹1, 福石和久2, 山本直矢3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2017.
Japanese Article P0652-4-AM. Efforts about the information sharing of renal function and the glaucoma using a prescription notebook cover
尾崎誠一1,2, 廣子真大2, 河田尚己2, 寺山恵子1,2, 渡辺宗男2, 松久哲章1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2017.
Japanese Article P0654-4-AM. Questionary survey to the health insurance pharmacy about having changed the doubt inquiry window of outside Parliament prescription contents from the physician to the drugstore medicine medicine cooperation room
柴田昌彦1, 室井政子1, 菅田優子1, 竹田健志1, 櫨山葉子1, 山東真寿美1, 高木麻里1, 吉田智江1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2017.
Japanese Article P0656-4-AM. Evaluation of the medicine medicine cooperation promotion workshop in Nanto-shi
小川紗知1, 讓原千広1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2017.
Japanese Article P0658-4-AM. Operation of the simplification protocol and change of doubt inquiry contents
大久保淑子1, 田中統子1, 堀川真由美2, 石井豪3, 松島綾乃4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2017.
Japanese Article P0660-4-AM. Questionary survey about the information sharing for the health insurance pharmacy using "the information contact book between institutions for drug proper use" and the future problem
垣越咲穂1, 鈴木亮平1, 脇田恵里1, 佐合健太1, 杉浦有香1, 井上佑美1, 小島あゆみ1, 長岡宏一1, 深津哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2017.
Japanese Article P0661-3-PM. Hold a "disaster relief pharmacist" workshop in Nagano Hokushin area; and than ... questionnaire results ...
滝澤康志1,9, 近藤智幸2,9, 追木正人3,9, 小林映子4,9, 下石和樹5,9, 雪本江里子6,9, 安藤和佳子7,9, 森一博8,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2017.
Japanese Article P0663-3-PM. It is ... for enforcement and improvement of the joint disaster training with the neighborhood pharmacy service under health insurance drugstore in disaster-response ability of evaluation - local pharmacist
中谷亮介1, 満田正樹1, 楠本梨賀1, 石本昌裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2017.
Japanese Article P0662-4-AM. Hold correspondence and problem ... great scale disaster correspondence workshop of the pharmaceutical products supply at disaster; and ...
坂田智美1, 渡辺瑞貴1, 家田正子1, 森下彩香1, 中嶋瀬里奈1, 石原慎1, 市村衣梨1, 西之坊実里1, 吉田宏二1, 吉年正宏1, 月岡康行1, 森嶋祥之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2017.
Japanese Article P0665-3-PM. The palliative care education of the pharmacy school business trainee and examination about the knowledge acquisition
神原諒1, 中山英夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2017.
Japanese Article P0667-3-PM. An attempt and problem of our hospital for the revision model core curriculum
貝嶋亮1, 大谷木俊吾1, 横田敬之1, 新井優1, 小泉盛1, 野田幸一1, 小岩まの1, 永野浩之1, 宇都宮暁1, 林良行1, 岸野亨1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2017.
Japanese Article P0669-3-PM. Efforts to the long-term business training along the new core curriculum in our hospital
坂本英之1, 石丸隆之1, 古賀清弘1, 谷川昇1, 田中早穂子1, 野中敏治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2017.
Japanese Article P0671-3-PM. Questionary survey about the usefulness of the visit to other institutions in the pharmacy business training
先崎郁美1, 児玉暁人1, 今井兼貴1, 高橋文香1, 八尾祥子1, 森信介1, 和田恭一2, 老田章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2017.
Japanese Article P0673-3-PM. Examination of the current situation and the task which we saw through pharmacy trainee after graduation course investigation
小野寺健1,2, 松浦誠1,3, 南川賢治1,4, 三浦裕恵1,5, 三浦清明1,6, 三浦俊弘1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2017.
Japanese Article P0675-3-PM. Pharmacy business training utilizing project learning and the portfolio
形部文寛1, 谷口智美1, 杉山健二郎1, 岡本明日佳1, 橋本修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2017.
Japanese Article P0666-4-AM. Efforts of the joint workshop holding about cancer treatment for the hospital in the area and a drugstore pharmacy trainee, a hospital and the drugstore pharmacist
大久保晃樹1,2, 東條唯1, 大野真理1, 横山博久1, 初瀬貴祐1, 上大薗智徳1, 南裕司1, 今奈良明人2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2017.
Japanese Article P0668-4-AM. Accumulation comparison - of the questionnaire for comparison - past seven years of the evaluation of the satisfaction of a student for the hospital training in University of Shizuoka and the instruction pharmacist
内野智信1, 平井啓太2, 宮嵜靖則1, 井上和幸2, 辻大樹2, 谷澤康玄3, 山田浩4, 伊藤邦彦2, 賀川義之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2017.
Japanese Article P0670-4-AM. To be the best, and to prepare for the exciting stage making (the second report) - of the lube Rick evaluation in the formulations training; ...
渡邉正教1, 日笠淳一1, 中沢修司1, 日比徹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2017.
Japanese Article P0672-4-AM. Trial investigation of 2 drugstore experiences type business training aiming at equalization of participation, experience-based type training contents
津田真弘1, 大澤史宜1, 山下富義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2017.
Japanese Article P0674-4-AM. The current situation investigation in the long-term business training in the Kumamoto University faculty of medicine hospital for the revision model core curriculum
中村純平1, 成田勇樹1,2, 城野博史1, 政賢悟1, 西澤裕美1, 清住友香1, 中村有紀子1, 橋口ゆみ1, 山下諒祐1, 山本珠美1, 山辺雄太1, 相澤実里1, 大坪謙一1, 高林学1, 玉野井祥子1, 児島強1, 本田義輝1, 齋藤秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2017.
Japanese Article P0676-4-AM. Effect - that CYP1A2 genetic polymorphism gives to the caffeine pharmacokinetics out of education material study - saliva for family pharmacist upbringing
坂口友唯1, 競和佳2, 今井美穂2, 木下健司2, 村田成範2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2017.
Japanese Article P0678-4-AM. Examination of the learning result through for the first time annual education and the early on-site training
永田隆之1, 吉田進1, 住谷賢治1, 福地祐司1, 石川暁志1, 吉川真一1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2017.
Japanese Article P0680-4-AM. Study support for the 6-year pharmacists who are a graduate in our hospital
坂口裕子1, 木本有香1, 舩越真理1, 土谷有美1, 津田正博1, 高松宏治2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2017.
Japanese Article P0682-4-AM. The pharmacist duties on-site training in "a team approach in medical care on-site training" of the faculty of medicine 1 annual and the effect
鈴木仁志1, 紫桃祐造1, 柴田近2,3, 大野薫3, 薄井健介1,4, 岡田浩司1,4, 渡辺善照1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2017.
Japanese Article P0684-4-AM. Efforts to new face educational program in our hospital
一瀬ひろみ1, 立道貴清1, 馬場亨1, 水川奈己1, 鈴木聖1, 辻繁子1, 冨田淳子1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2017.
Japanese Article P0686-4-AM. Effects such as pharmaceutical products education or the prevention of drug abuse education, and the like to junior and senior high school students by drug letter distribution and the consultation drugstore setting and a protector
中川璃子1, 大柳賀津夫2, 松下良3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2017.
Japanese Article P0688-4-AM. Inspection of practice of the case-based active learning using a clicker and the learning effect
仁木一順1, 幡生あすか1, 南園真哉1, 上島悦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2017.
Japanese Article P0690-4-AM. Examination of the pharmacist lecture in the heart disease classroom
潟永安亘1, 谷口潤2, 下澤那津2, 東島彰人2, 草葉一友1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2017.
Japanese Article P0677-3-PM. Summary of case study workshop two years for pharmacists of Okinawa
大澤友二1,2, 潮平英郎3,4, 伊差川サヤカ3,4, 古謝さなえ3,4, 中尾滋久4, 玉城武範4, 小島進4, 砂川智子3,4, 外間登3,4, 外間惟夫3,4, 中村克徳3,4, 小武家優子5, 大光正男5, 吉武穀人5, 亀谷浩昌4, 田場英治4, 神村武之4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2017.
Japanese Article P0679-3-PM. For postgraduate education enforcement of attitude survey - aromatherapy about the aromatherapy of the pharmacist -
梅田純代1, 柳本ひとみ2, 黒澤菜穂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2017.
Japanese Article P0681-3-PM. An attempt of the experience-based Evidence-based Medicine (EBM) education for a pharmacist, pharmacy students and the evaluation
上田昌宏1,2, 豊山美琴3, 大森志保4, 高垣伸匡5, 清水忠4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2017.
Japanese Article P0683-3-PM. Result and problem of the new face educational program to reach the third year
坂東佳汰1, 山下友也1, 比嘉耕基1, 徳留章1, 早坂敬明1, 木明貴幸1, 武田清孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2017.
Japanese Article P0685-3-PM. Look back on the holding of "the children medicine classroom"
浦上勇也1, 池田貴司1, 河田由紀子1, 大喜多美智代1, 富田伊津子1, 山本和幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2017.
Japanese Article P0687-3-PM. Establishment of the new face pharmacist education system by the mentor system
辻村行啓1, 矢部勝茂1, 塩川満1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2017.
Japanese Article P0689-3-PM. About the clinical pharmacist upbringing curriculum mainly on upbringing of the multicenter case study, independence
寺山義泰1, 舩津久美1, 中村英子1, 白石範子1, 林みどり1, 廣井順子1, 八木原栄1, 石原溶子1, 越田晃1, 松本啓一2, 松本智子2, 城田幹生2, 山村康比古2, 安藤恵2, 山口智2, 塩地園代2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2017.
Japanese Article P0691-4-PM. Usefulness of the checking prescription based on the clinical test value
鈴木芳1, 大塚恵理子1, 藤原涼1, 佐藤雄己1, 伊東弘樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2017.
Japanese Article P0693-4-PM. The enforcement situation investigation of doubt inquiry for the foreign prescription in the Iizuka Hospital
長崎皓光1, 山口健志1, 内田守次1, 梅田勇一1, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2017.
Japanese Article P0695-4-PM. Analysis of the doubt inquiry contents accompanied with the change to the prescription input on the basis of the quantity of once in the Mie University faculty of medicine hospital
熊野理奈1, 杉本浩子1, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2017.
Japanese Article P0697-4-PM. The current situation investigation for the simple suspension method introduction
本郷知世1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2017.
Japanese Article P0699-4-PM. About a stable change when we added an excipient to a tablet crush thing
門野冴美1, 金澤沙衣1, 菅大地1, 稲垣貴裕1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1, 佐藤隆司2, 渡辺一弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2017.
Japanese Article P0701-4-PM. Examination ... of the validity by confirming all efforts ... order to improve the effectiveness, safety of the medical therapy
吉田明弘1, 枝廣茂樹2, 下山真樹子3, 野村真里1, 藤原洋介1, 山田憲和1, 中村智子1, 吉川知世1, 吉村直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2017.
Japanese Article P0703-4-PM. Decrease in false instruction effect by the pharmaceutical instruction to the outpatient using the prescription automatic comparison system
冨岡謙二1, 黒崎由希子1, 小坂若那1, 淀川進也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2017.
Japanese Article P0705-4-PM. Usefulness of doubt inquiry using the prescription check system of the test value interlocking movement type
冨田猛1, 山本和宏1, 野崎晃1, 宇田篤史1, 阪上倫行1, 西岡達也1, 久米学1, 槇本博雄1, 平井みどり1, 矢野育子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2017.
Japanese Article P0707-4-PM. Examination of the usefulness of the operation with the checking prescription assist system associated with the clinical test value mention inside the hospital prescription and renal function
齋藤佳奈1, 徳丸隼平1, 山口晃司1, 栗島直希1, 佐々木琢也1, 橋本真也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2017.
Japanese Article P0709-4-PM. The construction of the formulations record system by Time-lapse photography and inspection of the effectiveness
竹下龍次1, 立石裕樹1, 田中博和1, 井上幸子1, 平川雅章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2017.
Japanese Article P0711-4-PM. Efforts of the adequacy of the drug administration to the decreased renal function patients
笠松依子1, 好川隆志1, 中根論士1, 高嶋孝次郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2017.
Japanese Article P0713-4-PM. [de-] Rebuilding of the 365 days injection formulations system with the injection drug automatic withdrawal device
六波羅孝1, 伊藤賢治1, 下平美紀1, 伊藤陽一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2017.
Japanese Article P0715-4-PM. Effect of preventive measures against dispensing errors by using formulations inspection system at inspection
多賀小枝子1, 吉村知哲1, 木村美智男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2017.
Japanese Article P0717-4-PM. Efficiency and usefulness of duties by the powdered medicine formulations robot introduction
岸本幸次1, 吉田咲紀1, 米田勇太1, 田中待紀1, 北野こずえ1, 小川充恵1, 山崎肇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2017.
Japanese Article P0719-4-PM. Efforts of the pharmacist in the radioisotope examination
橋沢幸佑1, 前川友宏1, 高橋治樹1, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2017.
Japanese Article P0721-4-PM. Inspection of the dispensing error prevention effect by the image inspection system introduction
岩田真子1, 青柳和代1, 関口陽子1, 小柳邦弘1, 粉川直明1, 高村誠1, 水野友紀子1, 山岸宏和1, 今成拓1, 五十嵐詠美1, 南場信人1, 鈴木さくら1, 矢吹剛1, 寺口敦1, 中嶋真希1, 貝瀬眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2017.
Japanese Article P0723-4-PM. Examination of use investigation by the powdered medicine formulations robot (DimeRo) introduction and the effective operation
田畑裕和1, 嘉屋則子1, 稲垣育宏1, 柴波明男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2017.
Japanese Article P0692-5-AM. Construction of PBPM accompanied with the agent type change at the oral medicine transluminal administration
白坂友基1, 釜澤雄太1, 小林薫1, 伊藤宏彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2017.
Japanese Article P0694-5-AM. A classification and change over time of the contents using the doubt inquiry record function of the electronic medical chart
五十嵐詠美1, 青柳和代1, 関口陽子1, 岩田真子1, 小柳邦弘1, 粉川直明1, 高村誠1, 水野友紀子1, 山岸宏和1, 今成拓1, 南場信人1, 鈴木さくら1, 矢吹剛1, 寺口敦1, 中嶋真希1, 貝瀬眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2017.
Japanese Article P0696-5-AM. Cost effectiveness about the medical security by the automatic formulations inspection system introduction
波々壁信也1, 飯島夏希1, 石丸勝之1, 村上咲妃1, 望月真太郎1, 山内拓2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2017.
Japanese Article P0698-5-AM. Result and problem by the compounding of medicines start of the set according to the parenteral injection individual of 24 hours
石井佳代子1, 泉澤友宏1, 関根綾子1, 松本明子1, 島崎博士1, 勝俣はるみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2017.
Japanese Article P0700-5-AM. Comparison of the formulations loss rate at dosage form change of the levetiracetam with the ketogenic diet therapy
菅寛史1, 矢嶋隆宏1, 山本吉章1, 中井正彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2017.
Japanese Article P0702-5-AM. The current situation investigation of the checking prescription in Nara Medical University Hospital
田村曉識1, 池田和之1, 吉川一吾1, 辻力夫1, 杉山幸正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2017.
Japanese Article P0704-5-AM. Study on combination advisability with magnesium oxide at simple suspension of the ACE inhibitor
高野由博1, 西村貴正2, 井戸田陽子2, 小山智志2, 矢野健太郎2, 荻原琢男1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2017.
Japanese Article P0706-5-AM. The effect that printing of the drug information of the injection prescription gives in prescription checking
中澤香子1, 田邊裕美子1, 三澤昭彦1, 荒川圭子1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2017.
Japanese Article P0708-5-AM. Effect of the test value notation to a prescription and doubt inquiry utilized the inspection system
服部真奈1, 杉浦龍也1, 森智規2, 守田覚1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2017.
Japanese Article P0710-5-AM. Efforts of the drug proper use to the decreased renal function patients in our center
的場美香1, 津田武典1, 川下絵莉香1, 橋本佑香1, 富士芳美1, 立川奈保美1, 高木麻里1, 吉田智江1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2017.
Japanese Article P0712-5-AM. Enforcement of the doubt inquiry support protocol by the hospital pharmacist
八島菜摘1, 岡本知子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2017.
Japanese Article P0714-5-AM. Chemical structural formula evaluation for parenteral injection incompatibility predictions
伊藤哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2017.
Japanese Article P0716-5-AM. Prescription doubt referral efforts carried out based on clinical test value written by a hospitalization prescription
飯田真由巳1, 西條雅美1, 仲則和1, 本田一春1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2017.
Japanese Article P0718-5-AM. About the effect to usefulness and the preparation duties of the simple suspension method that used ultrasonically vibrating it
土江亜季1, 松尾世為子1, 中尾元紀1, 畝佳子1, 向井啓2, 辻琢己2, 森英人3, 覺野律1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2017.
Japanese Article P0720-5-AM. About new efforts using the allergic information of the inpatient
本多明香里1, 日高博司1, 中嶋友代1, 齋藤暢人1, 植松翠1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2017.
Japanese Article P0722-5-AM. Efforts of the drugstore pharmacist for the renal function test value described in outside Parliament prescription
畠山規明1,2, 炭岡孝志2, 鶴田悦子1, 森博美1, 松野英子1, 星谷卓男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2017.
Japanese Article P0724-5-AM. Proper use of a doubt inquiry and pharmaceutical products by the clinical test value indication to a prescription
北侑未1, 多賀志乃1, 才田絢加1, 山田留美子1, 藤崎幸代1, 台蔵剛志1, 虎瀬和子1, 小野陽介1, 下川千賀子1, 山田千代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2017.
Japanese Article P0725-4-PM. Effect to give to serum copper of oral zinc and the zinc injection administration
尾崎正和1, 田中惇一1, 見元尚1, 赤松順1,2, 筒井由佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2017.
Japanese Article P0727-4-PM. Hospital preparation (the second report) - clinical use report, evaluation - of the intermediate report in the Kitasato University Hospital
東信太朗1, 友田吉則2, 引地文1, 坂倉智子1, 近藤留美子1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2017.
Japanese Article P0729-4-PM. The use situation of voriconazole eye drops in our hospital
高濱啓太1,2, 山田邦夫1, 中村郁勝1, 内田和孝1, 堤孝之2, 光田緑2, 森岡淳子1, 松本光希2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2017.
Japanese Article P0731-4-PM. Pharmacokinetic examination of the trazodone bougie in healthy adults
八瀬恵理子1, 山下大輔1, 山川宣2, 壷阪直子1, 續木康夫1, 福島昭二3, 関本裕美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2017.
Japanese Article P0733-4-PM. The risk of the microbial contamination in preservative non-component eye drops of the hospital preparation
下野梨麻1, 税所篤行1, 尾家重治2, 木村和博3, 古川裕之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2017.
Japanese Article P0735-4-PM. Examination of the medicinal solution change at mixture of the parenteral injection
増渕龍一郎1, 鈴木隆寛1, 中村秀三1, 渡邊紘子1, 赤羽正之1, 岩瀬利康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2017.
Japanese Article P0737-4-PM. Examination about the improvement of the gel plasticity of the methylcellulose solution
下山哲哉1, 磯貝純1, 伊藤邦彦1, 小林道也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2017.
Japanese Article P0739-4-PM. A preparation and evaluation of the drug fine particles with the drug release control function to apply to an orally disintegrating tablet
池田有希1, 池内由里1, 村永綾1, 太田美鈴2, 小林文香3, 大貫義則4, 日高慎二2, 大西啓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2017.
Japanese Article P0726-5-AM. Stability of right or wrong and the preparation of the borax addition to aluminum chloride liquid hospital preparation prescription
大野修司1, 山内理恵1, 竹場和代2, 川崎智子2, 北岡晃2, 渡邉雅行1, 久保元1, 浅井和範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2017.
Japanese Article P0728-5-AM. The effect that difference in preparation composition gives to stability of the indometacin oral cavity spray
田澤佑基1, 鏡圭介1, 渡辺祐子1, 久保田康生1, 原田幸子1, 小林正紀1, 山田武宏1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2017.
Japanese Article P0730-5-AM. Relation to use results investigation based on a hospital preparation ethic guideline
浦野敦1, 高嶋加奈子1, 小野田稔久1, 佐野君芳1, 真坂亙1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2017.
Japanese Article P0732-5-AM. It is an example using the Mohs ointment for a skin invasive cancer
高橋未來1, 中田和宏1, 加藤知孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2017.
Japanese Article P0734-5-AM. The making of the Beclometasone dipropionate enteric coated drug using the aciduric capsule and examination of the quality
工藤香澄1, 工藤唯1, 鈴木裕之2, 内田敬3, 猪岡京子3, 我妻恭行1, 高村千津子3, 中村仁2, 鈴木常義1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2017.
Japanese Article P0736-5-AM. Evaluation of preparation properties of the morin-containing gelation nano emulsion
松原巧1, 池内由里1, 松原弘明1, 小林文香2, 岩本美絵3, 大西啓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2017.
Japanese Article P0738-5-AM. Development of pharmaceutical products off-label use aiming at an offer of the reliable safe medical therapy and the special preparation handling procedure
松本紗織1, 川俣洋生1, 三好孝法1, 矢野篤次郎2, 安部初美2, 入江健司1, 松尾尚美1, 小田原真希1, 鶴山萌子1, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2017.
Japanese Article P0740-5-AM. Stirring operation to give to the characteristic of the ointment which assumes vaseline a basis and effect of the temperature
三木奏人1, 田路隆了1, 湯谷玲子1, 寺岡麗子1, 坂根稔康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2017.
Japanese Article P0742-5-AM. Example of the brown alien substance mixture of the tramadol OD tablets that a cause was found to production raw materials by the product objection from a pharmacist
大久保美穂1, 大久保正2,3, 田中真理子3, 大久保七枝4, 大久保節子5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2017.
Japanese Article P0744-5-AM. For the pharmaceutical products management of the world standard
土肥大典1, 鍵山智樹1, 新屋夏希1, 真壁秀樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2017.
Japanese Article P0746-5-AM. Effect on indomethacin capsule elution rate of the auxiliary pharmaceutical adjuvant
栗林和美1, 中川慧1, 沼津郁果1, 高畠亨2, 水野恵司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2017.
Japanese Article P0741-4-PM. Rheology properties of the salicylic acid vaseline ointment accompanied with the mixture with other agents and percutaneous absorption-related change
湯谷玲子1, 田原花奈子1, 宍戸康剛1, 寺岡麗子1, 北河修治2, 坂根稔康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2017.
Japanese Article P0743-4-PM. Stability of famotidine in the hyperalimentation
久保儀忠1, 大森仁2, 谷口はるか1, 小林大祐1, 柴山良彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2017.
Japanese Article P0745-4-PM. Advisability of the simple suspension method application of new proton pump inhibitor, Takecab tablets
石田志朗1, 伊藤達哉1, 武藤浩司2, 山川和宣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2017.
Japanese Article P0747-4-PM. Viscous and stable evaluation at warming of the ethanol non-component docetaxel preparation
浅見祥崇1, 下山哲哉1, 杉浦央2, 斎藤由起子2, 近藤覚也2, 伊藤邦彦1, 小林道也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2017.
Japanese Article P0750-5-AM. 1 case that repeated the asthmatic attack with the nonsteroidal antiinflammatory drug
柴田健太1, 本田隼人1, 中田和宏1, 加藤知孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2017.
Japanese Article P0752-5-AM. Efforts - drug global assessment adjustment addition to the polypharmacy in the convalescent ward increases; or ...
副島將司1, 織田雄一郎1, 北菜奈1, 小川大輔1, 三苫薫梨1, 中野聡1, 嶋彩夏1, 高橋瑞季1, 山本大策1, 海瀬有沙1, 深田充知1, 上野遥香1, 古田裕子1, 越川智子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2017.
Japanese Article P0754-5-AM. One case that developed drug-related pseudo aldosteronism by Polypharmacy
西山祐美1, 吉岡睦展1, 中川史絵1, 杉生雅和1, 小林敦子2, 辻隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2017.
Japanese Article P0756-5-AM. Attitude survey of the physician for the polypharmacy
佐藤拓行1, 松葉康利1, 野口宣之2, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2017.
Japanese Article P0758-5-AM. In-hospital manual preparation for the dementia night delirium, unrest
里見彩1, 若林厚史1, 辻依利1, 上村円香1, 田畑寛明1, 猿谷淳1, 向一美1, 地野幹子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2017.
Japanese Article P0760-5-AM. Efforts to the polypharmacy of the elderly inpatient
竹内和沙1, 向井聡志1, 小島佑太1, 岩下尚弘1, 荒井宏人1, 松田俊之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2017.
Japanese Article P0762-5-AM. Efforts to a fall, the delirium risk reduction with the sleeping drug
古川大樹1, 長谷川雅哉1, 川口美香2, 伊藤孝紀3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2017.
Japanese Article P0764-5-AM. Consideration from the calculation situation of the discharge drug global assessment adjustment addition in our hospital
高桑直子1, 高橋喜統1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2017.
Japanese Article P0766-5-AM. One consideration about the factor of the polypharmacy in the convalescent rehabilitation ward
保坂早紀1, 林宏行2, 小瀬英司2, 高根貴子1, 細田矢佳1, 岡添進1, 矢嶋美樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2017.
Japanese Article P0768-5-AM. The effect that the inhalational instruction of the pharmacist results in in inhalational adherence
市原真紀1, 加賀正基1, 内山真美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2017.
Japanese Article P0770-5-AM. Examination of the pharmaceutical intervention in the patients autoregulation pain relief
岩本真拡1, 平田一耕1, 鈴木正論1, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2017.
Japanese Article P0772-5-AM. Investigation of the pharmaceutical intervention in the cardiovascular surgery ward
原田澪1, 福島将友1, 曽我弘道1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2017.
Japanese Article P0774-5-AM. About 1 case that liver function abnormality was seen in by ward drug duties and hyperthyroidism of our hospital
山戸真子1, 佐々木智香1, 久保田厚子1, 末廣勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2017.
Japanese Article P0776-5-AM. Examination about the association of remedy, the discontinuation of the cerebral infarction onset and the antithrombotic drug in the orthopedics surgery in the Kochi medical center
岡崎弘志1, 田中広大1, 門口直仁1, 川田敬1, 山崎好恵1, 橋田真佐1, 段松雅弘1, 岡崎由紀1, 田中聡1, 沼本邦彦2, 時岡孝光2, 宮本典文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2017.
Japanese Article P0778-5-AM. Examination of the cutoff value of "the medication self-care" which assumed MMSE an index
近藤幸男1, 小西愛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2017.
Japanese Article P0780-5-AM. Fact-finding of doubt inquiry to affect the hospitalization and release of the ward pharmacist in our center
早舩美保子1, 衣笠芳1, 瀧川美和1, 佐藤麻美子1, 瀬尾誠1, 甲斐田浩輔1, 谷古宇美佳1, 田中達郎1, 瀧川正紀1, 島崎良知1, 横井妙子1, 森淑子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2017.
Japanese Article P0782-5-AM. Role vol.2 of the pharmacist in the local inclusion care ward
佐々木優1, 矢倉尚幸1, 加藤鈴1, 湯本哲郎2, 稲葉健二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2017.
Japanese Article P0784-5-AM. Efforts of the improvement in medication counseling calculation rate for pharmaceutical products needing safety management
宮森彩香1, 野村理恵1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2017.
Japanese Article P0786-5-AM. Contribution of the ward pharmacist for the amiodarone-induced thyroid function abnormality
山田恵里1, 福澤翔太1, 片岡智美1, 千崎康司1, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2017.
Japanese Article P0788-5-AM. The establishment of the ward drug duties support system and the effect
平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2017.
Japanese Article P0790-5-AM. About the correspondence in the pharmacist when the health hazard by the side effect occurred
浮池聡子1, 中村愛2, 鶴崎泰史1, 山形真一1, 中川義浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2017.
Japanese Article P0794-5-AM. Duties improvement effect on number of calculation of drug control instruction charges
梅田勇一1, 加来菜津美1, 水之江早希子1, 崎山美津好1, 宗克彦1, 長崎皓光1, 野相まどか1, 堀井康玄1, 森高啓太1, 渡邉鮎子1, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2017.
Japanese Article P0796-5-AM. An example of the prescription of drug suggestion intervention by the multi-type of job cooperation
小島香織1,2,3, 吉岡克幸1, 坂井田梨沙2, 千田沙季3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2017.
Japanese Article P0749-4-PM. The current situation of ward drug duties in the information on adverse drug reactions collection
池谷有紀子1, 小宮詠子1, 大森采菜1, 山内愛樹1, 赤津真衣子1, 坪谷綾子1, 松本浩1, 濱野公俊1, 坂下裕子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2017.
Japanese Article P0751-4-PM. The making of the pre-medication manual to the patients with a history of allergy to contrast media and the protective efficacy
清川真美1, 田嶋恭典1, 石田健太郎2, 夛田浩2, 渡邊享平1,3, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2017.
Japanese Article P0753-4-PM. From the viewpoint of intervention effect on convalescent rehabilitation ward inpatient - circulatory organ therapeutic drug of the heart failure measures team -
吉田章悟1, 加藤豊範1, 友原たき子2, 加納直明3,5, 小田高司4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2017.
Japanese Article P0755-4-PM. Relation of the ward pharmacist in the oral medicine management of elderly people
田村奈美子1, 吉政直美1, 山内健1, 坂梨綾香1, 松本俊治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2017.
Japanese Article P0757-4-PM. Led by patients with fact-finding - dysphagia about the relation of the pharmacist in the convalescent rehabilitation ward -
大坪博子1,2, 熊木良太1, 赤川圭子1, 倉田なおみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2017.
Japanese Article P0759-4-PM. Examination - diuretics, H2 receptor blocker about the safe medical therapy of elderly people, efforts ... to the prescription adequacy of the sleeping drug
小松めぐみ1, 西村奈保1, 田島千愛1, 市川麻美1, 田所美和1, 吉岡りえ1, 市吉真貴子1, 八木亜紀子1, 田中照夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2017.
Japanese Article P0761-4-PM. About efforts to an on admission remedy drug in the circulatory organ medical service and the adequacy
長藤多香美1, 糸川知江1, 佐々木麻里2, 宮森伸一1, 小田登3, 柳田祐子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2017.
Japanese Article P0763-4-PM. Introduction ... of examination - polypharmacy measures of the ward drug duties in the respiratory chronic disease ward
佐々木文子1, 田中翔一1, 梶井孝洋1, 水口敦子1, 西澤修一1, 西川正直1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2017.
Japanese Article P0765-4-PM. Efforts for the improvement in quality of duties by the goal setting according to the individual of the ward pharmacist
関口徳志1, 後藤純一1, 有川真理1, 菅原拓也1, 加川美由紀1, 延川正雄1, 松田圭一郎1, 荒井浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2017.
Japanese Article P0767-4-PM. Comparison between evaluation and regular hospital of the prescription representation input duties in the convalescent rehabilitation ward corresponding to PBPM
吉村友里1, 砂金秀美2, 澤村忠輝1, 山階規子1, 鈴木晴久1, 吉野宗宏1, 杉山博3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2017.
Japanese Article P0769-4-PM. The current situation and effect of medical treatment management (PBPM) based on the protocol
陸丸幹男1, 大塚愛美1, 原尻学志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2017.
Japanese Article P0771-4-PM. Effect on blood pressure between the drug of the levodopa combination drug
倉林誠1, 冨田昌志1, 阿部孝行1, 池井良貴1, 中山智央2, 伊藤規絵2, 大久保由希子2, 山田英俊1, 千葉進2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2017.
Japanese Article P0773-4-PM. Efforts and problem to the polypharmacy in the acute phase hospital
菅直恵1, 石橋さやか1, 岡野和真1, 楢原由生未1, 柳本正憲1, 岡本理恵子1, 若松佳子1, 益本周治1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2017.
Japanese Article P0775-4-PM. For improvement of the pharmaceutical intervention utilizing the template
満永大輔1, 垣添和弘1, 末武弘至1, 井無田優1, 渡部善博1, 吉原郁夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2017.
Japanese Article P0777-4-PM. Examination of the optimal dosage form in the childhood transluminal administration using the passage sex test
清水善仁1, 高橋喜統1, 高瀬文超1, 多賀允俊1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2017.
Japanese Article P0779-4-PM. Inspection of the drug control method of the inpatient in our center
團優子1, 合田泰志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2017.
Japanese Article P0781-4-PM. Evaluation of the pharmaceutical intervention to the polypharmacy in the local inclusion care bed
小玉博一1, 西平和子1, 安田智之1, 井尻香織1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2017.
Japanese Article P0783-4-PM. Construction and evaluation of the new face pharmacist education system to take ward duties on
大東敏和1, 檜山洋子1, 上代大地1, 柴田ゆうか1, 佐伯康之1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2017.
Japanese Article P0785-4-PM. Outcome analysis of the prescription suggestion in the ward duties of the pharmacist
菅原拓也1, 後藤純一1, 関口徳志1, 有川真理1, 延川正雄1, 松田圭一郎1, 荒井浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2017.
Japanese Article P0787-4-PM. Efforts for the current situation and the duties efficiency of the ward pharmacist duties in the urologic ward
高橋隆一1, 関礼輔1, 田島紳介1, 篠原高雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2017.
Japanese Article P0789-4-PM. Relation to efforts and a nursing necessary degree for the ward drug duties enforcement addition calculation of our hospital
安福平1, 松山哲史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2017.
Japanese Article P0791-4-PM. We manage the reopening of the antithrombotic drug after the operation in our hospital urology department
久保田聡1, 佐野裕司2, 吉田涼平1, 荒井梨江1, 春山幸子1, 金澤温子1, 満木由布菜1, 塩見めぐみ1,2, 田中庸一1,2, 渋谷清1,2, 久保田理恵1,2, 尾鳥勝也1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2017.
Japanese Article P0793-4-PM. The intervention of the pharmacist in the perioperative care team and the effect
石久保義紀1, 嶋田紘也1, 平岩知子1, 市川敬太2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2017.
Japanese Article P0795-4-PM. Survey of doubt inquiry in the ward
稲沢薫1, 小笠原蓉子1, 佐藤圭吾1, 西和哉1, 佐賀利英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2017.
Japanese Article P0797-4-PM. Pain evaluation at the erythropoietin preparation hypodermic injection in neonates
戸羽香織1,2,3, 山本枝美1, 長澤朋子2, 葛西香織2, 原山千穂子2, 小野寺幸子3, 内田俊彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2017.
Japanese Article P0799-4-PM. Cooperation with the multi-type of job in the practice of the haemodialysis patients that developed cerebral infarction
徳永貴之1, 槇山翔太1, 河田武志1, 小池恭正1, 濱岡照隆1, 佐藤穣1, 宮田香奈子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2017.
Japanese Article P0801-4-PM. The serious addition computation in the high care unit
鹿沼奈央1, 増田博也1, 新山綾子2, 久岡清子1, 中村正人3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2017.
Japanese Article P0803-4-PM. It is ... through the operation of efforts - home discharge pass to improvement of the medication adherence in the stroke acute phase
清水誉志1, 藤野真利子1, 山下悟史1, 福島将友1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2017.
Japanese Article P0805-4-PM. Investigation about the effect on pharmaceutical support by the ICU sojourn time of the pharmacist increasing
福島将友1, 前田朱香1, 曽我弘道1, 福地祐亮1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2017.
Japanese Article P0807-4-PM. Three-drug incompatibility test of the general-purpose injection drug in the critical care center
近藤匡慶1, 小澤正弥2, 玉木綾音2, 菅谷量俊1, 長野槙彦1, 津田充穂1, 田杭直哉1, 田上隆3, 久野将宗3, 畝本恭子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2017.
Japanese Article P0809-4-PM. One case of the cardiopulmonary arrest case by the fentanyl patch large quantities pasting
吉川博1, 佐藤智人1, 福島隆宏1, 畝井浩子1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2017.
Japanese Article P0811-4-PM. Administration of dry people in warfarin administration average blood clotting ninth factor complex experience for the acute subdural hematoma with the ventricular assist device wearing patients
奥村佳史1,5,6, 木村麻奈加1,5,6, 清水亜花音1,5, 浦上悠1,5, 中島康佑2,5,6, 井上航一3,6, 平岡有努3,6, 林田晃寛4,5,6, 森田孝子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2017.
Japanese Article P0813-4-PM. Experience the hydrogen sulfide inhalation accident by examination - science experiment at a lot of patients with poisoning conveyance for pharmacy; and ...
宮崎雄紀1, 林美和子1, 松原ちはる1, 水谷妙子1, 酒井美香1, 網野一真1, 小口正義1, 登内盛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2017.
Japanese Article P0815-4-PM. Intervention of the perioperative drug administration in the myasthenia gravis
野田貴義1, 勝又博司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2017.
Japanese Article P0798-5-AM. Evaluation of our hospital TPN cipher prescription in the NICU and ward drug duties
新井田サヤカ1, 丸山沙緒里1, 長江美奈1, 松浦詩麻1, 山崎友朗1, 平野桂子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2017.
Japanese Article P0800-5-AM. Effect to give to pharmaceutical products proper use of the pharmacist permanent residence in NICU, GCU
松崎芙実子1, 細野萌子1, 小山美菜1, 鈴木智尋1, 鈴木文子1, 鈴木博也1, 千田真理巴2, 戸澤和恵2, 佐藤信一3, 佐藤真由美1, 赤坂和俊1, 大平貴子2, 埴田卓志3, 小原拓1, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2017.
Japanese Article P0802-5-AM. Fact-finding of patients with acute intoxication in our hospital
中村亜由美1, 小守陽介1, 鈴木正論1, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2017.
Japanese Article P0804-5-AM. The prescription suggestion by the ICU exclusive duty pharmacist and the problem
國廣理菜1, 鈴木早苗1, 安藤和佳子1, 和久裕尚1, 池井健1, 堀部正記1, 遊見裕子1, 山岸雄幸1, 大谷仁士1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2017.
Japanese Article P0806-5-AM. Efforts to the pharmaceutical products management adequacy in the ICU
森雅之1, 昆貴志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2017.
Japanese Article P0808-5-AM. Examination about effect of treatment of the thrombomodulin alfa in patients with impaired renal function and the adverse event
岡部賢司1, 今浦将治1, 菅原悠佳1, 大村和也2, 永瀬怜司1, 高橋宏行2, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2017.
Japanese Article P0810-5-AM. Effect on bacteremia examination of the antimicrobial proper use support of the intensive care unit admission patients
津山博匡1, 木村正彦2, 丹羽英智3, 橋場英二3, 廣田和美3, 萱場広之2, 下山律子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2017.
Japanese Article P0812-5-AM. Fact-finding of the sedative sedative management after the sedative sedative protocol introduction for the artificial respiration management patients in the critical care center
末森千加子1, 酒井美和1, 山田真人1, 太田あづさ1, 塩田恵1, 相生勇作1, 吉田直恵1, 鴻野公伸2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2017.
Japanese Article P0814-5-AM. About the usefulness of the pharmacist duties in the ICU in rest Sundays and holidays
寺松洋美1, 神一夢1, 冨澤淳1, 小林昌宏1,2, 近藤留美子1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2017.
Japanese Article P0816-5-AM. Use of rasburicase fact-finding in the Shonan Kamakura General Hospital
星吉行1, 長岡和徳1, 仲鉢英夫1, 玉井洋太郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2017.
Japanese Article P0818-5-AM. Change of the use regimen in the Helicobacter pylori triple-drug therapy and sanitization rate
白石貴寿1, 沖田健太郎1, 臼井和明1, 近藤真由1, 松永里香1, 山村真貴子1, 安藤暢彦1, 上地純子1, 森田佳博1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2017.
Japanese Article P0820-5-AM. Investigation about the safety, and the like of the suvorexant administration for elderly people
森田春香1, 吉川明良1, 中谷治規1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2017.
Japanese Article P0822-5-AM. It is ... for the diabetes medical treatment instruction that is better than relation ... of the pharmacist in the outpatient specialized in our hospital diabetes
茂木秀敏1, 金古成美1, 橋場弘武1, 中村保子2, 高玉真光3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2017.
Japanese Article P0824-5-AM. Memoir about the association of an incident and the sleeping drug of a fall, the fall in our hospital
村岡佑梨子1, 柿本真佑2, 河野修治1,2, 権藤直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2017.
Japanese Article P0826-5-AM. The current situation investigation of the polypharmacy in our hospital and future efforts
山本修也1, 村上幸恵1, 今西明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2017.
Japanese Article P0828-5-AM. Examination about the effectiveness and the safety of the low-dose orchid geo-roll
佐々木紀彰1, 古元俊徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2017.
Japanese Article P0830-5-AM. Questionary survey about the understanding degree after the medication counseling of the outpatient
四釜亮太1, 南真進1, 矢島功1, 松浦直嗣1, 小杉隆祥1, 松本直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2017.
Japanese Article P0832-5-AM. Comparison ... before and after change - JSH2014 revision of the antihypertensive medications prescription trend in our hospital outpatient department
有木沙織1, 神崎浩孝1, 竹内英実2, 内田治仁2,3, 田中雄太1, 小川敦1, 西原茂樹1, 村川公央1, 和田淳2, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2017.
Japanese Article P0834-5-AM. Efforts (the second report) of the suvorexant introduction for the purpose of the reduction of a fall, the fall risk with the sleeping drug
平松祐哉1, 宮腰千紘1, 木南志朗1, 中島美治1, 伊藤仁1, 石田英明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2017.
Japanese Article P0836-5-AM. Comparison of the DOAC new prescription situation by the Idarucizumab release in our hospital
門野健二1, 木村順平1, 武田龍馬1, 山田和範2, 山澤裕司2, 本間和加子1, 中村博彦3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2017.
Japanese Article P0838-5-AM. About the Helicobacter pylori sanitization situation for patients having drug side effect history, and the like in our hospital
猿渡康宏1, 吉丸侑子1, 山本裕子1, 伊藤由希1, 寺本拓哉1, 赤坂綾1, 横山賢二1, 丸田佐知子1, 水本智子1, 平井裕子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2017.
Japanese Article P0840-5-AM. Attitude survey of patients about the clinical test value provided by a hospital
清水紗弥香1, 富岡佳久2, 庄野あい子3, 山内泰一4, 大木稔也1, 今井博久5, 佐藤秀昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2017.
Japanese Article P0842-5-AM. Examination about the proper use of combination tablets
松下久美1, 瀧祐介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2017.
Japanese Article P0844-5-AM. Can the PTP mis-deglutition prevent it? Fact-finding ... to ... pharmaceutical company
山口美穂1, 遠山幸男1, 小島庸子1, 堀田菜摘1, 糖塚理恵1, 笠原大輔2, 西川佳友2, 久田達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2017.
Japanese Article P0846-5-AM. Attitude survey of the protector about childhood bronchial asthma treatment
今野壮太1, 竹平理恵子1, 有田悦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2017.
Japanese Article P0848-5-AM. Analysis - that we paid our attention to consciousness, confidence of the drugstore pharmacist for the hypertensive medical treatment support and "worth doing" and associated - "aggressiveness" of the tissue climate
南佐智1, 庄司雅紀1, 恩田光子2, 岡田浩3,4, 中川康司5, 坂根直樹3, 中山健夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2017.
Japanese Article P0850-5-AM. Summary of the use of NS5B polymerase inhibitor case in our hospital
濱里真耶1, 松本みゆき1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2017.
Japanese Article P0852-5-AM. Comparison between understanding degree of the prescription notebook and use situation investigation - event participation citizen and inpatient -
村中太郎1, 中村郁子2,3, 倉兼広樹1, 清水達矢1, 古川奈緒子1, 遠藤孝1,3, 澁川真由2, 大原宏司2, 高橋将喜3, 北村哲治3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2017.
Japanese Article P0817-4-PM. Examination about a use trend of the antiPseudomonas aeruginosa medicine and the change of the Pseudomonas aeruginosa-resistant rate
臼井和明1, 栗原江未1, 安河内寿成1, 吉田悦朗1, 大石丸美1, 宇都宮奈々1, 松永里香1, 宗本佐知子1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2017.
Japanese Article P0819-4-PM. Use stocktaking of the daptomycin in the orthopedics domain
新木貴大1, 磯辺浩和1, 島田泉1, 吉田謙介1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2017.
Japanese Article P0821-4-PM. Prescription investigation for the antidepressant and evaluation of the clinical pharmacy
片山陽介1, 小坂隆介1, 有川仁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2017.
Japanese Article P0823-4-PM. Attitude survey ... for incompatibility ... nurses with the magnesium oxide preparation at simple suspension
長谷川彩1, 河原陽介1, 御子柴智聖1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2017.
Japanese Article P0825-4-PM. Investigation about the actual situation and the patients awareness of the polypharmacy in the health insurance pharmacy
亀山俊1, 重谷英寿1, 足立朋子1, 米川綾1, 佐藤知奈美1, 佐次田惇1, 村田まり子1, 早川美恵子1, 飯塚敏美1, 堀口雅巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2017.
Japanese Article P0827-4-PM. Effect on osteoporosis treatment rate after the proximal thighbone bone fracture by the osteoporotic liaison service introduction
森崎崇文1, 星野輝彦1, 塩津和則1, 清田克彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2017.
Japanese Article P0829-4-PM. About the DOAC proper use situation investigation in the Saiseikai Futsukaichi Hospital
辻村啓史1, 中野祐樹1, 横尾賢乗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2017.
Japanese Article P0831-4-PM. Questionary survey about the medication refusal of the pediatric steroid internal use for medical persons
喜多朝菜1, 矢野涼子1, 熊木真理子1, 齋藤讓一1, 間瀬広樹1, 秋山哲平1, 溝神文博2, 太田和秀3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2017.
Japanese Article P0833-4-PM. The current situation investigation of the assist use for effective inhalational instruction
前澤佳代子1,2, 石畑耕士1, 田村拓也1, 原由梨香1, 加藤芳徳1, 伊東岳1, 杉山奈津子1,2, 白木晶3, 駒瀬裕子4, 百瀬泰行1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2017.
Japanese Article P0835-4-PM. The use of anticoagulant situation in patients with cerebral hemorrhage at admission
新沼佑美1, 阿部誠也1, 関さやか1, 佐藤直也1, 猪狩崇子1, 児山麻佑1, 栗村淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2017.
Japanese Article P0837-4-PM. Current situation - of the inhalant re-instruction in construction - fourth report Suita-shi of the inhalational instruction cooperation in Suita-shi
駒居真紀子1, 児玉暁人1, 森信介1, 辻文生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2017.
Japanese Article P0839-4-PM. Effect (the second report) that the ketogenic diet therapy in patients with epilepsy (Atkins food strange law) gives to a combination antiepileptic drug
矢嶋隆宏1, 山本吉章1, 中井正彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2017.
Japanese Article P0841-4-PM. Start clinical test value mention to outside Parliament prescription; and attitude survey - of the local pharmacist by - questionnaire
田畑佳祐1, 森田紗代1, 垣尾尚美1, 玉置尚1, 南のどか1, 中須賀基1, 入江優美1, 植木彩1, 瀬川和子1, 辻本純子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2017.
Japanese Article P0843-4-PM. Fact-finding about the off-label use of pharmaceutical products in the Nagasaki University Hospital
黒崎友亮1, 室高広1, 橋詰淳哉1, 馬場安里1, 黄智剛1, 松丸由美1, 増山優紀1, 安岡しおり1, 中村忠博1, 佐々木均1, 北原隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2017.
Japanese Article P0845-4-PM. Can you discover the PTP mis-deglutition with X-rays? Inspection ... of an investigation and the radiolucency of ... PTP materials
小島庸子1, 遠山幸男1, 山口美穂1, 堀田菜摘1, 糠塚理恵1, 笠原大輔2, 山田将大3, 西川佳友2, 久田達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2017.
Japanese Article P0847-4-PM. The taking drug situation affecting the relation of the pharmacist in the urination care team and the lower urinary tract function in the urination independence intervention patients
越野優希1, 田井達也1, 小川真梨1, 安宅可南美1, 山下紗矢佳1, 冨田淳子1, 加地雅人1, 朝倉正登1,2, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2017.
Japanese Article P0849-4-PM. Analysis of inquiry contents about the subcutaneous infusion put than the pharmaceutical person concerned
佐々木美由紀1, 堀越由里1, 竹林佑花1, 津田朋枝1, 松田直子1, 星泉1, 吉岡小都子1, 岡崎哲也1, 福田まゆみ1, 河野裕則1, 岩原良晴1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2017.
Japanese Article P0851-4-PM. About the use situation of the Evolocumab in our hospital
山本諭1, 小田剛史1, 野井亜佐美1, 岩本佳代子1, 稲村勝志1, 南橋薫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2017.
Japanese Article P0853-4-PM. About the temporarily suspended attitude survey and current situation
鈴木美威瑠1,2, 滝澤大樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2017.
Japanese Article P0854-5-AM. Fact-finding - about the bringing of the drug in consideration of cancellation, a change of bringing medicine for elderly inpatient fact-finding - administration
諏訪万里菜1, 渋谷文則2, 新倉卓2, 高橋信2, 清海杏奈1, 中島由紀1, 杉浦宗敏1, 山村康比古2, 越田晃3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2017.
Japanese Article P0856-5-AM. The bringing medicine differentiation duties that collaborated with the nurse in the area short of pharmacists
竹谷美穂1, 菅野雄太1, 瓜智都1, 森本淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2017.
Japanese Article P0858-5-AM. Examination about the drug proper use for elderly patients judging from bringing medicine differentiation in the medical service
千田紗弓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2017.
Japanese Article P0860-5-AM. Prescription suggestion ... utilizing efforts - PIMs screening of the hospital pharmacist for the polypharmacy
佐藤由美1, 宮彩子1, 蛭川智晴1, 柴田彩佳1, 川井由貴1, 似内和也1, 佐藤裕司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2017.
Japanese Article P0862-5-AM. Development and duties improvement effect of the new bringing medicine input system in conjunction with a medical affairs system
三坂恒1, 原祐輔1, 岡本紘一2, 山岡紳介2, 嶋田努1, 崔吉道1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2017.
Japanese Article P0864-5-AM. Change investigation of the bringing medicine availability ratio before and after the bringing medicine center setting
二見早希1, 伊藤磨美1, 長谷川紗菜恵1, 原田千菜美1, 川口恵1, 北村悠里子1, 谷本香奈杏1, 村山蘭1, 吉住優里1, 土本寛子1, 石田あい1, 松下比奈子1, 久保智士1, 山崎瑞貴1, 鶴崎亮1, 今市沙有美1, 岡紗智子1, 木村真策1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2017.
Japanese Article P0866-5-AM. The construction of the bringing medicine differentiation system using Microsoft Excel and examination of the usefulness
川原裕1, 松本芳信1, 佐野雅昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2017.
Japanese Article P0868-5-AM. Efforts to medical security by the oral medicine management of the pharmacist
池田秀優1, 和田智美1, 宮内孝博1, 緒方雅章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2017.
Japanese Article P0870-5-AM. Construction of the unitary administration management system which the bringing medicine to the electronic medical chart top included
本田弘1, 佐藤亜希1, 菅野照2, 高城大作2, 馬場義徳2, 加島典子3, 中島繁美1, 石山秀一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2017.
Japanese Article P0855-4-PM. About operation of the bringing medicine in the Nagasaki medical center
綱脇徹意1,2, 植村隆1, 前田茂人2, 高田正温1, 東島彰人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2017.
Japanese Article P0857-4-PM. Participation of current situation investigation - hospital pharmacist of the polypharmacy of the elderly people who saw it from bringing medicine in our hospital and future problem ...
平野史1, 馬場亮一1, 岡田昌之1, 杉本悠花1, 成末まさみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2017.
Japanese Article P0859-4-PM. Effect to prescription temporary registration duties of the bringing medicine by the pharmacist and medical security
坪田有未1,2, 新谷智則1, 山下慎司1, 清川真美1, 五十嵐敏明1, 古俵孝明1, 渡邊享平1,2, 矢野良一1, 塚本仁1, 後藤伸之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2017.
Japanese Article P0861-4-PM. Is going to be operated on; examination for an evaluation and the subject clinical department expansion of the discontinuation instruction before operation in the patients
山崎夕貴1, 宮崎雄紀1, 水谷妙子1, 神戸千紘1, 田中文1, 唐澤綾1, 藤森和江1, 網野一真1, 小口正義1, 登内盛治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2017.
Japanese Article P0863-4-PM. Fact-finding study of the medication compliance in the elderly inpatient
中島章雄1,2, 坂元佑哉1, 藤木将勝1, 高瀬友美1,2, 宮崎元康1, 金子朋博1, 内山将伸1, 後藤美和1, 川原義弘1, 松尾宏一1,2, 今給黎修1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2017.
Japanese Article P0867-4-PM. 1 case of the transient complete atrioventricular block which was able to evade a pacemaker shrubbery by pharmacist intervention
花田聖典1, 下澤那津1, 高田正温1, 植村隆1, 東島彰人1, 松尾崇史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2017.
Japanese Article P0869-4-PM. Participation in change and incident accident of the bringing medicine evaluation method in the Secomedic Hospital
渡辺孔明1, 吉田有貴子1, 長澤宏之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2017.
Japanese Article P0871-4-PM. About the search hit number of health hazard suspicion change until the day when a notice of MHLW is given by the penciled eyebrow
佐藤亜希子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2017.
Japanese Article P0873-4-PM. Efforts for the use situation and proper use of the health food
合田泰志1, 團優子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2017.
Japanese Article P0875-4-PM. Fact-finding about the use of health food of a university student, the high school student
荒井國三1, 橋本佳奈1, 柴田実香1, 玉田実花1, 浦田航希1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2017.
Japanese Article P0877-4-PM. The supplement which raises solubility of celecoxib
武田有紀1, 高見陽一郎1, 小松原早織1, 浦上知香1, 笹原莉子1, 島田倫栄1, 福島由貴1, 小川壮寛2, 安倉央2, 江川孝3, 島田憲一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2017.
Japanese Article P0872-5-AM. The supplement intake in general local inhabitants: Kakegawa cohort study
菊池大輔1,2, 小原拓1,3,4, 永井雅人4, 石黒真美4, 松原博子5, 水野聖士4, 山中千鶴4, 菊谷昌浩1,4, 渡辺善照2, 栗山進一1,4,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2017.
Japanese Article P0874-5-AM. About the attitude survey about the health food of the health food management person society citizen open lecture participant
山本勇樹1, 水谷一寿2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2017.
Japanese Article P0876-5-AM. Effect of the chitosan on uptake to Caco-2 cells of losartan potassium
岩崎綾乃1, 岡田弦也1, 阿部真理子1, 今井公江1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2017.
Japanese Article P0878-5-AM. Elution behavior and preparation evaluation of the general Famotidine orally disintegrating tablet based on a plasma concentration change after the oral administration to a rat
斉藤佑治1, 浅野由佳1, 加藤美紀1, 灘井雅行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2017.
Japanese Article P0880-5-AM. Trial manufacture of an attitude survey and the communication tool of the foreign tourist about pharmaceutical products made in Japan
木下淳1, 高橋稔1, 苫田彩佳1, 山田純也1, 松尾実菜1, 中村任2, 佐野智行3, 奥田寛3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2017.
Japanese Article P0882-5-AM. The current situation investigation of recognition and the expectation of local inhabitants for "the healthy support by the pharmacist"
畔原篤1, 後藤亮平2, 前野哲博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2017.
Japanese Article P0879-4-PM. A study on proper use of the nonprescription drug: About the private brand of the pain-killer
宮地佑佳1, 横山沙和1, 仲山千佳1, 大嶋耐之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2017.
Japanese Article P0881-4-PM. Tension-type headache of the OTC medicine for the headache, effect on migraine headache, comparison of the user satisfaction
本屋敏郎1, 島居夏美2, 山下尚子3, 前薗裕美4, 倉澤克樹2, 田畑光一4, 吉村貴秀1, 河内明夫1, 園田純一郎1, 鳴海恵子1, 下堂薗権洋1, 佐藤圭創1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2017.
Japanese Article P0883-4-PM. Time of compounding, remedy-related evaluation accompanied with the drug agent type change to children
霍間尚樹1, 樋口利晴1, 池田考介1, 石川貢1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2017.
Japanese Article P0885-4-PM. Dissolution evaluation of the cabergoline tablets in the generic drug quality information review meeting
阿部康弘1, 吉田寛幸1, 伊豆津健一1, 合田幸広1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2017.
Japanese Article P0887-4-PM. Dissolution evaluation by the flow through cell method of the different ingredient preparation of the dosage form
永田佳子1, 石倉由紀子1, 藤木健行1, 金澤秀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2017.
Japanese Article P0889-4-PM. Evaluation of the price range of the medicine charge in pharmaceutical products mixed with in-hospital adopted pharmaceutical products at a drugstore at a hospital
舘知也1,2, 齊藤康介1, 江崎宏樹1, 兼松勇汰1, 吉田阿希1, 杉田郁人1, 野口義紘1, 牧野哲平2, 梅田道2, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2017.
Japanese Article P0891-4-PM. Effective and safe comparison of the starting pharmaceutical products and generic medicine of tacrolimus for the ulcerative colitis
今由香莉1,2, 船田茜1, 友寄旬1, 山下友輝1, 山本千秋2, 田中悠季1, 飛澤国広1, 小原秀治1, 小原郁司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2017.
Japanese Article P0893-4-PM. It is examination about the vascular pain in the change of the gemcitabine infusion liquid "Hospira" from the one for gem Saar injection
遠藤征裕1, 山田郁恵1, 平泉達哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2017.
Japanese Article P0884-5-AM. It is ... using an efforts ... simple type generic medicine comparison list in our hospital for 80% of generic medicine amount ratios
長岡麻由1, 船津洋子2, 藤原香2, 林田美香2, 岸本早苗2, 古川資啓3, 藤元公成4, 川浪泰男4, 山口真三志6, 小池城司5, 勝田洋輔5, 壁村哲平6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2017.
Japanese Article P0886-5-AM. Study on difference in crush properties between a zolpidem tartrate tablets innovator drug, the generic drug
稲葉一訓1, 大家才治2, 大竹裕子2, 井上知美2, 小竹武2, 長井紀章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2017.
Japanese Article P0888-5-AM. The current situation and problem about the change to generic medicine in our hospital
恒川朋子1, 太田真美1, 武藤達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2017.
Japanese Article P0890-5-AM. Risk factor investigation of the blood vessel-related complications by the generic medicine change in the Tri-Weekly TC (paclitaxel + Carboplatin) therapy
新田健太郎1, 武田浩文1, 鳥羽三佳代2, 永田将司1, 高橋弘充1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2017.
Japanese Article P0892-5-AM. Different innovator drug of the dosage form of the gemcitabine hydrochloride, comparison of the adverse event with the generic drug
久保果央莉1, 元茂拓法2, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2017.
Japanese Article P0894-5-AM. The effectiveness, safe comparison with a precedent article in the insulin glargine preparation in our hospital and the following article
近藤沙耶1, 多留木崇志1, 大橋正和1, 小野勝1, 村岡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2017.
Japanese Article P0896-5-AM. Examination about the effectiveness in the comparison with the innovator drug of the filgrastim bio follower product
山下剛史郎1, 柴田千保1, 西村美佳1, 鶴田和樹1, 馬島務1, 廣瀬孝一1, 小田剛史1, 田中恵美子1, 稲村勝志1, 南橋薫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2017.
Japanese Article P0898-5-AM. Functional analysis of a preparation and the acquisition antibody of the rat single strand Fv library for the seeds acquisition of antibody pharmaceutical products
加藤芳徳1, 重本佳予子1, 篠崎拓哉1, 長谷川奈菜1, 遠藤和輝1, 細川悠悟1, 山田治美1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2017.
Japanese Article P0895-4-PM. Examination about the effectiveness, the safety of the filgrastim note bio follower product for the purpose of the peripheral blood stem cell sampling
石井一也1, 上泰大1, 荻原好章1, 神原康佑1, 大塚識稔1, 原景子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2017.
Japanese Article P0899-4-PM. Efforts ... which is associated with a drug needing side effect monitor activity - periodical examination in the impartial kindness society
丸岡真琴1, 松本ミユキ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2017.
Japanese Article P0901-4-PM. An example with suspected collagen fiber-related colitis with lansoprazole
三浦恵理1, 奥野昌宏1, 吉村弥緒2, 中浴伸二1, 中田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2017.
Japanese Article P0903-4-PM. Safe profile associated with the bleeding of the direct action type oral anticoagulant drug in patients with atrial fibrillation
中村彰子1, 松井美月1, 東野真弓1, 穂積智美1, 宮本渚2, 須永登美子1, 稲本真弓3, 間瀬浩4, 若月大輔4, 下島桐4, 向後麻里3, 江波戸美緒4, 鈴木洋4, 渡邊徹1, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2017.
Japanese Article P0905-4-PM. Examination of collection, correspondence, joint ownership, the management method of the information on adverse drug reactions through ward duties in Rousaibyoin, Yamaguchi
下向井唯希1, 柴田文規1, 小川丈彦1, 梅野尚生1, 岡村智文1, 神谷真悟1, 管田彩乃1, 尾川友佳1, 田口みどり1, 竹田克明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2017.
Japanese Article P0907-4-PM. 1 case that led to a cardiac arrest from crown spastic angina induced by aspirin asthma
大辻陽子1, 榎屋友幸1, 石倉健2, 佐々木典子1, 岩本卓也1, 今井寛2, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2017.
Japanese Article P0909-4-PM. Evaluation of the side effect in patients hospitalized for the side effect of pharmaceutical products and the severity
勝野隼人1, 舘知也1,2, 青山智2, 大澤友裕2, 上野杏莉1, 大坪愛実1, 杉田郁人1, 兼松勇汰1, 吉田阿希1, 野口義紘1, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2017.
Japanese Article P0913-4-PM. It is examined the use situation of the tolvaptan after the surgery of the cardiovascular surgery and frequency and the risk factor of the high Na blood symptom in Gifu comprehensive medical care center
小寺聖1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2017.
Japanese Article P0915-4-PM. Local difference of the recognition about "the safe information report systems such as pharmaceutical products, medical equipment, and the like" in the pharmacist and the practice
小林智徳1, 赤坂和俊1, 小原拓1,2, 山口浩明1, 松浦正樹1, 村井ユリ子1,2, 土屋文人3, 北田光一3, 眞野成康1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2017.
Japanese Article P0917-4-PM. The side effect occurrence situation in the linezolid
又吉樹1, 森口真衣1, 吉川眞維樹1, 安田章太郎1, 駒井勇太2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2017.
Japanese Article P0921-4-PM. One patient whom the hepatic encephalopathy that was thought to be due to 5-FU during mFOLFOX6 therapy developed in
近藤万友美1, 正置耕一1, 澁谷奈穂1, 吉岡睦展1, 高瀬直人2, 辻隆志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2017.
Japanese Article P0923-4-PM. Examination about akathisia expression with prochlorperazine and the antiemesis effect
熊谷卓博1, 齋藤佳敬1, 山田武宏1, 小林正紀1, 熊井正貴1, 笠師久美子1, 小松嘉人2, 井関健3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2017.
Japanese Article P0925-4-PM. Evaluation of cardiac disorders by the nivolumab using domestic adverse event spontaneous report database (JADER)
岡田浩司1, 薄井健介1, 渡辺善照1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2017.
Japanese Article P0929-4-PM. An example of the hepatitis fulminant that it was thought that it was caused by Abiraterone ester acetate tablets
松本ミユキ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2017.
Japanese Article P0931-4-PM. 1 case of the type 2 diabetes merger non-small cell lung cancer that blood sugar control worsened after the nivolumab administration
長田知子1, 世古口典子1, 大西真裕2, 大西悠紀3, 日置三紀1, 岩本卓也1, 小林哲2, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2017.
Japanese Article P0933-4-PM. About onset of organ derangement by the difference in daily doses of ampicillin/sulbactam
今西嘉生里1, 中蔵伊知郎1, 坂倉広大1, 福田利明1, 佐光留美1, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2017.
Japanese Article P0935-4-PM. Examination about the safety when sulfamethoxazole trimethoprim is given for pneumocystis pneumonia onset inhibition
青山智1, 大澤友裕1, 梅田道1, 長谷川貴昭2, 石黒崇3, 堀場あかね3, 二村洋平3, 吉田勉3, 澤祥幸4, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2017.
Japanese Article P0937-4-PM. Side effect of consciousness and the weight gain of the pharmacist for the weight change in the SGLT2 inhibitor
蓮見和也1, 佐藤宏樹2, 三浦康正3, 高橋一之4, 小島孝一4, 藤原真理子5, 堀里子2, 澤田康文2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2017.
Japanese Article P0939-4-PM. One case that caused hypoglycemia by levofloxacin internal use
塚田寛子1, 明時凡子1, 一ノ瀬由衣1, 床島英雄1, 三砂義敬1, 田中基稔1, 近藤譲1, 宮崎靖之1, 山脇一浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2017.
Japanese Article P0941-4-PM. One patient whom aciclovir encephalopathy developed in after the valacyclovir administration
柳川智子1, 倉橋基尚1, 椿尾薫1, 青木里紗1, 卜部和美1, 澤崎高志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2017.
Japanese Article P0943-4-PM. Examination of the deep vein thrombosis (DVT) treatment with rivaroxaban in our center and warfarin
渡邊なお子1, 大塚公庸1, 中村益美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2017.
Japanese Article P0947-4-PM. Hospitalization and side effect investigation of the Yokukansan in patients with foreign going to hospital dementia
藤矢実那美1, 光岡里奈1, 矢野義孝1, 三浦誠2, 本橋秀之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2017.
Japanese Article P0949-4-PM. Evaluation of preventive measures against low Ca blood symptoms in the osteoporosis treatment denosumab administration
黒川瑠璃子1,2, 木全司1, 高原悠子1, 鬼頭克暢1, 鵜飼淳一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2017.
Japanese Article P0951-4-PM. Efforts to the bone fracture risk in patients with steroidal osteoporosis using FRAX
高澤麻美1, 土田美奈子1, 細沼万衣1, 丹羽直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2017.
Japanese Article P0953-4-PM. About the side effect of Thyradin (R) S tablets which we experienced in our hospital
山口千晶1, 野中榮夫1, 寺澤友基子1, 横塚智1, 仲田三佐子1, 北川亘2, 伊藤公一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2017.
Japanese Article P0955-4-PM. 1 case of the haemodialysis patients that disturbance of consciousness was prolonged after the blood aciclovir levels drop
澤田麻旺1, 榎屋友幸1, 新堂晃大2, 池村健治1, 佐々木典子1, 岩本卓也1, 今井寛2, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2017.
Japanese Article P0900-5-AM. Examination of the bleeding risk after the direct action type oral anticoagulant drug administration in deep vein thrombosis, the pulmonary thromboembolism
松井美月1,2, 清水朋美3, 東野真弓1,2, 穂積智美1,2, 高橋典子1,2, 中村彰子1,2, 宮本渚1, 須永登美子1,2, 向後麻里3, 江波戸美緒4, 鈴木洋4, 渡邊徹1,2, 佐々木忠徳2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2017.
Japanese Article P0902-5-AM. One case that showed a side effect of the hair loss of lansoprazole
高橋雄也1, 森本健幹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2017.
Japanese Article P0904-5-AM. One case with suspected agranulocytosis due to the mesalazine granule
山村知紗1, 梶原洋文1, 山田雅也1, 錦織英史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2017.
Japanese Article P0906-5-AM. 1 case that polypharmacy was improved by pharmaceutical intervention
菊地義明1, 高橋誠1, 庄崎沙耶1, 藤田果那1, 田中耕太1, 木下愛1, 山本翔太1, 山田将悟1, 前川英輝1, 藤林遼1, 鈴木直哉1, 地主隆文1, 森田高行1, 青田忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2017.
Japanese Article P0908-5-AM. Examination about the cancellation reason of the foreign chemotherapy in our hospital
五月女拓也1, 外山智章1, 坂本鉄弥1, 野沢三枝子1, 上野恵美1, 石濱洋美1, 本田雅巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2017.
Japanese Article P0910-5-AM. Association between oversedation and obesity by the new insomnia therapeutic drug suvorexant
鳥井栄貴1,2, 上池沙弥華1, 山本美和1, 安田大将1, 清水るみ子1, 平岡義範1, 橋田亨2, 久米典昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2017.
Japanese Article P0912-5-AM. The situation investigation of the GI bleeding due to a drug
清原めぐみ1, 川尻尚子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2017.
Japanese Article P0914-5-AM. Association of proton pump inhibitor administration and the side effect "hypomagnesemia" in our hospital and the consideration
伊集院聖司1, 水谷駿介2, 田中和子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2017.
Japanese Article P0916-5-AM. As compared with use comparison - Xa inhibitor of the anticoagulant, a Doac4 agent ...
中井聖子1, 佐藤倫由2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2017.
Japanese Article P0918-5-AM. Examination - case subject study - of the factor associated with the pseudoaldosteronism onset
小松旺広1, 吉野鉄大2, 佐野恵1, 中村智徳1, 金井隆典3, 渡辺賢治2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2017.
Japanese Article P0920-5-AM. It is ... mainly on the case that became the introduction hospitalization in characteristic - National Cardiovascular Center of the anthracyclines-induced myocardial disorder
平田尚人1,2, 小松稔典2, 栗林真理子2, 山田隆一1, 加藤文香1, 片桐玲奈1, 矢嶋明1, 下枝貞彦3, 戸塚信之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2017.
Japanese Article P0922-5-AM. Example that developed an immune-mediated adverse event by the nivolumab in our hospital
小竹優希1, 坂本竜平1, 向井淳治2, 吉田太映子1, 岸本典子1, 上西剛史1, 松山しま子3, 長谷川喜一4, 奥田広志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2017.
Japanese Article P0924-5-AM. It is a case using the azacitidine therapy for myelodysplastic syndrome treatment-related in our hospital
蓮尾憲作1, 村本慎悟1, 眞田功2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2017.
Japanese Article P0926-5-AM. Examination about the allergic reaction with oxaliplatin in our hospital
山下愛登1, 堀勇太1, 後藤隆2, 浦本邦弘1, 豊福篤志3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2017.
Japanese Article P0928-5-AM. Frequencies and expression factor of infusion reaction in the rituximab new administration method
北風晶子1, 辰己純代2, 飯田洋子2, 田久保慎吾2, 田中邦佳2, 柳井美奈2, 木村健2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2017.
Japanese Article P0930-5-AM. Effect on renal function with the voriconazole IV preparation in the blood-forming organ tumor case
安武夫1, 小沼貴晶2, 黒田誠一郎1, 高橋聡2, 東條有伸2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2017.
Japanese Article P0932-5-AM. Fact-finding of the hyperkalemia in the low-dose ST medical mixture remedy patients
加藤翔大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2017.
Japanese Article P0934-5-AM. An example of the infective endocarditis with suspected serious neutropenia with the daptomycin administration
牛島智子1, 西村文宏1, 宮村重幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2017.
Japanese Article P0936-5-AM. The effect that tazobactam/piperacillin combination gives to renal function in the patients receiving vancomycin
小林将文1, 島田泉1, 新木貴大1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2017.
Japanese Article P0938-5-AM. Cytotoxic comparison with the SGLT2 inhibitor in the cell line derived from human keratinocytes
松本彩夏1, 辻本雅之1, 折方琴音1, 白土恵理1, 辻本美菜1, 峯垣哲也1, 河渕真治2, 伊藤由佳子2, 栄田敏之2, 山本和宏3, 錦織千佳子4, 西口工司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2017.
Japanese Article P0940-5-AM. An example of patients on dialysis of recurrent pericarditis that developed rhabdomyolysis by colchicine
伊藤和幸1, 平嶋由貴1, 中村くみこ1, 長谷川彩1, 浦崎圭太1, 河井和子1, 磯谷聡1, 余語美奈2, 加田賢治2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2017.
Japanese Article P0942-5-AM. Consideration about the drug eruption accompanied with the pylori sanitization
真鍋健一1, 西田初博1, 甲斐真理子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2017.
Japanese Article P0948-5-AM. In patients with non-valvular atrial fibrillation is weighed hemorrhagic side effect frequencies of oral anticoagulant drug (DOAC) directly
河村真歩1, 門口直仁1, 山崎真妃呂1, 橋田真佐1, 田中聡1, 宮本典文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2017.
Japanese Article P0950-5-AM. About an adverse event report system in our hospital
村松奈緒美1, 山田倭花1, 内山乃映1, 大窪真理絵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2017.
Japanese Article P0952-5-AM. It is one patient with suspected bullous pemphigoid during sitagliptin internal use
千場美奈1,2, 山下克也1, 津曲恭一2, 山崎恵子1, 山道研1, 中村康彦1, 福澤美夕1, 田川幸1, 諌見圭佑1, 吉本有里1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2017.
Japanese Article P0954-5-AM. Examination of the effect that renal function in the eribulin mesilate gives for onset of neutropenia
鈴木訓史1, 村上寛知1, 橋下浩紀1, 遠藤雅之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2017.
Japanese Article P0956-5-AM. Quantity of glycyrrhizic acid of the study on crude drug ingredient (7) Glycyrrhiza combination Chinese medicine of Chinese medicine
黒田明平1, 社本典子1, 木下歩美1, 椎崇1,2, 三巻祥浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2017.
Japanese Article P0957-4-PM. The cardiovascular events risk assessment of the HMG-CoA reductase inhibitor and analysis of the CYP2J2 inhibitory action
伊東久貴1,2, 山折大1,2, 上条しのぶ2, 大森栄1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2017.
Japanese Article P0959-4-PM. Making of the Excel template performing the blood level simulation at absorption rate fixed number estimate of the drug based on package insert information and repeated doses
西田孝洋1, 徳永彩子1, 宮元敬天1, 井手陶子1, 谷口麻里子1, 麓伸太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2017.
Japanese Article P0961-4-PM. Modeling & Simulation for the purpose of the acute and subchronic nephrotoxic expression prediction at Cisplatin repeated doses
岡田章1, 藤田まい1, 中西真那1, 本田朱李1, 福島恵造1, 杉岡信幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2017.
Japanese Article P0963-4-PM. Examination about the internal change of the fexofenadine in the acute renal failure rat
武田芙蓉1, 武田瑛司1, 鎌田芽衣1, 三好そよ香1, 市村祐一1, 小田雅子1, 武田清孝2, 齊藤浩司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2017.
Japanese Article P0958-5-AM. The effect that the pharmaceutical products with the cAMP activity effect give to a drug metabolizing enzyme
高杉俊行1, 山下将司1, 田山剛崇1, 花野藍1, 西村さとみ1, 前田志津子1, 覚前美希1, 三宅勝志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2017.
Japanese Article P0960-5-AM. An internal change of 5-fluorouracil and effect of metronidazole giving it to onset of metabolism enzyme
山岸喜彰1, 前川遥1, 荻野晃大1, 金川一成1, 合田ひとみ1, 吉見猛1,2, 工藤敏之1, 伊藤清美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2017.
Japanese Article P0962-5-AM. About a change of the stable isotope ratio and selenium of nitrogen, carbon out of the hair by the ingredient nutrient preparation remedy
小笠原英樹1, 井上純孝2, 木村治3, 遠藤哲也3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2017.
Japanese Article P0964-5-AM. The dysfunction of the MATE transporter taking tubular secretion of dopamine produced in a kidney local site causes fluid retention
梶原望渡1,2, 伴毅2, 中西洋一3, 松原和夫2, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2017.
Japanese Article P0965-4-PM. About effect by the generic medicine introduction of amiodarone hydrochloride tablets
大谷拓也1, 池野洋平1, 戸田純司1, 藤本明子1, 室岡邦彦1, 中里祐二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2017.
Japanese Article P0967-4-PM. Pharmacokinetic analysis of the case given amikacin intravenously for peritoneal dialysis patients
篠田康孝1, 中島啓二1, 松岡知子1, 大橋健吾1, 新井かおり1, 竹中梨恵1, 加藤未紗1, 吉村知哲1,2, 杉山正2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2017.
Japanese Article P0969-4-PM. Examination of the haemodialysis clearance predictive model by quantitative structure - pharmacokinetic correlative analysis
鈴木大輔1, 中島準紀1, 青山隆彦1, 宮本葵1, 赤穂由望奈2, 吉川明良2, 開浩一2, 松本宜明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2017.
Japanese Article P0971-4-PM. Pharmacokinetics of Glecaprevir/Pibrentasvir (GLE/PIB) in healthy Japanese, whites and the Han race Chinese
内山尚孝1, Rajneet K. Oberoi2, Chih-Wei Lin2, Andrew Campbell2, Wei Liu2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2017.
Japanese Article P0973-4-PM. The population pharmacokinetics analysis in patients with gonococcal urethritis and evaluation of the effectiveness of sustained release azithromycin by the simulation
曽田翠1, 長瀬泉1, 松丸直樹2, 伊藤晋3,4, 安田満4, 塚本桂2, 出口隆4, 北市清幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2017.
Japanese Article P0975-4-PM. Pharmacokinetics, safety of Glecaprevir/Pibrentasvir (GLE/PIB) in the foreign patients, a liver damage and nephropathic effect on tolerability
杉本義幸1, Rajneet K. Oberoi2, Matthew P. Kosloski2, Federico Mensa2, Wei Liu2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2017.
Japanese Article P0966-5-AM. An example of the haemodialysis patients that blood level of the ceftriaxone showed high level, and presented a chorea symptom
横山泰昭1, 工藤敏之2, 合田ひとみ2, 伊藤清美2, 鈴木正論1, 細川直登3, 舟越亮寛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2017.
Japanese Article P0968-5-AM. The forerunner of the Teicoplanin, comparison about blood trough level that is in a steady state between patients receiving generic drug
中川光1, 住吉健太1, 山口佳津騎1, 磯部芳江1, 谷久美子1, 綾野武司1, 木村純夫1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2017.
Japanese Article P0970-5-AM. Can you utilize the correlation of cibenzoline blood level measurements and BNP level for medication counseling?
大久保七枝1, 大久保正2,3, 田中真理子3, 大久保節子4, 大久保美穂5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2017.
Japanese Article P0972-5-AM. Examination of the factor influencing a rise in serum creatinine level of sulfamethoxazole-trimethoprim
山上聡子1, 山本智也1,2, 勝浦正人1, 門脇裕子1, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2017.
Japanese Article P0974-5-AM. Analysis of the antiinflammatory effect of adalimumab on Crohn's disease
木村耕二1, 高柳理早1, 山田安彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2017.
Japanese Article P0976-5-AM. Examination about the predictive precision of the Teicoplanin blood level analysis to stop by according to renal function index
後藤総太郎1, 木下理恵1, 大村由紀子1, 白石範子1, 関谷紀貴2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2017.
Japanese Article P0978-5-AM. One case that measured serum and vancomycin levels out of the cerebral fluid for MRSA meningitis
猪岡真己1,2, 鈴木穂奈美1, 河野一実1, 奥平正美1, 杉浦洋二1, 勝見章男2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2017.
Japanese Article P0980-5-AM. Error factor investigation of blood vancomycin levels predicted value and the actual value in first aid, the intensive care domain
佐脇久美1, 山代栄士1, 末延道太1, 河村聡志1, 原尻学志1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2017.
Japanese Article P0982-5-AM. Examination of blood caffeine levels in the nonprescription drug large quantities remedy patients
佐藤一真1, 豊口禎子1, 鏡優貴1, 杉浦明日美2, 屋代祥典3, 白石正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2017.
Japanese Article P0984-5-AM. Establishment of the blood ganciclovir levels assay by a very small amount of drawing blood
須賀未稀1, 百賢二1, 杉浦優香1, 林潤1, 大澤拓郎1, 金崎祐哉1, 徳丸翔大1, 安武夫2, 長岡和徳3, 仲鉢英夫3, 高木彰子1, 濃沼政美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2017.
Japanese Article P0986-5-AM. Examination of the sunitinib therapeutic range area in renal carcinoma treatment of Japanese people
高崎新也1, 川崎芳英2, 菊地正史1, 田中雅樹1, 鈴鹿雅人1, 野田あおい1, 内野由紀子1, 佐藤祐司1, 木皿重樹1, 山口浩明1, 伊藤明宏2, 荒井陽一2, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2017.
Japanese Article P0988-5-AM. One case of the children who suffered from blood level control in the switches therapy from voriconazole parenteral injection to a dry syrup
楠川侑吾1, 村田龍宣1, 村岡淳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2017.
Japanese Article P0990-5-AM. Comparison of the blood level trough value after the loading of an innovator drug of the Teicoplanin and the generic drug
竹中梨恵1, 篠田康孝1, 松岡知子1, 大橋健吾1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2017.
Japanese Article P0992-5-AM. It is analyzed the frequency indicating the false-negative by the phenytoin blood level measurement by ARCHITECT
藤吉正哉1, 鈴木貴明2, 石井伊都子1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2017.
Japanese Article P0994-5-AM. Examination of cyclosporine and the factor affecting the Everolimus blood level measurements
佐藤汐莉1, 赤嶺由美子1, 加賀谷英彰1, 佐藤滋2, 三浦昌朋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2017.
Japanese Article P0996-5-AM. Examination of the risk factor that a trough value increases early in vancomycin hydrochloride administration by IV drip
宮崎祐介1, 長谷川浩司1, 石坂忠博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2017.
Japanese Article P0998-5-AM. Antimicrobial administration to the decreased renal function patients who took revised edition antimicrobial TDM guidelines into account
更谷和真1,2, 中澤明日香1, 徳濱潤一1, 原田晴司1, 更谷由夏2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2017.
Japanese Article P1000-5-AM. Association of a trough value and the effectiveness of the Teicoplanin for the febrile neutropenia that occurred during the treatment of the blood medical disease
内山数貴1, 田澤佑基1, 今井俊吾1, 鏡圭介1, 杉田純一3, 鳴海克哉2, 山田武宏1, 笠師久美子1, 小林正紀2, 豊嶋崇徳3, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2017.
Japanese Article P1002-5-AM. Usefulness of the pharmacist intervention through the vancomycin initial administration plan for patients with MRSA bacteremia
春木祐人1, 広本篤2, 毎熊隆誉2, 手嶋大輔2, 杉山哲大1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2017.
Japanese Article P1004-5-AM. Investigation about various parameter changes of the vancomycin (VCM) treated patients before and after the TDM guidelines revision
小椋大1, 花房喜子1, 小森亮子1, 鈴木ゆきえ1, 荒川裕明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2017.
Japanese Article P1006-5-AM. Is the initial administration plan using "a voriconazole TDM calculation tool" under the situation that genetic polymorphism is unknown useful?
土本大輔1, 桑原悠里1, 山本泰大1, 宮川佐和子1, 宇都宮純平1, 戸田康裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2017.
Japanese Article P1008-5-AM. Examination of the blood level in the case that a high dose before dialysis of the amikacin was given in
森章典1, 芳賀友輔1, 石田隆浩1, 渡邉絢史2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2017.
Japanese Article P1010-5-AM. Examination for the efforts of the VCM TDM analysis by the ward pharmacist in our hospital
坂口晋哉1, 牧陽介2, 杉枝里香1, 松尾圭祐3, 木村滋1, 合原嘉寿1, 林稔展1, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2017.
Japanese Article P1012-5-AM. Examination of a dose and the blood level of vancomycin in patients with blood tumor and patients with solid tumor
森紗世子1, 島田泉1, 小林将文1, 磯辺浩和1, 新木貴大1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2017.
Japanese Article P1014-5-AM. Intervention to initial administration plan for vancomycin hydrochloride proper use and the usefulness
横山晋一郎1, 塚原優太1, 横山香保2, 本田富得1, 古川哲也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2017.
Japanese Article P1016-5-AM. Dose investigation of the case that an initial trough value of vancomycin was less than 10 μg/mL
直朋弘1, 島田真理1, 本上ほなみ1, 大原沙織1, 梶田祐三子1, 石井恵理香1, 若松亮1, 馬場奈津美1, 大谷美奈子1, 見上千昭1, 西窪奈津子1, 西尾孝1, 辻本勉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2017.
Japanese Article P1018-5-AM. Examination of the usefulness of the peak value measurement in case of the blood vancomycin levels monitoring based on the Bayesian method
今西義紀1, 千田紗弓1, 加藤義章1, 伊藤久美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2017.
Japanese Article P1020-5-AM. In the diabetic nephropathy, the adjustment of the drug dose depending on a decreased renal function is often overlooked
百瀬公博1, 笹岡直輝1, 荒木真2, 秋月茂樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2017.
Japanese Article P1022-5-AM. Safe examination of the vancomycin loading dose in patients with impaired renal function
粟屋真理子1, 田中広紀1, 鈴木絢子2, 市川剛4, 楠裕美子1, 戸村和希1, 須永登美子1, 藤原久登1, 並木美加子2, 田中佐知子4, 渡邊徹1, 池田裕一3, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2017.
Japanese Article P1024-5-AM. Optimization of plasma carbapenem-based antimicrobial system of measurement using LC/MS-MS
村井晴香1, 長瀬泉1, 脇田瑠璃1, 三谷健人1, 土井光則2, 曽田翠1, 小倉真治3, 伊藤善規4, 北市清幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2017.
Japanese Article P1026-5-AM. We look at the rear about the causation of a blood tacrolimus levels change and the red blood cell count change in the hematopoietic stem cell transplantation patients and analyze a mark
吉川直樹1, 奥村学1, 平原康寿1, 岩切智美1, 池田龍二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2017.
Japanese Article P0977-4-PM. Efforts to improvement in blood level measurement rate of patients receiving vancomycin and TDM analysis rate
山脇一浩1, 大石裕樹2, 坂口晋哉2, 西野隆2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2017.
Japanese Article P0979-4-PM. Evaluation of the blood vancomycin drug levels monitoring by the ward pharmacist
東千夏1, 上原佳子1, 平田やよい1, 浜元善仁1, 翁長真一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2017.
Japanese Article P0983-4-PM. Establishment of the ganciclovir urine concentration assay
杉浦優香1, 百賢二1, 須賀未稀1, 林潤1, 大澤拓郎1, 金崎祐哉1, 徳丸翔大1, 安武夫2, 長岡和徳3, 仲鉢英夫3, 高木彰子1, 濃沼政美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2017.
Japanese Article P0985-4-PM. Establishment of the plasma lamotrigine densitometry system using the LC-MS/MS
板橋昇吾1, 西科舞香1, 尾藤里奈1, 福本真己1, 曽田翠1, 北市清幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2017.
Japanese Article P0987-4-PM. Examination ... by predictive - Monte Carlo simulation of the Cpeak arrival time for arbekacin
山口佳津騎1, 阿部武由2, 竹内敏己3, 渡邊政博4, 土屋浩一郎5, 猪川和朗6, 福岡憲泰7, 加地雅人1, 田中裕章1, 朝倉正登1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2017.
Japanese Article P0989-4-PM. An evaluation of the administration plan nomogram according to the VCM renal function in antimicrobial TDM guidelines and examination of the factor having an influence on the initial trough value
石井英俊1,2, 平井啓太2, 神戸宏憲1, 木苗あゆみ1, 須山由佳子1, 杉山恭平1, 伊藤邦彦2, 木村緑1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2017.
Japanese Article P0991-4-PM. Making of the administration plan assist sheet of imipenem/cilastatin using the minimal inhibitory concentration distribution in the institution
斎藤厚太1, 谷川浩司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2017.
Japanese Article P0993-4-PM. Significance of the blood level measurement in the use of foreign voriconazole patients
鴫田江理嘉1, 垰越崇範1, 冨田隆志1, 久保有子1, 佐伯康之1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2017.
Japanese Article P0995-4-PM. About the safety of the administration of Teicoplanin note method in our hospital
阪野和重1, 中西俊介1, 奥本真巳1, 武内恭範1, 篝忠宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2017.
Japanese Article P0997-4-PM. 2 cases that dose adjustment depending on renal function of the linezolid was useful
松田翔平1,2, 木村竜司1, 久保有子3, 今津智子1, 久賀谷幸昌1, 福澤正隆1, 渡邉貴志1, 前田頼伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2017.
Japanese Article P0999-4-PM. An example of childhood meningitis given concentrations simulation out of the cerebral fluid at vancomycin intraventricular administration
古庄弘和1, 平田憲史郎1, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2017.
Japanese Article P1001-4-PM. The current situation of the vancomycin TDM in our hospital and the future prospects
猿谷淳1,2, 里見彩1, 上村円香1, 田畑寛明1, 向一美1, 地野幹子1, 伊藤博徳2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2017.
Japanese Article P1003-4-PM. Factor analysis of the low trough level of vancomycin in the neurosurgical patients
岩村直矢1, 池田祐輔1, 曽根本恵美1, 溝口晶子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2017.
Japanese Article P1005-4-PM. Effect of the vancomycin maintenance doses design by the pharmacist
坂倉広大1, 中蔵伊知郎1, 今西嘉生里1, 福田利明1, 佐光留美1, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2017.
Japanese Article P1007-4-PM. Examination of the patients background that blood vancomycin levels and predicted value become estranged
濱野有里1, 中川千恵美1, 牧賢利1, 小山朋子1, 内畠久美子1, 中村孝佑1, 板野亨1, 相良義弘1, 堀田修次2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2017.
Japanese Article P1009-4-PM. One case that blood level of vancomycin became the high level in the patients after the thigh resection enforcement
田中雄介1, 磯辺浩和1, 五十嵐洋平1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2017.
Japanese Article P1011-4-PM. Examination of the patients background to influence blood level of vancomycin
片岡達夫1, 垰越崇範1, 福島隆宏1, 吉川博1, 鴫田江理嘉1, 冨田隆志1, 佐伯康之1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2017.
Japanese Article P1013-4-PM. Examination about the adaptation to our hospital of the antimicrobial TDM guidelines on vancomycin hydrochloride note 2016 recommendation doses in the initial administration plan
小林裕平1, 木幡雄至1, 石福奈々1, 菅野浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2017.
Japanese Article P1015-4-PM. Examination about the initial administration plan based on the vancomycin actual survey trough value
菅原大輔1, 菅野雄太1, 瓜智都1, 鎌田裕介1, 竹谷美穂1, 森本淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2017.
Japanese Article P1017-4-PM. Construction - pharmacist-led efforts to 100% of TDM analysis rate of use of the TDM enforcement system for Antimicrobial stewardship promotion and analysis ... of TDM analysis contents
田中裕子1, 渡部智貴1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2017.
Japanese Article P1019-4-PM. Examination of the case indicating the blood level low level in the TDM of the vancomycin hydrochloride
城尾晃太1, 山西彩香1, 植田実佐1, 長橋かよ子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2017.
Japanese Article P1021-4-PM. Examination about the precision of the renal function estimation type in elderly people
薗田晃弘1, 岩下佳敬1, 中尾承司1, 岩崎公美1, 兒玉麻代1, 川畑綾1, 高田侑那1, 浜園龍1, 宝来留美1, 久永あゆみ1, 登尾一平2, 石田和久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2017.
Japanese Article P1023-4-PM. Efforts to the Teicoplanin proper use in elderly people
有冨航平1, 笠田高志1, 木本弘江1, 高倉栄治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2017.
Japanese Article P1025-4-PM. Existing prediction-style comparison of blood vancomycin levels in the neonates department domain
大橋隼人1, 花井雄貴1,2, 松尾和廣2, 吉尾隆2, 横山智子1, 草野歩1, 坂本真紀1, 西澤健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2017.
Japanese Article P1027-4-PM. Examination of the dose of irinotecan based on UGT1A1 genetic polymorphism in the FOLFIRI therapy
高田遼1, 山崎将英1, 國本雄介1, 益子寛之1, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2017.
Japanese Article P1029-4-PM. The effect that a combination of CYP3A4 in the lung transplantation patients and 3A5 genetic polymorphism gives to the tacrolimus blood trough level/doses ratio
須野学1, 内嶺陽平2, 伊藤明花2, 中西里佳2, 伊藤雄大2, 宮内成美2, 松本准2, 有吉範高2, 大谷真二3, 大藤剛宏3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2017.
Japanese Article P1031-4-PM. About the linkage disequilibrium of the STAT3 - base variant in patients with tuberculosis
山下祐生1, 寳迫祐史1, 浅川亜梨紗1, 南利彩子1, 桂木聡子1, 大野雅子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2017.
Japanese Article P1033-4-PM. Examination about the incidence of the STAT3 genetic polymorphism in patients with tuberculosis
寳迫祐史1, 南利彩子1, 浅川亜梨紗1, 山下祐生1, 桂木聡子1, 大野雅子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2017.
Japanese Article P1028-5-AM. Examination of racial differences in the genetic polymorphism frequency to be involved in sensitivity of the gemcitabine and a change
長田莉花1, 辻大樹1, 中森春美1, 松本恵実1, 佐原由莉1, 松澤明希1, 伊藤邦彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2017.
Japanese Article P1030-5-AM. Effect of the genetic polymorphism on effect of treatment of azathioprine in the childhood Crohn's disease
南利彩子1, 浅川亜梨紗1, 寳迫祐史1, 桂木聡子1, 大野雅子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2017.
Japanese Article P1032-5-AM. An episode of care and genetic polymorphism of the ulcerative colitis of children using azathioprine
浅川亜梨紗1, 南利彩子1, 寳迫祐史1, 桂木聡子1, 大野雅子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2017.
Japanese Article P1034-5-AM. About the pharmacist outpatient department for patients with cancer construction and current situation report - of - first report operation
高橋文香1, 児玉暁人1, 今井兼貴1, 岡明美1, 八尾祥子1, 森信介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2017.
Japanese Article P1036-5-AM. Relation of the pharmacist for the combination of oral molecular target medicine and acid-secreting antagonist
後藤美穂1,2, 藤村浩司1,2, 吉村拓也2, 青木翔太1,2, 川原田祐貴2, 中村敏史2, 岩田智樹2, 川合甲祐2, 遠山幸男1,2, 山口智江2, 中根茂喜2, 板倉由縁3, 木村和哲4, 久田達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2017.
Japanese Article P1038-5-AM. Start the activity in the foreign cancer chemotherapy room; and the current situation and a problem of our hospital
串田康弘1,2, 牧賢利2, 中川千恵美2, 中山やちよ2, 相良義弘2, 木内司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2017.
Japanese Article P1040-5-AM. Discussion analysis with the pharmacist specialized in a cancer
延川正雄1, 松田圭一郎1, 菅原拓也1, 齋藤順1, 有川真理1, 関口徳志1, 後藤純一1, 荒井浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2017.
Japanese Article P1042-5-AM. Attitude survey of usefulness and the pharmacist of the brochure about the prevention of anticancer agent exposure in the patients home
徳留章1,3, 前田健太2, 石井貴大3, 南盛一3, 和野雅治3, 木明貴幸1, 太田智之3, 齊藤浩司4, 武田清孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2017.
Japanese Article P1044-5-AM. About the case that was available for the 10 cycles administration enforcement by FOLFIRINOX therapy
佐藤数馬1, 稲本正之1, 島田慰彦1, 石黒智也2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2017.
Japanese Article P1046-5-AM. Fact-finding of the emergency consultation in the foreign cancer chemotherapy
大神正宏1, 小島寛2, 黒澤豊彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2017.
Japanese Article P1048-5-AM. The change of the information sharing tool about the cancer domain prescription in the medicine medicine cooperation
中村久美1, 淺野未代子2, 鬼窪利英1,2, 大輪武司2, 小野里直彦2, 杉澤哲2, 平林克博2, 松澤直樹2, 松原重征2, 向山百合1,2, 村田稔弥2, 吉澤貴代美2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2017.
Japanese Article P1035-4-PM. The inquired current situation of the folinate Tegafur uracil therapy put by a pharmacist
杉山清子1, 伊藤友里1, 大矢根守1, 加藤みち代1, 近藤康則1, 種子田善仁1, 堀真理1, 櫻庭円1, 豕瀬悟1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2017.
Japanese Article P1037-4-PM. Inspection of the use effect of the assessment sheet in the cancer chemotherapy
内山有理香1, 手嶋由加1, 村田智弘1, 市川美佳1, 竹下龍次1, 吉武摩耶1, 横田沙紀1, 山内省吾2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2017.
Japanese Article P1039-4-PM. Explanation documentation about an administration, the excrement management, and the like of the oral anticancer medicine for the patients family
鮎田利恵1,2, 後藤宏明1, 平島ゆか1, 石原溶子1, 上野翠2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2017.
Japanese Article P1041-4-PM. Efforts and use experience of the Nivolumab treatment for the non-small cell lung cancer
小西史子1, 濱武清範1, 足立那々緒1, 飯田有香1, 岩井真里絵1, 梶美里1, 中西輝1, 松本弘誠1, 仲忠士1, 美和孝之1, 小島一晃1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2017.
Japanese Article P1043-4-PM. Prostate-specific antigen (PSA) in the Enzalutamide weight loss-response case-lowering effect
村上礼隆1, 開浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2017.
Japanese Article P1045-4-PM. One case with suspected arterial thrombosis by the administration regimen enforcement including the cisplatin
南真進1, 新海愛子1, 相澤雄介1, 小杉隆祥1, 松本直人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2017.
Japanese Article P1047-4-PM. 2 cases that a pharmacist intervened in in the patients with Lenvatinib remedy thyroid cancer
遠藤一江1, 齋藤美香1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2017.
Japanese Article P1049-4-PM. Tendency to communication of the pharmacist for sensitive contents
町村裕香1, 竹平理恵子1, 有田悦子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2017.
Japanese Article P1050-5-AM. Evaluation after the aprepitant addition for retching, vomiting with the irinotecan combination regimen in the colon cancer chemotherapy
篠原佳祐1, 宮田智陽1, 杉山昌秀1, 渡邉将隆1, 油井信明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2017.
Japanese Article P1052-5-AM. Fact-finding about the proper use of the antiemetic drug in the chemotherapy of stomach and the cancer of the esophagus
宇都宮奈々1, 沖田健太郎1, 植中英恵1, 長谷川将1, 末武亜依子1, 安河内寿成1, 近藤真由1, 吉田悦朗1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2017.
Japanese Article P1054-5-AM. Examination of dexamethasone doses and the antiemesis effect in patients who received breast cancer AC therapy
安達志乃1, 木村美智男1, 宇佐美英績1, 岡田和智1, 岩井美奈1, 浅野裕紀1, 伊藤大輔1, 川地雄基1, 守屋昭宏1, 栗林未帆1, 竹中翔也1, 西川智子1, 亀井桂太朗2, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2017.
Japanese Article P1056-5-AM. Effect of olanzapine on prominence-related retching, vomiting
齋藤浩司1, 安部一弥1, 横澤大輔1, 太田拓希1, 小島俊彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2017.
Japanese Article P1058-5-AM. Look at the rear about retching, vomiting at lung cancer amrubicin monotherapy enforcement; mark investigation
近藤綾子1, 山本泰大1, 水谷貴樹1, 福岡麻実1, 宇都宮純平1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2017.
Japanese Article P1060-5-AM. Relative examination with the chemotherapy-induced retching, vomiting expression and hyperemesis gravidarum in patients with female breast cancer
松本恵実1, 辻大樹1, 金容壱2, 山本圭祐3, 中森春美1, 長田莉花1, 佐原由莉1, 松澤明希1, 中道秀徳3, 塩川満3, 伊藤邦彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2017.
Japanese Article P1062-5-AM. Effect of the Aprepitant + Palonosetron + Dexamethasone triple-drug therapy on retching, vomiting at the Carboplatin combination therapy in patients with gynecologic cancer
松尾尚美1, 三好孝法1, 鶴田南奈子1, 川俣洋生1, 弓削乃利人1, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2017.
Japanese Article P1051-4-PM. Evaluation of the antiemesis therapy change in the colon cancer chemotherapy of the moderate emetic risk
柏宗伸1, 北岡由里子2, 田畑智丈3, 千野佳秀3, 佐藤功3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2017.
Japanese Article P1053-4-PM. Examination about steroid sparing by the aprepitant combination to Weekly TC therapy
神田紘介1, 室高広1, 黄智剛1, 橋詰淳哉1, 兒玉幸修1, 三浦清典2, 金内優典2, 増崎英明2, 佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2017.
Japanese Article P1055-4-PM. Comparison of the effect on calculation of the pharmacokinetics parameter in the rat of the Rikkunshito bougie and retching, vomiting
鎌田武志1, 内藤千鶴1, 川崎浩範1, 古河義行1, 岩田萌子1, 村田勇1, 井上裕1, 金本郁男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2017.
Japanese Article P1059-4-PM. Effect of antiemetic changes from granisetron in the THP-COP therapy to palonosetron
水岡大策1, 山口佳津騎1, 香西真衣1, 本田由紀1, 山本理恵1, 山本高成1, 久保智美1, 加地雅人1, 小坂信二1, 芳地一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2017.
Japanese Article P1061-4-PM. Fact-finding of the use of antiemetic drug according to the emetic risk in the cancer chemotherapy
野口直美1, 三宅秀敏1, 石川奈保子1, 永井和正1, 嶋崎悦子2, 善家恵美2, 佐藤瑞枝1, 古賀恭子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2017.
Japanese Article P1063-4-PM. Example that we were able to control with palonosetron hydrochloride without using dexamethasone for vomiting due to radiotherapy combination temozolomide internal use
章勇気1, 才野壽子1, 伊藤陽子1, 國原将洋1, 田阪武志1, 二五田基文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2017.
Japanese Article P1064-5-AM. Examination of the hydration method with the cisplatin (CDDP) preparation administration
嘉村基樹1, 福島ゆかり1, 岩崎ユリ2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2017.
Japanese Article P1066-5-AM. The case that was treated effectively with tramadol for vascular pain with dacarbazine
北御門由依1, 植村隆1, 糸永昇平1, 東島彰人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2017.
Japanese Article P1068-5-AM. It is adaptation expectation ... to ... chemotherapy-induced thrombocytopenia about an increased number of platelets effect of the Kamikihito
加藤敦1, 石川雄大1, 龍伸和1, 三村泰彦1, 足立伊佐雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2017.
Japanese Article P1070-5-AM. About renal failure inhibitory effect by the magnesium supplement in the cisplatin combination chemoradiation treatment
秋吉尚雄1, 桑村恒夫1, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2017.
Japanese Article P1072-5-AM. Reduction effect of fexofenadine and the bepotastine on infusion reaction with rituximab
松井頌明1, 難波優里1, 玉木宏樹1, 西村信弘1, 直良浩司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2017.
Japanese Article P1074-5-AM. Neutropenia of the paclitaxel + ramucirumab combination therapy for progress, the recurrent gastric cancer which is impossible of curative resection, investigation of the onset situation of the febrile neutropenia
仲野宏紀1, 庄野裕志1, 福田利明1, 佐光留美1, 山崎邦夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2017.
Japanese Article P1076-5-AM. Analysis of the effect on malignant lymphoma factor to give to an excretion delay of the high-dose methotrexate therapy
豕瀬諒1, 高橋克之1, 永山勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2017.
Japanese Article P1078-5-AM. Examination - weekly paclitaxel therapy ... of the effectiveness of the d- chlorpheniramine note
喜多由紀1, 中川雅史1, 西出貴義1, 中村純子1, 泉本裕美1, 岸孝行1, 樫葉利人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2017.
Japanese Article P1080-5-AM. The current situation and problem of oral mucositis with the chemoradiotherapy for head and neck cancer
大坪達弥1, 河村佳奈1, 三木有咲1, 城月智帆1, 林曜子1, 堀内あす香1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 村木優一2, 友金幹視1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2017.
Japanese Article P1082-5-AM. Effect of intraoral hypothermia (cryotherapy) on oral mucosa disorder in patients receiving idarubicin
森健太郎1, 深澤淑子1, 鈴木大介1, 矢野寛樹2, 畔柳敏弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2017.
Japanese Article P1084-5-AM. Safe examination according to the treatment line with the eribulin administration
田頭尚士1, 小野友香1, 上野杏菜1, 羽藤加奈恵1, 秋山一郎2, 臼井由行2, 木内司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2017.
Japanese Article P1086-5-AM. 1 case that paclitaxel + bevacizumab treatment was able to continue for recurrent metastatic breast cancer by pharmacist intervention
浦瀬剛嗣1, 川原和也1, 木場重徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2017.
Japanese Article P1088-5-AM. Safe inspection of short hydration at the cisplatin administration that substituted existing infusion preparation
久枝真一郎1, 宗広樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2017.
Japanese Article P1090-5-AM. Examination of the effect to give during an expression of resorption of bone antagonist association necrosis of the jaw bone (ARONJ) period in denosumab treated patients
大嶋美咲1, 中尾將彦1, 木村仁美1, 山崎直樹1, 吉田徹也1, 村田みどり1, 竹内昌司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2017.
Japanese Article P1092-5-AM. Ca preparation in the decreased renal function patients during denosumab administration and V. Examination about the onset of optimal dose of the D preparation and low Ca blood symptom risk factor
芳尾正悟1, 鈴木小夜1, 高木彰紀1, 木村元範2, 望月眞弓1,2, 中村智徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2017.
Japanese Article P1094-5-AM. Fact-finding of the elevated blood pressure in the Ramucirumab administration for the gastric cancer and search of the risk factor
菊池茜1, 魚井みゆき1, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2017.
Japanese Article P1096-5-AM. Investigation of the usefulness of the sustained G-CSF preparation in the FEC therapy for breast cancer treatment
吉田将之1, 平下智之1, 谷沢克弥1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2017.
Japanese Article P1098-5-AM. About the use situation and an adverse event of the nivolumab in our hospital
沖田健太郎1, 植中英恵1, 長谷川将1, 末武亜依子1, 安河内寿成1, 栗原江未1, 大石丸美1, 岩武幹乃1, 白石貴寿1, 面田恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2017.
Japanese Article P1100-5-AM. Examination of the effectiveness of the loperamide prophylaxis for the Afatinib diarrhea onset
金子裕美1, 和田啓伸2, 鈴木秀海2, 中島崇裕2, 中村貴子1, 鈴木貴明1, 吉野一郎2, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2017.
Japanese Article P1102-5-AM. Comparison of the effect of treatment of the osteocopic expression patients and non-expression patients with the G-CSF
三田恭平1, 荒木良介1, 宇野崇之1, 山田英紀1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2017.
Japanese Article P1104-5-AM. Examination of the correspondence method after the onset of interstitial lung disease by the nivolumab
櫻下弘志1, 泉谷悟1, 西垣内亮1, 村瀬哲也1, 佐伯康之1, 松尾裕彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2017.
Japanese Article P1106-5-AM. Examination of the peg filgrastim administration within 24 hours after the end of the anticancer agent administration in our hospital
丸岡浩太1, 内山乃映1, 村松奈緒美1, 山田倭花1, 大窪真理絵1, 伊代田萌子1, 梅澤仁美1, 小林誠一1, 河村紳介1, 坂口修治1, 富沢裕之1, 山下敦志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2017.
Japanese Article P1108-5-AM. Intervention effect of the pharmacist about the HBV at cancer chemotherapy enforcement-related measurement
青木鈴加1, 小柴聖史1, 木下史一1, 小林淳司1, 勝又博司1, 菅尾高裕1, 小池道明1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2017.
Japanese Article P1110-5-AM. Search of the onset of proteinuria factor in the molecular target medicine which assumed vascular endothelium growth factor (VEGF), vascular endothelium growth factor receptor (VEGFR) a target
福井梨乃1, 槙原克也1, 寺沢匡史1, 内山ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2017.
Japanese Article P1112-5-AM. Examination about the validity of the administration of the PEG-GCSF preparation primary prophylaxis in the breast cancer perioperative adjuvant setting
足立茂樹1, 一川悦子1, 谷沢克弥2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2017.
Japanese Article P1114-5-AM. Examination of the RAS inhibitor for the protein urine of the antiVEGF preparation
柳下博信1, 北條文啓1, 佐久間淳一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2017.
Japanese Article P1116-5-AM. The use situation and evaluation after the type B infection virus reactivation prophylactic system operation in the electronic medical chart
三枝都1, 石井直子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2017.
Japanese Article P1065-4-PM. Effect on peripheral neuropathy with the taxane system anticancer agent which serum erythropoietin concentrations give it to
小山なつの1, 山崎桃子1, 高木千明1, 里村藍子2, 永村陽一郎2, 日野斉一2, 中川沙織3, 大和進3, 太田伸1, 下枝貞彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2017.
Japanese Article P1067-4-PM. Examination of progress, the factor making the effect extend to the onset of hypomagnesemia in the cetuximab therapy for recurrent colon cancer
伊藤大輔1, 浅野裕紀1, 岩井美奈1, 安達志乃1, 岡田和智1, 木村美智男1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2017.
Japanese Article P1069-4-PM. Usefulness evaluation of the Moxifloxacin hydrochloride prior prescription for the febrile neutropenia during chemotherapy for the breast cancer perioperative period
高橋正也1, 高橋克之1, 小川和樹1, 高島勉2, 光川康子1, 柏木伸一郎2, 野田諭2, 小野田尚佳2, 大平雅一2, 永山勝也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2017.
Japanese Article P1071-4-PM. Effect on renal failure frequency by the short hydration method introduction at the cisplatin administration
樋口美奈子1, 和田依子1, 佐々木好美1, 岩坪沙奈恵1, 山口竜司1, 中野行孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2017.
Japanese Article P1073-4-PM. Investigation about the development situation of stomatitis for chemotherapy patients and the measures
草信晴美1, 塚本絢子1, 水嶋萌美1, 渡辺麻里子1, 監物英男1, 佐藤陽子2, 田中知子2, 笹本奈美2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2017.
Japanese Article P1075-4-PM. Analysis of the risk factor of the onset of cholinergic syndrome in patients who received FOLFIRINOX
川原田祐貴1, 片岡智美1, 石井沙也加1, 宮崎雅之1, 熊倉康郎1, 宮川泰宏1, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2017.
Japanese Article P1077-4-PM. The cardiac function diagnostic procedures situation of the use of trastuzumab patients in our hospital
坂野博紀1, 石川元章1, 町支優和1, 原田哲彦1, 村上仁志1, 石田隆浩1, 吉原基2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2017.
Japanese Article P1079-4-PM. Look at the rear about peripheral neuropathy by nab-Paclitaxel; mark investigation
野澤寿吉1, 松野由華1, 廣上典和1, 網谷智輝1, 朱亀進司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2017.
Japanese Article P1081-4-PM. The use situation of oxaliplatin and pregabalin for peripheral neuropathy by the paclitaxel
長瀬友樹1, 安室修2, 羽山幸子1, 舟越亮寛2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2017.
Japanese Article P1083-4-PM. Efforts - in the pharmacist outpatient department in the preventive measures against hepatitis B reactivation (the second report) - internal use anticancer agent in the cancer chemotherapy
伊藤弘美1, 浅野寿規1, 川瀬洋次1, 杉野善彦1, 竹田優作1, 大島有美子1, 桜田宏明1, 山村益己1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2017.
Japanese Article P1085-4-PM. One case that experienced DIC during chemotherapy in our hospital, and was given pharmaceutical intervention
相内尚也1, 津山博匡1, 工藤正純1, 下山律子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2017.
Japanese Article P1087-4-PM. Onset after the bevacizumab administration of cardiac hypertrophy and the factor analysis
有松冴1, 須川由理子1, 水谷薫1, 原美由紀1, 伊藤朱里1, 佐宗智之1, 出口賀奈子1, 川崎好人1, 出口裕之1, 橋本陽1, 小出哲朗1, 石川久高1, 鈴木秀郎2, 町支秀樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2017.
Japanese Article P1089-4-PM. Examination about the current situation and measures of Hypersensitive reaction in Oxaliplatin
渥美仁1, 浅井澄子1, 中山貴美子1, 澤口和代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2017.
Japanese Article P1091-4-PM. About the skin management with the antiEGFR analogous drug in our hospital
石井紀子1, 岡野芳彦1, 篠崎亮介1, 山口智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2017.
Japanese Article P1093-4-PM. Examination about the antiviral prophylaxis for the herpes zoster of patients with multiple myeloma
田中早穂子1, 原友子1, 松下尚弘1, 大畠綾子1, 石丸隆之1, 町田梨絵子1, 野中敏治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2017.
Japanese Article P1095-4-PM. Use results of the peg filgrastim in our hospital
山本輝尚1, 小沼大祐1, 新藤学1, 加藤一郎1, 中野茂治2, 鈴木正人2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2017.
Japanese Article P1097-4-PM. Effective evaluation of the polaprezinc for the zinc deficiency-related taste disturbance that occurred in patients who received cancer chemotherapy
若林雅人1, 上野真由美2, 矢嶋明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2017.
Japanese Article P1099-4-PM. Practice - HBV reactivation measures - of PBPM which systems construction realized
高田あゆみ1, 合津貴志1, 高橋紗英子1, 伊與田友和1, 渡邊弘枝1, 渡部照美1, 関根悠1, 田崎政則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2017.
Japanese Article P1101-4-PM. Examination about safety and the effectiveness in FOLFIRINOX therapy and the peg filgrastim combination
竹内麻理子1, 野崎圭佑1, 澤井祐樹1, 杉本貴洋1, 清水克次1, 角川幸男1, 中多陽子1, 坂上嘉浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2017.
Japanese Article P1103-4-PM. The use situation of the peg filgrastim in our hospital
町支優和1, 原田哲彦1, 坂野博紀1, 村上仁志1, 石川元章1, 石田隆浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2017.
Japanese Article P1105-4-PM. About the safety of the ramucirumab + paclitaxel (RAM + wPTX) therapy for patients with old gastric cancer
加藤雅斗1, 宮澤憲治1, 早川裕二1, 溝神文博1, 平野隆司1, 高橋朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2017.
Japanese Article P1107-4-PM. Examination of the drug used for hiccups at the cancer chemotherapy
水口敦子1, 綾田翔1, 井筒理子1, 田中翔一1, 佐々木文子1, 宮川貴行1, 梶井孝洋1, 西澤修一1, 西川正直1, 松久哲章2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2017.
Japanese Article P1109-4-PM. About the relations of paronychia and the effect by the Afatinib
北爪賀子1, 牧原玲子1, 先山奈緒美1, 石曽根好雅1, 関口昌利1, 橋本浩伸1, 寺門浩之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2017.
Japanese Article P1111-4-PM. One case of the bladder cancer which presented CDDP low Na blood symptom dangerously ill after administration
宮本康平1, 平井成和1, 土井啓員1, 増田雅行1, 佐野君芳1, 真坂亙1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2017.
Japanese Article P1113-4-PM. Effect on chronic peripheral neuropathy examination of the saccinia virus inoculation rabbit inflammation skin extract-containing preparation of oxaliplatin
柿本智広1, 三浦ひとみ3, 寺嶋圭子3, 大迫政彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2017.
Japanese Article P1115-4-PM. The effect that a suggestion timing from the pharmacy gives to an HBV-related examination item measurement rate
森善洋1, 吉岡大樹1, 佐道紳一1, 竹本智子2, 小坂幹子2, 峯孝志3, 樋口則英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2017.
Japanese Article P1117-4-PM. 2 cases that was effective using formula (viscosity adjustment) and that of Mohs ointment in our hospital
荒木杏奈1, 島三保子1, 松永智子1, 中村泰士1, 山口和記2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2017.
Japanese Article P1119-4-PM. Effect of the continuous pharmacist intervention by by medical examination front to patients with foreign cancer pain
上野理恵1, 山田正実1, 地丸裕美1, 松村千佳子1,2, 矢野義孝2, 高橋一栄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2017.
Japanese Article P1121-4-PM. Polypharmacy fact-finding of patients with end-stage cancer which a palliative care team intervened in
佐々木理絵1, 今多亮介1, 林晋太郎1, 新沼芳文1, 本郷文教1, 松本美奈2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2017.
Japanese Article P1123-4-PM. We input chart making for the adequacy of the relation opioid analgesic sustained injection of the pharmacist in the cancer support team, the lump of prescription, instructions
鳥井祥子1,2, 谷大輔1,2, 福島智子1,2, 有江宏樹1,2, 宮内紗和子3, 小木曽照子2, 土生康司3, 端裕之2, 小林政彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2017.
Japanese Article P1125-4-PM. It is ... based on introduction of investigation - periphery-related μ opioid antagonists naldemedine of the use of laxative situation of the use of opioid patients
齊藤未希1, 山崎理恵1, 桑野譲2, 清水綾子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2017.
Japanese Article P1127-4-PM. Examination of a stress relaxation effect and the immunity reinforcement effect by the mind Fournet's meditation who assumed the IgA out of saliva an index
輿石泰良1,2, 岡元ちよみ1, 小山なつの1, 宮坂英徳1, 深澤みく1, 中川沙織2, 大和進2, 太田伸1, 下枝貞彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2017.
Japanese Article P1129-4-PM. Multicenter study on effect on fentanyl patch to give to a bowel movement by opioid switching from oral oxycodone
衛藤智章1, 林稔展2, 福山雄卯介3, 築田晃直1, 仲田浩成1, 山下愛登4, 糸永昇平5, 小薮真紀子6, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2017.
Japanese Article P1131-4-PM. One patient who a pharmacist played a key role of the team, and associated with patients with childhood cancer, a family
前田弘志1, 野妻俊也1, 櫻木佳代子2, 塩満多華子2, 新小田雄一3, 福岡龍一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2017.
Japanese Article P1133-4-PM. Examination about the effect of the continuous pharmacist intervention on use of opioid analgesic of patients with foreign cancer pain
廣中佑香1, 松村千佳子1, 山田正実2, 地丸裕美2, 上野理恵2, 矢野義孝1, 高橋一栄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2017.
Japanese Article P1135-4-PM. In consideration of effect attenuation with rifampicin, it is ... through a case during one case - tuberculosis ward hospitalization that intervened in a drug choice of the chemotherapy for head and neck cancer
山崎彬史1, 奥野昌宏1, 中田学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2017.
Japanese Article P1137-4-PM. A preparation of the pregabalin intrarectal administration preparation which added absorbefacient and evaluation of the bioavailability
土井裕貴1, 林克典1, 熱田直也1, 村田勇1, 井上裕1, 山本泰大2, 金本郁男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2017.
Japanese Article P1139-4-PM. The use situation and problem of the fentanyl citrate buccal tablet
川嵜真太郎1, 堀敦雄1, 藤原信二1, 西嶋長1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2017.
Japanese Article P1141-4-PM. The case that morphine sustained administration was effective for the headache due to the metastatic brain tumor
鈴木駿介1,3, 高柳論也1,3, 平井栄一2,3, 小林恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2017.
Japanese Article P1143-4-PM. Attitude survey about the drug for the medical care of the nurse
薦田理恵1, 森田早貴1, 安原景子1, 阿部真寿美1, 華房幸代1, 二宮洋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2017.
Japanese Article P1145-4-PM. Relation of the pharmacist in opioid rounds aiming at early symptom relaxation
藤原歩1,2, 赤瀬博文1,2, 濱宏仁1, 西尾智尋2, 田中詳二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2017.
Japanese Article P1147-4-PM. One patient who worked on an evaluation of the strength of the pain of patients with cancer using BPS
杉浦龍也1,4, 守山浩子2,4, 守田覚1, 岡田祐二3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2017.
Japanese Article P1149-4-PM. Use experience in the tapentadol hydrochloride tablets administration in our hospital
谷口智美1, 形部文寛1, 升味紀子1, 橋本修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2017.
Japanese Article P1151-4-PM. The use situation of the opioid for the mucous membrane disorder at the head and neck cancer radiotherapy
下村純子1, 富井真一1, 伏見久美子1, 塚本真裕子1, 酒井郁美1, 藤堂未央1, 向山郁美1, 津田正博1, 古谷誠一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2017.
Japanese Article P1153-4-PM. Use investigation of the steroid for the inappetence in the cancer terminal phase
鳥居昌太1,2, 伊藤昌美2, 上田旭美1,2, 江崎秀樹1,2, 杉浦龍也2, 後藤健志2, 遠山幸男2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 足立守1, 板倉由縁3, 木村和哲4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2017.
Japanese Article P1155-4-PM. 2 cases that we switched to other opioid pain-killers from methadone
松下尚弘1, 永山淳2, 福島由紀3, 岐部綾子1, 河野吟美1, 野中敏治1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2017.
Japanese Article P1157-4-PM. Examination of the index to be useful for treatment in the terminal phase with infusion and prognostic grasp
宮本朋佳1, 福山紘基1, 畑中重克2, 天生浩子1, 富士谷昌典1, 小泉祐一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2017.
Japanese Article P1159-4-PM. Examination of the effectiveness by the combination of the opioid analgesic
鈴木景就1, 石渡明子2,4, 村川麻里子1,4, 明石浩史3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2017.
Japanese Article P1161-4-PM. An effect and problem of 1 case using the fentanyl immediate release in being at home
藤井武1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2017.
Japanese Article P1163-4-PM. Opioid consumption pulse-taking of the cancer palliative care patients in the Tokyo Women's Medical University east medical center
周治由香里1,2, 金杉恵1,2, 山賀亮祐1,3, 河越祐哉1,3, 古澤利紗1,3, 藤田亜希子1,3, 冨永春子2, 矢野有紀2, 伊東俊雅1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2017.
Japanese Article P1118-5-AM. Stomatitis measures using the indometacin spray by the chemotherapy radiotherapy in patients with head and neck cancer
藤田靖之1, 後藤慎一2, 岩永亜紀3, 原田周平1, 入江貞治1, 上原智1, 井上知哉1, 池田能利子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2017.
Japanese Article P1120-5-AM. Effect of the use situation investigation of the tumor internal medicine Abstral sublingual tablet and the pharmacist intervention
尾関あゆみ1,2, 礒部博隆2,3, 安永浩子2,4, 中川義浩1, 山本春風2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2017.
Japanese Article P1122-5-AM. The current situation of the drug self-care for the medical care in our hospital and the problem
古川登記子1, 南雲恵美2, 樋口伸子2, 村山貴子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2017.
Japanese Article P1124-5-AM. The use situation of the tapentadol hydrochloride extended-release in our hospital
小角麻衣1, 瀬名波宏昌1, 中西晶子1,2, 村山洋子1,2, 音地真理2, 滝本佳予2, 大山覚照2, 名徳倫明3, 川口進一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2017.
Japanese Article P1126-5-AM. Examination of the stress caused by mind Fournet's meditation relaxation effect who assumed oxytocin out of saliva an index
岡元ちよみ1, 輿石泰良1, 高木千明1, 中川沙織2, 大和進2, 太田伸1, 下枝貞彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2017.
Japanese Article P1130-5-AM. Clinical evaluations of the pregabalin bougie in patients with cancerous pain
山本泰大1, 犬塚涼子2, 斎藤寛子2, 築山郁人3, 西原真理4, 新井健一4, 金本郁男5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2017.
Japanese Article P1132-5-AM. The sedative current situation and problem of the cancer terminally ill patients in the Toho University medical center Ohashi Hospital
木村麗砂1, 吉田小百合1, 堀孔美恵1, 中村陽一1, 日浦寿美子2, 小林秀樹2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2017.
Japanese Article P1134-5-AM. 1 case that we switched from a buprenorphine patch to an oxycodone slow-release preparation, and pain control came to have good
築田晃直1, 三角紳博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2017.
Japanese Article P1136-5-AM. It is tried an evaluation and the set prescription making of a feeling of resistance of facing each other in the opioid analgesic prescription of the physician
端裕之1, 谷大輔2, 松村友和2, 田村訓子2, 瀬奈波暢子2, 鳥井祥子2, 小林政彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2017.
Japanese Article P1138-5-AM. Contribution degree investigation of the current situation and the charge pharmacist about the palliative care of the national hospital mechanism (the third report)
八本久仁子1, 形部文寛2, 中村孝祐3, 林俊吾4, 山崎富士子5, 武智宣佳6, 小野友香7, 波多江崇8, 八本聖秀9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2017.
Japanese Article P1140-5-AM. Examination about the effect reinforcement of the warfarin with the fentanyl tape
基村佳世1, 槙原克也1, 内山ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2017.
Japanese Article P1142-5-AM. Relation of the pharmacist to cancer palliative care patients
堀敦雄1, 久保寺祐季1, 川嵜真太郎1, 西嶋長1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2017.
Japanese Article P1144-5-AM. It is examination ... about the relation from a consultation example about need - relaxation of the pharmacist interview in the foreign chemotherapy room
伊東美歩1, 泉雄介1, 海老原貴之1, 川本拓馬1, 平原一也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2017.
Japanese Article P1146-5-AM. Use experience of the duloxetine hydrochloride for the peripheral neuropathy-related pain
安田明子1, 台蔵剛志1, 山田千代子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2017.
Japanese Article P1148-5-AM. The situation investigation of the continuous sedation using the midazolam in the multi-institution
高岡龍蔵1,2, 冨田祐作2, 久米初枝2, 柴田里美2, 杉山和弥2, 渡邉彰己2, 後藤健志2, 遠山幸男1,2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 板倉由縁3, 木村和哲4, 久田達也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2017.
Japanese Article P1150-5-AM. The mild medical current situation investigation in patients who received foreign chemotherapy
金井亮太1, 吉岡由理1, 大杉法子1, 春田貴史1, 大塚健太1, 安藤恵1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2017.
Japanese Article P1152-5-AM. Example that intervened in the local management of the progress breast cancer metastases to skin part
後藤純一1, 有川真理1, 木村裕子2, 角田孝彦3, 関口徳志1, 菅原拓也1, 延川正雄1, 松田圭一郎1, 荒井浩一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2017.
Japanese Article P1154-5-AM. About the sedative current situation for the purpose of the painful relaxation in our hospital palliative care unit
後藤義之1, 角紀一郎1, 岡田久美1, 石崎真由美1, 本田太朗1, 松岡未紗1, 光井彩1, 茶野下貴恵1, 島崎沙織1, 青木理恵1, 森戸敏志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2017.
Japanese Article P1156-5-AM. Case report about the differentiation of dementia and the delirium of the cancer terminally ill patients which we examined from the viewpoint of pharmacist
比嘉仁1, 増田多加子1, 船橋英樹2, 杉浦宗敏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2017.
Japanese Article P1158-5-AM. Examination of the case that conducted palliation by sedation by the midazolam
間瀬広樹1,2, 小林恵里奈2, 吉尾敬登1,2, 石嶋麗1,2, 江戸稚香子1,3, 三村優仁1,4, 秋山哲平2, 鵜浦雅志1,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2017.
Japanese Article P1160-5-AM. Usefulness of the hydrozincite starch in the at-home relaxation medical care
相良克海1, 森山愛子1, 横溝明美2, 小田慎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2017.
Japanese Article P1162-5-AM. Filling ... of efforts - PCA pump of the hospital pharmacist for the at-home palliative care
海老根香里1, 神谷未加2, 神賀正博3, 関利一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2017.
Japanese Article P1164-5-AM. Examination about the possibility that ward exclusive duty pharmacist placement contributes to the effectiveness, safety in the SP therapy
大久保聡1,2, 奈良克彦1, 山下裕玄2, 瀬戸泰之2, 高田龍平1, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2017.
Japanese Article P1166-5-AM. The use situation and side effect report of the nivolumab in the non-small cell lung cancer
菊池亮大1, 高橋典哉1, 淺沼優美1, 及川嵩人1, 城戸直人1, 菊池昌之1, 本庄伸輔1, 守義明2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2017.
Japanese Article P1168-5-AM. Examination of the rasburicase dosing period for the high-risk tumor lysis syndrome of patients with adult blood-forming organ malignant tumor
小林俊介1, 安武夫1, 佐藤圭1, 黒田誠一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2017.
Japanese Article P1170-5-AM. Examination of the tumor lysis syndrome (Tumor lysis syndrome: TLS) onset risk factor in the small cell lung cancer
平野真健1, 山下悟史1, 岸川春樹1, 丸子浩1, 富田敏章1, 町田聖治1, 入江利行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2017.
Japanese Article P1172-5-AM. Proteinuria frequencies and blood pressure fluctuation by the ramucirumab
祖父江伸匡1, 川嵜真太郎1, 堀敦雄1, 西嶋長1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2017.
Japanese Article P1176-5-AM. Efforts for the duties improvement by the cancer chemotherapy grouping and the future prospects
齊藤有希1, 近藤泰礼1, 志賀隆1, 石川達也1, 重野芳1, 畠山織江1, 朝倉弘太1, 馬場喜弓1, 佐藤邦義1, 荒川隆太郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2017.
Japanese Article P1178-5-AM. Examination about the effect on effectiveness and side effect of relative intensity of treatment in the gemcitabine + albumin suspension type paclitaxel combination therapy
大登剛1, 土屋裕伴1, 新井亘1, 増田裕一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2017.
Japanese Article P1180-5-AM. It is side effect expression and the medication situation of hormonal therapies after the operation for patients with postmenopausal breast cancer
芦埜和幸1, 大澤千鶴子1, 黒田晋平1, 齋藤善広2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2017.
Japanese Article P1182-5-AM. Effect of sex differences to give it to the blood toxicity of the use of rituximab patients in the non-Hodgkin's lymphoma
小林学1, 中村豪志1, 柳井美奈1, 吉原哲2, 岡田昌也3, 木村健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2017.
Japanese Article P1184-5-AM. It is evaluated an investigation and the weight loss of the enforcement situation of the adjuvant chemotherapy after the gastric cancer technique
中市里実1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2017.
Japanese Article P1186-5-AM. Search of the cisplatin dosage factor in the head and neck cancer chemoradiotherapy
前田愛1, 藤本保志2, 藤野泰孝1, 木下沙織1, 矢野亨治1, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2017.
Japanese Article P1188-5-AM. Examination about intensity of treatment and the safety in CHOP enforcement DLBCL patients 65 years or older
中村裕一1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2017.
Japanese Article P1190-5-AM. 1 case that was involved in the returning home support of patients with end-stage cancer of the foreign family register in the municipal hospital
岡田七津子1, 今村諭2, 市田千佳1, 高橋賢成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2017.
Japanese Article P1192-5-AM. Usefulness of the EGFR mutation in the gene as the effect predictor of the nivolumab in patients with non-small cell lung cancer
藤井良平1, 田中雅幸1, 今井雄介1, 打谷和記1, 岡崎和一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2017.
Japanese Article P1194-5-AM. Effective investigation of the trabectedin by the pathological classification
岩西雄大1, 角川幸男1, 脇條靖治1, 金銅葉子1, 中多陽子1, 坂上嘉浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2017.
Japanese Article P1196-5-AM. Examination of the cytomegalovirus (CMV) infection risk factor of transplant non-adaptation adult T-cell leukemia-lymphoma (ATLL) patients
福石和久1, 吉田裕生2, 津曲恭一3, 高田正温4, 川俣洋生5, 牛島知実1, 木村修徳6, 衛藤智章7, 齋田翌美8, 林稔展1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2017.
Japanese Article P1198-5-AM. Efforts of "the regimen cafe" which aimed at the improvement of cancer medicine medicine cooperation in the Mie University faculty of medicine hospital
日置三紀1, 石橋美紀1, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2017.
Japanese Article P1200-5-AM. Examination of the medical economics of the FOLFIRINOX, GEM + nabPTX, GEM for progress, recurrent pancreatic cancer and S-1 therapy
三岡麻千子1, 木村美智男1, 岩井美奈1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2017.
Japanese Article P1165-4-PM. It is the number of investigation in the survival month of patients with progress, recurrent colon, rectal cancer which is impossible of curative resection in the Higashi-Asahikawa Hospital
里見眞知子1, 河野透2, 山崎弘貴3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2017.
Japanese Article P1167-4-PM. Investigation of the onset situation and the risk factor of the hypomagnesemia by Panitumumab
西和哉1, 川田彰彦1, 高橋舞1, 佐々木崇1, 中澤泰子2, 高橋秀和2, 安田勝洋2, 大堀久詔2, 佐賀利英1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2017.
Japanese Article P1169-4-PM. Investigation of the cancer chemotherapy cancellation reason in the Shiga University of Medical Science faculty of medicine hospital
河原幸恵1, 須藤正朝1, 野田哲史1, 若杉吉宣1, 藪田直希1, 山本優1, 井堀仁美1, 中村春香1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2017.
Japanese Article P1171-4-PM. The effect that steroid used for cancer chemotherapy gives to bone density
早川怜花1, 山本花菜1, 澤木明2, 林高弘1,3, 安藤洋介3,4, 太田秀基3,4, 山田成樹3,4, 河田健司2, 安田公夫1, 池田義明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2017.
Japanese Article P1175-4-PM. Evaluation of the nutritional status using the Prognostic nutritional index in patients who received head and neck cancer CDDP+RT therapy
藤原大一朗1,2, 眞下惠次1,2, 木村佳世1, 星田唯史1, 森本奈緒美1, 和田祥明1, 野田明宏1, 多喜和夫1, 武田朋也2, 椿正寛2, 西田升三2, 阪口勝彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2017.
Japanese Article P1177-4-PM. 2 cases with suspected drug-related pulmonary disorder by Nivolumab
松浦暢子1, 小西千尋1, 南野智志1, 草薙みか1, 山本倫数1, 青山瑛里子1, 洪鉉寿2, 瓜生恭章2, 大里恭章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2017.
Japanese Article P1179-4-PM. The effect that BMI gives to thrombocytopenia in the Carboplatin treatment
田中千裕1, 塩内淑予1, 安藤洋介2,3, 林高弘1,2, 堀場瑠莉2,3, 宮田七帆2,3, 太田秀基2,3, 澤木明4, 河田健司4, 安田公夫1, 池田義明1, 山田成樹2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2017.
Japanese Article P1181-4-PM. Comparison ... by neutropenic frequency - first treatment at GN therapy enforcement for patients with pancreatic cancer and the second treatment
力丸理菜1, 槇田崇志1, 神崎浩孝1, 堀口繁2, 加藤博也2, 堤康一郎2, 田中雄太1, 小川敦1, 西原茂樹1, 村川公央1, 北村桂久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2017.
Japanese Article P1183-4-PM. Examination of the immune-mediated adverse event in the nivolumab treatment of the non-small cell lung cancer
白井敦史1, 埋橋賢吾1, 薮田ゆみ1, 中島恵子1, 橋本佳浩1, 近藤丈博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2017.
Japanese Article P1185-4-PM. Examination of the onset of dermatopathy risk by the eosinophil count before the nivolumab administration
井上誠二1, 大澤友裕1, 梅田道1, 渡邊久高1, 牧野哲平1, 長屋雄大1, 甲田明英1, 堀晃代1, 田中和秀1, 安田昌宏1, 水井貴詞1, 澤祥幸2, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2017.
Japanese Article P1187-4-PM. About lymphocytopenia of the EC therapy every every 21st and 14th in the postoperative chemotherapy before breast cancer technique
阿部多一1, 住谷達也1, 柳内亮祐1, 井口恵美子1, 猪股克彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2017.
Japanese Article P1189-4-PM. About a side effect and the effect of the case given nab-PAC+GEM therapy to treatment pancreatic cancer impossible of excision in every other week
石崎文子1, 相原敏彦1, 増尾昌則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2017.
Japanese Article P1191-4-PM. About the effectiveness and safety judging from difference in Afatinib initial dosage by the 1stLine treatment
坂田幸雄1,2, 村永諒1, 齋藤淳2, 山添雅巳2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2017.
Japanese Article P1193-4-PM. It is searched for recurrent predictor in the adjuvant chemotherapy after the colon cancer technique
星田唯史1, 藤原大一朗1, 眞下惠次1, 森本奈緒美1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2017.
Japanese Article P1195-4-PM. The detection bacteria situation investigation from patients with multiple myeloma and an each regimen
清水幸宏1,2, 井上博章1, 松本直人1, 庄司優2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2017.
Japanese Article P1197-4-PM. Evaluation of the usefulness of the elderly people usability test in the cancer chemotherapy management for patients with old gastric cancer
齊藤雅代1, 奈良克彦1, 山下裕玄2, 大久保聡1, 山本武人3, 高田龍平1, 瀬戸泰之2, 鈴木洋史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2017.
Japanese Article P1199-4-PM. Examination of administration cancellation, the postponement reason of the cancer chemotherapy
丸山昌広1, 定盛理純1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2017.
Japanese Article P1201-4-PM. Use fact-finding of the pharmaceutical products in the cancer domain out of the adaptation
文靖子1,3, 米盛勧2, 砂土居寛子3, 寺門浩之3, 藤原康弘2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2017.
Japanese Article P1202-5-AM. Efforts for use fact-finding and the proper use of the disinfectant of the foreign clinical department management
中田一孝1, 冨田有香1, 蚊野純代2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2017.
Japanese Article P1204-5-AM. Examination about the adequacy of the antimicrobial therapy in the ophthalmology perioperative period
青山響1, 上村賢介1, 須佐充1, 簔口紗織2, 風間伸介3, 中村裕介4, 大矢佳美5, 安藤伸朗4, 内坪誉歳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2017.
Japanese Article P1206-5-AM. Fact-finding of hepatitis B measures at colon cancer postoperative chemotherapy start using big data
室高広1, 福重友理1, 馬場安里1, 今村政信1, 中川博雄1, 北原隆志1, 佐々木均1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2017.
Japanese Article P1208-5-AM. Construction of the count system for the trend grasp of the oral antimicrobial medicine consumption
加藤善章1, 山本雅人1, 永井拓1, 八木哲也2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2017.
Japanese Article P1210-5-AM. The use situation investigation aiming at peramivir treatment standardization in our hospital
浅川杏子1, 清水忠洋1, 齊藤安昌1, 鎌田泉1, 曾根原亘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2017.
Japanese Article P1212-5-AM. Use of injection antimicrobial pulse-taking in our hospital
近藤提1, 杵渕貴洋2, 山根知1, 藤岡亮司1, 庄司雅代3, 上坂知佳3, 山路亜弓2, 角谷不二雄4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2017.
Japanese Article P1214-5-AM. Examination of the initial treatment in the fungemia
北川誠子1, 藤井哲英1, 二宮洋子1, 勝村登美子2, 平田早苗3,6, 石松昌己4, 河口豊4, 大石智洋5,6, 寺田喜平5,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2017.
Japanese Article P1216-5-AM. Relation of AST to a febrile neutropenia case at the breast cancer chemotherapy
寺松早紀1, 蔵王なつか1, 菊池衣里佳1, 中嶋陽一1, 松崎雄1, 白石亘1, 柿原圭佑1, 三上忠司1, 葉田昌生1, 藤井裕史1, 大塚弘子2, 山口美樹2, 田中眞紀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2017.
Japanese Article P1218-5-AM. Effect on use of antimicrobial situation and Pseudomonas aeruginosa before and after the antimicrobial round start-sensitive rate
小林誠一1, 丸岡浩太1, 内山乃映1, 村松奈緒美1, 山田倭花1, 大窪真理絵1, 伊代田萌子1, 梅澤仁美1, 河村紳介1, 坂口修治1, 富沢裕之1, 山下敦史1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2017.
Japanese Article P1220-5-AM. We work on antimicrobial appropriate support based on bacteria test result
堤克成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2017.
Japanese Article P1222-5-AM. Role of Candida Bundle compliance and the pharmacist in our hospital
林幹也1, 山元紀世子2, 後藤志典1, 伊藤美登里3, 白井雅美3, 赤崎淳子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2017.
Japanese Article P1224-5-AM. Inspection of the effectiveness of Tamiflu in the influenza infection prophylaxis measures our hospital
勝又一雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2017.
Japanese Article P1226-5-AM. Efforts and effect of Antimaicrobial Stewardship Team (AST) aiming at the shift to an initial support type
尾花祥世1,5, 吉田朱里1,5, 地守絢子2,5, 桑名良和2,5, 上野一枝3,5, 山本光成4,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2017.
Japanese Article P1228-5-AM. It is efforts for the one for infection prophylaxis antimicrobial senior envoy after the operation in the cardiovascular surgery
花房喜子1,3, 小椋大1,3, 小森亮子1,3, 鈴木ゆきえ1,3, 荒川裕明1,3, 藤宮剛2, 入江嘉仁2, 高木賢司3, 蛭田留里子3, 林靖子3, 中山晴夫3, 猪爪信夫4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2017.
Japanese Article P1230-5-AM. An in-hospital study session in the norovirus infection and investigation about the understanding degree
伊藤嘉英1, 清水智也1, 森広輔2, 長谷川雅哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2017.
Japanese Article P1232-5-AM. Intervention effect of the ICT on patients that Candida was detected than blood culture
石田茂伸1,2, 山田加代子2, 藤原大亮1,2, 笹谷純平2,3, 竹村陽介2,3, 田中まこと2,3, 川村真代2,3, 星育子1, 中井由佳1, 楠本茂雅4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2017.
Japanese Article P1234-5-AM. The prescription situation investigation of the oral cephalosporin antimicrobial in the ambulatory practice of the Iizuka Hospital
内田守次1, 梅田勇一1, 長崎皓光1, 進健司1, 牛島悠一1, 金澤康範1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2017.
Japanese Article P1236-5-AM. Investigation about the development of Clostridium difficile infection and the association of the antimicrobial proper use
小嶋希望1, 坪田晃司1, 宮本康史1, 竹内里哉1, 上野英文1, 齊藤拓也2, 長島明美2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2017.
Japanese Article P1238-5-AM. About antibiotic consumption by the aspiration pneumonia pass introduction and a change of the mean hospitalization
村雲智久1, 長濱藍1, 仲村亮太1, 新里勇二2, 与古田美智代3, 喜多洋嗣1, 喜多幸子1, 森智子1, 駒井勇太1, 小松祐輔1, 泉優貴1, 近藤理美1, 坂口勇斗1, 石井奈津季1, 久田潤平1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 竹治優紀1, 松元あみ1, 水野康平1, 山中愛美1, 吉村美菜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2017.
Japanese Article P1240-5-AM. Cause investigation and measures of the influenza mass outbreak
吉原涼子1, 溝田繁治1, 中村みさ2, 東島彰人1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2017.
Japanese Article P1242-5-AM. An effect of the AST intervention in staphylococcus aureus bacteremia treatment and study on pre-rear predictor
平野龍一1,2, 三橋達郎1,3,4, 北澤淳一1,5, 山本章二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2017.
Japanese Article P1244-5-AM. Antimicrobial proper use support in the small and medium size hospital
仲井修一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2017.
Japanese Article P1246-5-AM. Questionary survey about the antiHIV medicine storage management at needle pad accident in the Tokushukai group Hospital and body fluid exposure
手嶋由加1, 田中博和1, 井上幸子1, 平川雅章1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2017.
Japanese Article P1248-5-AM. Intervention example of the pharmacist in the prophylaxis at influenza outbreak
中島一1, 今村陽子1, 大石貴裕1, 池田浩和1, 高橋浩二郎1, 吉田綾2, 山中直子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2017.
Japanese Article P1250-5-AM. Examination of the antibody acquisition with the hepatitis B vaccination derived from a different antigen
山下克也1, 津曲恭一3, 尾田一貴5, 小園亜希4, 田中亮子2, 中村光与子2, 山道研1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2017.
Japanese Article P1252-5-AM. The MRSA rate of detection that antimicrobial consumption AUD and hand hygiene give, effect on separation rate
溝田繁治1, 吉原涼子1, 谷口潤1, 大野直義1, 永吉洋介1, 岩永直樹1, 中村みさ1, 江島遥1, 藤岡ひかる1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2017.
Japanese Article P1203-4-PM. Examination of the change over time at injectable vancomycin and furosemide injection combination under the acid condition
山岡真理子1, 笹原里美1, 畑勝友2, 宗像千恵3,4, 渕上由貴4, 萩森政頼4, 立木秀尚1, 川上茂4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2017.
Japanese Article P1205-4-PM. Examination about the MSSA blood culture-positive example in our hospital
川尻さおり1, 脇川富美子2, 橋口浩二3, 町田毅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2017.
Japanese Article P1207-4-PM. Construction and evaluation of the software making antimicrobial data as a table
堀尾秀明1, 土本大輔1, 宮川佐和子1, 宇都宮純平1, 戸田康裕1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2017.
Japanese Article P1209-4-PM. Comparison of the use of antimicrobial situation by the use of specific antimicrobial report method change
海野亜実1, 久保田綾乃1, 牧野和也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2017.
Japanese Article P1211-4-PM. Sensitivity change of efforts and Pseudomonas aeruginosa for the use of antimicrobial in our hospital
石毛宏治1, 松木祥彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2017.
Japanese Article P1213-4-PM. Evaluation of safety and the effectiveness of the influenza 4 values vaccination in the healthcare worker
赤坂和俊1, 小原拓1, 遠藤史郎2, 池田しのぶ3, 十日市文子1, 鈴木博也1, 久道周彦1, 山口浩明1, 賀来満夫3, 眞野成康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2017.
Japanese Article P1215-4-PM. Investigation about the effect to the infection control area by the assignment of the infection control authorization pharmacist in our hospital
高橋淳一1, 田中克幸1, 大沼明子1, 大箭彰1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2017.
Japanese Article P1217-4-PM. The current situation investigation for the drug-resistant measures action plan of a hospital medical doctor in hospital and the health insurance pharmacy pharmacist
坂本拓也1,2, 川村ひとみ1,2, 土佐直子1, 小川洋司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2017.
Japanese Article P1219-4-PM. What are the measures really necessary for an AMR measures action plan? Antimicrobial proper use approach ... to search for from ... drug resistance trend
小林岳1, 小林綾1,3, 町田浩晃1, 坂本光男2,3, 飯島尚志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2017.
Japanese Article P1221-4-PM. Review of the perioperative clinical path based on practice guidelines for infection prophylaxis antimicrobial proper use after the operation
小野雅文1,5, 藤原百々子4,5, 菅原麻貴3,5, 園部ゆかり3,5, 塩出昌弘2,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2017.
Japanese Article P1223-4-PM. The effect that a change of the prophylactic antimicrobial by the ICT intervention gives to an SSI incidence and medical expenses in the oral surgery surgery
吉田謙介1, 鈴木直人1, 新木貴大1, 磯辺浩和1,3, 西川敦2, 児玉泰光2, 高木律男2, 田邊嘉也3, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2017.
Japanese Article P1225-4-PM. Promotion of surgical-site infections surveillance and the perioperative infection prophylaxis antimicrobial proper use in the ICT
小関崇文1,4, 大貫敏明1,4, 日向早苗1,3, 湊栄治2, 安田麻美4, 高橋優香4, 杉浦健一4, 藤岡敬子4, 小林健太郎4, 西關由梨子4, 芦澤由佳4, 笠井洋輝4, 安西美咲4, 加藤由紀4, 小杉英恵4, 伊藤早紀4, 梅庭万理子4, 篠原成美4, 横山翔一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2017.
Japanese Article P1227-4-PM. About effect on use of antimicrobial density (AUD) and antimicrobial administration days (DOT) by the introduction of the carbapenem-based antimicrobial registration system using the registration of patient
高野温志1, 向井夏紀1, 伊賀正典1, 大川直美1, 牧俊一1, 神山治郎1, 田口茂正1, 天野雅子1, 町田充2, 高屋俊樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2017.
Japanese Article P1229-4-PM. Economic effect by the pharmacist of the infection measures team becoming the leadership, and intervening in the use of antiMRSA medicine patients
中野祐樹1, 大竹野久雄1, 船津康弘2, 熊谷康司3, 尾形博子4, 末安禎子5, 横尾賢乗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2017.
Japanese Article P1231-4-PM. The current situation and problem of AST of the JCHO Kurume General Hospital
蔵王なつか1, 寺松早紀1, 菊池衣里佳1, 中嶋陽一1, 松崎雄1, 白石亘1, 柿原圭佑1, 三上忠司1, 葉田昌生1, 藤井裕史1, 北里裕彦2, 田中眞紀3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2017.
Japanese Article P1233-4-PM. Efforts to the antimicrobial proper use for blood culture, endotoxin-positive patients
植竹宣江1, 長藤多香美1, 増田博久1, 宮森伸一1, 柳田祐子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2017.
Japanese Article P1235-4-PM. Examination of the understanding degree investigation of the pharmacist for hand washing and the infection control
清水智也1, 伊藤嘉英1, 長谷川雅哉1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2017.
Japanese Article P1237-4-PM. Efforts for antimicrobial proper use in our hospital
坂口結斗1, 仲村亮太1, 新里勇二2, 与古田美智代3, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 森智子1, 駒井勇太1, 小松祐輔1, 泉優貴1, 近藤理美1, 石井奈津季1, 久田潤平1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 竹治優紀1, 松元あみ1, 水野康平1, 山中愛美1, 吉村美菜1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2017.
Japanese Article P1239-4-PM. Trend of the carbapenem-based antimicrobial after the antimicrobial proper use support team start
梅林良英1, 三木芳晃1, 塚本啓介1, 渡邉優子1, 山口みなみ1, 岡千恵1, 安井良則2, 萱野勇一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2017.
Japanese Article P1241-4-PM. Investigation of the antimicrobial consumption after the antimicrobial appropriate support team introduction
齊田峻1, 松山良平1, 佐藤数馬1, 林智樹1, 稲本正之1, 鈴木徹士1, 大谷享央1, 塩練秀一2, 梅田真之3, 島田慰彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1418, 2017.
Japanese Article P1243-4-PM. Pulse-taking of methicillin-resistant staphylococcus aureus in our hospital and the antimicrobial consumption
原田大1,2, 中南秀将1, 北村好申2, 川久保孝2, 野口雅久1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1418, 2017.
Japanese Article P1245-4-PM. Effect of the pharmacist intervention in the antimicrobial prescription
杉浦右真1, 志野訓之1, 野村泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2017.
Japanese Article P1247-4-PM. Effective evaluation of the oseltamivir five days postexposure prophylaxis administration for the roommate, Look at the rear; a mark observational study
田中博和1, 手嶋由加1, 片渕由貴2, 宮津大輔1, 伊藤恭子2, 平川雅章1, 松林直2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2017.
Japanese Article P1249-4-PM. Grasp of the hand rough weather situation of the nurse using the original hand rough weather evaluation scale and examination of preventive measures against hand rough weather
吉井千菊1,2,3, 岡村吏華1, 棚田真紀1, 渡辺恵美1, 星野智美1, 波能満理惠1, 脇田真之1, 伊藤ひろみ2, 加藤勤3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2017.
Japanese Article P1251-4-PM. Activity for antimicrobial report rate improvement
森田啓嗣1, 川上恭弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2017.
Japanese Article P1253-4-PM. Consciousness and problem of the environmental hygiene in the ethical pharmacy staff
西澤健太1, 熊谷美穂1, 高嶋健太1, 北原昌和1, 染谷光洋1, 谷口亮央1, 宮本雄大1, 中島史雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2017.
Japanese Article P1254-5-AM. Advisability of the simple suspension method application of two kinds of antiHIV medicine containing the prodrug of the tenofovir
出口千裕1, 寺岡麗子1, 矢倉裕輝2, 湯谷玲子1, 坂根稔康1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2017.
Japanese Article P1258-5-AM. Change of the use situation and the serum creatinine level of antiHIV medicine FTC/TAF in our hospital
南川知央1, 安田明子1, 下川千賀子1, 山田千代子1, 渡邉珠代2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2017.
Japanese Article P1255-4-PM. 1 case that examined hemo filter clearance of the tenofovir during the sustained hemofiltration dialysis enforcement
築地茉莉子1, 山崎伸吾1, 鈴木達也1, 櫻井隆之2, 谷口俊文2, 中村貴子1, 鈴木貴明1, 猪狩英俊2, 石井伊都子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2017.
Japanese Article P1257-4-PM. About the relation of the pharmacist in the antiHIV medicine prescription situation and HIV ambulatory practice in our hospital
成田綾香1, 鈴木直人1, 外山聡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2017.
Japanese Article P1259-4-PM. Relation of the pharmacist for the HIV infection pregnant woman
下川千賀子1, 安田明子1, 南川知央1, 米澤美和1, 山田千代子1, 渡邉珠代2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2017.
Japanese Article P1261-4-PM. About a choice and a change of the antiHIV medicine in patients with HIV infection in our hospital
赤木圭太1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2017.
Japanese Article P1262-5-AM. Investigation of the infusion composition at hyperalimentation start in the neonatal intensive care unit
館内謙太郎1, 元木孝1, 高柳昌宏1, 千田泰健1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2017.
Japanese Article P1264-5-AM. Investigation about the combination of the PPI in the use of Heine E gel patients
重久友紀1, 柴田由香里1, 中目順子1, 深水知英1, 菅原英輝1, 武田泰生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2017.
Japanese Article P1266-5-AM. Having been able to see it from use of antimicrobial fact-finding for the nourishment support team rounds enforcement patients of our hospital
中村新1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2017.
Japanese Article P1268-5-AM. One case that overall status improved by NST intervention
西村尚芳1, 津曲恭一1, 尾之江剛樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2017.
Japanese Article P1263-4-PM. A pharmacist can do it from the viewpoint of search - NST intervention of a fall, the fall risk factor using DPC data, use drug
鈴木統子1, 細谷龍一郎1, 平野享子2, 宗山真梨奈1, 黒川美知代3, 日野斉一1, 鎌田智幸4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1431-1431, 2017.
Japanese Article P1265-4-PM. 1 case that a change of the rate of application was effective for the patients whom chyle was found in by lipid microsphere administration
河野大希1, 中嶋浩太郎1, 岩尾卓朗1, 則松郁香1, 鈴木寛人1, 上原智博1, 鈴田浩孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2017.
Japanese Article P1267-4-PM. Examination of the fluid therapy of patients with end-stage cancer
川野壮一1, 組橋由記1, 吉田郁子1, 松尾あずさ1, 鈴江朋子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2017.
Japanese Article P1269-4-PM. The investigation of the intervention effect by the pharmacist on polypharmacy of patients admitted to the digestive organ surgery ward: Single institution rearward observational study
小野塚和人1, 吉廣尚大1, 礒貝明彦1, 岡野愛子1, 中光篤志2, 橋本佳浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1433-1433, 2017.
Japanese Article P1271-4-PM. Examination of the self-care introduction using the RCS, FIM to patients with old forming disease in the convalescent rehabilitation ward
遠藤秀竜1, 堀浩子1, 細野真吾1, 加藤貴由1, 河村千晶1, 山崎崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2017.
Japanese Article P1273-4-PM. Examination for an evaluation of the drug consumption in elderly people and the future pharmaceutical intervention
竹下秀司1, 佐野一也1, 久保田倫代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2017.
Japanese Article P1275-4-PM. The prescription situation investigation of the sleeping drug to elderly people
今村陽子1, 安河内亮太1, 池田浩和1, 高橋浩二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2017.
Japanese Article P1277-4-PM. The use actual situation of the drug needing the careful administration in elderly patients 75 years or older
羽賀智宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2017.
Japanese Article P1279-4-PM. Relation of the pharmacist by dementia care team rounds
ソディ保子1, 高橋美和子2, 瀧本裕3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2017.
Japanese Article P1281-4-PM. Relation of an activity and the pharmacist of the dementia care team in our hospital
松本哲哉1, 土屋秀樹1, 月光淳1, 山野惣平1, 玉置秀成1, 中村智1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2017.
Japanese Article P1283-4-PM. Summary of the intervention case of the dementia care team and the prescription suggestion
菊池健1, 土屋早苗2, 澤野亜矢子3, 塩川哲男4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2017.
Japanese Article P1285-4-PM. The enforcement situation of the participation in planning of the pharmacist to the dementia care team and the pharmaceutical care
原口佳子1, 松崎真理子2, 本田省二3, 畦地なつき4, 星野輝彦1, 塩津和則1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2017.
Japanese Article P1287-4-PM. Efforts for the elderly people multiple drug prescription adequacy by pharmacist - physician collaboration
上田由貴1, 堀之内登2, 塩田星児2, 高倉健2, 島添陽子1, 山代栄士1, 和田祐一郎1, 森一生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2017.
Japanese Article P1289-4-PM. Development of the medication aid using 3D printer
大嶋耐之1, 田中美帆1, 廣瀬悠1, 千賀香織1, 宮地佑佳1, 仲山千佳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2017.
Japanese Article P1291-4-PM. Efforts of the prescription adequacy for the elderly people in house type pay nursing home
中川友之1, 丸一泰雅1, 角佳亮1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2017.
Japanese Article P1293-4-PM. Efforts (one case report) to the prescription adequacy by the polypharmacy reduction team
真野澪1, 宮澤憲治1, 溝神文博1, 早川裕二1, 加藤雅斗1, 平野隆司1, 荒井秀典2, 高橋朗1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2017.
Japanese Article P1295-4-PM. Fact-finding of the drug global assessment adjustment addition in our hospital
芦田理沙1, 四方純子1, 上羽沙綾1, 佐賀嘉英1, 門脇隼也1, 奥村智晴1, 塩見明日香1, 谷田有花1, 足立圭司1, 村上由樹1, 川見里奈1, 堀雅博1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2017.
Japanese Article P1270-5-AM. An evaluation and analysis of the ability for medication of elderly people using J-RACT and RCS in the convalescent rehabilitation ward
河村千晶1, 遠藤秀竜1, 細野真吾1, 堀浩子1, 加藤貴由1, 山崎崇1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2017.
Japanese Article P1272-5-AM. Pharmacist independent intervention for improvement in rheumatic patients medication adherence
舩木文子1, 河越祐哉1, 高木香恵2, 井上靖雄3, 伊東俊雅1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2017.
Japanese Article P1274-5-AM. Questionary survey for proper use manual preparation of the drug for the purpose of the sedation
渡辺智康1, 難波良平1, 山崎恵1, 高取孝一1, 安藤哲信1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2017.
Japanese Article P1276-5-AM. Effect with the use drug in the dementia care support team consultation example
西川裕美1, 伊藤匡伸1, 大野愛1, 大西邦明2, 桑山結子1, 杉浦真3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2017.
Japanese Article P1278-5-AM. One case of the composite topalgia syndrome that Yokukansan was effective for chronic intractable pain
江草徳幸1, 藤本雅宣1, 下岡由紀1, 安原昌子1, 堀川俊二1, 清水良2, 瀬浪正樹3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2017.
Japanese Article P1280-5-AM. Relation of the pharmacist to dementia in the diabetes outpatient
中司梨紗1, 杉本悠花1, 成末まさみ1, 福田康恵2, 平瀬万里3, 世羅康徳4, 赤澤昭一4, 田川雅浩5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2017.
Japanese Article P1282-5-AM. Consideration of the risk factor associated with the onset of the elderly people delirium
長谷川豊則1, 小野翔太郎1, 水谷加代子1, 金澤克洋1, 柴田紗希1, 鈴木彩美1, 中川由紀子1, 加賀香織1, 籾山智美1, 兼子結衣1, 山田実咲1, 板倉充沙1, 長谷川瑛美1, 松井千恵1, 加藤貴代1, 白上昇1, 上田周平1, 鵜飼克行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2017.
Japanese Article P1284-5-AM. Role of the pharmacist in the dementia care team
大波芙実子1, 富樫映一子2, 前田伸也3, 平岩知子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2017.
Japanese Article P1286-5-AM. We regard future efforts as a summary of the medical therapy in the intervention of our hospital urination care team through an investigation of the effect of treatment
吉田諒1, 庄司知摩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2017.
Japanese Article P1288-5-AM. The inhalational instruction example that cooperated with the welfare tool planner
酒井孝征1, 中島宏文2, 乾武広3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2017.
Japanese Article P1290-5-AM. Relation to the dentistry prescription in elderly patients except the hospitalization by the hospital pharmacist in connection with the multi-type of job to be engaged in community medical care
岩尾一生1,2, 及川孝司1,2, 末永智美3, 竹田瑞菜3, 吉野夕香4, 仲尾源太5, 丹羽正太5, 金本路5, 尾立光5,6, 遠藤泰1,2, 會田英紀5,6, 川上智史5,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2017.
Japanese Article P1292-5-AM. Examination of the press through pack for the use drug to patients with dementia
佐多照正1, 堀内智裕1, 中松穂菜美1, 鶴永大貴1, 中島理恵1, 中村有莉恵1, 赤星真広1, 上原友美1, 石神誠子1, 池増鮎美1, 西憲文2, 花木とき子3, 前之原茂穂4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2017.
Japanese Article P1294-5-AM. The current situation investigation of the polypharmacy in the convalescent rehabilitation ward and intervention effect by the pharmacist
小澤礼奈1, 金澤弥子1, 山崎理恵1, 鈴川活水2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2017.
Japanese Article P1296-5-AM. Continuous instructional activity for the improvement in knowledge of the medical staff by the monthly distribution of "medicine for "bedsore" newspaper"
朝倉寛達1, 池田直樹1, 秋山真二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2017.
Japanese Article P1299-4-PM. Resident the pharmacist to a community medical care room is consideration ... about - inquiry duties
新康憲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2017.
Japanese Article P1301-4-PM. Investigation about the cooperation with the drugstore in a hospital and the medical office
伊野陽子1, 舘知也2, 上野杏莉2, 大坪愛実2, 勝野隼人2, 杉田郁人2, 兼松勇汰2, 吉田阿希2, 野口義紘2, 堺千紘1, 井口和弘1, 川上ちひろ3, 藤崎和彦3, 寺町ひとみ2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2017.
Japanese Article P1303-4-PM. The enforcement situation of patients with stroke cooperation support system and the simple suspension method of the Kaga, Ishikawa district
高波太1, 川手佳幸1, 作田広幸1, 示野哲也1, 西山郁雄1, 大田栄一1, 久保勝1, 下野典子2, 白崎直樹2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2017.
Japanese Article P1305-4-PM. An advantage and problem of the visit drug control instruction to the terminally ill patients whom hospital pharmacist receives
長友孝純1, 的場つかさ1, 楠本結香1, 高橋唯1, 森江遥1, 平田有佳理1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2017.
Japanese Article P1307-4-PM. For the at-home mild medical care with community medical care cooperation - connection in the health insurance pharmacy
西村美和1, 舛甚路子1, 阿部恵1, 阿部伸也1, 岡田早苗1, 臺丸谷卓1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2017.
Japanese Article P1309-4-PM. An activity and problem of the diabetes medical treatment instruction person (CDEJ, CDEL)
伊東健一1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2017.
Japanese Article P1311-4-PM. The effect that a medication adjuvant product gives to the disintegration of the levofloxacin orally disintegrating tablet and dissolution
福井嵩浩1, 鷹觜彩香1, 山口亜希子2, 西村奈緒恵3, 平舩寛彦1, 千葉健史1, 立木秀尚3, 富田隆1, 工藤賢三1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2017.
Japanese Article P1313-4-PM. Effect on medical therapy of the patients in the division formulations of the long-term prescription
小林庸祐1, 佐藤秀昭2, 金親正知1, 富岡佳久3, 中尾裕之4, 今井博久5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2017.
Japanese Article P1315-4-PM. Cooperation with the physician through efficacy, the side effect monitoring for the adrenal cortical steroid introduction patients
井堀仁美1, 大石和美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1454-1454, 2017.
Japanese Article P1319-4-PM. One case that home discharge was enabled as patients who received hospitalization cancer chemotherapy that had difficulty in diet intake received introduction of HPN and side effect monitoring
前田康裕1, 坂谷英亨1, 木村嘉明1, 平賀貴志1, 高畠栄一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2017.
Japanese Article P1321-4-PM. Activity as the pharmacist of the local inclusion care ward
川村大輔1, 吉川真央1, 松田喜美子3, 水澤佑介3, 山口明美2, 久岡清子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2017.
Japanese Article P1323-4-PM. Example that the multi-type of job cooperation made possible home care
角佳亮1, 中野真理子1, 河村洋平太1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2017.
Japanese Article P1325-4-PM. Quantitative evaluation about the takeoff operation from the PTP sheet of pharmaceutical products
村上雅裕1, 安田恵1, 前田初男1, 新村健2, 天野学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2017.
Japanese Article P1327-4-PM. Duties to the at-home medicine for the purpose of the problems search by the multi-type of job cooperation and attitude survey
柳本ひとみ1, 櫻井秀彦2, 黒澤菜穂子3, 古田精一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2017.
Japanese Article P1329-4-PM. Intervention of the multi-type of job cooperation in the day care care and the institution pharmacist
中野匡介1, 浅見友一1, 峰川久美子2, 池田えり子2, 飯塚敏美1, 原広子2, 堀口雅巳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2017.
Japanese Article P1331-4-PM. It is ... for multi-type of job cooperation - area inclusion care bed in our hospital
横山知美1, 副島啓司1, 古海和博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2017.
Japanese Article P1298-5-AM. At-home life return support ... by participation - prescription adequacy and the regional alliances of the pharmacist in the local inclusion care ward
中島美紀1, 原竜太郎1, 濱浦睦雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2017.
Japanese Article P1300-5-AM. Elucidation of the enforcement factor of the cooperation with the drugstore in the medical office
上野杏莉1, 舘知也1, 伊野陽子2, 大坪愛実1, 勝野隼人1, 杉田郁人1, 兼松勇汰1, 吉田阿希1, 野口義紘1, 堺千紘2, 井口和弘2, 川上ちひろ3, 藤崎和彦3, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2017.
Japanese Article P1302-5-AM. Literature review about the intervention effect of the pharmacist in the treatment at home
片原憂斗1, 高橋信洋1, 藤田健二2, 串田一樹3, 川口崇1, 竹内裕紀1, 畝崎榮1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2017.
Japanese Article P1304-5-AM. Possibility of the person of brain cardiovascular procedure disease risk grasp by the establishment of the screening technique of blood glucose level spikes in the community pharmacy
長谷川利幸1, 岡田昌浩2, 土谷大樹3, 梶原敏道4, 山田真弘5, 長崎信浩6, 小嶋英二朗6, 横田いつ子7, 数野博8, 徳毛孝至9, 杉原成美6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2017.
Japanese Article P1306-5-AM. Outcome evaluation of the visit drug control instruction duties in the health insurance pharmacy
柴田賢三1, 宇野達也1, 山田直也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2017.
Japanese Article P1308-5-AM. New role of the health insurance pharmacy pharmacist to see from the voice of the patients with dementia caregiver
谷博子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2017.
Japanese Article P1310-5-AM. The current situation of the treatment at home activity by the drugstore pharmacist and future problem
今西孝至1, 山本康平1, 高山明1, 楠本正明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2017.
Japanese Article P1314-5-AM. Measurement ... of new role - oral cavity function of the pharmacist in the super-aged society with a low birth rate
渡部雅俊1, 横山俊介1, 松村久男2, 藤原邦彦2, 榊原幹夫3, 久保田洋子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2017.
Japanese Article P1316-5-AM. Until we work on the appropriate management of pharmaceutical products from efforts 1 - action start of the pharmacist in the care old man health healthcare facility
久岡清子1, 増田博也1, 合田さやか1, 佐々木健志1, 澤口友紀1, 亀岡喬1, 間千晴1, 鹿沼奈央1, 川村大輔1, 大荒政志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2017.
Japanese Article P1318-5-AM. Enforcement of reporting, the education about the drug to efforts 3 - nursing facility staff of the pharmacist in the care health insurance for aged institution
増田博也1, 久岡清子1, 合田さやか1, 佐々木健志1, 澤口友紀1, 亀岡喬1, 間千晴1, 鹿沼奈央1, 川村大輔1, 大荒政志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2017.
Japanese Article P1320-5-AM. Efforts of regional alliances through the inhalational instruction
鈴木絢子1, 小菅健志1, 椿佳子2, 大島幸徳2, 平山明子2, 関水康成2, 山崎秀之2, 鹿間裕介3, 渡邊徹1,4, 佐々木忠徳4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2017.
Japanese Article P1322-5-AM. Efforts to instruction joint at the discharge of the insurance pharmacist participation type that we can transfer to treatment at home smoothly
川路明子1, 水井貴詞1, 堀晃代1, 渡邉成子2, 高橋健2, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2017.
Japanese Article P1324-5-AM. 1 case that a drugstore pharmacist became the pivot of the cooperation in the shift to treatment at home
杉浦聡1, 懸山啓太2, 亀田祥代2, 安野和浩2, 岡野美香2, 薮本佳弘2, 守安洋子1, 高橋正志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2017.
Japanese Article P1326-5-AM. Efforts for the home care patient visit drug control instruction charges calculation
明時凡子1, 三砂義敬1, 出口裕子2, 一ノ瀬由衣1, 床島英雄1, 田中基稔1, 塚田寛子1, 近藤譲1, 宮崎靖之1, 山脇一浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2017.
Japanese Article P1328-5-AM. About the effectiveness of the medication support in being at home using the medication support system
末松菜月1, 菊池千草1, 神林純二2, 野本愼一3, 鈴木隆博4, 澤田砂織5, 鈴木匡1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2017.
Japanese Article P1330-5-AM. Relation of the hospital pharmacist in the case that death in being at home was hoped for
川見里奈1, 四方純子1, 上羽沙綾1, 佐賀嘉英1, 門脇隼也1, 奥村智晴1, 塩見明日香1, 谷田有花1, 足立圭司1, 村上由樹1, 堀雅博1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2017.
Japanese Article P1332-5-AM. Pollen scattering reporting by the number of the cedar genus and the Cupressaceae pollen scattering measurement
岡田和智1, 田中孝治1, 森万希子1, 多賀小枝子1, 馬淵将吾1, 長屋貴昭1, 竹中翔也1, 吉田真也1, 日野光記枝1, 宇佐美英績1, 吉村知哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1468-1468, 2017.
Japanese Article P1333-4-PM. Introduction of the formulations support system for the purpose of the risk aversion
後藤千寿1, 土田陽子1, 梅田道1, 甲田明英1, 水井貴詞1, 小林健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1469-1469, 2017.
Japanese Article P1335-4-PM. Investigation (the third report) of the dispensing error accompanied with the outside Parliament outpatient department prescription issuance
添田真司1, 尾崎昌大1, 三村一平1, 渡邊昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2017.
Japanese Article P1337-4-PM. Efforts to the stock rearranging of ward storage pharmaceutical products in connection with a medical safety management room
永倉優子1, 橋本恵津子1, 村田雅子1, 高島伸也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2017.
Japanese Article P1339-4-PM. Efforts for an unlicensed drug, the medicine in the general hospital out of the adaptation
徳山洋子1, 瓦比呂子1, 西本好児1, 松本圭司1, 野口裕介1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2017.
Japanese Article P1341-4-PM. Approach of a recognition enlightenment activity of the staff for the high-risk medicine and the improvement in drug control instruction rate of use
入江健司1, 宮田拓周1, 川俣洋生1, 三好孝法1, 小田原真希1, 松尾尚美1, 松本紗織1, 鶴山萌子1, 平木洋一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2017.
Japanese Article P1343-4-PM. Evaluation of the resuscitation class in the JCHO Kyushu Hospital
吉国健司1, 宮本愛子1, 白石史遠1, 井上英一2, 中野政弘3, 中村英樹4, 松本一志5, 海野聡美6, 川地尚子7, 古賀和代8, 冨田美砂8, 馬渡由紀子8, 中嶋恭子8, 松隈眞紀子8, 百名洋平9, 宮田健二9, 末松文博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2017.
Japanese Article P1345-4-PM. Construction of the prescription limit system of medicine contraindicated to the pregnant woman using the order ring system in our hospital and the allergic origin medicine
上西幸治1, 奥貫裕美1, 星野伸夫1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2017.
Japanese Article P1347-4-PM. Understanding degree analysis ... about the high-risk medicine of the nurse by understanding degree investigation - questionnaire about the high-risk medicine
岡村吏華1, 吉井千菊1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1, 脇田真之1, 加治江利子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2017.
Japanese Article P1349-4-PM. Example ... of problem and solution - Bukta (R) combination lock of the checking prescription system
木村洸1,2, 吉開晶一1, 北村智哉1, 村山慶2, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2017.
Japanese Article P1351-4-PM. Activity report 2 - of observance situation monitoring - pharmaceutical products safety management team of the operational procedure of midazolam parenteral injection and the flunitrazepam parenteral injection
吉開晶一1, 木村洸1, 北村智哉1, 西田麻以1, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2017.
Japanese Article P1353-4-PM. It is examined a factor search of the delirium and a sleeping drug and the association of the delirium onset after the operation
大南貴裕1, 野元裕1, 中西雅之1, 日野真美1, 高取真吾1, 檜垣宏美2, 内舛健2, 田中守2, 田中亮裕2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2017.
Japanese Article P1355-4-PM. The information management system and the development situation investigation about the interaction of pharmaceutical products and the medical equipment
中村浩規1, 眞野成康2, 杉浦伸一3, 鮎澤純子4, 佐藤景二5, 嶋森好子6, 配島由二7, 藤盛啓成8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2017.
Japanese Article P1357-4-PM. Relations with the sleeping drug internal use situation and a fall, the fall of elderly people
酒井牧子1, 今井孝1, 福間勇2, 菱本敏美2, 河野通盛1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2017.
Japanese Article P1359-4-PM. Investigation of potential risk and problems in the foreign perioperative drug control before anesthesiology technique
米澤龍1, 宮坂善之1, 上嶋浩順2, 石川恵美子3, 川上由香子3, 吉田雅子3, 栗原竜也1, 大嶽浩司2, 佐々木忠徳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2017.
Japanese Article P1361-4-PM. About the association of the risk with fact-finding and the sleeping drug of a fall, the fall of the inpatient in our hospital
大久保翔1, 井上結夏1, 福澤祐幸1, 宇都直哉2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2017.
Japanese Article P1363-4-PM. Efforts of one "fire pharmacy Action Card development"
田原雅子1, 平昭圭介1, 花田徳子1, 新谷茂之1, 熊本拓也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2017.
Japanese Article P1365-4-PM. Efforts (the second report) to medical security using an incident calendar
今井祐貴子1, 熱海幸恵1, 大川藍子1, 李娜1, 大野翔子1, 添田真司1, 金渕一雄2, 渡邊昌之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2017.
Japanese Article P1367-4-PM. Efforts of the pharmacist in the JCI certification acquisition
喜多幸子1, 長濱藍1, 森智子1, 小松祐輔1, 人見百合子1, 石井英之1, 田仲祐子1, 泉優貴1, 氏川郁穂1, 近藤理美1, 石井奈津季1, 久田潤平1, 宮川千珠1, 三浦捺樹1, 峯浩太朗1, 竹治優紀1, 山中愛美1, 吉村美菜1, 松元あみ1, 水野康平1, 羽山紗樹乃1, 喜多洋嗣1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1478-1478, 2017.
Japanese Article P1334-5-AM. As for every injection drug 1 application about operation of our hospital about the set and the contribution of the latest ampoule picker
小沼大祐1, 畑下真希1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2017.
Japanese Article P1336-5-AM. The actual situation of the prevention of false administration of muscle relaxant seen by an attitude survey and the institution investigation about the understanding in the prefecture lower hospital of the Yamaguchi prefecture pharmacist
藏田康秀1,2,, 伊東真由子1,3, 岡智之1,4,, 尾崎正和1,5,, 木下英樹1,6, 塚原邦浩1,7, 平岡ひろ子1,8, 光末尚代1,9, 山本武史1,10, 佐藤真也1,11, 古川裕之1,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2017.
Japanese Article P1338-5-AM. Efforts to analysis and the damage example decrease in damage cause of pharmaceutical products in our hospital
友池和敬1, 中島文1, 和佐野英子1, 合原嘉寿1, 福石和久1, 林稔展1, 山脇一浩2, 西野隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2017.
Japanese Article P1340-5-AM. The analysis of the incident report in the duties change period of the pharmacist and future problem
帖地伸子1, 宮本彩1, 徳竹裕貴1, 香西久美子2, 福本由美子2, 阿河直子2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2017.
Japanese Article P1346-5-AM. Medical safety measures of the pharmacist in the acute phase hospital leading emergency lifesaving center
田中敏1, 我妻雄太1, 村上久美2, 最首俊夫2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2017.
Japanese Article P1348-5-AM. Analysis of the potentially serious medical errors example about the infusion preparation
岩原良晴1, 乾賢一1, 坂口至1, 早田和生1, 福岡誠次1, 田中修一1, 藤冨徹1, 多田義孝1, 籾井明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2017.
Japanese Article P1350-5-AM. Activity report 3 - of proper use situation - pharmaceutical products safety management team of the zoledronic acid hydrate
西田麻以1, 大熊沙代子1, 長尾由佳1, 小林宏太朗1, 北村智哉1, 吉開晶一1, 木村洸1, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2017.
Japanese Article P1352-5-AM. Activity report 1 - of observance situation monitoring - pharmaceutical products safety management team of incident investigation and the handling official regulations of the highly-concentrated electrolyte solution that pharmaceutical products are associated with
北村智哉1, 吉開晶一1, 木村洸1, 西田麻以1, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1484-1484, 2017.
Japanese Article P1354-5-AM. The "natto taboo" of the diet in the hospital offered to the warfarin potassium tablet remedy patients setting situation investigation
金井隆安1, 加藤一雅1, 篠原高雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1484-1484, 2017.
Japanese Article P1356-5-AM. Conduct the allergy history investigation of allergic possession situation ... nurse of the healthcare worker; and ...
野毛一郎1, 長谷川雅紀1, 福本康之1, 佐藤雅也1, 川上典子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2017.
Japanese Article P1358-5-AM. Efforts to hepatitis B reactivation measures by the multi-type of job cooperation
大岡千寿子1, 野洌孝二1, 中村俊之1, 平良薫2, 藤田忠夫3, 堀江智美4, 神田雄史1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2017.
Japanese Article P1360-5-AM. Participation of the pharmacist in drug allergy information check function at prescription, injection order input
鈴木めぐみ1, 片山広美1, 佐藤篤郎1, 鈴木厚志1, 板倉由縁1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2017.
Japanese Article P1362-5-AM. The current situation and problem of "the protocol about the doubt inquiry simplification in the outside Parliament prescription" of our hospital
森光恵1, 山本裕実子2, 藤本淑子3, 村本恵美子3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2017.
Japanese Article P1364-5-AM. Consideration of the role of the pharmacist in the nurse new face education and the effective training method
水木麻里1, 石井大志1, 後藤康平1, 中川博之1, 長江萌菜美1, 河野大嗣1, 竹原香織1, 中條恭孝1, 大村ふみ1, 福井伸也1, 中川朱美1, 野田好典1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2017.
Japanese Article P1366-5-AM. Evaluation according to the new point of view of doubt inquiry for the foreign chemotherapy
川岸亨1, 久保田康生1, 原田幸子1, 松浦泰寛1, 菅原亮輔1, 吉川佳那1, 堤竹蔵1, 笠師久美子1, 山田武宏1, 小林正紀1, 井関健1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2017.
Japanese Article P1368-5-AM. Needs of the lecture judging from the student attending a lecture questionnaire results of the pharmacist lecture specialized in Nagano hospital pharmacist society
三浦篤史1, 佐藤勝治1,3, 六波羅孝1,4, 成田芳昭1,5, 田中健二1,6, 竹澤崇1,7, 鬼窪利英1,2, 林美和子1,8, 堀勝幸1,6, 町田忍1,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2017.
Japanese Article P1370-5-AM. An evaluation and problem of the new face education system in the Kanazawa Medical University hospital pharmacy
宮東利恵1, 西田祥啓1, 高瀬文超1, 丹羽修1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2017.
Japanese Article P1372-5-AM. Construction - third report ... of the education system for the early duties acquisition for the new adoption pharmacist
佐藤仁宣1, 保田未奈子1, 小沼大祐1, 本郷知世1, 古林園子1, 新藤学1, 加藤一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2017.
Japanese Article P1374-5-AM. Role of the cancer clinical pharmacy workshop in the Tokyo Women's Medical University Hospital resident education
大平優1,4, 石丸睦美1,4, 只見智恵子1, 塚川麻利子1,4, 柏瀬しのぶ1,4, 深谷寛1,4, 伊東俊雅2, 小林恵美子3, 浜田幸宏1, 木村利美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2017.
Japanese Article P1376-5-AM. Approach ... experience type learning 2017 ... of the Saitama hospital pharmacist society area training sectional meeting west block
唐澤匠太1,7, 新井成俊2,7, 鍵山智樹3,7, 黒下龍二4,7, 古高裕子5,7, 加藤剛6,7, 北澤貴樹8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2017.
Japanese Article P1378-5-AM. The academic place of exchange of the young pharmacist? Establishment of ... multicenter young pharmacist workshop and future problem ...
齋藤雅俊1, 安武夫2, 堀井剛史3, 林太祐4, 原田大5, 津田泰正6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2017.
Japanese Article P1369-4-PM. Efforts - for activity report - infection control authorization, specialized pharmacist upbringing of the specialized pharmacist Board of Education infection control sectional meeting in the Aichi hospital pharmacist society
奥平正美1,2, 稲垣孝行1,2, 梅村拓巳1,2, 小林義和1,2, 塩田有史1,2, 中根茂喜1,2, 坂野昌志1,2, 森健1,2, 板倉由縁2, 山田清文2, 木村哲和2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2017.
Japanese Article P1371-4-PM. Make use of reflection of construction - last year of new face education system; and ...
樋本繭子1, 清水愛1, 檀和貴1, 日原章詔1, 松岡詩子1, 高瀬尚武1, 中田日早枝1, 室井延之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2017.
Japanese Article P1373-4-PM. Examination - of the education technique with high learning effect on upbringing thirteenth report - new face pharmacist of the pharmacist carrying the next generation
小川瑶子1, 久保和子1, 猪田宏美1, 北村佳久1, 千堂年昭1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2017.
Japanese Article P1375-4-PM. Efforts to postgraduate education for the purpose of the acquisition of the basic clinical medicine knowledge
山田雅也1,2,3, 力武隆浩2, 森一生3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2017.
Japanese Article P1377-4-PM. To make use of the voice of the clinical drug settings training - settings by the researcher of the pharmaceutical company in a preparation study; ...
瀬野淳1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2017.
Japanese Article P1379-4-PM. Result of the balun strike scorecard introduction that continued in the Yokohama General Hospital and efforts this year
廣瀬直樹1, 佐村優1, 小川寿子1, 倉田武徳1, 鯉淵寛之1, 高田啓介1, 仙内光子1, 内田仁樹1, 関根寿一1, 金田昌之2, 赤瀬朋秀2,4, 佐藤透3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2017.
English Article IP01. Activities of hospital pharmacists in ambulatory care in Japan - Admission support division -
Atsumi Nishikori1, Yusuke Igawa1, Hiromi Ida1, Hideki Nawa1, Yoshihisa Kitamura1, Toshiaki Sendo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1510-1511, 2017.
English Article IP02. Nicotine alter cognitive impairment and anxiety-like behavior in chemotherapeutic model of rats
Yoshihisa Kitamura1,2, Misaki Sugimoto2, Erika Kanemoto2, Ayumi Machida2, Yuka Nakamura2, Nanami Naito2, Toshiaki Sendo1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2017.
English Article IP03. NST Pharmacists' Approaches in a University Hospital - Through Collaboration with Ward Pharmacists -
Hideki Nawa1, Hayato Hino1, Yoshihisa Kitamura1, Toshiaki Sendo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1512-1512, 2017.
English Article IP04. Effects of Parenteral Nutrition Support with NST in Critically Ill Patients
Lee Jeeyang1, Seo Kyunghee1, Lee Sohyun1, Kim Youngmi1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1513, 2017.
English Article IP05. Evaluation of antibiotic dosing regimens in patients with impaired renal function
Mi Hye Park1, Kyong Nam Ye1, Kyung Ju Jung1, Jung Tae Kim1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1514, 2017.
English Article IP06. Comparison of effects and safety profiles between Sevelamer HCl and Sevelamer carbonate in patients on dialysis
In Hye Park1, Jin Joo Kim1, Hye Young Kim1, Eyn Young Kwon1, Soon Joo Kim1, Shin Yi Hwangbo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2017.
English Article IP07. Comparison of Clinical Efficacy and Safety between Roflumilast 250mcg and 500mcg daily dose in Chronic Obstructive Pulmonary Disease
Soo Kyung Lee1, Jae Eun Sim1, Hye Lim Ahn1, Sun Choi1, Soon Joo Kim1, Shin Yi Hwangbo1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1515-1515, 2017.
English Article IP08. Contamination of the Used Blister Packs by Lenalidomide in Clinical Situation
Akiko Kaneta1, Yuta Takahashi1,2,3, Hideaki Yashima1,2, Tadashige Abe1, Takuya Araki1,2, Koujirou Yamamoto1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2017.
English Article IP09. A Pharmacists-Led Quality Control Improved Chemotherapy Induced Febrile Neutropenia in Proton and Heavy Ion Radiation Oncology Setting in CHINA
Qiong Du1,2,3, Zi-Han Guo1,2,3, Xian-Chun Dai3, Bo Yu1,2,3, Qing Zhai1,2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2017.
English Article IP10. A study on collaboration between hospitals and community pharmacies
Saki Kimura1, Ran Satoh1, Takao Orii1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2017.
English Article IP11. Efficacy and safety of lapatinib in Chinese breast cancer patients: A real-world study
Xuan Ye1,2, Bo Yu1,2, Qing Zhai1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2017.
English Article IP12. In vitro and in vivo effects of 1-(2-chlorine) phenyl-9-butyl-β-carboline against Echinococcus granulosus
Gao Hui-Jing1, Chen Bei1, Zhao Jun1, Wang Jian-Hua
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1518-1518, 2017.
English Article IP13. Practice of Clinical Pharmacists in The Drug Treatment of Patients with Heat Stroke
Li Li1, Li Zhuo1, Zhu Ya-Ning1, Zhang Peng1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1518-1518, 2017.
English Article IP14. The Document Analysis of Health Popularization Research in China for 20 Years
Wu Yibo1, Xing Yunhui1, Liu Zhe1, Li Xia1, Li Yingying1, Zhang Yue1, Jia Shuxian1, Yang Yujie1, Gao Wenzhen1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2017.
English Article IP15. Working Modes and Analysis by Pharmacist of Safety Surveillance Model of Post-marketing Drugs
Yadan Chen1, Xiujuan Fu1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2017.
English Article IP16. Regulation of tumor associated genes and cytokines expression by Venetoclax in AML
Zhao Shuang1, Song Yianqing1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1520-1520, 2017.
English Article IP17. Current Sedation Practice in Pediatric Intensive Care Unit
Mi Hee Yang1, Ji Eon Park1, Ae Hee Jung1, Jung Mi Lim1, Sun Hoi Jung1, Sung Yun Suh1, Hyeon Joo Hahn1, Yoon Sook Cho1, Yu Hyun Choi2, Jun Dong Park2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1520-1521, 2017.
English Article IP18. A retrospysis ective analof vancomycin pharmacokinetics in Korean neonates
Hyun Jung Shin1, Moon Jin Kim1, Ae Hee Jung1, Jung Mi Lim1, Sun Hoi Jung1, Sung Yun Suh1, Hyeon Joo Hahn1, Yoon Sook Cho1, Seung Han Shin2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2017.
English Article IP19. Analysis on cardiovascular combination drug usage in a single hospital
Yujin Hur1, Danhee Choi1, Yonghwa Lee1, Sunhoi Jung1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2017.
▲